[
    {
        "id": 0,
        "sentence": "@DRUG1$: Cholestyramine may increase the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), @DRUG2$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines @DRUG1$ (e.g. phenothiazines), @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6,
        "sentence": "Antiepileptic Drugs: Sporadic cases of seizures have been reported during concomitant use of @DRUG1$ and @DRUG2$ (phenytoin, carbamazepine).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 8,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG1$, cisapride, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 9,
        "sentence": "Dexbrompheniramine can interact with @DRUG1$ or other @DRUG2$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 10,
        "sentence": "This article looks at five commonly used @DRUG1$ in turn (corticosteroids, cyclosporin, azathioprine, @DRUG2$, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 11,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 12,
        "sentence": "However, since aspirin, NSAIDs, and @DRUG1$ are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or @DRUG2$ with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 13,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 14,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, @DRUG1$ and @DRUG2$) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 15,
        "sentence": "Patients receiving other @DRUG1$, antipsychotics, @DRUG2$, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 16,
        "sentence": "@DRUG1$ (spironolactone, amiloride,@DRUG2$, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 17,
        "sentence": "Since @DRUG1$ (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease @DRUG2$ levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 18,
        "sentence": "@DRUG1$: Weakness hyperreflexia, and incoordination have been reported rarely when 5-HT1 agonists have been co-administered with @DRUG2$ (e. g.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 19,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 20,
        "sentence": "When initiating a multi-day course of @DRUG1$ in a patient maintained on @DRUG2$, the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 21,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 22,
        "sentence": "@DRUG1$ can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG2$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 23,
        "sentence": "The drug interaction between @DRUG1$ and @DRUG2$ is not well known.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 24,
        "sentence": "Using in situ hybridization, we observed that @DRUG1$ caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist SCH-23390 but not by an atypical neuroleptic @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 25,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 26,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 27,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., @DRUG2$), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 28,
        "sentence": "Caffeine: @DRUG1$ is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 29,
        "sentence": "Concurrent use of @DRUG1$ may antagonize the anorectic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 30,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, cannabinoids, @DRUG2$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 31,
        "sentence": "Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as @DRUG1$ and erythromycin or inhibitors of CYP2C19 such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 32,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 33,
        "sentence": "If chlorprothixene is given concomitantly with opioids, the @DRUG1$ dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of @DRUG2$ massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 34,
        "sentence": "@DRUG1$: Coadministration of @DRUG2$ and MEPRON Suspension results in a significant decrease in average steady- state plasma atovaquone concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 35,
        "sentence": "@DRUG1$ with desipramine or protriptyline and possibly other @DRUG2$ cause striking and sustained increases in the concentration of d-amphetamine in the brain;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 36,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 37,
        "sentence": "It is, however, possible that concomitant use of other known @DRUG1$ such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and @DRUG2$ might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 38,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most antidepressants (SSRIs, many tricyclics), @DRUG1$, antiarrhythmics, and @DRUG2$ are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 39,
        "sentence": "Certain drugs, including @DRUG1$ (NSAIDs), salicylates, @DRUG2$, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 40,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 41,
        "sentence": "@DRUG1$ regimens consisted of two reverse transcriptase inhibitors and one @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 42,
        "sentence": "@DRUG1$ may enhance the nephrotoxicity of @DRUG2$ Parenteral.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 43,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 44,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 45,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG1$, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 46,
        "sentence": "When @DRUG1$ is co-administered with probenecid (500 mg p.o. every 6 hours), @DRUG2$ competes for active tubular secretion and reduces the renal clearance of ertapenem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 47,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 48,
        "sentence": "Clinical experience with concomitant administration of bosentan and @DRUG1$ in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the @DRUG2$ dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 49,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 50,
        "sentence": "In addition, under the influence of sympatholytic medicinal products such as @DRUG1$, clonidine, guanethidine, and @DRUG2$, the signs of hypoglycemia may be reduced or absent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 51,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 52,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 53,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 54,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG2$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 55,
        "sentence": "However, the systemic administration of some @DRUG1$ has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic @DRUG2$ concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 56,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, @DRUG2$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 57,
        "sentence": "Patients taking REVIA may not benefit from @DRUG1$ containing medicines, such as cough and cold preparations, antidiarrheal preparations, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 58,
        "sentence": "Beta-blockers, @DRUG1$, lithium salts, and @DRUG2$ may either potentiate or weaken the blood-glucose-lowering effect of insulin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 59,
        "sentence": "@DRUG1$, @DRUG2$, and halothane decrease the ED50 of NUROMAX by 30% to 45%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 60,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 61,
        "sentence": "Animal experience indicates that @DRUG1$ prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of @DRUG2$, but does not exhibit monoamine oxidase inhibition.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 62,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 63,
        "sentence": "Concomitant administration of an @DRUG1$-containing antacid had no significant effect in the bioavailability of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 64,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing @DRUG1$ (Maalox ) decreased @DRUG2$ AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 65,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 66,
        "sentence": "Phenytoin: If acitretin is given concurrently with @DRUG1$, the protein binding of @DRUG2$ may be reduced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 67,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., @DRUG1$ 500 mg BID, verapamil 240 mg QD, @DRUG2$ 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 68,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 69,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, @DRUG2$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 70,
        "sentence": "Those for which effectiveness is reported includes @DRUG1$, hydroxyzine, orphenadrine, pyrilamine, phenyltoloxamine, @DRUG2$, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 71,
        "sentence": "@DRUG1$: A study in normal healthy volunteers has shown that concomitant administration of DynaCirc  (@DRUG2$) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 72,
        "sentence": "Quinolone Antibiotics: @DRUG1$ should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of @DRUG2$ are decreased when administered with antacids containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 73,
        "sentence": "Cyclosporine: Concomitant administration of @DRUG1$ and @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 74,
        "sentence": "and disulfiram When @DRUG1$ is given with @DRUG2$ agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 75,
        "sentence": "Carbamazepine: Coadministration of carbamazepine (200 mg BID), a potent CYP3A4 inducer, with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both @DRUG1$ and its active metabolite, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 76,
        "sentence": "A pharmacokinetic study evaluating the administration of a single dose of @DRUG1$ 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of @DRUG2$ and a 5.4-fold increase in AUC of eplerenone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 77,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 78,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: Cyclosporine (@DRUG1$ substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 79,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 80,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 81,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 82,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 83,
        "sentence": "Amprenavir significantly decreases clearance of @DRUG1$ and @DRUG2$, and the combination is poorly tolerated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 84,
        "sentence": "In vitro studies have shown that the metabolism of @DRUG1$ may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, terfenadine, ketoconazole, erythromycin, and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 85,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of @DRUG1$ on the concomitant anesthetic, sedative, hypnotic or @DRUG2$ may be required.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 86,
        "sentence": "Acute dosing with @DRUG1$ failed to alter the behavioral effects of @DRUG2$ in either procedure even when tested up to doses that produced pharmacological effects alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 87,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 88,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of @DRUG1$  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that @DRUG2$ may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 89,
        "sentence": "The uptake inhibitors @DRUG1$ and @DRUG2$ (3 mumol/liter) potentiated the positive inotropic effects of norepinephrine in nonfailing myocardium (p < 0.05) but not in functional class IV myocardium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 90,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, @DRUG2$, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 91,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 92,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 93,
        "sentence": "The concomitant administration of quinolones including @DRUG1$ with @DRUG2$ (a sulfonylurea agent) has, on rare occasions, resulted in severe hypoglycemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 94,
        "sentence": "@DRUG1$ and @DRUG2$ should not be administered together.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 95,
        "sentence": "The results of a study of coadministration of @DRUG1$ (50 mg/kg) with an @DRUG2$ containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 96,
        "sentence": "@DRUG1$ produced only minor changes in the levels of @DRUG2$ and its metabolites.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 97,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, @DRUG1$) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 98,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], @DRUG2$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 99,
        "sentence": "In a controlled clinical trial, a 20% reduction of the phenytoin dose at the initiation of @DRUG1$  therapy resulted in @DRUG2$ levels comparable to those prior to Felbatol  administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 100,
        "sentence": "This drug may interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 101,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral @DRUG1$ supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the magnesium intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic @DRUG2$ overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 102,
        "sentence": "If antacids are required during OMNICEF therapy, @DRUG1$ should be taken at least 2 hours before or after the @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 103,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 104,
        "sentence": "@DRUG1$: Increased serum lithium levels and symptoms of @DRUG2$ toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 105,
        "sentence": "@DRUG1$ pretreatment augmented the depressant effect of @DRUG2$ on the early components P1 and N1, while attenuating alcohol's influence on components P2 and P3.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 106,
        "sentence": "THE POTENTIATING ACTION OF @DRUG1$ MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH @DRUG2$ SUCH AS NARCOTICS, NON-NARCOTIC ANALGESICS AND BARBITURATES.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 107,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 108,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other opioids, general anesthetics, barbiturates, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 109,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 110,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 111,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as @DRUG1$  (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 112,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, @DRUG2$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 113,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (@DRUG2$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 114,
        "sentence": "Chlorpropamide: @DRUG1$s plasma half-life may be prolonged by allopurinol, since @DRUG2$ and chlorpropamide may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 115,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 116,
        "sentence": "As with other antihypertensive agents, the antihypertensive effect of @DRUG1$ may be blunted by the non-steroidal anti-inflammatory drug @DRUG2$",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 117,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., @DRUG2$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 118,
        "sentence": "Intestinal adsorbents (e. g., charcoal) and @DRUG1$ containing carbohydrate-splitting enzymes (e. g., amylase, @DRUG2$) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 119,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 120,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 121,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 122,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that sirolimus, in combination with @DRUG1$ or tacrolimus, might have the potential to reduce the frequency of rejection episodes, permit reductions in cyclosporine or @DRUG2$ dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 123,
        "sentence": "Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, @DRUG1$, or similar agents, and such an effect may be anticipated with @DRUG2$ because of its structural similarity to other tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 124,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 125,
        "sentence": "In the experiments reported here, we examined the interactions between @DRUG1$ and the @DRUG2$ 4-hydroxytamoxifen (TAM), which also induces apoptosis in MCF-7 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 126,
        "sentence": "Coadministration of Itraconazole with oral @DRUG1$ or @DRUG2$ has resulted in elevated plasma concentrations of the latter two drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 127,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG1$, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 128,
        "sentence": "The fraction of @DRUG1$ absorbed is unaffected by the concomitant administration of a @DRUG2$ (oxymetazoline), but the rate of absorption is decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 129,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG2$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 130,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, rifabutin, @DRUG1$, phenytoin, carbamazepine, @DRUG2$ and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 131,
        "sentence": "and disulfiram When amitriptyline HCl is given with anticholinergic agents or @DRUG1$ drugs, including @DRUG2$ combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 132,
        "sentence": "The serum concentration of @DRUG1$ increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of @DRUG2$ and other drugs had not changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 133,
        "sentence": "@DRUG1$ enhance the renal toxicity of @DRUG2$ in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 134,
        "sentence": "Warfarin, @DRUG1$, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by @DRUG2$ (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 135,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG1$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 136,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as @DRUG1$, thiazide diuretics, sulfonylureas, @DRUG2$, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 137,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 138,
        "sentence": "Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on @DRUG1$ therapy may require downward adjustment of their @DRUG2$ dosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 139,
        "sentence": "Ketoconazole: @DRUG1$ may inhibit both synthetic and catabolic enzymes of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 140,
        "sentence": "Nicotine: @DRUG1$ may provoke vasoconstriction in some patients, predisposing to a greater ischemic response to @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 141,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG1$, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 142,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 143,
        "sentence": "@DRUG1$ and sucralfate: Sucralfate and antacids containing magnesium or @DRUG2$, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 144,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG1$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 145,
        "sentence": "@DRUG1$: Concurrent administration of certain anticholinergic compounds, such as belladonna alkaloids and @DRUG2$, would be expected to compromise the beneficial effects of cisapride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 146,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG1$ for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 147,
        "sentence": "The administration of local anesthetic solutions containing @DRUG1$ or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG2$ may produce severe, prolonged hypertension.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 148,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 149,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 150,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, @DRUG2$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 151,
        "sentence": "In a placebo-controlled trial in normal volunteers, the administration of a single 1 mg dose of @DRUG1$ on day 1 of a four-day regimen of oral cimetidine (400 mg twice daily) resulted in a 10% increase in mean AUC of @DRUG2$ (p=0.006), and a slight but not statistically significant increase in mean Cmax and mean half-life of doxazosin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 152,
        "sentence": "Therefore, to maximize the effects of @DRUG1$, it is recommended that @DRUG2$ should be taken with water",
        "answer": "none",
        "label": 4
    },
    {
        "id": 153,
        "sentence": "Pharmacological/Pharmacodynamic Interactions with @DRUG1$ Concomitant administration of @DRUG2$ and lithium may increase the risk of neurotoxic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 154,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 155,
        "sentence": "Experience with @DRUG1$ (@DRUG2$) suggests the potential for interactions with furosemide and ACE inhibitors.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 156,
        "sentence": "Concomitant use of @DRUG1$ with alcohol, tricyclic antidepressants, @DRUG2$, or other central nervous system depressants may have an additive effect.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 157,
        "sentence": "and @DRUG1$ When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local @DRUG2$, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 158,
        "sentence": "Certain drugs including @DRUG1$, corticosteroids, thyroid products, and @DRUG2$ may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 159,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 160,
        "sentence": "Anticonvulsants (carbamazepine, @DRUG1$, @DRUG2$, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 161,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 162,
        "sentence": "Alprazolam: When fluvoxamine maleate (100 mg qd) and @DRUG1$ (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of @DRUG2$ were approximately twice those observed when alprazolam was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 163,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 164,
        "sentence": "This drug may interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG2$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 165,
        "sentence": "Methotrexate: An increased risk of hepatitis has been reported to result from combined use of @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 166,
        "sentence": "- a @DRUG1$ such as propranolol (Inderal), atenolol (Tenormin), acebutolol (Sectral), @DRUG2$ (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 167,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 168,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 169,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, @DRUG1$, verapamil, glyburide, @DRUG2$, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 170,
        "sentence": "In vitro mixing of an @DRUG1$ with beta-lactamtype @DRUG2$ (penicillins or cephalosporins) may result in a significant mutual inactivation.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 171,
        "sentence": "Approximately 2/3 of the patients in the Phase 3 study received either prophylactic low dose @DRUG1$ (unfractionated heparin up to 15,000 units/day) or prophylactic doses of @DRUG2$ as indicated in the prescribing information for the specific products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 172,
        "sentence": "@DRUG1$:Clinical evidence has shown that @DRUG2$ can be formed with concurrent ingestion of acitretin and ethanol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 173,
        "sentence": "For example, since @DRUG1$ may reduce the gastrointestinal absorption of both the oral anticoagulants and @DRUG2$, the net effects are unpredictable.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 174,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of ZYVOX and serotonergic agents, including @DRUG1$ such as selective serotonin reuptake inhibitors (@DRUG2$), have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 175,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas @DRUG1$ binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 176,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 177,
        "sentence": "In clinical studies, coadministration of WelChol  with @DRUG1$, lovastatin, or @DRUG2$ did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 178,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 179,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 180,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 181,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as @DRUG1$, itraconazole, troleandomycin, @DRUG2$, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 182,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 183,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 184,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 185,
        "sentence": "@DRUG1$/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, @DRUG2$, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 186,
        "sentence": "In vitro mixing of an @DRUG1$ with beta-lactamtype antibiotics (penicillins or @DRUG2$) may result in a significant mutual inactivation.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 187,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 188,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 189,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., Nardil), procarbazine (e.g., @DRUG2$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 190,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], @DRUG2$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 191,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, @DRUG1$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 192,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 193,
        "sentence": "astemizole @DRUG1$, @DRUG2$ cisapride ergot derivatives voriconazole",
        "answer": "none",
        "label": 4
    },
    {
        "id": 194,
        "sentence": "@DRUG1$: Concurrent use of @DRUG2$ and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 195,
        "sentence": "@DRUG1$: Flurbiprofen like other nonsteroidal anti-inflammatory drugs, has been shown to affect bleeding parameters in patients receiving @DRUG2$, and serious clinical bleeding has been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 196,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic @DRUG1$ containing 60 mg of elemental @DRUG2$ (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 197,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 198,
        "sentence": "In addition, under the influence of sympatholytic medicinal products such as beta-blockers, @DRUG1$, guanethidine, and @DRUG2$, the signs of hypoglycemia may be reduced or absent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 199,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 200,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 201,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 202,
        "sentence": "Anticonvulsants (@DRUG1$, felbamate, phenobarbital, @DRUG2$, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 203,
        "sentence": "The present work involved the administration of both @DRUG1$ and @DRUG2$ to groups of rats, followed by determination of the homocysteine excretion rate in urine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 204,
        "sentence": "Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain @DRUG1$ by up to 60%, leading to increased risk of @DRUG2$ side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 205,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral magnesium supplementation which is totally atoxic since it palliates @DRUG1$ deficiencies by simply normalizing the @DRUG2$ intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 206,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other @DRUG2$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 207,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 208,
        "sentence": "Valproic Acid: The mean steady-state trough serum @DRUG1$ concentrations prior to and during concomitant @DRUG2$ administration (400 mg TID;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 209,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 210,
        "sentence": "- @DRUG1$: Generally should not be given with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 211,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 212,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 213,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, @DRUG2$ and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 214,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 215,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 216,
        "sentence": "@DRUG1$: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of @DRUG2$ 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 217,
        "sentence": "@DRUG1$: Concomitant administration of aluminum and magnesium hydroxides does not interfere with absorption of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 218,
        "sentence": "Repeated oral administration of coumaphos in sheep: interactions of coumaphos with @DRUG1$, @DRUG2$, and phenobarbital sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 219,
        "sentence": "@DRUG1$: @DRUG2$ are known to induce hypercalcemia by the reduction of calcium excretion in urine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 220,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 221,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 222,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, @DRUG1$, clarithromycin, @DRUG2$, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 223,
        "sentence": "Oral Anticoagulants: In some normal volunteers, the concomitant administration of @DRUG1$ and warfarin, acenocoumarol, or @DRUG2$ resulted in prolongation of prothrombin time.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 224,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 225,
        "sentence": "Concurrent use of @DRUG1$ with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and @DRUG2$) may result in increased central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 226,
        "sentence": "Drugs That Inhibit CYP3A4 CYP3A4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethylzaleplon (formed via CYP3A4 in vitro) and its metabolites, @DRUG1$ and 5-oxo-desethylzaleplon glucuronide, account for only 9% of the urinary recovery of a @DRUG2$ dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 227,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 228,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG1$, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 229,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 230,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, hydrochlorothiazide, cimetidine, @DRUG2$, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 231,
        "sentence": "Antacids increase the rate of absorption of @DRUG1$, while @DRUG2$ decreases it.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 232,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) Use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood",
        "answer": "none",
        "label": 4
    },
    {
        "id": 233,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 234,
        "sentence": "These include probenecid, @DRUG1$, and some antibiotics (e.g. erythromycin, rifamipicin, ampicillin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 235,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 236,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 237,
        "sentence": "Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of @DRUG1$ to plasma proteins is only slightly reduced by @DRUG2$ (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 238,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG2$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 239,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, @DRUG1$, @DRUG2$ and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 240,
        "sentence": "Lithium: @DRUG1$ produced an elevation of plasma @DRUG2$ levels and a reduction in renal lithium clearance in a study of eleven normal volunteers.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 241,
        "sentence": "Since there have been conflicting results regarding the effect of @DRUG1$ levels, it is recommended that @DRUG2$ levels be monitored when initiating, adjusting, and discontinuing diltiazem hydrochloride therapy to avoid possible over- or under-digitalization.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 242,
        "sentence": "In patients receiving another @DRUG1$ in combination with monoamine oxidase inhibitors (@DRUG2$), there have been reports of serious, sometimes fatal, reactions including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 243,
        "sentence": "Because @DRUG1$ is highly bound to serum protein, the administration of Anafranil to patients taking other drugs that are highly bound to protein (e.g., warfarin, @DRUG2$) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 244,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, @DRUG1$, @DRUG2$, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 245,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 246,
        "sentence": "It is, however, possible that concomitant use of other known @DRUG1$ such as griseofulvin, thiazide diuretics, sulfonylureas, @DRUG2$, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 247,
        "sentence": "The use of @DRUG1$ before @DRUG2$ to attenuate some of the side effects of succinylcholine has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 248,
        "sentence": "Anesthetics/Sedatives/@DRUG1$/@DRUG2$: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 249,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG1$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 250,
        "sentence": "@DRUG1$: @DRUG2$ plasma concentrations were not affected by co-administration of cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 251,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 252,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 253,
        "sentence": "Potassium-sparing diuretics (spironolactone, amiloride, @DRUG1$, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 254,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 255,
        "sentence": "Phenytoin: @DRUG1$ may increase serum levels of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 256,
        "sentence": "Drug interaction studies with @DRUG1$ and these @DRUG2$ have not been conducted.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 257,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 258,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 259,
        "sentence": "These effects have been observed with co-administration of @DRUG1$ (a potent @DRUG2$ inhibitor).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 260,
        "sentence": "Metoclopramide: When coadministered with MONUROL, @DRUG1$, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 261,
        "sentence": "Concomitant administration of an @DRUG1$-containing @DRUG2$ had no significant effect in the bioavailability of 6MNA.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 262,
        "sentence": "@DRUG1$s: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with @DRUG2$ containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 263,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, @DRUG1$ may elevate phenytoin serum levels and @DRUG2$ has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 264,
        "sentence": "Hypotension was more likely to occur if the @DRUG1$ were a dihydropyridine derivative, e.g., nifedipine, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either @DRUG2$ or diltiazem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 265,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and @DRUG1$ may increase the clearance of @DRUG2$ and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 266,
        "sentence": "Pimozide and @DRUG1$ - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to @DRUG2$ given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 267,
        "sentence": "Concurrent use of @DRUG1$ may render oral @DRUG2$ less effective.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 268,
        "sentence": "Beta-blockers, @DRUG1$, @DRUG2$ salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 269,
        "sentence": "@DRUG1$: Twelve healthy male volunteers were administered one 200-mg @DRUG2$ capsule twice daily for 6 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 270,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 271,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 272,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 273,
        "sentence": "- a @DRUG1$ such as propranolol (Inderal), atenolol (Tenormin), acebutolol (@DRUG2$), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 274,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 275,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG1$, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 276,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 277,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 278,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of @DRUG1$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and @DRUG2$ (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 279,
        "sentence": "Butyrophenones (such as @DRUG1$) and phenothiazines can suppress the @DRUG2$rgic renal and mesenteric vasodilation induced with low dose dopamine infusion.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 280,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 281,
        "sentence": "The intake of @DRUG1$ and @DRUG2$ should be separated by at least two hours.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 282,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG1$ (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 283,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG1$, grapefruit juice, nefazadone, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 284,
        "sentence": "Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of @DRUG1$ (a sulfonylurea similar to @DRUG2$) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 285,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 286,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 287,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 288,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 289,
        "sentence": "Lithium: Increased serum @DRUG1$ levels and symptoms of lithium toxicity have been reported in patients receiving @DRUG2$ during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 290,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 291,
        "sentence": "H2 Blockers/@DRUG1$: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, @DRUG2$ and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 292,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect @DRUG1$ pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of @DRUG2$ resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 293,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other opioids, general anesthetics, @DRUG2$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 294,
        "sentence": "Ethanol:Clinical evidence has shown that @DRUG1$ can be formed with concurrent ingestion of acitretin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 295,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 296,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG2$ propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 297,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG2$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 298,
        "sentence": "The results from a study in which eight HIV-infected individuals were treated with @DRUG1$, 8 +/- 0.4 mg/kg/day, showed that the pharmacokinetics of zidovudine were not affected during concomitant administration of @DRUG2$, 100 mg b.i.d.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 299,
        "sentence": "Patients currently receiving @DRUG1$ therapy should be carefully monitored for a change in pharmacological effect when initiating and discontinuing therapy with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 300,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local @DRUG1$ like lidocaine, procaine, @DRUG2$, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 301,
        "sentence": "However, the effects of stress and @DRUG1$ on the subjective and behavioral effects of @DRUG2$ have not been well studied in humans.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 302,
        "sentence": "Probenecid or @DRUG1$: Concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 303,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 304,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 305,
        "sentence": "Dexbrompheniramine can interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 306,
        "sentence": "@DRUG1$ or other @DRUG2$ (concurrent use with dinoprost may result in uterine hypertonus, possibly causing uterine rupture or cervical laceration, especially in the absence of adequate cervical dilatation;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 307,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 308,
        "sentence": "Acarbose may affect @DRUG1$ bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max @DRUG2$ by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 309,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 310,
        "sentence": "Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of @DRUG1$ with @DRUG2$, and with some angiotensin II receptor antagonists.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 311,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 312,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other opioids, general @DRUG2$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 313,
        "sentence": "Protease Inhibitors: In vitro data indicate that @DRUG1$ and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma @DRUG2$ levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 314,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most antidepressants (SSRIs, many tricyclics), beta-blockers, @DRUG1$, and @DRUG2$ are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 315,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 316,
        "sentence": "@DRUG1$ with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of @DRUG2$ in the brain;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 317,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 318,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 319,
        "sentence": "@DRUG1$ has demonstrated superiority over @DRUG2$ in nucleoside-experienced patients, although combining these 2 agents may represent the best approach in these circumstances.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 320,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on @DRUG1$ : Carbamazepine: Population pharmacokinetic analyses indicate that @DRUG2$ clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 321,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of @DRUG1$ (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased @DRUG2$ AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 322,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 323,
        "sentence": "Probenecid or Cimetidine: Concomitant administration of probenecid or @DRUG1$ decreases the elimination of @DRUG2$, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 324,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 325,
        "sentence": "Caution should be observed when anileridine is coadministered with other @DRUG1$, sedatives, phenothiazines, or @DRUG2$, as these agents may increase respiratory and circulatory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 326,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 327,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), @DRUG1$, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 328,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 329,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 330,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 331,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 332,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 333,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as @DRUG1$, itraconazole, troleandomycin, clarithromycin, @DRUG2$, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 334,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 335,
        "sentence": "If @DRUG1$ are required during @DRUG2$ therapy, OMNICEF should be taken at least 2 hours before or after the antacid.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 336,
        "sentence": "Other: There appears to be no pharmacokinetic interaction between acitretin and @DRUG1$, @DRUG2$, or glyburide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 337,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 338,
        "sentence": "No significant interactions with digoxin, @DRUG1$, @DRUG2$, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 339,
        "sentence": "The concomitant administration of @DRUG1$ including norfloxacin with @DRUG2$ (a sulfonylurea agent) has, on rare occasions, resulted in severe hypoglycemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 340,
        "sentence": "@DRUG1$: @DRUG2$ has not been shown to alter the pharmacokinetics of phenytoin in a study in seven healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 341,
        "sentence": "The anxiogenic effects of theophylline were reduced by pretreatment with @DRUG1$, an A2-selective agonist, but not by N6-cyclopentyladenosine (@DRUG2$), an A1-selective agonist.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 342,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 343,
        "sentence": "Fluconazole and Ketoconazole: @DRUG1$ and @DRUG2$ are predominantly CYP 3A4 and 2C9 inhibitors, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 344,
        "sentence": "@DRUG1$s: After repeated co-administration of @DRUG2$, the AUC of felodipine was lowered by 28% [90% CI: 20-33].",
        "answer": "none",
        "label": 4
    },
    {
        "id": 345,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 346,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG1$, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 347,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, phenothiazines, and the Type 1C antiarrhythmics propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 348,
        "sentence": "The concomitant use of transdermal @DRUG1$ with ritonavir or other potent 3A4 inhibitors such as ketoconazole, @DRUG2$, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 349,
        "sentence": "Careful observations on hepatotoxicity are suggested when @DRUG1$ is prescribed with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 350,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of ergotamine-containing or ergot-type medications (like @DRUG1$ or methysergide) and @DRUG2$ within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 351,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), @DRUG2$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 352,
        "sentence": "Pharmacokinetic data from these patients demonstrated a decrease in @DRUG1$ clearance of approximately 33% when TAXOL was administered following @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 353,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 354,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG1$], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 355,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 356,
        "sentence": "@DRUG1$ (carbamazepine, felbamate, phenobarbital, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some @DRUG2$, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 357,
        "sentence": "No significant interactions with digoxin, @DRUG1$, hydralazine, sulfinpyrazone, oral @DRUG2$, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 358,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., @DRUG1$, carbamazepine, phenytoin) may result in reduced plasma concentrations of @DRUG2$ that may result in decreased efficacy of Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 359,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 360,
        "sentence": "@DRUG1$ increase the rate of absorption of @DRUG2$, while kaolin decreases it.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 361,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 362,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 363,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 364,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 365,
        "sentence": "Ketoconazole at 400 mg daily (the maximum approved prescription dose) co-administered with @DRUG1$ (500 mcg BID) for 7 days has been shown to increase @DRUG2$ Cmax by 53% in males and 97% in females, and AUC by 41% in males and 69% in females.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 366,
        "sentence": "The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other @DRUG1$, @DRUG2$, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 367,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an @DRUG1$-sensitive (P-type) channel and @DRUG2$/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 368,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related @DRUG2$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 369,
        "sentence": "Cimetidine Co-administration of @DRUG1$ with @DRUG2$ (a non-specific CYP-450 inhibitor) resulted in an increase of approximately 50% in the AUC and the Cmax, of felodipine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 370,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 371,
        "sentence": "When concomitant treatment with @DRUG1$ and clonidine is to be terminated, the @DRUG2$ should be discontinued first.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 372,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 373,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between @DRUG2$ and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 374,
        "sentence": "Because @DRUG1$ is highly bound to serum protein, the administration of @DRUG2$ to patients taking other drugs that are highly bound to protein (e.g., warfarin, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 375,
        "sentence": "@DRUG1$ has been administered without any evidence of an adverse drug interaction to patients receiving thiazide diuretics, @DRUG2$s, and nonsteroidal anti-inflammatory drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 376,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 377,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of @DRUG1$ (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing @DRUG2$ (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 378,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$. amantadine @DRUG2$ of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 379,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 380,
        "sentence": "Concurrent administration of @DRUG1$ and didanosine significantly reduces the level of exposure to indinavir, but it is unclear how soon after @DRUG2$ administration indinavir may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 381,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG1$, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 382,
        "sentence": "Data from a randomized trial of HEXALEN and cisplatin plus or minus @DRUG1$ in ovarian cancer indicated that @DRUG2$ significantly reduced neurotoxicity;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 383,
        "sentence": "The benzodiazepines, including @DRUG1$, produce additive CNS depressant effects when co-administered with other psychotropic medications, @DRUG2$, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 384,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 385,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG1$, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 386,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 387,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 388,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], @DRUG2$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 389,
        "sentence": "A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with @DRUG1$ 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 390,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 391,
        "sentence": "Because of the danger of a potentially fatal prolongation of the QTc interval, @DRUG1$ must not be given simultaneously with or subsequent to @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 392,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 393,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG-DRUG$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 394,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine @DRUG1$ of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 395,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 396,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 397,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, @DRUG1$, nelfinavir, and nefazadone may result in an increase in @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 398,
        "sentence": "Approximately 2/3 of the patients in the Phase 3 study received either prophylactic low dose @DRUG1$ (@DRUG2$ up to 15,000 units/day) or prophylactic doses of low molecular weight heparins as indicated in the prescribing information for the specific products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 399,
        "sentence": "Ethanol or @DRUG1$: No significant differences were observed in the pharmacokinetics of triazolam (0.125 mg) and @DRUG2$ (10 mg) when given together as a single dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 400,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 401,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG2$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 402,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 403,
        "sentence": "Concomitant treatment with methylxanthines (aminophylline, @DRUG1$), steroids, or diuretics may potentiate any hypokalemic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 404,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 405,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 406,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 407,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including @DRUG1$) concomitantly with @DRUG2$ and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 408,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 409,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 410,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG1$, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 411,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG2$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 412,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 413,
        "sentence": "When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), @DRUG1$ competes for active tubular secretion and reduces the renal clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 414,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG2$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 415,
        "sentence": "Although the mechanism of interaction between fenoprofen and @DRUG1$ is not totally known, enzyme induction and displacement of @DRUG2$ from plasma albumin binding sites are possibilities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 416,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 417,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, @DRUG1$, or other CNS depressants (including alcohol) concomitantly with hydrocodone and @DRUG2$ tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 418,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 419,
        "sentence": "Concomitant administration of FACTIVE and @DRUG1$, cimetidine, omeprazole, or an estrogen/progesterone oral @DRUG2$ produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 420,
        "sentence": "Concurrent use of @DRUG1$ and @DRUG2$ is therefore not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 421,
        "sentence": "No significant interactions with digoxin, @DRUG1$, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 422,
        "sentence": "THE POTENTIATING ACTION OF @DRUG1$ MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS @DRUG2$, NON-NARCOTIC ANALGESICS AND BARBITURATES.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 423,
        "sentence": "Other antiarrhythmic drugs (eg, @DRUG1$, procainamide, lidocaine, @DRUG2$) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 424,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 425,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 426,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG1$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 427,
        "sentence": "Cimetidine: @DRUG1$ does not affect the pharmacokinetics of @DRUG2$ when coadministered with MONUROL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 428,
        "sentence": "Cisapride should not be used concomitantly with other drugs known to prolong the QT interval: certain antiarrhythmics, including those of Class IA (such as @DRUG1$ and procainamide) and Class III (such as @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 429,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 430,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, @DRUG1$, @DRUG2$, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 431,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 432,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral magnesium supplementation which is totally atoxic since it palliates @DRUG1$ deficiencies by simply normalizing the magnesium intake and pharmacological @DRUG2$ therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 433,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG2$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 434,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, @DRUG2$, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 435,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, @DRUG2$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 436,
        "sentence": "Concomitant administration of @DRUG1$ with the oral @DRUG2$ warfarin has been shown not to potentiate the anticoagulant effect of warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 437,
        "sentence": "@DRUG1$: Coadministration of rifampin and @DRUG2$ Suspension results in a significant decrease in average steady- state plasma atovaquone concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 438,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 439,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with @DRUG1$ and @DRUG2$ tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 440,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 441,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 442,
        "sentence": "In vitro mixing of an aminoglycoside with beta-lactamtype antibiotics (@DRUG1$ or @DRUG2$) may result in a significant mutual inactivation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 443,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 444,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG1$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 445,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 446,
        "sentence": "Antacids and @DRUG1$: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 447,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 448,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 449,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, @DRUG2$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 450,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, @DRUG2$, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 451,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG2$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 452,
        "sentence": "Furthermore, @DRUG1$, @DRUG2$, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 453,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG1$, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 454,
        "sentence": "@DRUG1$ increased the AUC of @DRUG2$ by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 455,
        "sentence": "Concurrent administration of indinavir and didanosine significantly reduces the level of exposure to @DRUG1$, but it is unclear how soon after @DRUG2$ administration indinavir may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 456,
        "sentence": "Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG1$ (@DRUG2$) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 457,
        "sentence": "These data suggest that @DRUG1$ are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an @DRUG2$-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 458,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 459,
        "sentence": "In patients taking an anticonvulsant (eg, @DRUG1$, carbamazepine, @DRUG2$ or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 460,
        "sentence": "In vivo studies: @DRUG1$: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of @DRUG2$ in healthy middle-aged subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 461,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG1$ (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 462,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 463,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG1$, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 464,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 465,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG1$), selegiline (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 466,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, @DRUG1$, clofibrate, methyldopa, nicotinic acid (@DRUG2$), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 467,
        "sentence": "Iron Supplements and Foods Fortified With @DRUG1$ Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental @DRUG2$ (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 468,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 469,
        "sentence": "Vitamin A and oral @DRUG1$: Concomitant administration of vitamin A and/or other oral retinoids with @DRUG2$ must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 470,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 471,
        "sentence": "The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when @DRUG1$ was coadministered, although the daily dosage of phenytoin and other @DRUG2$ had not changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 472,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG1$, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 473,
        "sentence": "Iron Supplements and Foods Fortified With @DRUG1$ Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental @DRUG2$ reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 474,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 475,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 476,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 477,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 478,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 479,
        "sentence": "The results of a study of coadministration of @DRUG1$ (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of @DRUG2$ may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 480,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 481,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 482,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 483,
        "sentence": "@DRUG1$ (20 mg QD) increased the concentration of duloxetine (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 484,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG1$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 485,
        "sentence": "These data suggest that @DRUG1$ are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/@DRUG2$/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 486,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 487,
        "sentence": "Serum concentration of @DRUG1$ and @DRUG2$ may increase when patients take antithyroid agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 488,
        "sentence": "@DRUG1$: It should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional @DRUG2$ overdosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 489,
        "sentence": "Plasma was analyzed for @DRUG1$, and urine was analyzed for tolbutamide and its two metabolites, @DRUG2$ and carboxytolbutamide by means of HPLC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 490,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 491,
        "sentence": "An adequate period of observation must be provided for any patient in whom either @DRUG1$ (such as @DRUG2$) or large doses of short-acting benzodiazepines (such as  10 mg of midazolam) have been used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 492,
        "sentence": "Median gastric pH was significantly higher when @DRUG1$ was taken after @DRUG2$ administration;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 493,
        "sentence": "both compounds attenuate @DRUG1$-induced locomotion in @DRUG2$-experienced rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 494,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 495,
        "sentence": "The concurrent use of Robinul Injection with other @DRUG1$ or medications with anticholinergic activity, such as phenothiazines, antiparkinson drugs, or @DRUG2$, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 496,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 497,
        "sentence": "@DRUG1$: Coadministration of carbamazepine (200 mg BID), a potent CYP3A4 inducer, with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 498,
        "sentence": "Concomitant administration of erythromycin and @DRUG1$ has been reported to result in elevated @DRUG2$ serum levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 499,
        "sentence": "While all the selective @DRUG1$ (SSRIs), e.g., fluoxetine, @DRUG2$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 500,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 501,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 502,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG2$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 503,
        "sentence": "The concomitant administration of @DRUG1$ including @DRUG2$ with glyburide (a sulfonylurea agent) has, on rare occasions, resulted in severe hypoglycemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 504,
        "sentence": "Theophylline: @DRUG1$ is a competitive inhibitor of the metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 505,
        "sentence": "@DRUG1$: Co-administration with high doses of @DRUG2$ [800 mg twice daily] increased the Cmax of rofecoxib by 21%, the AUC0-120hr by 23% and the t1/2 by 15%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 506,
        "sentence": "and disulfiram When amitriptyline HCl is given with @DRUG1$ agents or @DRUG2$ drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 507,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 508,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., Nardil), @DRUG2$ (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 509,
        "sentence": "@DRUG1$: Interaction with Drugs that Inhibit Metabolism via Cytochrome P450 3A (CYP3A): The metabolism of estazolam to the major circulating metabolite @DRUG2$ and the metabolism of other triazolobenzodiazepines is catalyzed by CYP3A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 510,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 511,
        "sentence": "If possible, @DRUG1$ should be withdrawn at least 24 hours before initiating @DRUG2$ therapy.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 512,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 513,
        "sentence": "Ibogaine attenuates, but @DRUG1$ potentiates, the acute locomotor effects of @DRUG2$;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 514,
        "sentence": "Therefore, @DRUG1$ should not be used in any condition in which a @DRUG2$ is being employed.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 515,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 516,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 517,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG1$, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 518,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., @DRUG2$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 519,
        "sentence": "Pimozide and Celexa - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic @DRUG1$ 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to @DRUG2$ given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 520,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG2$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 521,
        "sentence": "Studies in healthy volunteers have shown that @DRUG1$ has no effect on either the pharmacokinetics or pharmacodynamics of @DRUG2$, nifedipine, propranolol, or ranitidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 522,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 523,
        "sentence": "Specific and aspecific treatments of magnesium depletion are tricky using for example magnesium sparing diuretics, pharmacological doses of vitamin B6, physiological doses of @DRUG1$ and of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 524,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 525,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG1$, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 526,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 527,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 528,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 529,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 530,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG2$, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 531,
        "sentence": "Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when @DRUG1$ was given concomitantly with indomethacin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 532,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, @DRUG1$, orphenadrine, @DRUG2$, phenyltoloxamine, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 533,
        "sentence": "However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of @DRUG1$ or NSAIDs with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 534,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, @DRUG1$, or an estrogen/progesterone oral @DRUG2$ produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 535,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 536,
        "sentence": "@DRUG1$ or H 2 receptor antagonists: When @DRUG2$ is administered immediately following antacids or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 537,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG1$, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 538,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 539,
        "sentence": "The concurrent use of @DRUG1$ Injection with other @DRUG2$ or medications with anticholinergic activity, such as phenothiazines, antiparkinson drugs, or tricyclic antidepressants, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 540,
        "sentence": "We examined the effect of exogenous estradiol on the changes in serum steroid hormone levels induced by a nonlethal dose of Escherichia coli @DRUG1$ in male rats and the deaths due to nonlethal and lethal doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 541,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, @DRUG2$, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 542,
        "sentence": "No drug interaction studies have been conducted for @DRUG1$, however the use of orally administered antibiotics could, theoretically, interfere with the release of @DRUG2$ in the colon.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 543,
        "sentence": "When patients being treated with @DRUG1$ have a positive urine test for @DRUG2$ using these techniques confirmation should be made by using more specific methods such as a gas chromatographic-mass spectrometer technique.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 544,
        "sentence": "Clinical experience with concomitant administration of @DRUG1$ and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the @DRUG2$ dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 545,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG1$, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 546,
        "sentence": "@DRUG1$ containing @DRUG2$, aluminum, or calcium;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 547,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 548,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 549,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 550,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG2$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 551,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. @DRUG1$ antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. @DRUG2$), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 552,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 553,
        "sentence": "@DRUG1$ injection and potassium-depleting agents: When @DRUG2$ are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 554,
        "sentence": "Inhibition of renal @DRUG1$ clearance leading to increases in plasma @DRUG2$ concentrations has also been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 555,
        "sentence": "@DRUG1$ potentiates other @DRUG2$ such as succinylcholine or organophosphate and carbamate insecticides.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 556,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 557,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 558,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 559,
        "sentence": "It is desirable to monitor TCAplasma levels whenever an agent of the @DRUG1$ including @DRUG2$ is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 560,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most @DRUG1$ (SSRIs, many tricyclics), beta-blockers, antiarrhythmics, and @DRUG2$ are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 561,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 562,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other opioids, general anesthetics, @DRUG2$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 563,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 564,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, @DRUG1$, erythromycin, grapefruit juice, @DRUG2$) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 565,
        "sentence": "Administration of @DRUG1$ with other CYP3A4 inhibitors (e.g., @DRUG2$ 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 566,
        "sentence": "Therefore, increased monitoring of @DRUG1$ is recommended when initiating, adjusting, or discontinuing @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 567,
        "sentence": "Concomitant use of antihistamines with alcohol, @DRUG1$, barbiturates, or other @DRUG2$ may have an additive effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 568,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 569,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 570,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing @DRUG1$, @DRUG2$, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 571,
        "sentence": "In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, @DRUG1$, and @DRUG2$, the signs of hypoglycemia may be reduced or absent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 572,
        "sentence": "Tolbutamide: @DRUG1$, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of @DRUG2$ (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 573,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG1$, general @DRUG2$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 574,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 575,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG1$ may result in increased CNS depressant effects), @DRUG2$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 576,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 577,
        "sentence": "@DRUG1$ and @DRUG2$ did not change fasting or overload glycemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 578,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 579,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 580,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 581,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG1$ (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between @DRUG2$ and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 582,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 583,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 584,
        "sentence": "Acarbose may affect @DRUG1$ bioavailabillty and may require dose adjustment of @DRUG2$ by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 585,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, @DRUG1$, @DRUG2$, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 586,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG1$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 587,
        "sentence": "This article looks at five commonly used @DRUG1$ in turn (corticosteroids, @DRUG2$, azathioprine, methotrexate, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 588,
        "sentence": "Serotonergic Agents: Co-administration of @DRUG1$ and @DRUG2$ was not associated with serotonin syndrome in Phase 1, 2 or 3 studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 589,
        "sentence": "Since there have been conflicting results regarding the effect of @DRUG1$ levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing @DRUG2$ therapy to avoid possible over- or under-digitalization.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 590,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and @DRUG2$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 591,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 592,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG1$, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 593,
        "sentence": "The concurrent use of Robinul Injection with other @DRUG1$ or medications with anticholinergic activity, such as phenothiazines, @DRUG2$, or tricyclic antidepressants, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 594,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, @DRUG1$, voriconazole, and @DRUG2$ has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 595,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, isosorbide dinitrate, morphine, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 596,
        "sentence": "On the basis of the metabolism of @DRUG1$ by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 597,
        "sentence": "Methadone levels may be decreased; increased dosages may be required to prevent symptoms of @DRUG1$ withdrawal. @DRUG2$ maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 598,
        "sentence": "BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, @DRUG1$, or drugs known to prolong the QTc interval because the action of @DRUG2$ on the cardiovascular system may be potentiated by these agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 599,
        "sentence": "Erythromycin (500 mg t.i.d) produced a 4-fold increase in @DRUG1$ AUC and a 3-fold increase in Cmax when co-administered with @DRUG2$ 5 mg in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 600,
        "sentence": "Acarbose may affect digoxin bioavailabillty and may require dose adjustment of @DRUG1$ by 16% (90% confidence interval: 8-23%), decrease mean C max @DRUG2$ by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 601,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, @DRUG2$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 602,
        "sentence": "Comparison of @DRUG1$ pharmacokinetics in patients treated with 202.5 mg/m2 plus @DRUG2$ to those in patients treated with 100 mg/m2 without thiosulfate indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of cisplatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 603,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 604,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and @DRUG1$ (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 605,
        "sentence": "@DRUG1$ is also expected to reduce plasma concentrations of other oral @DRUG2$ that are predominantly metabolized by CYP2C9 or CYP3A4.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 606,
        "sentence": "Administration of @DRUG1$ with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, @DRUG2$ 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 607,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG1$ suggest a possible drug interaction with @DRUG2$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 608,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (@DRUG1$), salicylates, monoamine oxidase inhibitors, and @DRUG2$ may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 609,
        "sentence": "An increase in serum lithium concentration has been reported during concomitant administration of @DRUG1$ with ATACAND, so careful monitoring of serum @DRUG2$ levels is recommended during concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 610,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 611,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 612,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 613,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 614,
        "sentence": "Concomitant use of antihistamines with alcohol, @DRUG1$, @DRUG2$, or other central nervous system depressants may have an additive effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 615,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, phenobarbital, @DRUG1$, topiramate): Increase the metabolism of ethinyl estradiol and/or some @DRUG2$, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 616,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (@DRUG1$), acebutolol (Sectral), metoprolol (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 617,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (@DRUG1$), salicylates, @DRUG2$, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 618,
        "sentence": "Beta-adrenergic Blocking Agents: The effect of @DRUG1$ on blood pressure response to @DRUG2$ and atenolol was evaluated in men with mild uncomplicated hypertension (n = 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 619,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 620,
        "sentence": "Because both of these drugs have negative inotropic properties and the effects of coadministration with TAMBOCOR are unknown, neither @DRUG1$ nor @DRUG2$ should be administered concurrently with TAMBOCOR unless, in the judgment of the physician, the benefits of this combination outweigh the risks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 621,
        "sentence": "- a beta-blocker such as propranolol (@DRUG1$), atenolol (@DRUG2$), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 622,
        "sentence": "The actions of the benzodiazepines may be potentiated by barbiturates, @DRUG1$, @DRUG2$, monoamine oxidase inhibitors or other antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 623,
        "sentence": "Phospholine Iodide potentiates other @DRUG1$ such as @DRUG2$ or organophosphate and carbamate insecticides.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 624,
        "sentence": "It is recommended that @DRUG1$ be taken at least 2 hours following @DRUG2$ administration.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 625,
        "sentence": "@DRUG1$: Concomitant administration of magnesium hydroxide and @DRUG2$ does not interfere with the rate or extent of the absorption of ketoprofen administered as Orudis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 626,
        "sentence": "At 24 hours postdose, a similar proportion of patients treated with methotrexate alone (94%) and subsequently treated with methotrexate co-administered with 75 mg of @DRUG1$ (88%) had @DRUG2$ plasma concentrations below the measurable limit (5 ng/mL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 627,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 628,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG1$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 629,
        "sentence": "On the other hand, the enhanced secretion of colonic fluid by @DRUG1$, given intraluminally, was only half of that in control rats, whereas the colonic transit-enhancing effect of @DRUG2$ in cecectomized rats was more pronounced than in control rats at 15 but not at 30 min after its administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 630,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 631,
        "sentence": "Oral @DRUG1$ may potentiate the hypoglycemic action of @DRUG2$, eg, tolbutamide and chlorpropamide, by inhibiting their metabolism in the liver.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 632,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., @DRUG1$, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 633,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 634,
        "sentence": "Effects of other Antiepilepsy Drugs (@DRUG1$) on @DRUG2$ : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 635,
        "sentence": "Concomitant administration of Norpace and quinidine resulted in slight increases in plasma @DRUG1$ levels and slight decreases in plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 636,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 637,
        "sentence": "Praziquantel: In the fed state, @DRUG1$ (40 mg/kg) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 638,
        "sentence": "There are no clinical data on concomitant use of @DRUG1$ and other nondepolarizing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 639,
        "sentence": "Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without @DRUG1$ indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 640,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 641,
        "sentence": "In vitro studies have shown that the metabolism of @DRUG1$ may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, @DRUG2$, ketoconazole, erythromycin, and troleandomycin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 642,
        "sentence": "Because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of @DRUG1$, Duloxetine and @DRUG2$ should not be co-administered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 643,
        "sentence": "@DRUG1$ (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, @DRUG2$) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 644,
        "sentence": "@DRUG1$ prolong and intensify the anticholinergic effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 645,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, @DRUG2$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 646,
        "sentence": "In patients taking an anticonvulsant (eg, @DRUG1$, @DRUG2$, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 647,
        "sentence": "Drugs which induce CYP3A4 activity (eg, @DRUG1$, @DRUG2$, rifabutin) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 648,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG2$ (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 649,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, @DRUG1$, itraconazole, @DRUG2$, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 650,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, @DRUG2$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 651,
        "sentence": "Anticoagulants: @DRUG1$ like other @DRUG2$, has been shown to affect bleeding parameters in patients receiving anti-coagulants, and serious clinical bleeding has been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 652,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 653,
        "sentence": "Among these patients, the incidence of upper gastrointestinal adverse experiences in the patients treated with @DRUG1$ 150 mg once monthly was similar to that in patients treated with @DRUG2$ 2.5 mg once daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 654,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 655,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 656,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 657,
        "sentence": "It is recommended that the dose of @DRUG1$ be reduced to one-half the usual dose when administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 658,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG1$, opiates, @DRUG2$, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 659,
        "sentence": "Studies with ACE inhibitors in combination with diuretics indicate that the dose of the @DRUG1$ can be reduced when it is given with a @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 660,
        "sentence": "@DRUG1$: @DRUG2$ increases the metabolism of ethinyl estradiol and some progestins (norethindrone) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 661,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 662,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 663,
        "sentence": "Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving @DRUG1$ in conjunction with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 664,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 665,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 666,
        "sentence": "Immunosuppressive Drugs, Fibric Acid Derivatives, Niacin (Nicotinic Acid, @DRUG1$, @DRUG2$: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 667,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and @DRUG1$, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 668,
        "sentence": "Drugs that inhibit cytochrome P450IID6, such as @DRUG1$ , might increase the plasma concentrations of @DRUG2$ in patients that are on chronic flecainide therapy;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 669,
        "sentence": "Risk of Anaphylactic Reaction: Although it is known that patients on beta-blockers may be refractory to @DRUG1$ in the treatment of anaphylactic shock, @DRUG2$ can, in addition, interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 670,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, ACE inhibitors, @DRUG1$, glyburide, @DRUG2$, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 671,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 672,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 673,
        "sentence": "@DRUG1$ - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg/day @DRUG2$ for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 674,
        "sentence": "The behavioral effects of the stereoisomers of @DRUG1$ (NANM) were compared with those of @DRUG2$ (PCP) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 675,
        "sentence": "Eprosartan doses of up to 300 mg b.i.d. have been safely used concomitantly with sustained-release @DRUG1$ (sustained-release @DRUG2$) with no clinically significant adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 676,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by @DRUG2$, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 677,
        "sentence": "Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide, these disturbances have been reported with oral @DRUG1$ and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose @DRUG2$ therapy).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 678,
        "sentence": "Phenytoin: @DRUG1$ has not been shown to alter the pharmacokinetics of @DRUG2$ in a study in seven healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 679,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 680,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 681,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 682,
        "sentence": "there was no effect on the 3 major metabolites (@DRUG1$, 5-FU and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 683,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 684,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, @DRUG2$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 685,
        "sentence": "Serum @DRUG1$ concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, @DRUG2$ (metronidazole or ciprofloxacin) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 686,
        "sentence": "@DRUG1$: Co-administration of bosentan 125 mg b.i.d. and ketoconazole, a potent CYP3A4 inhibitor, increased the plasma concentrations of @DRUG2$ by approximately 2-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 687,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 688,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 689,
        "sentence": "Intestinal adsorbents (e. g., @DRUG1$) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., @DRUG2$, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 690,
        "sentence": "Short-Acting beta2-agonists: Aerosol @DRUG1$ of the short-acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 691,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most @DRUG1$ (SSRIs, many tricyclics), beta-blockers, @DRUG2$, and antipsychotics are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 692,
        "sentence": "Noncardioselective beta-blockers (nadolol,porpranolol,@DRUG1$) may exacerbate rebound hypertension when @DRUG2$ is withdrawn.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 693,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG1$ (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 694,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 695,
        "sentence": "@DRUG1$ or @DRUG2$: Concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 696,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 697,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 698,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 699,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG2$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 700,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 701,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 702,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 703,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 704,
        "sentence": "Furosemide: Clinical studies, as well as post-marketing observations, have shown that @DRUG1$ can reduce the natriuretic effect of @DRUG2$ and thiazides in some patients.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 705,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 706,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG2$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 707,
        "sentence": "@DRUG1$ potentiates other cholinesterase inhibitors such as @DRUG2$ or organophosphate and carbamate insecticides.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 708,
        "sentence": "Serum @DRUG1$ concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, antibiotics (metronidazole or @DRUG2$) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 709,
        "sentence": "In patients taking an @DRUG1$ (eg, @DRUG2$, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 710,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 711,
        "sentence": "Oral @DRUG1$ may enhance the effect of @DRUG2$ in anticoagulants by decreasing vitamin K availability.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 712,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 713,
        "sentence": "The effects @DRUG1$ on the pharmacokinetics and/or pharmacodynamics of @DRUG2$, ketoconazole, methotrexate, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 714,
        "sentence": "STUDY OBJECTIVE: To evaluate the effect of @DRUG1$ on the pharmacokinetics and cardiovascular safety of @DRUG2$ at steady state in healthy men.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 715,
        "sentence": "@DRUG1$: Concurrent administration of certain anticholinergic compounds, such as @DRUG2$ and dicyclomine, would be expected to compromise the beneficial effects of cisapride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 716,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 717,
        "sentence": "In patients taking an @DRUG1$ (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of @DRUG2$ may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 718,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 719,
        "sentence": "Aprepitant is unlikely to interact with drugs that are substrates for the P-glycoprotein transporter, as demonstrated by the lack of interaction of @DRUG1$ with @DRUG2$ in a clinical drug interaction study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 720,
        "sentence": "@DRUG1$ has no effect on the pharmacokinetics of itraconazole, @DRUG2$, or the active metabolite of mycophenolate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 721,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG2$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 722,
        "sentence": "Antacids or H 2 receptor antagonists: When @DRUG1$ is administered immediately following @DRUG2$ or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 723,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG1$, diltiazem, grapefruit juice, nefazadone, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 724,
        "sentence": "in one man, the C max of @DRUG1$ was 8.1 ng/mL with terfenadine alone and 7.2 ng/mL with @DRUG2$ plus dirithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 725,
        "sentence": "CNS-Active Drugs Ethanol An additive effect on psychomotor performance was seen with coadministration of @DRUG1$ and ethanol 0.70 g/kg for up to 4 hours after @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 726,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG2$ (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 727,
        "sentence": "In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of @DRUG1$ alone were compared to PRINIVIL given concomitantly with indomethacin, the use of @DRUG2$ was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 728,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, @DRUG2$, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 729,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG1$, opiates, sedatives, or @DRUG2$) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 730,
        "sentence": "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH @DRUG1$ SUCH AS NARCOTICS, NON-NARCOTIC ANALGESICS AND @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 731,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 732,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most antidepressants (SSRIs, many tricyclics), @DRUG1$, @DRUG2$, and antipsychotics are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 733,
        "sentence": "Rates of patients with maximum potassium levels  5.5 mEq/L were similar regardless of the use of @DRUG1$/@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 734,
        "sentence": "In a study in diabetics with microalbuminuria INSPRA 200 mg combined with the ACE inhibitor @DRUG1$ 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on @DRUG2$ alone to 38%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 735,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG2$, and the Type 1C antiarrhythmics propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 736,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, @DRUG1$, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and @DRUG2$), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 737,
        "sentence": "Although specific drug interaction studies have not been conducted with @DRUG1$, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG2$, opiates, sedatives, or anesthetics) should be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 738,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 739,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of @DRUG1$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas @DRUG2$ binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 740,
        "sentence": "If @DRUG1$ is given concomitantly with @DRUG2$, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 741,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, @DRUG2$, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 742,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 743,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 744,
        "sentence": "Digoxin: Concomitant administration of @DRUG1$ did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 745,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG1$, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 746,
        "sentence": "- Phenytoin (e.g., Dilantin) Use of phenytoin with @DRUG1$ may increase the chance of side effects affecting the liver and/or the side effects of @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 747,
        "sentence": "Ketoconazole tablets may alter the metabolism of cyclosporine, @DRUG1$, and @DRUG2$, resulting in elevated plasma concentrations of the latter drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 748,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 749,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG2$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 750,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 751,
        "sentence": "An adequate period of observation must be provided for any patient in whom either long-acting benzodiazepines (such as @DRUG1$) or large doses of @DRUG2$ (such as  10 mg of midazolam) have been used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 752,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 753,
        "sentence": "Dexbrompheniramine can interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 754,
        "sentence": "Amphotericin B injection and potassium-depleting agents: When @DRUG1$ are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, @DRUG2$), patients should be observed closely for development of hypokalemia.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 755,
        "sentence": "The benzodiazepines, including @DRUG1$, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, @DRUG2$, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 756,
        "sentence": "Since @DRUG1$ is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when @DRUG2$ is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 757,
        "sentence": "@DRUG1$, fluvoxamine, cimetidine (consider @DRUG2$ dose reduction).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 758,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an @DRUG1$/@DRUG2$ oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 759,
        "sentence": "Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, quinidine, fluoxetine, or @DRUG1$) can inhibit @DRUG2$ elimination and cause increased blood levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 760,
        "sentence": "@DRUG1$ and Celexa - In a controlled study, a single dose of @DRUG2$ 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 761,
        "sentence": "If antacids are required during @DRUG1$ therapy, OMNICEF should be taken at least 2 hours before or after the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 762,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 763,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 764,
        "sentence": "Propoxyphene: The concurrent administration of @DRUG1$ does not affect the bioavailability of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 765,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG1$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 766,
        "sentence": "Effects of Erythromycin on Felbatol  The coadministration of @DRUG1$ (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax, Cmin, AUC, CI/kg or tmax at @DRUG2$ daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 767,
        "sentence": "Pharmacokinetic interactions between @DRUG1$ and beta-blockers (@DRUG2$, propranolol) were variable and not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 768,
        "sentence": "@DRUG1$ enhance the renal toxicity of edetate calcium disodium in animals. 7 @DRUG2$ interferes with the action of zinc insulin preparations by chelating the zinc. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 769,
        "sentence": "@DRUG1$: Coadministration of ketoconazole with @DRUG2$ resulted in a 35% increase in nelfinavir plasma A.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 770,
        "sentence": "@DRUG1$: Coadministration of digoxin, a P-glycoprotein substrate, with oral conivaptan resulted in a reduction in clearance and an increase in @DRUG2$ Cmax and AUC values.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 771,
        "sentence": "Probenecid: Concomitant administration of TORADOL ORAL and probenecid resulted in decreased clearance of @DRUG1$ and significant increases in @DRUG2$ plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 772,
        "sentence": "BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with @DRUG1$, @DRUG2$, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 773,
        "sentence": "Metoclopramide: When coadministered with @DRUG1$, @DRUG2$, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 774,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 775,
        "sentence": "d-amphetamine with desipramine or @DRUG1$ and possibly other tricyclics cause striking and sustained increases in the concentration of @DRUG2$ in the brain;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 776,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 777,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and @DRUG2$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 778,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG1$, @DRUG2$, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 779,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (@DRUG1$) Injection, USP to subjects already receiving propranolol, there have been reports that @DRUG2$ may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 780,
        "sentence": "Nevirapine and @DRUG1$ should not beadministered concomitantly becausedecreases in @DRUG2$ plasmaconcentrations may reduce the efficacy of the drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 781,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 782,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 783,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 784,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 785,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG1$ may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 786,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 787,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG1$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 788,
        "sentence": "Concurrent administration of indinavir and @DRUG1$ significantly reduces the level of exposure to indinavir, but it is unclear how soon after @DRUG2$ administration indinavir may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 789,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, @DRUG1$, tranquilizers, and @DRUG2$) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 790,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 791,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 792,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of @DRUG1$, @DRUG2$, or droperidol but not after administration of fentayl alone or after pentobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 793,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 794,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, @DRUG1$, clofibrate, methyldopa, @DRUG2$ (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 795,
        "sentence": "Administration of @DRUG1$ with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of @DRUG2$ ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 796,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 797,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 798,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG1$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 799,
        "sentence": "Studies showed that @DRUG1$ increased the AUC of @DRUG2$ and triazolam by 3-4 fold and the Cmax by 2-fold, compared to placebo.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 800,
        "sentence": "The ratios of the AUCs of unbound @DRUG1$ to the AUCs of the total @DRUG2$ were 11.1 %, 13.0%, and 11.5%, with coadministration of 0, 1200, and 2400 mg/day of Felbatol , respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 801,
        "sentence": "H2 Blockers/@DRUG1$: Long-term suppression of gastric acid secretion by @DRUG2$ or proton pump inhibitors (eg, famotidine and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 802,
        "sentence": "Tablets: The @DRUG1$, including @DRUG2$, produce CNS-depressant effects when administered with such medications as barbiturates or alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 803,
        "sentence": "@DRUG1$: Phenytoin Phenobarbital @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 804,
        "sentence": "Potassium-sparing diuretics (spironolactone, @DRUG1$,triamterene, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 805,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 806,
        "sentence": "In contrast, in isolated single pancreatic acinar cells, @DRUG1$ had no effect on @DRUG2$-induced responses.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 807,
        "sentence": "@DRUG1$ may increase the action of @DRUG2$, amphetamines, procainamide, and quinidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 808,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 809,
        "sentence": "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS @DRUG1$, NON-NARCOTIC ANALGESICS AND @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 810,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 811,
        "sentence": "Interactions between treatments with coumaphos, bishydroxycoumarin (an anticoagulant), @DRUG1$ (an @DRUG2$), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 812,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 813,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 814,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by @DRUG1$, amphotericin B, mycophenolate, nelfinavir, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 815,
        "sentence": "The objective of this study was to determine if there is a pharmacokinetic interaction when amprenavir is given with @DRUG1$ or @DRUG2$ and to determine the effects of these drugs on the erythromycin breath test (ERMBT).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 816,
        "sentence": "@DRUG1$ (@DRUG2$): The concomitant administration of a nonsteroidal anti inflammatory drug with a quinolone may increase the risks of CNS stimulation and convulsions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 817,
        "sentence": "Ergotamine: Concurrent use of erythromycin and @DRUG1$ or @DRUG2$ has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 818,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 819,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 820,
        "sentence": "In a controlled clinical trial, a 20% reduction of the @DRUG1$ dose at the initiation of Felbatol  therapy resulted in @DRUG2$ levels comparable to those prior to Felbatol  administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 821,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, procaine, beta-blockers, metaclopramide, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 822,
        "sentence": "The actions of the benzodiazepines may be potentiated by barbiturates, @DRUG1$, phenothiazines, @DRUG2$ or other antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 823,
        "sentence": "In patients taking furosemide, @DRUG1$, diltiazem, ACE inhibitors, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 824,
        "sentence": "As with other @DRUG1$, the antihypertensive effect of @DRUG2$ may be blunted by the non-steroidal anti-inflammatory drug indomethacin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 825,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, @DRUG1$, itraconazole, @DRUG2$, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 826,
        "sentence": "Nonsteroidal anti-inflammatory agents (@DRUG1$): Concomitant use of @DRUG2$ (or other nonsteroidal antiinflammatory agents) and corticosteroids increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 827,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 828,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 829,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG2$, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 830,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 831,
        "sentence": "The concomitant use of transdermal @DRUG1$ with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, @DRUG2$, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 832,
        "sentence": "@DRUG1$ (450 mg BID for 7 days) had no effect on @DRUG2$ pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 833,
        "sentence": "Because prostaglandina play an important role in hemostasis and @DRUG1$ has an effect on platelet function as well, concurent therapy with @DRUG2$ and warfarin requires close monitoring of patients on both drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 834,
        "sentence": "Potassium-sparing diuretics such as spironolactone, @DRUG1$, or @DRUG2$, or potassium supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 835,
        "sentence": "@DRUG1$ can interact with @DRUG2$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 836,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 837,
        "sentence": "Differential actions of intrathecal @DRUG1$ on blocking the tail-flick inhibition induced by intraventricular @DRUG2$ and morphine in rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 838,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 839,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (@DRUG1$), acebutolol (@DRUG2$), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 840,
        "sentence": "In 5 other schizophrenic patients treated with oral haloperidol and @DRUG1$, discontinuation of rifampin produced a mean 3.3-fold increase in @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 841,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 842,
        "sentence": "An increase in serum @DRUG1$ concentration has been reported during concomitant administration of lithium with ATACAND, so careful monitoring of serum @DRUG2$ levels is recommended during concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 843,
        "sentence": "Oral anticoagulants may potentiate the hypoglycemic action of @DRUG1$, eg, tolbutamide and @DRUG2$, by inhibiting their metabolism in the liver.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 844,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain @DRUG2$, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 845,
        "sentence": "The benzodiazepines, including @DRUG1$, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, @DRUG2$, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 846,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 847,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 848,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by @DRUG1$, amphotericin B, mycophenolate, @DRUG2$, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 849,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 850,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as @DRUG1$, @DRUG2$, ketoconazole, erythromycin, and troleandomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 851,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 852,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 853,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 854,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG1$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 855,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG1$), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 856,
        "sentence": "Pharmacological/Pharmacodynamic Interactions with @DRUG1$ Concomitant administration of carbamazepine and @DRUG2$ may increase the risk of neurotoxic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 857,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG2$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 858,
        "sentence": "These in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated @DRUG1$, which may lead to a decreased antiretroviral effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 859,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 860,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, @DRUG1$, @DRUG2$, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 861,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 862,
        "sentence": "@DRUG1$: Co-administration of @DRUG2$ and serotonergic agents was not associated with serotonin syndrome in Phase 1, 2 or 3 studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 863,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 864,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 865,
        "sentence": "Use of @DRUG1$ with potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), @DRUG2$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 866,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 867,
        "sentence": "Data from a randomized trial of HEXALEN and @DRUG1$ plus or minus @DRUG2$ in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 868,
        "sentence": "Ventricular tachycardia induced by @DRUG1$ was generally converted to sinus rhythm following administration of Innovar, @DRUG2$, or droperidol but not after administration of fentayl alone or after pentobarbital.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 869,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 870,
        "sentence": "Anesthetics/@DRUG1$/@DRUG2$/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 871,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as @DRUG1$, telithromycin, protease inhibitors, @DRUG2$, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 872,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 873,
        "sentence": "Because of the possible additive effects of drugs that may depress the nervous system, ethanol or @DRUG1$ should be used cautiously in combination with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 874,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with @DRUG1$ containing @DRUG2$, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 875,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 876,
        "sentence": "It is recommended that serum @DRUG1$ levels be monitored frequently if enalapril is administered concomitantly with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 877,
        "sentence": "Behavioral responses to repeated @DRUG1$ exposure in mice selectively bred for differential sensitivity to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 878,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 879,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other @DRUG1$ (including alcohol) concomitantly with @DRUG2$ and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 880,
        "sentence": "Furosemide: In normal volunteers, the concomitant administration of @DRUG1$ and furosemide had no effect on the diuretic activity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 881,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 882,
        "sentence": "@DRUG1$/Itraconazole, @DRUG2$, Including Erythromycin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 883,
        "sentence": "@DRUG1$ @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 884,
        "sentence": "Experience with nonsteroidal anti-inflammatory drugs (NSAIDs) suggests the potential for interactions with @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 885,
        "sentence": "Some @DRUG1$, including ciprofloxacin, have also been shown to interfere with the metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 886,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, @DRUG2$, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 887,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG1$, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 888,
        "sentence": "@DRUG1$/Sedatives/@DRUG2$/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 889,
        "sentence": "Data from a randomized trial of HEXALEN and @DRUG1$ plus or minus pyridoxine in ovarian cancer indicated that @DRUG2$ significantly reduced neurotoxicity;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 890,
        "sentence": "Antacids or H 2 receptor antagonists: When @DRUG1$ is administered immediately following antacids or @DRUG2$, the absorption of dirithromycin is slightly enhanced.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 891,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG2$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 892,
        "sentence": "It is recommended that the combination of intravenous dantrolene sodium and @DRUG1$, such as @DRUG2$, not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 893,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 894,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 895,
        "sentence": "@DRUG1$ doses of up to 300 mg b.i.d. have been safely used concomitantly with sustained-release @DRUG2$ (sustained-release nifedipine) with no clinically significant adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 896,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 897,
        "sentence": "Systemic exposure to @DRUG1$ is expected to be increased when coadministered with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 898,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 899,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 900,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG1$, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 901,
        "sentence": "Should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently, the @DRUG1$ should be discontinued slowly over several days before the gradual withdrawal of @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 902,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 903,
        "sentence": "BROVANA, as with other @DRUG1$, should be administered with extreme caution to patients being treated with @DRUG2$, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 904,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 905,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 906,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG1$, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 907,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 908,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, @DRUG1$, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and @DRUG2$), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 909,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, @DRUG1$, @DRUG2$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 910,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 911,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), @DRUG2$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 912,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 913,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 914,
        "sentence": "However, the systemic administration of some @DRUG1$ has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant @DRUG2$ and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 915,
        "sentence": "@DRUG1$/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 916,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 917,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, @DRUG1$, ketoconazole, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 918,
        "sentence": "If signs and symptoms suggestive of digoxin toxicity occur when enoxacin and @DRUG1$ are given concomitantly, physicians are advised to obtain serum @DRUG2$ levels and adjust digoxin doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 919,
        "sentence": "The safety of using @DRUG1$ and @DRUG2$ (sumatriptan) Nasal Spray during the same episode of migraine has not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 920,
        "sentence": "The concomitant administration of @DRUG1$ including norfloxacin with glyburide (a @DRUG2$) has, on rare occasions, resulted in severe hypoglycemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 921,
        "sentence": "Simvastatin and Other @DRUG1$: Co-administration of @DRUG2$ decreased the plasma concentrations of simvastatin (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 922,
        "sentence": "Agents Affecting Sympathetic Activity The sympathetic nervous system may be especially important in supporting blood pressure in patients receiving @DRUG1$ alone or with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 923,
        "sentence": "Ketamine: When administered to patients on a @DRUG1$, this parenteral @DRUG2$ may cause hypertension and tachycardia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 924,
        "sentence": "Potassium-sparing diuretics (spironolactone, amiloride,@DRUG1$, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 925,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 926,
        "sentence": "@DRUG1$: Concomitant administration of TORADOL ORAL and @DRUG2$ resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 927,
        "sentence": "This effect may be mediated by the known inhibition of hepatic cytochrome P- 450 by @DRUG1$, which could decrease first pass metabolism of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 928,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with @DRUG1$, a reduction in dosage of PRECEDEX on the concomitant anesthetic, @DRUG2$, hypnotic or opioid may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 929,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG1$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 930,
        "sentence": "Potassium-sparing diuretics such as spironolactone, triamterene, or @DRUG1$, or @DRUG2$ supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 931,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 932,
        "sentence": "Anticoagulants: Flurbiprofen like other @DRUG1$, has been shown to affect bleeding parameters in patients receiving @DRUG2$, and serious clinical bleeding has been reported.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 933,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG1$, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 934,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 935,
        "sentence": "@DRUG1$: Nonclinical data demonstrate that the solubility of @DRUG2$ is pH dependent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 936,
        "sentence": "In controlled clinical trials, however, @DRUG1$ including metoprolol were concurrently administered with @DRUG2$ and were well tolerated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 937,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 938,
        "sentence": "Dexbrompheniramine can interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 939,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 940,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG2$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 941,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 942,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 943,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 944,
        "sentence": "Other: There appears to be no pharmacokinetic interaction between @DRUG1$ and cimetidine, digoxin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 945,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of @DRUG1$ are not altered by itraconazole, amphotericin B, @DRUG2$, nelfinavir, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 946,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, @DRUG1$, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 947,
        "sentence": "@DRUG1$: In a pharmacokinetic study, maximum plasma concentrations of @DRUG2$ were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, carbamazepine, or phenobarbital) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 948,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 949,
        "sentence": "This drug may interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 950,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, @DRUG2$, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 951,
        "sentence": "Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when @DRUG1$ is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 952,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general @DRUG1$, local anesthetics like lidocaine, procaine, beta-blockers, metaclopramide, lithium carbonate, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 953,
        "sentence": "These include probenecid, cholestyramine, and some @DRUG1$ (e.g. erythromycin, rifamipicin, ampicillin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 954,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 955,
        "sentence": "@DRUG1$, @DRUG2$ and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 956,
        "sentence": "@DRUG1$: Concomitant administration of magnesium hydroxide and aluminum hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 957,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 958,
        "sentence": "Caution should be used when @DRUG1$ inhibitors are co-administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 959,
        "sentence": "Therefore, when @DRUG1$ and @DRUG2$ are used concomitantly, patients should be observed to determine whether the desired effect on blood pressure is obtained.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 960,
        "sentence": "Although metoclopramide may increase the bioavailability of @DRUG1$ by increasing gastric emptying, @DRUG2$ may also adversely affect disease control by its dopamine receptor antagonistic properties.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 961,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, procaine, beta-blockers, @DRUG1$, lithium carbonate, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 962,
        "sentence": "Ethanol or Triazolam: No significant differences were observed in the pharmacokinetics of @DRUG1$ (0.125 mg) and @DRUG2$ (10 mg) when given together as a single dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 963,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 964,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG2$, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 965,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 966,
        "sentence": "@DRUG1$, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of @DRUG2$ (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 967,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, @DRUG2$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 968,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that @DRUG1$ (1 mg/kg) removes the antiedematous action of diazepam, phenazepam, @DRUG2$ and amizyl and reduces the action of phentolamine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 969,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG1$, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 970,
        "sentence": "- @DRUG1$ (e.g., Dilantin) Use of @DRUG2$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 971,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain @DRUG2$, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 972,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, @DRUG1$, or @DRUG2$) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 973,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 974,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 975,
        "sentence": "Drugs That Should Not Be Coadministered With @DRUG1$/@DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 976,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG1$, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 977,
        "sentence": "Based on anecdotal reports, there may be an interaction between @DRUG1$ and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 978,
        "sentence": "Effects of @DRUG1$ are increased with MAO inhibitors and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 979,
        "sentence": "@DRUG1$: Chlorpromazine blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of @DRUG2$, and can be used to treat amphetamine poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 980,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, @DRUG1$ and @DRUG2$ might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 981,
        "sentence": "@DRUG1$ at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 982,
        "sentence": "As with other agents with b-blocking properties, if COREG is to be administered orally with @DRUG1$ of the @DRUG2$ or diltiazem type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 983,
        "sentence": "@DRUG1$: May increase CYP metabolism of @DRUG2$ leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 984,
        "sentence": "In a placebo-controlled trial in normal volunteers, the administration of a single 1 mg dose of @DRUG1$ on day 1 of a four-day regimen of oral cimetidine (400 mg twice daily) resulted in a 10% increase in mean AUC of doxazosin (p=0.006), and a slight but not statistically significant increase in mean Cmax and mean half-life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 985,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 986,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 987,
        "sentence": "@DRUG1$ therapy should be monitored, particularly during the first few weeks, after initiating therapy with BEXTRA in patients receiving @DRUG2$ or similar agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 988,
        "sentence": "Should it be decided to discontinue therapy in patients receiving @DRUG1$ and clonidine concurrently, the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 989,
        "sentence": "Drugs That Inhibit CYP3A4 CYP3A4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethylzaleplon (formed via CYP3A4 in vitro) and its metabolites, 5-oxo-desethylzaleplon and @DRUG1$, account for only 9% of the urinary recovery of a @DRUG2$ dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 990,
        "sentence": "@DRUG1$: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG2$ and thiazides in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 991,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, @DRUG1$, phenytoin, topiramate): Increase the metabolism of @DRUG2$ and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 992,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 993,
        "sentence": "In addition, the beneficial effects of @DRUG1$ in Parkinsons disease have been reported to be reversed by @DRUG2$ and papaverine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 994,
        "sentence": "Increased toxicity (CNS depression): @DRUG1$, MAO inhibitors, tricyclic antidepressants, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 995,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (@DRUG1$) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of @DRUG2$ by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 996,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. @DRUG1$), antihistamines @DRUG2$ (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 997,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, @DRUG1$, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 998,
        "sentence": "Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of @DRUG1$ and @DRUG2$ is contraindicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 999,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, @DRUG1$, metoclopramide, propantheline, digoxin, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1000,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG1$, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1001,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1002,
        "sentence": "Dexbrompheniramine can interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG2$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1003,
        "sentence": "@DRUG1$: Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1004,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, @DRUG2$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1005,
        "sentence": "The concurrent use of Robinul Injection with other anticholinergics or medications with anticholinergic activity, such as phenothiazines, @DRUG1$, or @DRUG2$, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1006,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1007,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, terfenadine, @DRUG1$, @DRUG2$, and troleandomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1008,
        "sentence": "Concurrent use of butorphanol with @DRUG1$ (e.g., alcohol, barbiturates, @DRUG2$, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1009,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1010,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, alfentanil, cisapride, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1011,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1012,
        "sentence": "Drugs That Inhibit CYP3A4 CYP3A4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethylzaleplon (formed via CYP3A4 in vitro) and its metabolites, @DRUG1$ and @DRUG2$, account for only 9% of the urinary recovery of a zaleplon dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1013,
        "sentence": "In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free @DRUG1$ may be decreased when @DRUG2$ are started thus increasing thyroid requirements.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1014,
        "sentence": "In order to examine some molecular mechanisms of PCP-induced behavioral changes, Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with @DRUG1$, DCG-IV, and @DRUG2$ was carried out.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1015,
        "sentence": "If the usual amounts of nondepolarizing relaxants are given, the time for recovery from neuromuscular blockade will be longer in the presence of @DRUG1$ than when halothane or @DRUG2$ with a balanced technique are used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1016,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, @DRUG1$, hypnotics, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1017,
        "sentence": "Co-administration of anastrozole and @DRUG1$ resulted in a reduction of @DRUG2$ plasma levels by 27% compared with those achieved with anastrozole alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1018,
        "sentence": "Certain antibiotic, @DRUG1$, cyclosporine, @DRUG2$, foscarnet, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1019,
        "sentence": "Ketoconazole: Co-administration of bosentan 125 mg b.i.d. and @DRUG1$, a potent CYP3A4 inhibitor, increased the plasma concentrations of @DRUG2$ by approximately 2-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1020,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1021,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1022,
        "sentence": "Concomitant treatment with methylxanthines (aminophylline, @DRUG1$), @DRUG2$, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1023,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1024,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG1$, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1025,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (@DRUG2$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1026,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1027,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG1$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1028,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., @DRUG1$ 500 mg BID, @DRUG2$ 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1029,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1030,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG1$ (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1031,
        "sentence": "Estrogen, Oral @DRUG1$: @DRUG2$ tend to increase serum thyroxine-binding globulin (TBg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1032,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1033,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1034,
        "sentence": "d-amphetamine with @DRUG1$ or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of @DRUG2$ in the brain;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1035,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1036,
        "sentence": "Use of PRINIVIL with potassium-sparing diuretics (e.g., @DRUG1$, @DRUG2$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1037,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of diazepam, phenazepam, phenibut and @DRUG1$ and reduces the action of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1038,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1039,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1040,
        "sentence": "@DRUG1$: In the fed state, @DRUG2$ (40 mg/kg) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given albendazole alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1041,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG1$], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1042,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1043,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1044,
        "sentence": "At 24 hours postdose, a similar proportion of patients treated with @DRUG1$ alone (94%) and subsequently treated with methotrexate co-administered with 75 mg of @DRUG2$ (88%) had methotrexate plasma concentrations below the measurable limit (5 ng/mL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1045,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG1$, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1046,
        "sentence": "Loop Diuretics: @DRUG1$ administered concurrently with @DRUG2$ does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1047,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1048,
        "sentence": "If @DRUG1$ is given concomitantly with opioids, the @DRUG2$ dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1049,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1050,
        "sentence": "Anticoagulant therapy should be monitored, particularly during the first few weeks, after initiating therapy with @DRUG1$ in patients receiving @DRUG2$ or similar agents.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1051,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1052,
        "sentence": "Coadministration of @DRUG1$ and strong CYP3A4 inhibitors, such as clarithromycin, @DRUG2$, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1053,
        "sentence": "In order to maintain phenytoin levels, limit adverse experiences, and achieve the @DRUG1$ dose of 3600 mg/day, a @DRUG2$ dose reduction of approximately 40% was necessary for eight of these 10 subjects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1054,
        "sentence": "Certain drugs including thiazides, @DRUG1$, thyroid products, and @DRUG2$ may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1055,
        "sentence": "Warfarin: Multiple oral doses of @DRUG1$ (20 mg q24h for 13 days) did not affect the pharmacokinetics of warfarin (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1056,
        "sentence": "Cimetidine Co-administration of felodipine with @DRUG1$ (a non-specific CYP-450 inhibitor) resulted in an increase of approximately 50% in the AUC and the Cmax, of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1057,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1058,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1059,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1060,
        "sentence": "Using in situ hybridization, we observed that @DRUG1$ caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist SCH-23390 but not by an @DRUG2$ clozapine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1061,
        "sentence": "The concomitant use of transdermal fentanyl with @DRUG1$ or other potent 3A4 inhibitors such as ketoconazole, @DRUG2$, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1062,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1063,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1064,
        "sentence": "- Phenytoin (e.g., Dilantin) Use of @DRUG1$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1065,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing magnesium or @DRUG1$, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1066,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, @DRUG1$, rifapentine, @DRUG2$, carbamazepine, phenobarbital and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1067,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1068,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1069,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1070,
        "sentence": "Anticholinergics: Concurrent administration of certain @DRUG1$, such as @DRUG2$ and dicyclomine, would be expected to compromise the beneficial effects of cisapride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1071,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1072,
        "sentence": "In this study we investigated the effect of ginsenosides on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers nimodipine (L-type), @DRUG1$ (N-type), or @DRUG2$ (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1073,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of @DRUG1$ are decreased when administered with antacids containing magnesium, @DRUG2$, or aluminum.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1074,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1075,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1076,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1077,
        "sentence": "Alprazolam: When fluvoxamine maleate (100 mg qd) and alprazolam (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of @DRUG1$ were approximately twice those observed when @DRUG2$ was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1078,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1079,
        "sentence": "Plasma TCA concentrations may need to be monitored and the dose of the @DRUG1$ may need to be reduced if a @DRUG2$ is co-administered with Duloxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1080,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1081,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1082,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1083,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing @DRUG1$, calcium, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1084,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1085,
        "sentence": "(See CLINICAL PHARMACOLOGY) Coadministration of Femara and @DRUG1$ 20 mg daily resulted in a reduction of @DRUG2$ plasma levels by 38% on average.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1086,
        "sentence": "Antiepileptic Drugs: Sporadic cases of seizures have been reported during concomitant use of TORADOL and antiepileptic drugs (@DRUG1$, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1087,
        "sentence": "@DRUG1$, Digoxin, Salicylate, and Heparin The in vitro binding of @DRUG2$ to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1088,
        "sentence": "Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, antibiotics (@DRUG1$ or @DRUG2$) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1089,
        "sentence": "The concomitant use of transdermal fentanyl with @DRUG1$ or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, @DRUG2$, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1090,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1091,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1092,
        "sentence": "Immunosuppressive Drugs, Fibric Acid Derivatives, Niacin (@DRUG1$, Erythromycin, @DRUG2$: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1093,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1094,
        "sentence": "Patients treated with @DRUG1$ plus @DRUG2$ should, therefore, be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo, syncope/presyncope, or orthostatic changes in blood pressure without compensatory tachycardia.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1095,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, @DRUG1$, protease inhibitors, voriconazole, and @DRUG2$ has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1096,
        "sentence": "Because the @DRUG1$ have been shown to depress plasma prothrombin activity, patients who are on @DRUG2$ therapy may require downward adjustment of their anticoagulant dosage.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1097,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1098,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, @DRUG1$, @DRUG2$, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1099,
        "sentence": "Venlafaxine: Coadministration of a single dose of @DRUG1$ 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1100,
        "sentence": "Two studies were conducted in HIV-infected subjects to assess the potential for @DRUG1$ to interact with @DRUG2$ and dideoxyinosine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1101,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1102,
        "sentence": "- a @DRUG1$ such as propranolol (Inderal), atenolol (Tenormin), @DRUG2$ (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1103,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1104,
        "sentence": "Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus @DRUG1$ to those in patients treated with 100 mg/m2 without thiosulfate indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1105,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as @DRUG1$, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of @DRUG2$ (thereby raising systemic exposure).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1106,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of ZYVOX and serotonergic agents, including antidepressants such as @DRUG1$ (@DRUG2$), have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1107,
        "sentence": "@DRUG1$, clonidine, @DRUG2$ salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1108,
        "sentence": "Pharmacokinetic interactions between @DRUG1$ and beta-blockers (atenolol, @DRUG2$) were variable and not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1109,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, rifabutin, rifapentine, @DRUG1$, @DRUG2$, phenobarbital and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1110,
        "sentence": "Carbamazepine: Coadministration of carbamazepine (200 mg BID), a potent CYP3A4 inducer, with @DRUG1$ (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1111,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1112,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), @DRUG1$, monoamine oxidase inhibitors, and @DRUG2$ may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1113,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1114,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1115,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, @DRUG2$, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1116,
        "sentence": "Nonsteroidal anti-inflammatory agents (@DRUG1$): Concomitant use of aspirin (or other nonsteroidal antiinflammatory agents) and @DRUG2$ increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1117,
        "sentence": "Concurrent use of @DRUG1$ with central nervous system depressants (e.g., alcohol, @DRUG2$, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1118,
        "sentence": "Ketoconazole/@DRUG1$, Macrolides, Including @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1119,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, phenytoin, @DRUG1$, and @DRUG2$ have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1120,
        "sentence": "Valproate: A recent case study has shown a possible increase in the plasma level of @DRUG1$ when co administered with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1121,
        "sentence": "@DRUG1$ (500 mg t.i.d) produced a 4-fold increase in @DRUG2$ AUC and a 3-fold increase in Cmax when co-administered with Vardenafil 5 mg in healthy volunteers.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1122,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1123,
        "sentence": "In addition, studies in healthy volunteers have shown that @DRUG1$ does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of propranolol (40 mg twice daily), @DRUG2$, theophylline, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1124,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other @DRUG1$, phenothiazines, carbamazepine, and @DRUG2$ (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1125,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1126,
        "sentence": "@DRUG1$: The influence of the bile-acidsequestering agent @DRUG2$ on the pharmacokinetits of cerivastatin sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1127,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX on the concomitant @DRUG1$, @DRUG2$, hypnotic or opioid may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1128,
        "sentence": "There is insufficient experience to assess the safety and efficacy of @DRUG1$ administered concurrently with @DRUG2$, and therefore such use is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1129,
        "sentence": "Two different types of therapy with @DRUG1$ are used: physiological oral magnesium supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the @DRUG2$ intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1130,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1131,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1132,
        "sentence": "Certain antibiotic, cisplatin, cyclosporine, diuretic, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1133,
        "sentence": "@DRUG1$ has been reported to significantly alter the metabolism of nonsedating antihistamines @DRUG2$ and astemizole when taken concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1134,
        "sentence": "- @DRUG1$ (e.g., Aldomet) Use of @DRUG2$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1135,
        "sentence": "There have been reports of interactions of @DRUG1$ with @DRUG2$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1136,
        "sentence": "Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including @DRUG1$, @DRUG2$ (metronidazole or ciprofloxacin) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1137,
        "sentence": "At 24 hours postdose, a similar proportion of patients treated with methotrexate alone (94%) and subsequently treated with @DRUG1$ co-administered with 75 mg of rofecoxib (88%) had @DRUG2$ plasma concentrations below the measurable limit (5 ng/mL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1138,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, @DRUG1$, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of @DRUG2$, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1139,
        "sentence": "- @DRUG1$ (e.g., Depakene) Use of @DRUG2$ with these medicines may increase the chance of side effects affecting the liver",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1140,
        "sentence": "@DRUG1$, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect @DRUG2$ pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1141,
        "sentence": "In a controlled clinical trial, a 20% reduction of the phenytoin dose at the initiation of @DRUG1$  therapy resulted in phenytoin levels comparable to those prior to @DRUG2$  administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1142,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, @DRUG2$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1143,
        "sentence": "Concurrent use of butorphanol with @DRUG1$ (e.g., @DRUG2$, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1144,
        "sentence": "Effects of @DRUG1$ on @DRUG2$  The coadministration of erythromycin (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax, Cmin, AUC, CI/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1145,
        "sentence": "Additive depressant effect when used with general anesthetics, sedatives, @DRUG1$, hypnotics, @DRUG2$, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1146,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1147,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1148,
        "sentence": "@DRUG1$s: @DRUG2$ should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1149,
        "sentence": "therefore, plasma concentrations of @DRUG1$ should also be monitored when it is given concurrently with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1150,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1151,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of @DRUG1$ of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1152,
        "sentence": "@DRUG1$: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor @DRUG2$ .",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1153,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, @DRUG2$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1154,
        "sentence": "@DRUG1$ has been administered without any evidence of an adverse drug interaction to patients receiving @DRUG2$, beta-blocking agents, and nonsteroidal anti-inflammatory drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1155,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG1$ [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1156,
        "sentence": "The @DRUG1$, including alprazolam, produce additive CNS depressant effects when co-administered with other @DRUG2$, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1157,
        "sentence": "Serum theophylline concentrations increase when @DRUG1$ is initiated in a patient maintained on @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1158,
        "sentence": "The Cmax of @DRUG1$ was 13% higher when it was coadministered with @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1159,
        "sentence": "Experience with nonsteroidal anti-inflammatory drugs (@DRUG1$) suggests the potential for interactions with furosemide and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1160,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1161,
        "sentence": "@DRUG1$ increased mean @DRUG2$ plasma concentrations (AUC) by 29%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1162,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1163,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1164,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most @DRUG1$ (SSRIs, many tricyclics), @DRUG2$, antiarrhythmics, and antipsychotics are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1165,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1166,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1167,
        "sentence": "@DRUG1$: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to increased risk of @DRUG2$ side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1168,
        "sentence": "Alternatives to @DRUG1$,such as @DRUG2$, should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1169,
        "sentence": "In this study we investigated the effect of ginsenosides on high threshold voltage-dependent Ca(2+) channel subtypes using their @DRUG1$ nimodipine (L-type), @DRUG2$ (N-type), or omega-agatoxin IVA (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1170,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, @DRUG1$, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1171,
        "sentence": "The actions of the @DRUG1$ may be potentiated by barbiturates, narcotics, phenothiazines, @DRUG2$ or other antidepressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1172,
        "sentence": "@DRUG1$ may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max @DRUG2$ by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1173,
        "sentence": "CNS-Active Drugs @DRUG1$ An additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1174,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1175,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1176,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1177,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1178,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG1$, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1179,
        "sentence": "Digoxin: Some @DRUG1$ may increase the concentration of @DRUG2$ in the blood.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1180,
        "sentence": "and @DRUG1$ When @DRUG2$ is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1181,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1182,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1183,
        "sentence": "@DRUG1$ works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of @DRUG2$ does not appear to overlap to any great extent with that associated with cyclosporine or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1184,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, @DRUG1$, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1185,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1186,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1187,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1188,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1189,
        "sentence": "- a beta-blocker such as propranolol (Inderal), @DRUG1$ (Tenormin), acebutolol (Sectral), @DRUG2$ (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1190,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1191,
        "sentence": "Cimetidine - In subjects who had received 21 days of 40 mg/day racemic @DRUG1$, combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in @DRUG2$ AUC and Cmax of 43% and 39%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1192,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other opioids, general @DRUG2$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1193,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some azoles and other drugs that are highly protein bound, salicylates, @DRUG2$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1194,
        "sentence": "Sublingual @DRUG1$ may be taken if necessary for the control of acute angina attacks during @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1195,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1196,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1197,
        "sentence": "Patients receiving other @DRUG1$, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with @DRUG2$ and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1198,
        "sentence": "The administration of local anesthetic solutions containing epinephrine or @DRUG1$ to patients receiving @DRUG2$ or tricyclic antidepressants may produce severe, prolonged hypertension.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1199,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1200,
        "sentence": "@DRUG1$ (SSRIs) (e.g., fluoxetine, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1201,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1202,
        "sentence": "@DRUG1$, as with other beta2-agonists, should be administered with extreme caution to patients being treated with @DRUG2$, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1203,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1204,
        "sentence": "Immunosuppressive Drugs, @DRUG1$, Niacin (Nicotinic Acid, @DRUG2$, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1205,
        "sentence": "This drug may interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG2$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1206,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (@DRUG2$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1207,
        "sentence": "In clinical studies, coadministration of WelChol  with atorvastatin, lovastatin, or @DRUG1$ did not interfere with the lipid-lowering activity of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1208,
        "sentence": "Selegiline: @DRUG1$ may increase the serum concentration of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1209,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1210,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general @DRUG1$, local anesthetics like lidocaine, procaine, beta-blockers, metaclopramide, @DRUG2$, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1211,
        "sentence": "The concurrent use of @DRUG1$ Injection with other anticholinergics or medications with anticholinergic activity, such as phenothiazines, @DRUG2$, or tricyclic antidepressants, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1212,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., @DRUG1$, triamterene, @DRUG2$), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1213,
        "sentence": "@DRUG1$ levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning @DRUG2$ therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1214,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, @DRUG2$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1215,
        "sentence": "Calcium Antagonists: After repeated co-administration of @DRUG1$, the AUC of @DRUG2$ was lowered by 28% [90% CI: 20-33].",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1216,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1217,
        "sentence": "Cerubidine should not be used in patients who have previously received the recommended maximum cumulative doses of @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1218,
        "sentence": "However, it was observed that the pharmacokinetics of @DRUG1$  was unaltered by concomitant @DRUG2$ in rheumatoid arthritis patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1219,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of @DRUG1$ and serotonergic agents, including antidepressants such as selective serotonin reuptake inhibitors (@DRUG2$), have been reported.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1220,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1221,
        "sentence": "However, since @DRUG1$, @DRUG2$, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1222,
        "sentence": "Drug interaction studies with @DRUG1$ and these imidazole and @DRUG2$ have not been conducted.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1223,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of @DRUG1$-containing or @DRUG2$ (like dihydroergotamine or methysergide) and FROVA within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1224,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that sirolimus, in combination with cyclosporine or tacrolimus, might have the potential to reduce the frequency of rejection episodes, permit reductions in @DRUG1$ or @DRUG2$ dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1225,
        "sentence": "Use of @DRUG1$ with @DRUG2$ (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1226,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1227,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1228,
        "sentence": "When administered concurrently, the following drugs may interact with @DRUG1$: @DRUG2$, general: exaggeration of the hypotension induced by general anesthetics.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1229,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG1$ as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1230,
        "sentence": "@DRUG1$: In one study of 10 healthy volunteers, administration of @DRUG2$ for 45 minutes at a plasma concentration of 1 (one) ng/mL resulted in no clinically meaningful increases in the magnitude or neuromuscular blockade associated with rocuronium administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1231,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local @DRUG1$ like lidocaine, @DRUG2$, beta-blockers, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1232,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1233,
        "sentence": "certain @DRUG1$ (such as @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1234,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, @DRUG1$ 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of @DRUG2$ ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1235,
        "sentence": "These include probenecid, @DRUG1$, and some antibiotics (e.g. erythromycin, rifamipicin, @DRUG2$ and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1236,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1237,
        "sentence": "Tablets: The benzodiazepines, including lorazepam, produce CNS-depressant effects when administered with such medications as @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1238,
        "sentence": "@DRUG1$: mammalian target of @DRUG2$ inhibitor to prevent kidney rejection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1239,
        "sentence": "These in vitro studies suggest that concomitant administration of zalcitabine and @DRUG1$ in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine, which may lead to a decreased @DRUG2$ effect of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1240,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1241,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1242,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1243,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with @DRUG1$ because plasma concentrations of @DRUG2$ are decreased when administered with antacids containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1244,
        "sentence": "Cisapride should not be used concomitantly with other drugs known to prolong the QT interval: certain @DRUG1$, including those of Class IA (such as quinidine and @DRUG2$) and Class III (such as sotalol);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1245,
        "sentence": "Co-administration with efavirenz or @DRUG1$ had a modest effect on the pharmacokinetics of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1246,
        "sentence": "Certain @DRUG1$, cisplatin, @DRUG2$, diuretic, foscarnet, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1247,
        "sentence": "The concomitant use of @DRUG1$ or proton pump inhibitors with @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1248,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1249,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar, ketamine, or @DRUG1$ but not after administration of fentayl alone or after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1250,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1251,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1252,
        "sentence": "Both @DRUG1$ and ibogaine are sequestered in fat and, like @DRUG2$, 18-MC probably has an active metabolite.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1253,
        "sentence": "Immunosuppressive Drugs, Fibric Acid Derivatives, Niacin (@DRUG1$, @DRUG2$, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1254,
        "sentence": "The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, @DRUG1$, monoamine oxidase inhibitors or other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1255,
        "sentence": "When concomitant treatment with agents with b-blocking properties and @DRUG1$ is to be terminated, the @DRUG2$ should be discontinued first.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1256,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1257,
        "sentence": "Methotrexate: Concomitant administration of methotrexate and some @DRUG1$ has been reported to reduce the clearance of @DRUG2$, enhancing the toxicity of methotrexate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1258,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG1$, sedatives, or @DRUG2$) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1259,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1260,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), @DRUG1$, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1261,
        "sentence": "Oral @DRUG1$ and other hormonalmethods of birth control should not be usedas the sole method of contraception inwomen taking @DRUG2$, since nevirapinemay lower the plasma levels of thesemedications.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1262,
        "sentence": "@DRUG1$s: VIDEX should be administered at least 2 hours after or 6 hours before dosing with @DRUG2$ because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1263,
        "sentence": "@DRUG1$ elicited 62% enhancement of post-@DRUG2$ lipolytic activity and 100% increase of 3H-triglyceride fractional clearance rate compared with placebo treatment.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1264,
        "sentence": "Beta-blockers, clonidine, lithium salts, and @DRUG1$ may either potentiate or weaken the blood-glucose-lowering effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1265,
        "sentence": "Anesthetics/Sedatives/Hypnotics/@DRUG1$: Co-administration of PRECEDEX with @DRUG2$, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1266,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1267,
        "sentence": "@DRUG1$ (NSAIDs): The concomitant administration of a @DRUG2$ with a quinolone may increase the risks of CNS stimulation and convulsions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1268,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1269,
        "sentence": "Specific and aspecific treatments of magnesium depletion are tricky using for example @DRUG1$, pharmacological doses of vitamin B6, physiological doses of vitamin D and of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1270,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, @DRUG1$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1271,
        "sentence": "@DRUG1$, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or @DRUG2$ did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1272,
        "sentence": "@DRUG1$ - Combined administration of racemic citalopram (40 mg/day for 14 days) and @DRUG2$ (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1273,
        "sentence": "Increased nephrotoxicity has been reported following concomitant administration of @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1274,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, @DRUG1$ or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1275,
        "sentence": "@DRUG1$: In cases of propoxyphene overdosage, @DRUG2$ CNS stimulation is potentiated and fatal convulsions can occur.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1276,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1277,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1278,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, rifabutin, @DRUG1$, phenytoin, @DRUG2$, phenobarbital and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1279,
        "sentence": "A smaller 24-week study has suggested @DRUG1$ may be superior to the PI @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1280,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1281,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines @DRUG2$ (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1282,
        "sentence": "@DRUG1$: @DRUG2$ may provoke vasoconstriction in some patients, predisposing to a greater ischemic response to ergot therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1283,
        "sentence": "Thus, when @DRUG1$ and @DRUG2$ are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1284,
        "sentence": "While all the selective @DRUG1$ (SSRIs), e.g., fluoxetine, sertraline, and @DRUG2$, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1285,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1286,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1287,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG2$, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1288,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), @DRUG2$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1289,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG1$, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1290,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1291,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG2$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1292,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG1$, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1293,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of @DRUG1$, and enhance the effects of the oral @DRUG2$ warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1294,
        "sentence": "@DRUG1$ doses, trough concentrations, and AUC exhibited similar temporal patterns during the course of the study regardless of the co-administered @DRUG2$ dose level (P = .13, .82, and .76, respectively).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1295,
        "sentence": "Steroids enhance the renal toxicity of @DRUG1$ in animals. 7 Edetate calcium disodium interferes with the action of @DRUG2$ preparations by chelating the zinc. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1296,
        "sentence": "However, in vivo drug interaction studies of @DRUG1$ with @DRUG2$ have not been investigated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1297,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1298,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1299,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1300,
        "sentence": "Certain drugs including thiazides, corticosteroids, @DRUG1$, and sympathomimetics may reduce the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1301,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1302,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1303,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1304,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG1$ suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1305,
        "sentence": "Warfarin: When healthy subjects were administered @DRUG1$ 120 mg three times daily before meals for four days in combination with a single dose of @DRUG2$ 30 mg on day 2, there were no alterations in the pharmacokinetics of either agent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1306,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1307,
        "sentence": "Other antiarrhythmic drugs (eg, quinidine, @DRUG1$, lidocaine, @DRUG2$) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1308,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, cetirizine, famotidine, fluconazole, lamivudine, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1309,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG1$ and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG2$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1310,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1311,
        "sentence": "@DRUG1$ may potentiate the hypotensive effects of antihypertensive drugs and the anticholinergic effects of @DRUG2$-type drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1312,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1313,
        "sentence": "Animal experience indicates that @DRUG1$ prolongs the sleeping time after hexobarbital or after @DRUG2$, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1314,
        "sentence": "Plasma concentrations of @DRUG1$ should therefore be closely monitored, and its dosage reduced accordingly, in patients treated with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1315,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (@DRUG1$, cyclosporin, azathioprine, methotrexate, @DRUG2$), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1316,
        "sentence": "and calcium channel antagonists e.g., verapamil), CYP1A2 inducers (@DRUG1$) and CYP1A2 inhibitors (@DRUG2$ and clarithromycin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1317,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, @DRUG1$, or an estrogen/@DRUG2$ oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1318,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1319,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by @DRUG1$ or proton pump inhibitors (eg, famotidine and omeprazole) is likely to reduce @DRUG2$ exposure.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1320,
        "sentence": "In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after @DRUG1$ and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of @DRUG2$ in healthy middle-aged subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1321,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, hydrochlorothiazide, cimetidine, @DRUG2$, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1322,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1323,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1324,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1325,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (@DRUG1$), acebutolol (Sectral), @DRUG2$ (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1326,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1327,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1328,
        "sentence": "Other antiarrhythmic drugs (eg, quinidine, @DRUG1$, lidocaine, propranolol) have occasionally been used concurrently with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1329,
        "sentence": "Patients receiving other narcotic analgesics, @DRUG1$, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with @DRUG2$ and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1330,
        "sentence": "Local and some general @DRUG1$, @DRUG2$ and other drugs that interfere with neuromuscular transmission should be used cautiously, if at all, in patients with myasthenia gravis;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1331,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1332,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1333,
        "sentence": "Similarly, the effects of phenytoin on @DRUG1$, valproic acid and sodium plasma @DRUG2$ concentrations are unpredictable",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1334,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1335,
        "sentence": "No significant interactions with @DRUG1$, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral @DRUG2$, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1336,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1337,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1338,
        "sentence": "Patients receiving other narcotic analgesics, @DRUG1$, @DRUG2$, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1339,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1340,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1341,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1342,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG2$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1343,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, @DRUG1$, ketoconazole, @DRUG2$ and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1344,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1345,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1346,
        "sentence": "@DRUG1$: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1347,
        "sentence": "Anesthetics/@DRUG1$/Hypnotics/Opioids: Co-administration of @DRUG2$ with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1348,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on @DRUG1$ : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG2$ with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1349,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an @DRUG1$/progesterone oral contraceptive produced minor changes in the pharmacokinetics of @DRUG2$, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1350,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, alfentanil, cisapride, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1351,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1352,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1353,
        "sentence": "In a study in diabetics with microalbuminuria INSPRA 200 mg combined with the @DRUG1$ @DRUG2$ 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on enalapril alone to 38%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1354,
        "sentence": "@DRUG1$: In normal volunteers, the concomitant administration of @DRUG2$ and furosemide had no effect on the diuretic activity of furosemide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1355,
        "sentence": "The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, @DRUG1$, @DRUG2$, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1356,
        "sentence": "Marked symptomatic orthostatic hypotension has been reported when @DRUG1$ and organic @DRUG2$ were used in combination.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1357,
        "sentence": "SINCE @DRUG1$ RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER @DRUG2$ RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1358,
        "sentence": "Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using @DRUG1$, but not with those using @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1359,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1360,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, @DRUG2$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1361,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1362,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1363,
        "sentence": "Concomitant administration of @DRUG1$ and calcium carbonate, cimetidine, omeprazole, or an @DRUG2$/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1364,
        "sentence": "It is concluded that @DRUG1$ modulates in an opposite way the function of the enkephalinergic neurons and the central action of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1365,
        "sentence": "@DRUG1$ and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1366,
        "sentence": "Drug Interactions with @DRUG1$: Concomitant use of fenoldopam with @DRUG2$ should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1367,
        "sentence": "Skeletal muscle relaxants: amphotericin B-induced hypokalemia may enhance the curariform effect of @DRUG1$ (e.g., @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1368,
        "sentence": "@DRUG1$: acute pulmonary toxicity has been reported in patients receiving intravenous amphotericin B and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1369,
        "sentence": "In addition, studies in healthy volunteers have shown that @DRUG1$ does not affect the pharmacokinetics or pharmacodynamics of @DRUG2$, or the pharmacokinetics of propranolol (40 mg twice daily), phenytoin, theophylline, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1370,
        "sentence": "Concurrent use of @DRUG1$ with central nervous system depressants (e.g., alcohol, barbiturates, @DRUG2$, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1371,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG2$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1372,
        "sentence": "No interaction with the @DRUG1$ @DRUG2$ was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1373,
        "sentence": "Phenytoin: If @DRUG1$ is given concurrently with @DRUG2$, the protein binding of phenytoin may be reduced.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1374,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1375,
        "sentence": "If @DRUG1$ are required during OMNICEF therapy, @DRUG2$ should be taken at least 2 hours before or after the antacid.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1376,
        "sentence": "@DRUG1$ may prevent the urinary antiseptic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1377,
        "sentence": "@DRUG1$ or H 2 receptor antagonists: When dirithromycin is administered immediately following @DRUG2$ or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1378,
        "sentence": "Oral Contraceptives @DRUG1$ did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1379,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1380,
        "sentence": "Ethoxzolamide may increase the action of @DRUG1$, amphetamines, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1381,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral @DRUG1$ @DRUG2$ and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1382,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG1$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1383,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and @DRUG2$ (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1384,
        "sentence": "and calcium channel antagonists e.g., verapamil), CYP1A2 inducers (omeprazole) and CYP1A2 inhibitors (@DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1385,
        "sentence": "Agents Increasing Serum Potassium: Enalapril and @DRUG1$ IV attenuate potassium loss caused by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1386,
        "sentence": "Cyclosporine, @DRUG1$ and digoxin concentrations should be monitored at the initiation of @DRUG2$ therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1387,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG1$, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1388,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, @DRUG1$, methotrexate, @DRUG2$, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1389,
        "sentence": "@DRUG1$: Ketoconazole may inhibit both synthetic and catabolic enzymes of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1390,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1391,
        "sentence": "@DRUG1$/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with @DRUG2$, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1392,
        "sentence": "@DRUG1$ injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, @DRUG2$), patients should be observed closely for development of hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1393,
        "sentence": "It is recommended that the combination of intravenous @DRUG1$ and calcium channel blockers, such as @DRUG2$, not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1394,
        "sentence": "Dexamethasone at 10(-10) M or @DRUG1$ at about 3 X 10(-9) M inhibits proliferation stimulated by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1395,
        "sentence": "We examined the effect of exogenous @DRUG1$ on the changes in serum steroid hormone levels induced by a nonlethal dose of Escherichia coli endotoxin in male rats and the deaths due to nonlethal and lethal doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1396,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1397,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., @DRUG2$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1398,
        "sentence": "Since @DRUG1$ may reduce pulse and blood pressure, caution in using drugs such as @DRUG2$ (ophthalmic and systemic), antihypertensives, and cardiac glycosides is advised.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1399,
        "sentence": "Heparin: Since heparin is contraindicated in patients with heparin-induced thrombocytopenia, the co-administration of @DRUG1$ and @DRUG2$ is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1400,
        "sentence": "Drug Interactions with @DRUG1$ Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and @DRUG2$ containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1401,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1402,
        "sentence": "@DRUG1$: @DRUG2$ has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to increased risk of corticosteroid side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1403,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1404,
        "sentence": "d-amphetamine with @DRUG1$ or protriptyline and possibly other @DRUG2$ cause striking and sustained increases in the concentration of d-amphetamine in the brain;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1405,
        "sentence": "Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma @DRUG1$ and reduction in renal @DRUG2$ clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1406,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1407,
        "sentence": "@DRUG1$ Reversible increases in serum @DRUG2$ concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1408,
        "sentence": "SINCE CHOLESTYRAMINE @DRUG1$ MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE @DRUG2$ (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1409,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with @DRUG1$ or ranitidine did not affect @DRUG2$ pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1410,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1411,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, @DRUG1$, omeprazole, or an estrogen/progesterone oral @DRUG2$ produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1412,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1413,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term @DRUG1$ therapy (eg, @DRUG2$, carbamazepine, or phenobarbital) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1414,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1415,
        "sentence": "Amphotericin B injection and potassium-depleting agents: When @DRUG1$ are administered concomitantly with potassium-depleting agents (e.g., @DRUG2$, diuretics), patients should be observed closely for development of hypokalemia.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1416,
        "sentence": "@DRUG1$ and @DRUG2$ each may be associated with increased serum potassium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1417,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of @DRUG1$ with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental @DRUG2$ reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1418,
        "sentence": "@DRUG1$ may decrease the hypotensive effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1419,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG2$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1420,
        "sentence": "In a parallel group drug interaction study comparing the intravenous prodrug form of @DRUG1$ at 40 mg BID (n=10) vs placebo (n=9), valdecoxib had no effect on in vitro @DRUG2$-mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1421,
        "sentence": "Tolbutamide: @DRUG1$, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of @DRUG2$ and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1422,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1423,
        "sentence": "in one man, the C max of terfenadine was 8.1 ng/mL with @DRUG1$ alone and 7.2 ng/mL with @DRUG2$ plus dirithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1424,
        "sentence": "@DRUG1$, tacrolimus, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1425,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1426,
        "sentence": "Limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50% for the first sixty (60) minutes following ALFENTA induction The concomitant use of @DRUG1$ with @DRUG2$ can significantly inhibit ALFENTA clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1427,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1428,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with @DRUG2$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1429,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1430,
        "sentence": "Coadministration of oral contraceptives, @DRUG1$, @DRUG2$, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1431,
        "sentence": "Since INVIRASE is coadministered with @DRUG1$, the @DRUG2$ label should be reviewed for additional drugs that should not be coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1432,
        "sentence": "Tablets Simultaneous administration of @DRUG1$ and @DRUG2$ tablets may reduce the natriuretic and antihypertensive effects of furosemide.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1433,
        "sentence": "When ertapenem is co-administered with @DRUG1$ (500 mg p.o. every 6 hours), @DRUG2$ competes for active tubular secretion and reduces the renal clearance of ertapenem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1434,
        "sentence": "Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma @DRUG1$ concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1435,
        "sentence": "@DRUG1$ (@DRUG2$, felbamate, phenobarbital, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1436,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1437,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an @DRUG1$ and magnesium containing antacid (Maalox ) decreased @DRUG2$ AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1438,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1439,
        "sentence": "When coadministered with @DRUG1$ in treatment-naive patients, the recommended dose of atazanavir is 300 mg with @DRUG2$ 100 mg and SUSTIVA 600 mg (all once daily).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1440,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG1$, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1441,
        "sentence": "In a controlled clinical trial, a 20% reduction of the @DRUG1$ dose at the initiation of @DRUG2$  therapy resulted in phenytoin levels comparable to those prior to Felbatol  administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1442,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG1$ (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas @DRUG2$ binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1443,
        "sentence": "@DRUG1$ and Celexa - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to @DRUG2$ given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1444,
        "sentence": "- Methyldopa (e.g., Aldomet) Use of @DRUG1$ with @DRUG2$ may increase the chance of side effects affecting the liver and/or the blood",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1445,
        "sentence": "Amphotericin, Foscarnet, and @DRUG1$: Drugs such as amphotericin, @DRUG2$, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1446,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1447,
        "sentence": "@DRUG1$: lovastatin, @DRUG2$ WARNING potential for serious reactions such as risk of myopathy including rhabdomyolysis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1448,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG2$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1449,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1450,
        "sentence": "Plasma was analyzed for tolbutamide, and urine was analyzed for tolbutamide and its two metabolites, @DRUG1$ and @DRUG2$ by means of HPLC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1451,
        "sentence": "Although there was a slight reduction in blood sugar concentrations during concomitant administration of @DRUG1$ and @DRUG2$, there were no signs or symptoms of hypoglycemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1452,
        "sentence": "Moreover, its activity was enhanced when it was combined with either @DRUG1$ or @DRUG2$ with 90% parasite reduction at the highest concentration tested.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1453,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on @DRUG1$ : @DRUG2$: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1454,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1455,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as @DRUG1$, terfenadine, @DRUG2$, erythromycin, and troleandomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1456,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1457,
        "sentence": "Should it be decided to discontinue therapy in patients receiving @DRUG1$ and @DRUG2$ concurrently, the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1458,
        "sentence": "Nonsteroidal anti-inflammatory agents (NSAIDS): Concomitant use of @DRUG1$ (or other nonsteroidal antiinflammatory agents) and @DRUG2$ increases the risk of gastrointestinal side effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1459,
        "sentence": "@DRUG1$: The concurrent administration of @DRUG2$ does not affect the bioavailability of meclofenamate sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1460,
        "sentence": "@DRUG1$ @DRUG2$ 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1461,
        "sentence": "In a single study, rats given high intraperitoneal doses of an @DRUG1$ plus @DRUG2$ experienced severe toxicity, including convulsions and death.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1462,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1463,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like @DRUG1$, procaine, @DRUG2$, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1464,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG1$], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1465,
        "sentence": "Studies in healthy volunteers have shown that @DRUG1$ has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1466,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1467,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1468,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1469,
        "sentence": "@DRUG1$: Although the results of a clinical study did not indicate a safe problem associated with the administration of @DRUG2$  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1470,
        "sentence": "Studies showed that diltiazem increased the AUC of @DRUG1$ and @DRUG2$ by 3-4 fold and the Cmax by 2-fold, compared to placebo.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1471,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1472,
        "sentence": "Certain drugs including thiazides, corticosteroids, thyroid products, and @DRUG1$ may reduce the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1473,
        "sentence": "In another drug interaction study, co-administration of orally inhaled ciclesonide and oral @DRUG1$, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of @DRUG2$ remained unchanged.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1474,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1475,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1476,
        "sentence": "@DRUG1$: @DRUG2$ 400 mg daily did not have any clinically important effect on the pharmacokinetics of rofecoxib.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1477,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG2$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1478,
        "sentence": "Steroids enhance the renal toxicity of @DRUG1$ in animals. 7 @DRUG2$ interferes with the action of zinc insulin preparations by chelating the zinc. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1479,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1480,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1481,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1482,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG1$, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1483,
        "sentence": "Loop Diuretics: @DRUG1$ administered concurrently with captopril does not alter the pharmacokinetics of @DRUG2$ in renally impaired hypertensive patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1484,
        "sentence": "Talk to your doctor if you are taking certain antibiotics such as erythromycin, @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1485,
        "sentence": "It is recommended that serum lithium levels be monitored frequently if @DRUG1$ is administered concomitantly with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1486,
        "sentence": "This article looks at five commonly used @DRUG1$ in turn (@DRUG2$, cyclosporin, azathioprine, methotrexate, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1487,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral @DRUG1$, tolbutamide, or @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1488,
        "sentence": "Cholestyramine: @DRUG1$ may increase the clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1489,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1490,
        "sentence": "Resveratrol (5-35 micromol/l) induced concentration-dependent relaxation of mesenteric arteries preconstricted with @DRUG1$ (8 micromol/l) or @DRUG2$ (125 mmol/l) from both lean and dietary-obese rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1491,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, @DRUG1$, nicotinic acid (niacin), @DRUG2$, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1492,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1493,
        "sentence": "However, in clinical studies the consequences of concomitant @DRUG1$ on the pharmacodynamics of @DRUG2$ were negligible.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1494,
        "sentence": "@DRUG1$: In a study in healthy volunteers, a six-day course of @DRUG2$ at 600 mg/day followed by a single 5 mg dose of isradipine resulted in a reduction in isradipine levels to below detectable limits.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1495,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1496,
        "sentence": "Drug Interactions, General: Although there have been no formal interaction studies, intravenous @DRUG1$ has been administered safely with drugs such as digitalis and sublingual @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1497,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG1$, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1498,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG1$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1499,
        "sentence": "Concomitant treatment with methylxanthines (@DRUG1$, @DRUG2$), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1500,
        "sentence": "Fluconazole and @DRUG1$: @DRUG2$ and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1501,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1502,
        "sentence": "Interactions between treatments with @DRUG1$, bishydroxycoumarin (an anticoagulant), @DRUG2$ (an organophosphorous compound), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1503,
        "sentence": "Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of @DRUG1$ preparations by chelating the @DRUG2$. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1504,
        "sentence": "The actions of the benzodiazepines may be potentiated by @DRUG1$, narcotics, @DRUG2$, monoamine oxidase inhibitors or other antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1505,
        "sentence": "Nonsteroidal Anti-inflammatory Drugs (@DRUG1$): The concomitant administration of a @DRUG2$ with a quinolone may increase the risks of CNS stimulation and convulsions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1506,
        "sentence": "Oral @DRUG1$ Interaction studies with warfarin and @DRUG2$ failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1507,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG1$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1508,
        "sentence": "The actions of the benzodiazepines may be potentiated by @DRUG1$, @DRUG2$, phenothiazines, monoamine oxidase inhibitors or other antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1509,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1510,
        "sentence": "These data suggest that @DRUG1$ are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an @DRUG2$-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1511,
        "sentence": "Failure of @DRUG1$ to modify @DRUG2$ induced hypertension in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1512,
        "sentence": "Subjects treated with 200 mg of @DRUG1$ twice daily for 21 days received 1200 mg of @DRUG2$ or an equivalent amount of placebo/day for Days 8 to 21.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1513,
        "sentence": "The uptake inhibitors @DRUG1$ and desipramine (3 mumol/liter) potentiated the positive inotropic effects of @DRUG2$ in nonfailing myocardium (p < 0.05) but not in functional class IV myocardium.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1514,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, @DRUG1$, or other CNS depressants (including @DRUG2$) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1515,
        "sentence": "In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when @DRUG1$ are started thus increasing @DRUG2$ requirements.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1516,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1517,
        "sentence": "Ethoxzolamide may increase the action of @DRUG1$, @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1518,
        "sentence": "However, caution should be exercised because there have been a few spontaneous reports of prolonged prothrombin times, with or without bleeding, in @DRUG1$-treated patients receiving concomitant @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1519,
        "sentence": "Several @DRUG1$ have been reported to block the pharmacologic effects of @DRUG2$, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1520,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1521,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1522,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1523,
        "sentence": "Inhibitors or substrates of CYP2D6 (i.e., @DRUG1$, @DRUG2$ [SSRIs]) may increase the plasma concentration of doxepin when administered concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1524,
        "sentence": "These pharmacokinetic effects seen during @DRUG1$ coadministration can result in increased clinical effects (e.g., prolonged sodation)of both @DRUG2$ and triazolam.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1525,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG1$, the phenothiazines, @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1526,
        "sentence": "In this study we investigated the effect of ginsenosides on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers @DRUG1$ (L-type), omega-conotoxin GVIA (N-type), or @DRUG2$ (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1527,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas @DRUG2$ binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1528,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1529,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG1$ and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1530,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, phenothiazines, and the Type 1C antiarrhythmics @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1531,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1532,
        "sentence": "These include @DRUG1$, cholestyramine, and some antibiotics (e.g. erythromycin, rifamipicin, ampicillin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1533,
        "sentence": "Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., @DRUG2$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1534,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG1$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1535,
        "sentence": "Therefore, if theophylline is co-administered with @DRUG1$, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of @DRUG2$ should to monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1536,
        "sentence": "Certain drugs including @DRUG1$, corticosteroids, @DRUG2$, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1537,
        "sentence": "These in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine, which may lead to a decreased @DRUG1$ effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1538,
        "sentence": "Prednisolone: @DRUG1$ may inhibit the metabolism of @DRUG2$, leading to increased plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1539,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, @DRUG1$, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1540,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with @DRUG1$, with metal cations such as iron, or with multivitamins containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1541,
        "sentence": "Comparison of @DRUG1$ pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without thiosulfate indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1542,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1543,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG1$], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1544,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with @DRUG1$, @DRUG2$, ketoconazole, erythromycin and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1545,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1546,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and @DRUG1$), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1547,
        "sentence": "@DRUG1$ Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with @DRUG2$, and with some angiotensin II receptor antagonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1548,
        "sentence": "The @DRUG1$, including @DRUG2$, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1549,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1550,
        "sentence": "Data from a randomized trial of @DRUG1$ and cisplatin plus or minus @DRUG2$ in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1551,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG1$ and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1552,
        "sentence": "When administered concurrently, the following drugs may interact with @DRUG1$: Anesthetics, general: exaggeration of the hypotension induced by general @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1553,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1554,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1555,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1556,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1557,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, @DRUG2$, and the Type 1C antiarrhythmics propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1558,
        "sentence": "Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, @DRUG1$, @DRUG2$, or ranitidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1559,
        "sentence": "Dexbrompheniramine can interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG2$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1560,
        "sentence": "and @DRUG1$ When amitriptyline HCl is given with anticholinergic agents or @DRUG2$ drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1561,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and @DRUG2$), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1562,
        "sentence": "@DRUG1$: Grepafloxacin is a competitive inhibitor of the metabolism of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1563,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1564,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1565,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, @DRUG1$, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1566,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing @DRUG1$ or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1567,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1568,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1569,
        "sentence": "When @DRUG1$ and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when @DRUG2$ is used alone because pralidoxime may potentiate the effect of atropine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1570,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1571,
        "sentence": "- @DRUG1$ (@DRUG2$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1572,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1573,
        "sentence": "@DRUG1$: Some calcium blockers may increase the concentration of @DRUG2$ in the blood.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1574,
        "sentence": "Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1575,
        "sentence": "A causal relationship between these events and the concomitant administration of @DRUG1$ and @DRUG2$ has not been established;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1576,
        "sentence": "As with other @DRUG1$, if COREG is to be administered orally with calcium channel blockers of the verapamil or @DRUG2$ type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1577,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1578,
        "sentence": "During concomitant therapy with @DRUG1$, the patient should be observed closely for signs of renal failure, as well as to assure @DRUG2$ efficacy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1579,
        "sentence": "and @DRUG1$ When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including @DRUG2$ combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1580,
        "sentence": "Phase II clinical trial data, where @DRUG1$ and @DRUG2$ have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1581,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of @DRUG1$ on the concomitant anesthetic, sedative, @DRUG2$ or opioid may be required.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1582,
        "sentence": "The actions of the benzodiazepines may be potentiated by @DRUG1$, narcotics, phenothiazines, @DRUG2$ or other antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1583,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1584,
        "sentence": "Concurrent use of butorphanol with @DRUG1$ (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased @DRUG2$ effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1585,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, @DRUG1$, @DRUG2$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1586,
        "sentence": "The concomitant administration of @DRUG1$ and warfarin resulted in the need for an unusually high maintenance dose of @DRUG2$ (20 mg per day) in order to produce a therapeutic effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1587,
        "sentence": "and calcium channel antagonists e.g., verapamil), CYP1A2 inducers (@DRUG1$) and CYP1A2 inhibitors (furafylline and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1588,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1589,
        "sentence": "Effects of Other Drugs on @DRUG1$ Based on in-vitro studies, @DRUG2$ is metabolized by CYP 3A4.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1590,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : @DRUG1$: Population pharmacokinetic analyses indicate that @DRUG2$ clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1591,
        "sentence": "@DRUG1$: In cases of @DRUG2$ overdosage, amphetamine CNS stimulation is potentiated and fatal convulsions can occur.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1592,
        "sentence": "@DRUG1$: Since heparin is contraindicated in patients with @DRUG2$-induced thrombocytopenia, the co-administration of Argatroban and heparin is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1593,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1594,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG1$, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1595,
        "sentence": "@DRUG1$ did not significantly affect @DRUG2$'s pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1596,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1597,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1598,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1599,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as @DRUG1$, @DRUG2$, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1600,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general @DRUG1$, local anesthetics like lidocaine, procaine, @DRUG2$, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1601,
        "sentence": "Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or @DRUG1$ may potentiate any hypokalemic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1602,
        "sentence": "The ratios of the AUCs of unbound valproate to the AUCs of the total @DRUG1$ were 11.1 %, 13.0%, and 11.5%, with coadministration of 0, 1200, and 2400 mg/day of @DRUG2$ , respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1603,
        "sentence": "@DRUG1$ add some further antihypertensive effect to @DRUG2$, but the overall response is less than additive.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1604,
        "sentence": "Methadone levels may be decreased; increased dosages may be required to prevent symptoms of @DRUG1$ withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and @DRUG2$ dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1605,
        "sentence": "After prolonged administration of @DRUG1$ the displacing effect of cerulein, an analog of cholecystokinin octapeptide, was replaced by the stimulant action on @DRUG2$ binding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1606,
        "sentence": "however, as with other NSAIDs, concomitant administration of @DRUG1$ and @DRUG2$ is not generally recommended because of the potential of increased adverse effects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1607,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1608,
        "sentence": "If signs and symptoms suggestive of digoxin toxicity occur when @DRUG1$ and digoxin are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust @DRUG2$ doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1609,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of @DRUG1$ and serotonergic agents, including antidepressants such as @DRUG2$ (SSRIs), have been reported.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1610,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1611,
        "sentence": "Because @DRUG1$ is metabolized by multiple enzyme systems, inhibition of a single enzyme may not appreciably decrease @DRUG2$ clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1612,
        "sentence": "BROVANA, as with other @DRUG1$, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, @DRUG2$, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1613,
        "sentence": "Concurrent use of butorphanol with @DRUG1$ (e.g., alcohol, @DRUG2$, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1614,
        "sentence": "@DRUG1$: MAOI antidepressants, as well as a metabolite of @DRUG2$, slow amphetamine metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1615,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, rifabutin, rifapentine, phenytoin, @DRUG1$, @DRUG2$ and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1616,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (@DRUG2$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1617,
        "sentence": "Patients on @DRUG1$ therapy may require dosage adjustment of the anticoagulant during and after @DRUG2$ therapy.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1618,
        "sentence": "Because Anafranil is highly bound to serum protein, the administration of Anafranil to patients taking other drugs that are highly bound to protein (e.g., @DRUG1$, @DRUG2$) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1619,
        "sentence": "The extent to which @DRUG1$-TCA interactions may pose clinical problems will depend on the degree of inhibition, and the pharmacokinetics of the @DRUG2$ involved.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1620,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG1$ (e.g., Matulane), selegiline (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1621,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1622,
        "sentence": "@DRUG1$ or Corticosteroids or @DRUG2$ (ACTH)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1623,
        "sentence": "@DRUG1$ enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of @DRUG2$ preparations by chelating the zinc. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1624,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, @DRUG1$, propantheline, @DRUG2$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1625,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG1$, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1626,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., @DRUG1$ 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, @DRUG2$ 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1627,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1628,
        "sentence": "@DRUG1$: Co-administration of bosentan 125 mg b.i.d. and @DRUG2$, a potent CYP3A4 inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1629,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1630,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of @DRUG1$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG2$ (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1631,
        "sentence": "These include probenecid, cholestyramine, and some antibiotics (e.g. erythromycin, rifamipicin, @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1632,
        "sentence": "Because oral anticoagulants may interfere with the hepatic metabolism of @DRUG1$, toxic levels of the anticonvulsant may occur when an oral @DRUG2$ and phenytoin are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1633,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1634,
        "sentence": "When @DRUG1$ @DRUG2$ is given for long periods of time, concomitant supplementation with water-miscible (or parenteral) forms of fat-soluble vitamins should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1635,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (@DRUG1$, barbiturates, opiates, sedatives, or @DRUG2$) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1636,
        "sentence": "@DRUG1$ containing magnesium, aluminum, or @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1637,
        "sentence": "@DRUG1$: When coadministered with @DRUG2$, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1638,
        "sentence": "Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of @DRUG1$ that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an @DRUG2$ or aspirin potentiated the risk of bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1639,
        "sentence": "@DRUG1$ (Didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because these products may interfere with absorption resulting in lower serum and urine levels of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1640,
        "sentence": "Administration of @DRUG1$ with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, @DRUG2$ 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1641,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1642,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, @DRUG1$, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1643,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1644,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, @DRUG1$, rifapentine, phenytoin, carbamazepine, @DRUG2$ and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1645,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1646,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1647,
        "sentence": "Amphotericin B or @DRUG1$ or Corticotropin (@DRUG2$)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1648,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, @DRUG1$, itraconazole, erythromycin, @DRUG2$, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1649,
        "sentence": "Phenobarbital or @DRUG1$ : No formal pharmacokinetic studies have been performed examining the addition of @DRUG2$ to regimens containing phenobarbital or primidone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1650,
        "sentence": "Netilmicin should not be administered concomitantly with potent loop diuretics such as @DRUG1$ and @DRUG2$ as the potential for ototoxicity is enhanced by the combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1651,
        "sentence": "Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since @DRUG1$ and @DRUG2$ may compete for excretion in the renal tubule.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1652,
        "sentence": "@DRUG1$: cyclosporine, @DRUG2$, sirolimus",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1653,
        "sentence": "Anticonvulsants (@DRUG1$, felbamate, phenobarbital, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some @DRUG2$, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1654,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1655,
        "sentence": "Increased toxicity (CNS depression): @DRUG1$, MAO inhibitors, @DRUG2$, phenothiazines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1656,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like @DRUG1$, procaine, beta-blockers, metaclopramide, @DRUG2$, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1657,
        "sentence": "If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because @DRUG1$ amplifies the therapeutic actions and side-effects of @DRUG2$ massively.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1658,
        "sentence": "Concomitant administration of @DRUG1$ and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of @DRUG2$, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1659,
        "sentence": "When @DRUG1$ and @DRUG2$ were concomitantly administered intravenously to normal volunteers, there was a 10-20% increase in digoxin blood levels at some time points.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1660,
        "sentence": "CHOLESTYRAMINE: The influence of the bile-acidsequestering agent @DRUG1$ on the pharmacokinetits of @DRUG2$ was evaluated in 12 healthy males in 2 separate randomized crossover studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1661,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: @DRUG2$, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1662,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1663,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1664,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1665,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, @DRUG2$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1666,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, mycophenolate, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1667,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1668,
        "sentence": "Use of PRINIVIL with potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG1$), @DRUG2$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1669,
        "sentence": "Other @DRUG1$ (eg, quinidine, procainamide, lidocaine, @DRUG2$) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1670,
        "sentence": "Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including @DRUG1$, antibiotics (metronidazole or @DRUG2$) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1671,
        "sentence": "Routine administration of @DRUG1$ or toxoids should be deferred until @DRUG2$ therapy is discontinued if possible.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1672,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG2$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1673,
        "sentence": "Paroxetine: Coadministration of once daily doses of @DRUG1$, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1674,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1675,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1676,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1677,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, @DRUG1$) with felodipine may lead to several- fold increases in the plasma levels of @DRUG2$, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1678,
        "sentence": "Caution in using concomitant drugs such as @DRUG1$ (ophthalmic and systemic), anti-hypertensives and/or @DRUG2$ is advised.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1679,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG2$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1680,
        "sentence": "Potassium-sparing diuretics such as spironolactone, @DRUG1$, or amiloride, or @DRUG2$ supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1681,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1682,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1683,
        "sentence": "@DRUG1$: Rifampin increases the metabolism of ethinyl estradiol and some @DRUG2$ (norethindrone) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1684,
        "sentence": "Elevated serum levels of @DRUG1$ have been reported with the concomitant use of some quinolones and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1685,
        "sentence": "@DRUG1$: A study in normal healthy volunteers has shown that concomitant administration of DynaCirc  (isradipine) and @DRUG2$ does not result in altered pharmacoktnetics of either drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1686,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1687,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1688,
        "sentence": "Co-administration of multiple doses of 10 mg of lenalidomide had no effect on the single dose pharmacokinetics of @DRUG-DRUG$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1689,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1690,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between @DRUG1$ and low affinity binding sites for @DRUG2$ in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1691,
        "sentence": "Aprepitant increased the AUC of @DRUG1$ by 25% on Day 4 and decreased the AUC of @DRUG2$ by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1692,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1693,
        "sentence": "When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when @DRUG1$ is used alone because pralidoxime may potentiate the effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1694,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1695,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1696,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1697,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1698,
        "sentence": "Drug Interactions with @DRUG1$ Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing @DRUG2$ (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1699,
        "sentence": "In vitro data suggest that @DRUG1$ also markedly inhibits the biotransformation system mainly responsible for the metabolism of @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1700,
        "sentence": "Studies with ACE inhibitors in combination with @DRUG1$ indicate that the dose of the @DRUG2$ can be reduced when it is given with a diuretic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1701,
        "sentence": "On the basis of the metabolism of @DRUG1$ by cytochrome P450 3A4, ketoconazole, itraconazole, @DRUG2$, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1702,
        "sentence": "The thiazolidinediones (@DRUG1$ and pioglitazone), a new class of oral @DRUG2$, are \"insulin sensitizers\"",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1703,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1704,
        "sentence": "Those for which effectiveness is reported includes @DRUG1$, hydroxyzine, orphenadrine, pyrilamine, phenyltoloxamine, promethazine, @DRUG2$, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1705,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG1$, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1706,
        "sentence": "Tablets, Injection, and Oral Solution One study in six subjects demonstrated that the combination of @DRUG1$ and @DRUG2$ temporarily reduced creatinine clearance in patients with chronic renal insufficiency.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1707,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1708,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1709,
        "sentence": "The urinary excretion of @DRUG1$ is unaffected by aspirin, indicating no change in @DRUG2$ absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1710,
        "sentence": "Bile acid binding resins may also interfere with the absorption of oral @DRUG1$ supplements and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1711,
        "sentence": "The absorption of @DRUG1$ may be affected by the simultaneous administration of indigestion remedies, @DRUG2$ or zinc supplements.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1712,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG1$, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1713,
        "sentence": "When @DRUG1$ and @DRUG2$ are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1714,
        "sentence": "Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of @DRUG1$ with ACE inhibitors, and with some @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1715,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1716,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1717,
        "sentence": "In patients taking @DRUG1$, @DRUG2$, diltiazem, ACE inhibitors, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1718,
        "sentence": "May lead to loss of virologic response and possible resistance to @DRUG1$ or to the class of protease inhibitors or other coadministered @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1719,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), @DRUG2$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1720,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1721,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1722,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1723,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1724,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1725,
        "sentence": "@DRUG1$, Fibric Acid Derivatives, Niacin (Nicotinic Acid, Erythromycin, @DRUG2$: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1726,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1727,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1728,
        "sentence": "Concomitant use of antihistamines with @DRUG1$, tricyclic antidepressants, @DRUG2$, or other central nervous system depressants may have an additive effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1729,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that @DRUG1$ (1 mg/kg) removes the antiedematous action of diazepam, phenazepam, phenibut and @DRUG2$ and reduces the action of phentolamine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1730,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1731,
        "sentence": "Nafazodone, fluvoxamine, @DRUG1$ (consider @DRUG2$ dose reduction).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1732,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, @DRUG1$, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of @DRUG2$, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1733,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1734,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1735,
        "sentence": "Tablets Simultaneous administration of sucralfate and @DRUG1$ tablets may reduce the natriuretic and antihypertensive effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1736,
        "sentence": "Two different types of therapy with @DRUG1$ are used: physiological oral magnesium supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the magnesium intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic @DRUG2$ overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1737,
        "sentence": "@DRUG1$: acute pulmonary toxicity has been reported in patients receiving intravenous @DRUG2$ and leukocyte transfusions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1738,
        "sentence": "Ketoconazole: Potential interaction of @DRUG1$ and @DRUG2$ may exist.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1739,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1740,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, @DRUG2$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1741,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1742,
        "sentence": "Seizures have been reported in patients taking another @DRUG1$ and the @DRUG2$ fenbufen concurrently.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1743,
        "sentence": "Should it be decided to discontinue therapy in patients receiving @DRUG1$ and clonidine concurrently, the @DRUG2$ should be discontinued slowly over several days before the gradual withdrawal of clonidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1744,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1745,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1746,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1747,
        "sentence": "Warfarin, @DRUG1$, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when @DRUG2$ plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1748,
        "sentence": "Seizures have been reported in patients taking another quinolone class antimicrobial and the @DRUG1$ @DRUG2$ concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1749,
        "sentence": "@DRUG1$ - Combined administration of racemic @DRUG2$ (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1750,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1751,
        "sentence": "@DRUG1$: Concurrent administration of certain anticholinergic compounds, such as belladonna alkaloids and dicyclomine, would be expected to compromise the beneficial effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1752,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1753,
        "sentence": "@DRUG1$ should be used cautiously in conjunction with @DRUG2$ in patients suffering from hypopro-thrombinemia.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1754,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of @DRUG1$ and serotonergic agents, including @DRUG2$ such as selective serotonin reuptake inhibitors (SSRIs), have been reported.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1755,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1756,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1757,
        "sentence": "In patients taking @DRUG1$, nifedipine, diltiazem, ACE inhibitors, verapamil, @DRUG2$, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1758,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1759,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1760,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1761,
        "sentence": "@DRUG1$ may accentuate the electrolyte loss associated with @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1762,
        "sentence": "Oral anticoagulants may potentiate the hypoglycemic action of @DRUG1$, eg, @DRUG2$ and chlorpropamide, by inhibiting their metabolism in the liver.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1763,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1764,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1765,
        "sentence": "Caution should be used if @DRUG1$ is administered simultaneously with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1766,
        "sentence": "May interact with addictive medications, especially @DRUG1$ with habituating potential (prolonged concurrent use may increase the risk of habituation), @DRUG2$ or CNS depression producing medications (concurrent use may increase the CNS depressant effects of either these medications or ethinamate).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1767,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1768,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG1$, coumarins, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1769,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1770,
        "sentence": "Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 @DRUG1$ interferes with the action of zinc insulin preparations by chelating the @DRUG2$. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1771,
        "sentence": "Concomitant treatment with methylxanthines (@DRUG1$, theophylline), @DRUG2$, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1772,
        "sentence": "The uptake inhibitors cocaine and @DRUG1$ (3 mumol/liter) potentiated the positive inotropic effects of @DRUG2$ in nonfailing myocardium (p < 0.05) but not in functional class IV myocardium.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1773,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1774,
        "sentence": "@DRUG1$ or @DRUG2$ or Corticotropin (ACTH)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1775,
        "sentence": "Dexbrompheniramine can interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1776,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1777,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1778,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), @DRUG2$ (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1779,
        "sentence": "Ampicillin: In a study of healthy volunteers, @DRUG1$ significantly reduced the bioavailability of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1780,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or @DRUG1$ did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of @DRUG2$ resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1781,
        "sentence": "When coadministered with SUSTIVA in treatment-naive patients, the recommended dose of @DRUG1$ is 300 mg with @DRUG2$ 100 mg and SUSTIVA 600 mg (all once daily).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1782,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG1$], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1783,
        "sentence": "When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and @DRUG1$ may enhance the action of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1784,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, isosorbide dinitrate, morphine, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1785,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1786,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), @DRUG2$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1787,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, @DRUG1$, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1788,
        "sentence": "Concomitant use of antihistamines with alcohol, tricyclic antidepressants, @DRUG1$, or other @DRUG2$ may have an additive effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1789,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1790,
        "sentence": "Therefore, the potential exists for a drug interaction between @DRUG1$ and drugs that affect the CYP2B6 isoenzyme (e.g., orphenadrine and @DRUG2$).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1791,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, @DRUG2$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1792,
        "sentence": "Carbamazepine: Coadministration of @DRUG1$ (200 mg BID), a potent CYP3A4 inducer, with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1793,
        "sentence": "Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and @DRUG1$ or inhibitors of CYP2C19 such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1794,
        "sentence": "Phase II clinical trial data, where @DRUG1$ and vinorelbine have been used concomitantly, indicate that @DRUG2$ may exacerbate the neutropenic effect of vinorelbine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1795,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1796,
        "sentence": "Neuromuscular Blockers: In one study of 10 healthy volunteers, administration of @DRUG1$ for 45 minutes at a plasma concentration of 1 (one) ng/mL resulted in no clinically meaningful increases in the magnitude or neuromuscular blockade associated with @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1797,
        "sentence": "Digoxin: Coadministration of @DRUG1$, a P-glycoprotein substrate, with oral conivaptan resulted in a reduction in clearance and an increase in @DRUG2$ Cmax and AUC values.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1798,
        "sentence": "Venlafaxine: Coadministration of a single dose of @DRUG1$ 10 mg and multiple doses of @DRUG2$ ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1799,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar, @DRUG1$, or droperidol but not after administration of @DRUG2$ alone or after pentobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1800,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1801,
        "sentence": "- a beta-blocker such as propranolol (Inderal), @DRUG1$ (Tenormin), @DRUG2$ (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1802,
        "sentence": "Drug Interactions with @DRUG1$ Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an @DRUG2$ and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1803,
        "sentence": "It is, however, possible that concomitant use of other known @DRUG1$ such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, @DRUG2$ and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1804,
        "sentence": "Additive depressant effect when used with general anesthetics, @DRUG1$, @DRUG2$, hypnotics, alcohol, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1805,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1806,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG1$, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1807,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of @DRUG1$, and enhance the effects of the oral anticoagulant @DRUG2$ and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1808,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1809,
        "sentence": "@DRUG1$, oral: Co-administration of corticosteroids and warfarin usually results in inhibition of response to @DRUG2$, although there have been some conflicting reports.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1810,
        "sentence": "Concomitant single dose administration of @DRUG1$ 20 mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1811,
        "sentence": "Since Zarontin (@DRUG1$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and @DRUG2$ has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1812,
        "sentence": "Results from human in vitro metabolism studies and nonclinical studies show that @DRUG1$  (lenalidomide) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that @DRUG2$ is not likely to cause or be subject to P450-based metabolic drug interactions in man.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1813,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1814,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1815,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG2$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1816,
        "sentence": "@DRUG1$s: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of @DRUG2$ are decreased when administered with antacids containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1817,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1818,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1819,
        "sentence": "Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as @DRUG1$ and @DRUG2$ or inhibitors of CYP2C19 such as omeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1820,
        "sentence": "Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of @DRUG1$ ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either @DRUG2$ or venlafaxine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1821,
        "sentence": "Effects of sympathomimetics are increased with @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1822,
        "sentence": "Clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the @DRUG1$ dose during the trials due to changes in INR or due to adverse events was similar among @DRUG2$- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1823,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG1$, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1824,
        "sentence": "Ergotamine: Concurrent use of @DRUG1$ and ergotamine or @DRUG2$ has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1825,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, nonbarbiturate hypnotics, @DRUG2$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1826,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1827,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1828,
        "sentence": "In a study of 12 schizophrenic patients coadministered oral @DRUG1$ and @DRUG2$, plasma haloperidol levels were decreased by a mean of 70% and mean scores on the Brief Psychiatric Rating Scale were increased from baseline.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1829,
        "sentence": "The potential effects of @DRUG1$ and @DRUG2$ on potassium kinetics and renal function should be considered when these agents are administered concurrently.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1830,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1831,
        "sentence": "Since bacteriostatic drugs may interfere with the bactericidal action of @DRUG1$, it is advisable to avoid giving tetracyclines in conjunction with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1832,
        "sentence": "- a @DRUG1$ such as propranolol (Inderal), atenolol (@DRUG2$), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1833,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of @DRUG1$ (40 mg twice daily), phenytoin, @DRUG2$, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1834,
        "sentence": "In another drug interaction study, co-administration of orally inhaled @DRUG1$ and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of @DRUG2$ by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1835,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1836,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of @DRUG1$ with a therapeutic iron supplement containing 60 mg of elemental @DRUG2$ (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1837,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1838,
        "sentence": "@DRUG1$ (nadolol,porpranolol,timolol) may exacerbate rebound hypertension when @DRUG2$ is withdrawn.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1839,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1840,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1841,
        "sentence": "- @DRUG1$ (@DRUG2$s) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1842,
        "sentence": "Drugs which induce CYP3A4 activity (eg, phenobarbital, @DRUG1$, @DRUG2$) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1843,
        "sentence": "Drug Interaction with @DRUG1$ and @DRUG2$ Fexofenadine has been shown to exhibit minimal (ca. 5%) metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1844,
        "sentence": "The administration of local anesthetic solutions containing epinephrine or @DRUG1$ to patients receiving monoamine oxidase inhibitors or @DRUG2$ may produce severe, prolonged hypertension.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1845,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1846,
        "sentence": "Those for which effectiveness is reported includes @DRUG1$, hydroxyzine, orphenadrine, pyrilamine, phenyltoloxamine, promethazine, methdilazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1847,
        "sentence": "Coadministration in HIV-infected individuals with a history of injection drug use resulted in decreased plasma levels of @DRUG1$ and signs of @DRUG2$ withdrawal.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1848,
        "sentence": "@DRUG1$/Itraconazole, Macrolides, Including @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1849,
        "sentence": "@DRUG1$, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of @DRUG2$ on the cardiovascular system may be potentiated by these agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1850,
        "sentence": "While it is not known whether this interaction occurs with fibrates other than @DRUG1$, myopathy and rhabdomyolysis have occasionally been associated with the use of @DRUG2$ alone, including clofibrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1851,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1852,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1853,
        "sentence": "In a study of 12 schizophrenic patients coadministered oral haloperidol and @DRUG1$, plasma @DRUG2$ levels were decreased by a mean of 70% and mean scores on the Brief Psychiatric Rating Scale were increased from baseline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1854,
        "sentence": "MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the @DRUG1$ @DRUG2$ .",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1855,
        "sentence": "@DRUG1$ prolong and intensify the anticholinergic effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1856,
        "sentence": "CNS-Active Drugs @DRUG1$ An additive effect on psychomotor performance was seen with coadministration of eszopiclone and @DRUG2$ 0.70 g/kg for up to 4 hours after ethanol administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1857,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1858,
        "sentence": "Concomitant administration of @DRUG1$ and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1859,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of @DRUG1$, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic @DRUG2$ concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1860,
        "sentence": "Other antiarrhythmic drugs (eg, @DRUG1$, @DRUG2$, lidocaine, propranolol) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1861,
        "sentence": "@DRUG1$ pretreatment attenuated the hypotensive effect of a single dose of propranolol but not @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1862,
        "sentence": "Several tricyclic antidepressants have been reported to block the pharmacologic effects of @DRUG1$, @DRUG2$, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1863,
        "sentence": "Fluconazole and @DRUG1$: Ketoconazole and @DRUG2$ are predominantly CYP 3A4 and 2C9 inhibitors, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1864,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG1$, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1865,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or @DRUG2$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1866,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG2$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1867,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (@DRUG1$, cyclosporin, @DRUG2$, methotrexate, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1868,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, cetirizine, famotidine, @DRUG2$, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1869,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of propranolol (40 mg twice daily), @DRUG1$, @DRUG2$, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1870,
        "sentence": "SIDE EFFECTS (@DRUG1$) The most common adverse reaction during treatment with @DRUG2$ is transient drowsiness (10-63%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1871,
        "sentence": "Inhibitors of CYP2D6: Because CYP2D6 is involved in @DRUG1$ metabolism, concomitant use of @DRUG2$ with potent inhibitors of CYP2D6 may result in higher concentrations of duloxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1872,
        "sentence": "Therefore, @DRUG1$, including oral, injectable, transdermal, and implantable forms, may not be reliable when @DRUG2$ is co-administered.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1873,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1874,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1875,
        "sentence": "The combination of therapeutic doses of intravenous @DRUG1$ and verapamil in @DRUG2$ a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1876,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1877,
        "sentence": "@DRUG1$: In cases of @DRUG2$ overdosage, amphetamine CNS stimulation is potentiated and fatal convulsions can occur.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1878,
        "sentence": "@DRUG1$: May increase plasma concentration of @DRUG2$, possibly by inhibiting conjugation.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1879,
        "sentence": "Although there was no effect of Aprepitant on the plasma AUC of @DRUG-DRUG$ determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1880,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an @DRUG1$-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/@DRUG2$/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1881,
        "sentence": "Oral Contraceptives Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1882,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., @DRUG2$), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1883,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG1$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1884,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1885,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG2$, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1886,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1887,
        "sentence": "Rifampin: Rifampin increases the metabolism of ethinyl estradiol and some @DRUG1$ (@DRUG2$) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1888,
        "sentence": "Digoxin: Concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of @DRUG1$ or the mean daily trough serum level of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1889,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1890,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1891,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1892,
        "sentence": "Videx (Didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG1$, because these products may interfere with absorption resulting in lower serum and urine levels of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1893,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, ACE inhibitors, verapamil, @DRUG1$, @DRUG2$, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1894,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1895,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1896,
        "sentence": "@DRUG1$ (carbamazepine, felbamate, @DRUG2$, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1897,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG1$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1898,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of @DRUG1$ may reduce seizure control by lowering the plasma levels of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1899,
        "sentence": "A pharmacokinetic study evaluating the administration of a single dose of @DRUG1$ 100 mg with @DRUG2$ 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1900,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, @DRUG1$, chloramphenicol, probenecid, coumarins, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1901,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1902,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1903,
        "sentence": "The concomitant use of transdermal @DRUG1$ with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, @DRUG2$, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1904,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1905,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, @DRUG2$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1906,
        "sentence": "Repeated oral administration of @DRUG1$ in sheep: interactions of coumaphos with bishydroxycoumarin, @DRUG2$, and phenobarbital sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1907,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1908,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1909,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1910,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin and rifampin may increase the clearance of @DRUG2$ and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1911,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, @DRUG1$, phenytoin, @DRUG2$): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1912,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1913,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1914,
        "sentence": "The most significant drug interactions following administration of @DRUG1$ are expected to occur with drugs that interact with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1915,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1916,
        "sentence": "The behavioral effects of the stereoisomers of N-allylnormetazocine (@DRUG1$) were compared with those of phencyclidine (@DRUG2$) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1917,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1918,
        "sentence": "@DRUG1$ and sucralfate: Sucralfate and @DRUG2$ containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1919,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1920,
        "sentence": "When Vardenafil dosing was separated from @DRUG1$ 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of @DRUG2$ experienced a decrease in standing systolic blood pressure below 85 mm Hg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1921,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1922,
        "sentence": "Patients receiving @DRUG1$ should be advised against the concurrent use of other @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1923,
        "sentence": "@DRUG1$ can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1924,
        "sentence": "Oral neomycin sulfate may enhance the effect of @DRUG1$ in @DRUG2$ by decreasing vitamin K availability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1925,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1926,
        "sentence": "These pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects (e.g., prolonged sodation)of both @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1927,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1928,
        "sentence": "Drugs that may have their plasma concentration altered by @DRUG1$ @DRUG2$ increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1929,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1930,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1931,
        "sentence": "The serum concentration of @DRUG1$ increased dramatically from 16.6 to 49.1 microg/mL when @DRUG2$ was coadministered, although the daily dosage of phenytoin and other drugs had not changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1932,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an @DRUG1$ containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of @DRUG2$ may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1933,
        "sentence": "Specific and aspecific treatments of magnesium depletion are tricky using for example @DRUG1$, pharmacological doses of vitamin B6, physiological doses of @DRUG2$ and of selenium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1934,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1935,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1936,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1937,
        "sentence": "Anesthetics/@DRUG1$/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1938,
        "sentence": "Possible extrarenal mechanisms of action of cimetidine on @DRUG1$ and @DRUG2$ transport were also examined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1939,
        "sentence": "Physostigmine pretreatment augmented the depressant effect of @DRUG1$ on the early components P1 and N1, while attenuating @DRUG2$'s influence on components P2 and P3.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1940,
        "sentence": "This study indicates that: (a) the maximal effects of @DRUG1$ on resistance arteries from lean and dietary-obese rats are not effected by endothelial dysfunction, and (b) the effects of @DRUG2$ in lean animals (where endothelial function is not impaired), but not in dietary-obese rats, are mediated via NO.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1941,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of @DRUG1$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for @DRUG2$ in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1942,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of @DRUG1$ are not altered by itraconazole, amphotericin B, mycophenolate, @DRUG2$, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1943,
        "sentence": "@DRUG1$: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving @DRUG2$, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1944,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1945,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of @DRUG1$, or the pharmacokinetics of @DRUG2$ (40 mg twice daily), phenytoin, theophylline, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1946,
        "sentence": "Cyclosporine: Elevated serum levels of cyclosporine have been reported with concomitant use of @DRUG1$ with other members of the @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1947,
        "sentence": "There has been too little experience with the coadministration of @DRUG1$ with @DRUG2$ or diltiazem to recommend concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1948,
        "sentence": "Lastly local use of the mucocutaneous and cytoprotective properties of @DRUG1$ is still valid, in @DRUG2$ and for preservation of transplants particularly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1949,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of diazepam, phenazepam, @DRUG1$ and amizyl and reduces the action of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1950,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1951,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1952,
        "sentence": "Paroxetine: Coadministration of once daily doses of @DRUG1$, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both @DRUG2$ and paroxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1953,
        "sentence": "An immune response to @DRUG1$ may interfere with subsequent diagnostic serum tests that utilize @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1954,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, phenothiazines, and the Type 1C antiarrhythmics @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1955,
        "sentence": "However, the systemic administration of some @DRUG1$ has been shown to elevate plasma concentrations of @DRUG2$, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1956,
        "sentence": "Interactions between treatments with coumaphos, bishydroxycoumarin (an @DRUG1$), @DRUG2$ (an organophosphorous compound), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1957,
        "sentence": "Certain antibiotic, cisplatin, cyclosporine, @DRUG1$, foscarnet, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1958,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1959,
        "sentence": "Paroxetine (20 mg QD) increased the concentration of @DRUG1$ (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1960,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG1$, general anesthetics, @DRUG2$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1961,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1962,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1963,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], @DRUG2$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1964,
        "sentence": "and calcium channel antagonists e.g., @DRUG1$), CYP1A2 inducers (@DRUG2$) and CYP1A2 inhibitors (furafylline and clarithromycin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1965,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG2$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1966,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1967,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1968,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, @DRUG2$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1969,
        "sentence": "Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with @DRUG1$ may inhibit the desired @DRUG2$-induced drop in colonic pH.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1970,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, @DRUG1$, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1971,
        "sentence": "These include probenecid, @DRUG1$, and some antibiotics (e.g. @DRUG2$, rifamipicin, ampicillin and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1972,
        "sentence": "Increased toxicity (CNS depression): CNS depressants, MAO inhibitors, @DRUG1$, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1973,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG2$, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1974,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1975,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, @DRUG2$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1976,
        "sentence": "Nonsteroidal Antiinflammatory Agents: @DRUG1$ is contraindicated in patients who are hypersensitive to @DRUG2$ agents.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1977,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, @DRUG1$, or @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1978,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1979,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, @DRUG1$, sulfonylureas, @DRUG2$, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1980,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1981,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG1$, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1982,
        "sentence": "Plasma was analyzed for tolbutamide, and urine was analyzed for @DRUG1$ and its two metabolites, 4-hydroxytolbutamide and @DRUG2$ by means of HPLC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1983,
        "sentence": "Certain drugs including @DRUG1$, @DRUG2$, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1984,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1985,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, @DRUG1$, @DRUG2$, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1986,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1987,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1988,
        "sentence": "Limited clinical experience indicates that requirements for @DRUG1$ are reduced by 30 to 50% for the first sixty (60) minutes following @DRUG2$ induction The concomitant use of erythromycin with ALFENTA can significantly inhibit ALFENTA clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1989,
        "sentence": "@DRUG1$/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, @DRUG2$, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1990,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1991,
        "sentence": "@DRUG1$ works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with @DRUG2$ or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1992,
        "sentence": "Both 18-MC and @DRUG1$ are sequestered in fat and, like ibogaine, @DRUG2$ probably has an active metabolite.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1993,
        "sentence": "@DRUG1$: In a study in healthy volunteers, a six-day course of rifampicin at 600 mg/day followed by a single 5 mg dose of isradipine resulted in a reduction in @DRUG2$ levels to below detectable limits.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1994,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1995,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1996,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1997,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1998,
        "sentence": "Theophylline @DRUG1$ 12.5, 25, and 50 mg administered once daily for 7 days increased plasma @DRUG2$ concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1999,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG1$, fluconazole, @DRUG2$, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2000,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2001,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG2$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2002,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2003,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2004,
        "sentence": "Inhibitors of CYP3A4 (eg, @DRUG1$) or CYP2D6 (eg, quinidine, fluoxetine, or paroxetine) can inhibit @DRUG2$ elimination and cause increased blood levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2005,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG2$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2006,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (@DRUG1$, barbiturates, opiates, @DRUG2$, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2007,
        "sentence": "It is, however, possible that concomitant use of other known @DRUG1$ such as @DRUG2$, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2008,
        "sentence": "Oral Anticoagulants: In some normal volunteers, the concomitant administration of diflunisal and warfarin, @DRUG1$, or @DRUG2$ resulted in prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2009,
        "sentence": "@DRUG1$: @DRUG2$ is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of methylxanthines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2010,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG1$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2011,
        "sentence": "Anesthetics/Sedatives/Hypnotics/@DRUG1$: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2012,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2013,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2014,
        "sentence": "Anesthetics/Sedatives/@DRUG1$/Opioids: Co-administration of @DRUG2$ with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2015,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG1$, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2016,
        "sentence": "@DRUG1$ preparations are incompatible with @DRUG2$ preparations.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2017,
        "sentence": "@DRUG1$: If acitretin is given concurrently with phenytoin, the protein binding of @DRUG2$ may be reduced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2018,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG2$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2019,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, @DRUG1$, and antihistamines) may result in increased @DRUG2$ effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2020,
        "sentence": "Certain @DRUG1$, cisplatin, cyclosporine, diuretic, @DRUG2$, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2021,
        "sentence": "Cimetidine, @DRUG1$: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of @DRUG2$ resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2022,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2023,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2024,
        "sentence": "Tablets Simultaneous administration of @DRUG1$ and furosemide tablets may reduce the natriuretic and antihypertensive effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2025,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2026,
        "sentence": "Oral @DRUG1$: Bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2027,
        "sentence": "@DRUG1$: @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2028,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2029,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2030,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2031,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and @DRUG1$ containing @DRUG2$ (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2032,
        "sentence": "@DRUG1$: The combined use of TRICOR and @DRUG2$ should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2033,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2034,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, cetirizine, famotidine, fluconazole, @DRUG2$, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2035,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, @DRUG1$, @DRUG2$, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2036,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2037,
        "sentence": "Amphotericin, Foscarnet, and @DRUG1$: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other @DRUG2$-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2038,
        "sentence": "Since @DRUG1$ (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, @DRUG2$ may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2039,
        "sentence": "A 21 (17)% decrease in the steady-state AUC of @DRUG1$ was observed when VIDEX was administered 2 hours prior to @DRUG2$, but not when the two drugs were administered simultaneously (n = 12).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2040,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG2$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2041,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG1$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2042,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2043,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2044,
        "sentence": "A 30 to 45% increase in AUC and Cmax of @DRUG1$ was observed with concomitant administration of @DRUG2$ twice daily.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2045,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or @DRUG2$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2046,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine @DRUG1$ of class (e.g. quinidine), @DRUG2$ antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2047,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2048,
        "sentence": "@DRUG1$ midazolam, triazolam @DRUG2$ ergot derivatives voriconazole",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2049,
        "sentence": "The @DRUG1$ (rosiglitazone and pioglitazone), a new class of oral @DRUG2$, are \"insulin sensitizers\"",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2050,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2051,
        "sentence": "@DRUG1$ Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2052,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG1$), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2053,
        "sentence": "@DRUG1$: The effects of warfarin and @DRUG2$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2054,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, pyrilamine, phenyltoloxamine, promethazine, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2055,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, @DRUG1$, methyldopa, nicotinic acid (niacin), @DRUG2$, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2056,
        "sentence": "@DRUG1$ was administered over the last two hours of the @DRUG2$ infusion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2057,
        "sentence": "These in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated @DRUG1$, which may lead to a decreased @DRUG2$ effect of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2058,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, @DRUG2$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2059,
        "sentence": "@DRUG1$ increased the extent of dissolution of @DRUG2$ in proportion to the added concentration, which was also verified by equilibrium solubilization studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2060,
        "sentence": "Certain drugs, including @DRUG1$ (@DRUG2$), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2061,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2062,
        "sentence": "In patients receiving treatment with @DRUG1$, close monitoring for toxicity and a @DRUG2$ dose reduction should be considered if systemic administration of a potent CYP3A4 inhibitor cannot be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2063,
        "sentence": "@DRUG1$ - In subjects who had received 21 days of 40 mg/day racemic @DRUG2$, combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2064,
        "sentence": "@DRUG1$ Supplements and Potassium-Sparing Diuretics Lotensin can attenuate potassium loss caused by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2065,
        "sentence": "Due to wide interindividual variability in the dose adjustment required, it is recommended that @DRUG1$ concentrations be monitored closely after initiation of carvedilol therapy and that the dose of @DRUG2$ be adjusted as appropriate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2066,
        "sentence": "Co-administration of @DRUG1$ and bosentan resulted in markedly increased plasma concentrations of @DRUG2$ in animals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2067,
        "sentence": "@DRUG1$: Benzodiazepines GI Motility Agents @DRUG2$ Antifungal",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2068,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, phenothiazines, and the @DRUG2$ propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2069,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, @DRUG1$, cimetidine, metoclopramide, propantheline, digoxin, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2070,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2071,
        "sentence": "In vivo studies: @DRUG1$: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after @DRUG2$ and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2072,
        "sentence": "@DRUG1$: Since heparin is contraindicated in patients with heparin-induced thrombocytopenia, the co-administration of Argatroban and @DRUG2$ is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2073,
        "sentence": "@DRUG1$: Aerosol bronchodilators of the short-acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2074,
        "sentence": "Additive depressant effect when used with general anesthetics, sedatives, @DRUG1$, hypnotics, alcohol, and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2075,
        "sentence": "These include probenecid, cholestyramine, and some @DRUG1$ (e.g. erythromycin, rifamipicin, @DRUG2$ and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2076,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2077,
        "sentence": "@DRUG1$ and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or @DRUG2$ supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2078,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, @DRUG2$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2079,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG1$ agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2080,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with @DRUG1$ (alcohol, barbiturates, opiates, @DRUG2$, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2081,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2082,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, @DRUG2$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2083,
        "sentence": "This drug may interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2084,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with sucralfate, with metal cations such as @DRUG2$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2085,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2086,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2087,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of @DRUG1$ on the concomitant @DRUG2$, sedative, hypnotic or opioid may be required.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2088,
        "sentence": "Alprazolam: When @DRUG1$ (100 mg qd) and alprazolam (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of @DRUG2$ were approximately twice those observed when alprazolam was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2089,
        "sentence": "Drug-Drug Interactions Albuterol - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) @DRUG1$ (or other beta2 agonists) because the action of @DRUG2$ on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2090,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, @DRUG1$, cimetidine, @DRUG2$, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2091,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG2$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2092,
        "sentence": "Other @DRUG1$ (eg, quinidine, procainamide, @DRUG2$, propranolol) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2093,
        "sentence": "@DRUG1$ may potentiate the hypotensive effects of @DRUG2$ and the anticholinergic effects of atropine-type drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2094,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2095,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2096,
        "sentence": "Interactions between treatments with coumaphos, @DRUG1$ (an anticoagulant), trichlorfon (an @DRUG2$), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2097,
        "sentence": "@DRUG1$: Co-administration of bosentan 500 mg b.i.d. for 6 days decreased the plasma concentrations of both @DRUG2$ (a CYP2C9 substrate) and R-warfarin (a CYP3A4 substrate) by 29 and 38%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2098,
        "sentence": "However, since @DRUG1$, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of @DRUG2$ or NSAIDs with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2099,
        "sentence": "Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral @DRUG1$ and @DRUG2$ are administered concurrently.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2100,
        "sentence": "@DRUG1$ plasma concentrations should be monitored when @DRUG2$ and isoniazid are coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2101,
        "sentence": "Concomitant administration of @DRUG1$ and quinidine resulted in slight increases in plasma @DRUG2$ levels and slight decreases in plasma quinidine levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2102,
        "sentence": "@DRUG1$ does not increase serum @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2103,
        "sentence": "@DRUG1$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2104,
        "sentence": "@DRUG1$: Elevated serum levels of cyclosporine have been reported with concomitant use of @DRUG2$ with other members of the quinolone class.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2105,
        "sentence": "The administration of local anesthetic solutions containing @DRUG1$ or @DRUG2$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2106,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2107,
        "sentence": "In a placebo-controlled trial in normal volunteers, the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral @DRUG1$ (400 mg twice daily) resulted in a 10% increase in mean AUC of @DRUG2$ (p=0.006), and a slight but not statistically significant increase in mean Cmax and mean half-life of doxazosin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2108,
        "sentence": "Clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or @DRUG1$ dose (baseline vs. end of the clinical studies), and the need to change the @DRUG2$ dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2109,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, @DRUG2$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2110,
        "sentence": "@DRUG1$ plasma concentrations should be monitored when Itraconazole and @DRUG2$ are coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2111,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, ACE inhibitors, @DRUG1$, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2112,
        "sentence": "@DRUG1$: MAOI antidepressants, as well as a metabolite of furazolidone, slow @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2113,
        "sentence": "Drug-Drug Interactions Albuterol - @DRUG1$ should be administered with caution to patients being treated with systemically-administered (oral or intravenous) @DRUG2$ (or other beta2 agonists) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2114,
        "sentence": "Tissue culture and animal studies indicate that ELSPAR can diminish or abolish the effect of @DRUG1$ on malignant cells.14 This effect on @DRUG2$ activity persists as long as plasma asparagine levels are suppressed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2115,
        "sentence": "Rifampin: Coadministration of rifampin and @DRUG1$ Suspension results in a significant decrease in average steady- state plasma @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2116,
        "sentence": "Other antiarrhythmic drugs (eg, quinidine, procainamide, @DRUG1$, propranolol) have occasionally been used concurrently with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2117,
        "sentence": "@DRUG1$: @DRUG2$ Phenobarbital Carbamazepine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2118,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG1$) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2119,
        "sentence": "Because @DRUG1$ reduces the clearance of both diazepam and its active metabolite, @DRUG2$, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2120,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2121,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, @DRUG1$, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of @DRUG2$, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2122,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2123,
        "sentence": "Rifampin: Coadministration of @DRUG1$ and MEPRON Suspension results in a significant decrease in average steady- state plasma @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2124,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2125,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2126,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2127,
        "sentence": "Potassium-sparing diuretics (@DRUG1$, amiloride,triamterene, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2128,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2129,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, @DRUG1$, sulfinpyrazone, oral contraceptives, tolbutamide, or @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2130,
        "sentence": "In seven experiments reactions to @DRUG1$ and oxytocin were @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2131,
        "sentence": "Vitamin A and oral retinoids: Concomitant administration of @DRUG1$ and/or other oral retinoids with @DRUG2$ must be avoided because of the risk of hypervitaminosis A.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2132,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG1$, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2133,
        "sentence": "Concurrent administration of indinavir and didanosine significantly reduces the level of exposure to @DRUG1$, but it is unclear how soon after didanosine administration @DRUG2$ may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2134,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2135,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2136,
        "sentence": "Concurrent administration of indinavir and didanosine significantly reduces the level of exposure to indinavir, but it is unclear how soon after @DRUG1$ administration @DRUG2$ may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2137,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG2$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2138,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of @DRUG1$ that may result in decreased efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2139,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2140,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2141,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2142,
        "sentence": "@DRUG1$: The influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of @DRUG2$ was evaluated in 12 healthy males in 2 separate randomized crossover studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2143,
        "sentence": "The results from a study in which eight HIV-infected individuals were treated with zidovudine, 8 +/- 0.4 mg/kg/day, showed that the pharmacokinetics of @DRUG1$ were not affected during concomitant administration of @DRUG2$, 100 mg b.i.d.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2144,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2145,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX on the concomitant @DRUG1$, sedative, hypnotic or @DRUG2$ may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2146,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG1$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2147,
        "sentence": "@DRUG1$: Patients on @DRUG2$ may be at increased risk of arrhythmias due to hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2148,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2149,
        "sentence": "Probenecid: Concomitant administration of @DRUG1$ ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in @DRUG2$ plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2150,
        "sentence": "The ratios of the AUCs of unbound @DRUG1$ to the AUCs of the total valproate were 11.1 %, 13.0%, and 11.5%, with coadministration of 0, 1200, and 2400 mg/day of @DRUG2$ , respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2151,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2152,
        "sentence": "@DRUG1$ or other oxytocics (concurrent use with @DRUG2$ may result in uterine hypertonus, possibly causing uterine rupture or cervical laceration, especially in the absence of adequate cervical dilatation;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2153,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, @DRUG2$, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2154,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like @DRUG1$, @DRUG2$, beta-blockers, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2155,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2156,
        "sentence": "In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of @DRUG1$ with @DRUG2$ was associated with a higher occurrence of torsade de pointes.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2157,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2158,
        "sentence": "In vitro, @DRUG1$ does not displace tightly bound drugs like phenytoin, propranolol, and @DRUG2$ from serum proteins.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2159,
        "sentence": "Experience with nonsteroidal anti-inflammatory drugs (@DRUG1$) suggests the potential for interactions with @DRUG2$ and ACE inhibitors.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2160,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, procaine, beta-blockers, @DRUG1$, @DRUG2$, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2161,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing @DRUG1$ or @DRUG2$, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2162,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2163,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2164,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, @DRUG1$, @DRUG2$, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2165,
        "sentence": "When @DRUG1$ dosing was separated from @DRUG2$ 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of Vardenafil experienced a decrease in standing systolic blood pressure below 85 mm Hg.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2166,
        "sentence": "Concomitant single dose administration of @DRUG1$ 20 mg with multiple doses of ketoconazole and @DRUG2$ produced a significant increase in exposure of valdecoxib.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2167,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG1$, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2168,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2169,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG2$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2170,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2171,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG1$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2172,
        "sentence": "Certain other @DRUG1$ (@DRUG2$ and polymyxin) have also been reported to interfere with the nerve transmission at the neuromuscular junction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2173,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2174,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2175,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2176,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2177,
        "sentence": "@DRUG1$: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and @DRUG2$ may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2178,
        "sentence": "Phenytoin: If @DRUG1$ is given concurrently with phenytoin, the protein binding of @DRUG2$ may be reduced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2179,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG1$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2180,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), @DRUG2$, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2181,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other antidepressants, @DRUG2$, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2182,
        "sentence": "Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of @DRUG1$, nifedipine, @DRUG2$, or ranitidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2183,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG1$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2184,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, procaine, @DRUG1$, metaclopramide, @DRUG2$, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2185,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2186,
        "sentence": "The @DRUG1$ (rosiglitazone and @DRUG2$), a new class of oral antidiabetic agents, are \"insulin sensitizers\"",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2187,
        "sentence": "@DRUG1$: @DRUG2$ may inhibit the metabolism of prednisolone, leading to increased plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2188,
        "sentence": "Drug-Drug Interactions: The pharmacokinetic and pharmacodynamic interactions between @DRUG1$ and other @DRUG2$ have not been determined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2189,
        "sentence": "@DRUG1$ (oral agents and @DRUG2$): hypoglycemia or hyperglycemia;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2190,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2191,
        "sentence": "Since apraclonidine may reduce pulse and blood pressure, caution in using drugs such as @DRUG1$ (ophthalmic and systemic), antihypertensives, and @DRUG2$ is advised.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2192,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2193,
        "sentence": "@DRUG1$: An increased risk of hepatitis has been reported to result from combined use of methotrexate and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2194,
        "sentence": "Immunosuppressants: @DRUG1$, @DRUG2$, sirolimus",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2195,
        "sentence": "The behavioral effects of the stereoisomers of N-allylnormetazocine (@DRUG1$) were compared with those of @DRUG2$ (PCP) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2196,
        "sentence": "Oral @DRUG1$: In some normal volunteers, the concomitant administration of diflunisal and warfarin, @DRUG2$, or phenprocoumon resulted in prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2197,
        "sentence": "The effect may be mediated by the known inhibition of @DRUG1$ on hepatic cytochrome P-450, the enzyme system probably responsible for the first-pass metabolism of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2198,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG1$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2199,
        "sentence": "In a study in diabetics with microalbuminuria INSPRA 200 mg combined with the @DRUG1$ enalapril 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on @DRUG2$ alone to 38%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2200,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2201,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2202,
        "sentence": "Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, @DRUG1$) may reduce the effect of @DRUG2$ and should not be taken concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2203,
        "sentence": "Antacids or H 2 receptor antagonists: When dirithromycin is administered immediately following @DRUG1$ or H 2 -receptor antagonists, the absorption of @DRUG2$ is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2204,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as @DRUG1$, @DRUG2$, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2205,
        "sentence": "@DRUG1$ concentrations were equivocally higher when given with @DRUG2$, but this is not likely to be clinically important.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2206,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2207,
        "sentence": "@DRUG1$: @DRUG2$s plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2208,
        "sentence": "Effects of @DRUG1$ are increased with @DRUG2$ and beta adrenergic blockers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2209,
        "sentence": "@DRUG1$ may increase the action of tricyclics, @DRUG2$, procainamide, and quinidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2210,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and @DRUG1$ has been reported to both increase and decrease @DRUG2$ levels).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2211,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2212,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2213,
        "sentence": "@DRUG1$ at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of @DRUG2$ compared to NaCMC alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2214,
        "sentence": "Upon administration of 10 mg of @DRUG1$ with 800 mg TID indinavir, the Cmax and AUC of @DRUG2$ were reduced by 40% and 30%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2215,
        "sentence": "Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with @DRUG1$, and with some @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2216,
        "sentence": "Ergotamine: Concurrent use of @DRUG1$ and @DRUG2$ or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2217,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for @DRUG1$ in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2218,
        "sentence": "Coadministration of ethoxzolamide with other diuretics, @DRUG1$, and @DRUG2$ may cause hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2219,
        "sentence": "The results of a study of coadministration of @DRUG1$ (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2220,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of ergotamine-containing or @DRUG1$ (like dihydroergotamine or @DRUG2$) and FROVA within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2221,
        "sentence": "Coadministration of @DRUG1$ with other diuretics, @DRUG2$, and corticosteroids may cause hypokalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2222,
        "sentence": "In patients receiving another serotonin reuptake inhibitor drug in combination with @DRUG1$ (@DRUG2$), there have been reports of serious, sometimes fatal, reactions including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2223,
        "sentence": "@DRUG1$ steady-state Cmax, A.C. and Cmin were increased by 12%, 15%, and 14%, respectively, by concomitant @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2224,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (@DRUG1$), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2225,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2226,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG1$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2227,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2228,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by @DRUG1$ or @DRUG2$ (eg, famotidine and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2229,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG2$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2230,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG1$, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2231,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2232,
        "sentence": "@DRUG1$ significantly decreases clearance of rifabutin and @DRUG2$, and the combination is poorly tolerated.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2233,
        "sentence": "Warfarin, Digoxin, Salicylate, and @DRUG1$ The in vitro binding of @DRUG2$ to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2234,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], @DRUG2$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2235,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2236,
        "sentence": "Other: There appears to be no pharmacokinetic interaction between acitretin and cimetidine, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2237,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, @DRUG1$, @DRUG2$, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2238,
        "sentence": "However, in a follow-up study in normal subjects, single-dose administration of colestipol hydrochloride and @DRUG1$ and twice-a-day administration for 5 days of both agents did not affect the extent of @DRUG2$ absorption, but had a small yet statistically significant effect on its rate of absorption;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2239,
        "sentence": "Therefore, such combined treatment should be approached with caution and patients should be monitored closely when @DRUG1$ is combined with these drugs, particularly with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2240,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG1$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2241,
        "sentence": "@DRUG1$ should be used with caution in patients receiving @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2242,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG1$, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2243,
        "sentence": "Certain drugs, including @DRUG1$ (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2244,
        "sentence": "The concomitant use of @DRUG1$ with @DRUG2$ and calcium antagonists may have additive effects on prolonging atrioventricular conduction time.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2245,
        "sentence": "@DRUG1$ VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2246,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2247,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$ in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2248,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, @DRUG2$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2249,
        "sentence": "Ketoconazole/Itraconazole, @DRUG1$, Including @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2250,
        "sentence": "@DRUG1$ and Other Statins: Co-administration of @DRUG2$ decreased the plasma concentrations of simvastatin (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2251,
        "sentence": "@DRUG1$ and @DRUG2$ are excreted by the kidney, and the risk of toxic reactions to this therapy may be greater in patients with impaired renal function.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2252,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2253,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of @DRUG1$ (2 x 60 mg capsule) within 15 minutes of an aluminum and @DRUG2$ containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2254,
        "sentence": "In addition, studies in healthy volunteers have shown that @DRUG1$ does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of @DRUG2$ (40 mg twice daily), phenytoin, theophylline, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2255,
        "sentence": "Since @DRUG1$ is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as @DRUG2$ and erythromycin or inhibitors of CYP2C19 such as omeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2256,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2257,
        "sentence": "The effects @DRUG1$ on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, @DRUG2$, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2258,
        "sentence": "and @DRUG1$ When amitriptyline HCl is given with @DRUG2$ agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2259,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2260,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2261,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or @DRUG1$), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2262,
        "sentence": "Although specific drug interaction studies have not been conducted with @DRUG1$, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, or @DRUG2$) should be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2263,
        "sentence": "Caution should be exercised when @DRUG1$ and @DRUG2$ are administered concomitantly.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2264,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2265,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2266,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2267,
        "sentence": "Data from a randomized trial of @DRUG1$ and cisplatin plus or minus pyridoxine in ovarian cancer indicated that @DRUG2$ significantly reduced neurotoxicity;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2268,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2269,
        "sentence": "@DRUG1$: Co-administration of a single dose of intravenously administered @DRUG2$ (20 mg) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2270,
        "sentence": "Repeated oral administration of @DRUG1$ in sheep: interactions of @DRUG2$ with bishydroxycoumarin, trichlorfon, and phenobarbital sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2271,
        "sentence": "@DRUG1$    Prolonged action of @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2272,
        "sentence": "Rifampicin: In a study in healthy volunteers, a six-day course of rifampicin at 600 mg/day followed by a single 5 mg dose of @DRUG1$ resulted in a reduction in @DRUG2$ levels to below detectable limits.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2273,
        "sentence": "@DRUG1$: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a @DRUG2$ similar to chlorpropamide) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2274,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2275,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2276,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$. amantadine antiarrhythmic agents of class (e.g. @DRUG2$), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2277,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2278,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2279,
        "sentence": "Furosemide: In normal volunteers, the concomitant administration of @DRUG1$ and @DRUG2$ had no effect on the diuretic activity of furosemide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2280,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2281,
        "sentence": "Because heparin, @DRUG1$, or @DRUG2$ may cause bleeding complications, careful monitoring for bleeding is advised, especially at arterial puncture sites.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2282,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2283,
        "sentence": "Antihistamines: Benzodiazepines GI Motility Agents @DRUG1$ @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2284,
        "sentence": "However, in patients treated with oral @DRUG1$, rare instances of drug interactions have occurred with high-dose @DRUG2$ therapy.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2285,
        "sentence": "The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, @DRUG1$, @DRUG2$, and other drugs which themselves produce CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2286,
        "sentence": "The concomitant administration of quinolones including norfloxacin with @DRUG1$ (a @DRUG2$) has, on rare occasions, resulted in severe hypoglycemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2287,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG1$, or @DRUG2$) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2288,
        "sentence": "Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of @DRUG1$ (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of @DRUG2$ and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2289,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2290,
        "sentence": "Poor metabolizers have higher than expected plasma concentrations of @DRUG1$ (@DRUG2$) when given usual doses.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2291,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG1$, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2292,
        "sentence": "Patients taking @DRUG1$ when @DRUG2$ is given should be observed for the appearance of unsteady gait or marked changes in mental status;",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2293,
        "sentence": "@DRUG1$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving @DRUG2$ during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2294,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2295,
        "sentence": "Concomitant administration of FACTIVE and @DRUG1$, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of @DRUG2$, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2296,
        "sentence": "This article looks at five commonly used @DRUG1$ in turn (corticosteroids, cyclosporin, azathioprine, methotrexate, @DRUG2$), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2297,
        "sentence": "Pharmacokinetics of @DRUG1$ were also not affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2298,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2299,
        "sentence": "Ethanol:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of @DRUG1$ and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2300,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2301,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, @DRUG1$, and Type 1C antiarrhythmics (eg, propafenone, @DRUG2$, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2302,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2303,
        "sentence": "@DRUG1$: Multiple oral doses of @DRUG2$ (20 mg q24h for 13 days) did not affect the pharmacokinetics of warfarin (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2304,
        "sentence": "@DRUG1$ may decrease thyroidal uptake of @DRUG2$, a rebound in uptake may occur up to 5 days after sudden withdrawal of Carbimazole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2305,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2306,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, @DRUG1$, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2307,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2308,
        "sentence": "Clearance of @DRUG1$ decreased by about 27% when dolasetron mesylate was administered intravenously concomitantly with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2309,
        "sentence": "Additive depressant effect when used with general anesthetics, sedatives, antianxiety drugs, @DRUG1$, alcohol, and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2310,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, @DRUG1$, @DRUG2$, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2311,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2312,
        "sentence": "and @DRUG1$ e.g., verapamil), CYP1A2 inducers (omeprazole) and CYP1A2 inhibitors (furafylline and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2313,
        "sentence": "Pharmacokinetic studies indicate that administration of @DRUG1$ or diazepam does not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2314,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2315,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2316,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2317,
        "sentence": "Propantheline and @DRUG1$, by decreasing gut motility, may increase @DRUG2$ absorption.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2318,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG1$, and the Type 1C antiarrhythmics propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2319,
        "sentence": "These include @DRUG1$, cholestyramine, and some antibiotics (e.g. @DRUG2$, rifamipicin, ampicillin and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2320,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and @DRUG1$, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2321,
        "sentence": "When atropine and @DRUG1$ are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because @DRUG2$ may potentiate the effect of atropine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2322,
        "sentence": "Beta-blockers, clonidine, @DRUG1$ salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2323,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2324,
        "sentence": "Plasma was analyzed for @DRUG1$, and urine was analyzed for @DRUG2$ and its two metabolites, 4-hydroxytolbutamide and carboxytolbutamide by means of HPLC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2325,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2326,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2327,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2328,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2329,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2330,
        "sentence": "The concomitant administration of @DRUG1$ and @DRUG2$ resulted in the need for an unusually high maintenance dose of warfarin (20 mg per day) in order to produce a therapeutic effect.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2331,
        "sentence": "Cimetidine: Co-administration with high doses of @DRUG1$ [800 mg twice daily] increased the Cmax of @DRUG2$ by 21%, the AUC0-120hr by 23% and the t1/2 by 15%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2332,
        "sentence": "However, since aspirin, @DRUG1$, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or @DRUG2$ with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2333,
        "sentence": "Reported examples of this interaction include the following: @DRUG1$: @DRUG2$ is a potent inducer of CYP3A4.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2334,
        "sentence": "There have been reports of @DRUG1$-related side effects in patients on concomitant therapy with @DRUG2$ and theophylline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2335,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, @DRUG2$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2336,
        "sentence": "Co-administration with @DRUG1$ or @DRUG2$ had a modest effect on the pharmacokinetics of azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2337,
        "sentence": "No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including cyclosporine, corticosteroids, and either @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2338,
        "sentence": "These include @DRUG1$, @DRUG2$, and some antibiotics (e.g. erythromycin, rifamipicin, ampicillin and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2339,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG1$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2340,
        "sentence": "@DRUG1$: An increased risk of hepatitis has been reported to result from combined use of @DRUG2$ and etretinate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2341,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., @DRUG2$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2342,
        "sentence": "Anesthetics/Sedatives/Hypnotics/@DRUG1$: Co-administration of PRECEDEX with anesthetics, sedatives, @DRUG2$, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2343,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2344,
        "sentence": "Nonsteroidal anti-inflammatory agents (@DRUG1$): Concomitant use of aspirin (or other @DRUG2$) and corticosteroids increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2345,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2346,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. @DRUG1$), @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2347,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as @DRUG1$, @DRUG2$, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2348,
        "sentence": "@DRUG1$ (nadolol,porpranolol,@DRUG2$) may exacerbate rebound hypertension when guanfacine is withdrawn.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2349,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2350,
        "sentence": "Lack of interaction between @DRUG1$ and @DRUG2$: pharmacokinetics and drug disposition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2351,
        "sentence": "@DRUG1$: Accutane has not been shown to alter the pharmacokinetics of @DRUG2$ in a study in seven healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2352,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, @DRUG1$, beta-blockers, @DRUG2$, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2353,
        "sentence": "@DRUG1$ and @DRUG2$ should not beadministered concomitantly becausedecreases in ketoconazole plasmaconcentrations may reduce the efficacy of the drug.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2354,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2355,
        "sentence": "The concomitant use of transdermal @DRUG1$ with @DRUG2$ or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2356,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG1$, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2357,
        "sentence": "Drug-Drug Interactions @DRUG1$ - @DRUG2$ should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other beta2 agonists) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2358,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, @DRUG1$, and @DRUG2$ (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2359,
        "sentence": "Oral @DRUG1$ Rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2360,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG1$) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2361,
        "sentence": "Like @DRUG1$, desflurane does not predispose to premature ventricular arrhythmias in the presence of exogenously infused @DRUG2$ in swine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2362,
        "sentence": "@DRUG1$ was more potent in lysing human red blood cells, whereas @DRUG2$ was more potent in inhibiting yeast cell growth;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2363,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2364,
        "sentence": "- a beta-blocker such as @DRUG1$ (@DRUG2$), atenolol (Tenormin), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2365,
        "sentence": "Since @DRUG1$ may reduce pulse and blood pressure, caution in using drugs such as beta-blockers (ophthalmic and systemic), @DRUG2$, and cardiac glycosides is advised.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2366,
        "sentence": "Coadministration of entecavir with lamivudine, @DRUG1$,or @DRUG2$ did not result in significant drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2367,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with @DRUG1$, antipyrine, ketoconazole, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2368,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2369,
        "sentence": "Caution in using concomitant drugs such as beta-blockers (ophthalmic and systemic), @DRUG1$ and/or @DRUG2$ is advised.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2370,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2371,
        "sentence": "Even though such interactions have not been seen in clinical studies with @DRUG1$  (@DRUG2$), an increased volume of circulating fluids might be required if such an interaction were to occur.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2372,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (@DRUG1$, barbiturates, @DRUG2$, sedatives, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2373,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2374,
        "sentence": "@DRUG1$: Concurrent administration of certain @DRUG2$, such as belladonna alkaloids and dicyclomine, would be expected to compromise the beneficial effects of cisapride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2375,
        "sentence": "Other @DRUG1$ (eg, quinidine, procainamide, lidocaine, propranolol) have occasionally been used concurrently with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2376,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental @DRUG1$ (as FeSO4) or @DRUG2$ supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2377,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2378,
        "sentence": "Like isoflurane, @DRUG1$ does not predispose to premature ventricular arrhythmias in the presence of exogenously infused @DRUG2$ in swine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2379,
        "sentence": "No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including @DRUG1$, corticosteroids, and either @DRUG2$ or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2380,
        "sentence": "Beta-adrenergic Blocking Agents: The effect of @DRUG1$ on blood pressure response to propranolol and @DRUG2$ was evaluated in men with mild uncomplicated hypertension (n = 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2381,
        "sentence": "An adequate period of observation must be provided for any patient in whom either @DRUG1$ (such as diazepam) or large doses of short-acting benzodiazepines (such as  10 mg of @DRUG2$) have been used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2382,
        "sentence": "@DRUG1$: @DRUG2$ can inhibit the metabolism of chloroquine, increasing its plasma level.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2383,
        "sentence": "When atropine and @DRUG1$ are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2384,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2385,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), @DRUG1$, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2386,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2387,
        "sentence": "Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that @DRUG1$ clearance is 60% greater in patients taking @DRUG2$ (primidone) with or without other enzyme-inducing AEDs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2388,
        "sentence": "Other: There appears to be no pharmacokinetic interaction between @DRUG1$ and cimetidine, @DRUG2$, or glyburide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2389,
        "sentence": "Paroxetine: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with @DRUG1$ 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both @DRUG2$ and paroxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2390,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG2$, and the Type 1C antiarrhythmics propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2391,
        "sentence": "@DRUG1$: Rifampin increases the metabolism of @DRUG2$ and some progestins (norethindrone) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2392,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2393,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other @DRUG1$, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2394,
        "sentence": "@DRUG1$ and sucralfate: Sucralfate and antacids containing @DRUG2$ or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2395,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG2$, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2396,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, @DRUG1$, clarithromycin, nelfinavir, and nefazadone may result in an increase in @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2397,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2398,
        "sentence": "Pharmacokinetic data from these patients demonstrated a decrease in @DRUG1$ clearance of approximately 33% when @DRUG2$ was administered following cisplatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2399,
        "sentence": "Coadministration of oral @DRUG1$ increased the maximum plasma concentration of @DRUG2$ by 18%, decreased clearance by 22%, and increased half-life by 29%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2400,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2401,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2402,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2403,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and @DRUG1$ (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for @DRUG2$ in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2404,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2405,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG1$, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2406,
        "sentence": "Digoxin: Coadministration of @DRUG1$, a P-glycoprotein substrate, with oral @DRUG2$ resulted in a reduction in clearance and an increase in digoxin Cmax and AUC values.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2407,
        "sentence": "Anticonvulsants (carbamazepine, @DRUG1$, phenobarbital, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some @DRUG2$, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2408,
        "sentence": "The concomitant use of @DRUG1$ and @DRUG2$ Parenteral should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2409,
        "sentence": "In patients taking furosemide, nifedipine, @DRUG1$, ACE inhibitors, @DRUG2$, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2410,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG1$, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2411,
        "sentence": "Use of PRINIVIL with @DRUG1$ (e.g., @DRUG2$, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2412,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG1$, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2413,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2414,
        "sentence": "To avoid this interaction, delavirdine or @DRUG1$ should be given 1 hour prior to dosing with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2415,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2416,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, @DRUG1$ and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the @DRUG2$ for Topical Solution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2417,
        "sentence": "- a @DRUG1$ such as propranolol (Inderal), @DRUG2$ (Tenormin), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2418,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2419,
        "sentence": "Increased toxicity (CNS depression): CNS depressants, @DRUG1$, tricyclic antidepressants, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2420,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2421,
        "sentence": "@DRUG1$ injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., @DRUG2$, diuretics), patients should be observed closely for development of hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2422,
        "sentence": "Cisapride should not be used concomitantly with other drugs known to prolong the QT interval: certain @DRUG1$, including those of Class IA (such as quinidine and procainamide) and Class III (such as @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2423,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, @DRUG1$, erythromycin, @DRUG2$, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2424,
        "sentence": "The therapeutic efficacy of @DRUG1$ may be compromised in these patients when @DRUG2$ is discontinued.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2425,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2426,
        "sentence": "Concurrent administration of @DRUG1$ and didanosine significantly reduces the level of exposure to @DRUG2$, but it is unclear how soon after didanosine administration indinavir may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2427,
        "sentence": "Intestinal adsorbents (e. g., @DRUG1$) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of @DRUG2$ and should not be taken concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2428,
        "sentence": "Interaction of @DRUG1$ and @DRUG2$ in rats.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2429,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG2$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2430,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, @DRUG2$, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2431,
        "sentence": "For this reason the dose of @DRUG1$ should be restricted and an @DRUG2$ administered as appropriate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2432,
        "sentence": "@DRUG1$ may also have an additive effect when given with @DRUG2$ .",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2433,
        "sentence": "Similarly, the effects of @DRUG1$ on phenobarbital, valproic acid and sodium plasma @DRUG2$ concentrations are unpredictable",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2434,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of @DRUG1$, ketamine, or droperidol but not after administration of fentayl alone or after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2435,
        "sentence": "Nonsteroidal Anti-inflammatory Drugs (@DRUG1$): The concomitant administration of a nonsteroidal anti inflammatory drug with a @DRUG2$ may increase the risks of CNS stimulation and convulsions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2436,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2437,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, phenobarbital, @DRUG1$, topiramate): Increase the metabolism of @DRUG2$ and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2438,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2439,
        "sentence": "Also, bleeding and/or increased prothrombin time have been reported in a few patients taking @DRUG1$s concomitantly with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2440,
        "sentence": "These include probenecid, cholestyramine, and some antibiotics (e.g. @DRUG1$, rifamipicin, @DRUG2$ and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2441,
        "sentence": "Theophylline @DRUG1$ 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2442,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2443,
        "sentence": "When coadministered with SUSTIVA in treatment-naive patients, the recommended dose of atazanavir is 300 mg with @DRUG1$ 100 mg and @DRUG2$ 600 mg (all once daily).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2444,
        "sentence": "An increase in serum lithium concentration has been reported during concomitant administration of lithium with @DRUG1$, so careful monitoring of serum @DRUG2$ levels is recommended during concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2445,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2446,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG1$, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2447,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., @DRUG1$, triamterene, amiloride), @DRUG2$ supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2448,
        "sentence": "The biochemical toxicology of @DRUG1$, a known metabolite of the major ingredient of the pesticide Gliftor (@DRUG2$), was investigated in vivo and in vitro.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2449,
        "sentence": "Concomitant administration of @DRUG1$ and calcium carbonate, cimetidine, omeprazole, or an estrogen/@DRUG2$ oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2450,
        "sentence": "The anxiogenic effects of @DRUG1$ were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by N6-cyclopentyladenosine (@DRUG2$), an A1-selective agonist.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2451,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG2$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2452,
        "sentence": "However, careful attention must be directed to cross toxicity and possible pharmacokinetic interactions between @DRUG-DRUG$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2453,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2454,
        "sentence": "Heparin: Since heparin is contraindicated in patients with @DRUG1$-induced thrombocytopenia, the co-administration of @DRUG2$ and heparin is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2455,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2456,
        "sentence": "Such individuals are referred to as poor metabolizers of drugs such as debrisoquin, @DRUG1$, the @DRUG2$, and clozapine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2457,
        "sentence": "Grapefruit juice Co-administration of @DRUG1$ with grapefruit juice resulted in more than 2-fold increase in the AUC and Cmax, but no prolongation in the half- life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2458,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2459,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with @DRUG1$, a reduction in dosage of PRECEDEX on the concomitant anesthetic, sedative, @DRUG2$ or opioid may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2460,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., @DRUG1$, barbiturates, tranquilizers, and antihistamines) may result in increased @DRUG2$ effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2461,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG1$, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2462,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2463,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2464,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2465,
        "sentence": "On the basis of the metabolism of @DRUG1$ by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, @DRUG2$, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2466,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local @DRUG1$ like @DRUG2$, procaine, beta-blockers, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2467,
        "sentence": "Thus, when @DRUG1$ and lithium are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2468,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG1$, cisapride, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2469,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2470,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of @DRUG1$ are decreased when administered with @DRUG2$ containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2471,
        "sentence": "This drug may interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2472,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and @DRUG1$/omega-conotoxin GVIA/@DRUG2$-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2473,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2474,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2475,
        "sentence": "These data suggest that @DRUG1$ are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and @DRUG2$/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2476,
        "sentence": "The administration of local anesthetic solutions containing @DRUG1$ or norepinephrine to patients receiving @DRUG2$ or tricyclic antidepressants may produce severe, prolonged hypertension.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2477,
        "sentence": "Serious cardiac dysrhythmias, some resulting in death, have occurred in patients receiving @DRUG1$ concomitantly with other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2478,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2479,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2480,
        "sentence": "In seven experiments reactions to @DRUG1$ and @DRUG2$ were PGF2alpha.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2481,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2482,
        "sentence": "Praziquantel: In the fed state, @DRUG1$ (40 mg/kg) increased mean maximum plasma concentration and area under the curve of @DRUG2$ by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given albendazole alone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2483,
        "sentence": "In this study we investigated the effect of ginsenosides on high threshold voltage-dependent Ca(2+) channel subtypes using their @DRUG1$ @DRUG2$ (L-type), omega-conotoxin GVIA (N-type), or omega-agatoxin IVA (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2484,
        "sentence": "and disulfiram When amitriptyline HCl is given with anticholinergic agents or @DRUG1$ drugs, including epinephrine combined with local @DRUG2$, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2485,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with @DRUG1$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2486,
        "sentence": "Some quinolones, including @DRUG1$, have also been shown to interfere with the metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2487,
        "sentence": "@DRUG1$ may affect @DRUG2$ bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2488,
        "sentence": "Reported examples of this interaction include the following: @DRUG1$s: Cyclosporine (CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2489,
        "sentence": "Methotrexate: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of @DRUG1$, enhancing the toxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2490,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2491,
        "sentence": "and @DRUG1$ , (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones, resulting in systemic levels considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2492,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2493,
        "sentence": "Drugs that may have their plasma concentration altered by @DRUG1$ Gleevec increases the mean cmax and AUC of @DRUG2$ (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2494,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other @DRUG1$ (including @DRUG2$) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2495,
        "sentence": "Nafazodone, @DRUG1$, @DRUG2$ (consider Xanax dose reduction).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2496,
        "sentence": "@DRUG1$, @DRUG2$, and nadolol (low hepatic clearance or no first-pass metabolism) are unlikely to be affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2497,
        "sentence": "However, since aspirin, NSAIDs, and @DRUG1$ are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of @DRUG2$ or NSAIDs with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2498,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, rifabutin, rifapentine, @DRUG1$, carbamazepine, @DRUG2$ and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2499,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2500,
        "sentence": "Warfarin: Co-administration of @DRUG1$ 500 mg b.i.d. for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and @DRUG2$ (a CYP3A4 substrate) by 29 and 38%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2501,
        "sentence": "The plasma concentration of @DRUG1$ has been reported to be increased by the concomitant administration of @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2502,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, @DRUG1$, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some @DRUG2$, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2503,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, @DRUG2$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2504,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2505,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2506,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2507,
        "sentence": "When initiating a multi-day course of grepafloxacin in a patient maintained on @DRUG1$, the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum @DRUG2$ concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2508,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, @DRUG2$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2509,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2510,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as @DRUG1$, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and @DRUG2$ might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2511,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2512,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, hydrochlorothiazide, @DRUG2$, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2513,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, @DRUG1$, lamivudine, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2514,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of @DRUG2$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2515,
        "sentence": "@DRUG1$ : @DRUG2$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2516,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2517,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2518,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with @DRUG1$ because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2519,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, @DRUG2$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2520,
        "sentence": "@DRUG1$: Coadministration of once daily doses of @DRUG2$, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and paroxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2521,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2522,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2523,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG2$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2524,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2525,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2526,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2527,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2528,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2529,
        "sentence": "Similarly, the effects of @DRUG1$ on phenobarbital, @DRUG2$ and sodium plasma valproate concentrations are unpredictable",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2530,
        "sentence": "Paroxetine: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with @DRUG1$ 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2531,
        "sentence": "@DRUG1$ (such as haloperidol) and phenothiazines can suppress the @DRUG2$rgic renal and mesenteric vasodilation induced with low dose dopamine infusion.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2532,
        "sentence": "@DRUG1$: Co-administration of @DRUG2$ 500 mg b.i.d. for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and R-warfarin (a CYP3A4 substrate) by 29 and 38%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2533,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2534,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2535,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2536,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG1$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2537,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), @DRUG2$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2538,
        "sentence": "This drug may interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2539,
        "sentence": "In this formal interaction study, @DRUG1$ and @DRUG2$ were each found to have negative inotropic effects;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2540,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG1$, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2541,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2542,
        "sentence": "A smaller 24-week study has suggested @DRUG1$ may be superior to the @DRUG2$ nelfinavir.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2543,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of @DRUG1$ on the concomitant anesthetic, @DRUG2$, hypnotic or opioid may be required.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2544,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG1$, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2545,
        "sentence": "@DRUG1$ taken concomitantly with digoxin increases the serum @DRUG2$ concentration by 70% after one day.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2546,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG1$ [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2547,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2548,
        "sentence": "@DRUG1$: Coadministration of @DRUG2$, a P-glycoprotein substrate, with oral conivaptan resulted in a reduction in clearance and an increase in digoxin Cmax and AUC values.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2549,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG1$, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2550,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG1$, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2551,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2552,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2553,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2554,
        "sentence": "Quinolone Antibiotics: @DRUG1$ should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2555,
        "sentence": "Antacids and sucralfate: @DRUG1$ and antacids containing @DRUG2$ or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2556,
        "sentence": "Dexbrompheniramine can interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2557,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2558,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG1$): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2559,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, @DRUG1$, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2560,
        "sentence": "Furthermore, rifampin, @DRUG1$, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2561,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, @DRUG2$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2562,
        "sentence": "@DRUG1$ or Cimetidine: Concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2563,
        "sentence": "In patients taking an @DRUG1$ (eg, valproic acid, carbamazepine, @DRUG2$ or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2564,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2565,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of @DRUG1$ binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG2$ (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2566,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2567,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., @DRUG2$), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2568,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, @DRUG2$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2569,
        "sentence": "A case report of one patient taking @DRUG1$ 200 mg and @DRUG2$ 800 mg three times a day resulted in increases in amiodarone concentrations from 0.9 mg/L to 1.3 mg/L.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2570,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2571,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2572,
        "sentence": "@DRUG1$ and Foods Fortified With Iron Concomitant administration of @DRUG2$ with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2573,
        "sentence": "@DRUG1$ levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. @DRUG2$ maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2574,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2575,
        "sentence": "Pharmacoeconomic analyses indicate that @DRUG1$ does not significantly increase, and may even decrease, the overall direct treatment costs of schizophrenia, compared with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2576,
        "sentence": "In patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent cimetidine therapy, discontinuation of @DRUG1$ has been reported to decrease established steady-state serum @DRUG2$ levels and compromise their therapeutic effects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2577,
        "sentence": "However, the systemic administration of some @DRUG1$ has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral @DRUG2$ warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2578,
        "sentence": "There was no effect of @DRUG1$ on prothrombin time in patients on stable doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2579,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, @DRUG2$, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2580,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2581,
        "sentence": "however, as with other @DRUG1$, concomitant administration of Lodine and @DRUG2$ is not generally recommended because of the potential of increased adverse effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2582,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG1$), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2583,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, @DRUG1$ 240 mg QD, saquinavir 1200 mg TID, @DRUG2$ 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2584,
        "sentence": "While the effects of chronic @DRUG1$ or @DRUG2$ therapy on the action of NIMBEX are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2585,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. @DRUG2$), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2586,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2587,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, @DRUG1$, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the @DRUG2$ for Topical Solution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2588,
        "sentence": "In another drug interaction study, co-administration of orally inhaled @DRUG1$ and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of @DRUG2$ remained unchanged.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2589,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2590,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2591,
        "sentence": "Furosemide: In normal volunteers, the concomitant administration of diflunisal and @DRUG1$ had no effect on the diuretic activity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2592,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, @DRUG2$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2593,
        "sentence": "Clinical experience with concomitant administration of @DRUG1$ and @DRUG2$ in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2594,
        "sentence": "@DRUG1$, tacrolimus and digoxin concentrations should be monitored at the initiation of @DRUG2$ therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2595,
        "sentence": "If @DRUG1$ are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2596,
        "sentence": "Amphotericin, Foscarnet, and @DRUG1$: Drugs such as amphotericin, foscarnet, and @DRUG2$ may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2597,
        "sentence": "The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other @DRUG1$, anticonvulsants, antihistaminics, @DRUG2$, and other drugs which themselves produce CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2598,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2599,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2600,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG2$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2601,
        "sentence": "When @DRUG1$ and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2602,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2603,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$ did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of digoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2604,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, @DRUG2$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2605,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that @DRUG1$ (1 mg/kg) removes the antiedematous action of diazepam, @DRUG2$, phenibut and amizyl and reduces the action of phentolamine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2606,
        "sentence": "Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that @DRUG1$ clearance is 60% greater in patients taking phenobarbital (@DRUG2$) with or without other enzyme-inducing AEDs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2607,
        "sentence": "@DRUG1$: In vitro data indicate that indinavir and @DRUG2$ markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2608,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2609,
        "sentence": "@DRUG1$ should not be used concomitantly with other drugs known to prolong the QT interval: certain antiarrhythmics, including those of Class IA (such as quinidine and procainamide) and Class III (such as @DRUG2$);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2610,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2611,
        "sentence": "In addition, studies in healthy volunteers have shown that @DRUG1$ does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of propranolol (40 mg twice daily), phenytoin, @DRUG2$, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2612,
        "sentence": "While it is not known whether this interaction occurs with @DRUG1$ other than @DRUG2$, myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone, including clofibrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2613,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term @DRUG1$ therapy (eg, phenytoin, carbamazepine, or @DRUG2$) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2614,
        "sentence": "@DRUG1$ or @DRUG2$ acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2615,
        "sentence": "@DRUG1$: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, @DRUG2$, or phenobarbital) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2616,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of @DRUG1$, ketoconazole, methotrexate, @DRUG2$, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2617,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2618,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG1$ [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2619,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2620,
        "sentence": "astemizole midazolam, @DRUG1$ cisapride ergot derivatives @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2621,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2622,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2623,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with sucralfate, with metal cations such as iron, or with @DRUG2$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2624,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2625,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, @DRUG1$, phenothiazines, @DRUG2$ and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2626,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral magnesium supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the @DRUG1$ intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic @DRUG2$ overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2627,
        "sentence": "@DRUG1$ may affect digoxin bioavailabillty and may require dose adjustment of @DRUG2$ by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2628,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing @DRUG1$ or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2629,
        "sentence": "Since apraclonidine may reduce pulse and blood pressure, caution in using drugs such as beta-blockers (ophthalmic and systemic), @DRUG1$, and @DRUG2$ is advised.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2630,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2631,
        "sentence": "d-amphetamine with desipramine or @DRUG1$ and possibly other @DRUG2$ cause striking and sustained increases in the concentration of d-amphetamine in the brain;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2632,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2633,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2634,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, @DRUG1$, pyrilamine, phenyltoloxamine, @DRUG2$, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2635,
        "sentence": "Use of @DRUG1$ with potassium-sparing diuretics (e.g., spironolactone, @DRUG2$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2636,
        "sentence": "@DRUG1$: Concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of @DRUG2$ or the mean daily trough serum level of digoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2637,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including @DRUG2$, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2638,
        "sentence": "Alprazolam: When fluvoxamine maleate (100 mg qd) and @DRUG1$ (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of alprazolam were approximately twice those observed when @DRUG2$ was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2639,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2640,
        "sentence": "Known drug interactions include @DRUG1$, @DRUG2$, and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2641,
        "sentence": "Oral @DRUG1$: In some normal volunteers, the concomitant administration of diflunisal and @DRUG2$, acenocoumarol, or phenprocoumon resulted in prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2642,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., @DRUG2$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2643,
        "sentence": "If concomitant treatment with @DRUG1$ and an @DRUG2$ is clinically warranted, appropriate observation of the patient is advised.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2644,
        "sentence": "@DRUG1$ (@DRUG2$, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2645,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with @DRUG1$, @DRUG2$, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2646,
        "sentence": "Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after @DRUG1$ or after @DRUG2$, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2647,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2648,
        "sentence": "The concomitant use of transdermal @DRUG1$ with ritonavir or other potent 3A4 inhibitors such as @DRUG2$, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2649,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG2$, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2650,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2651,
        "sentence": "If iron supplements are required during @DRUG1$ therapy, @DRUG2$ should be taken at least 2 hours before or after the supplement.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2652,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2653,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2654,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2655,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2656,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG1$, morphine, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2657,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2658,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2659,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2660,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, @DRUG1$, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2661,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2662,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG1$ other than alprazolam suggest a possible drug interaction with @DRUG2$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2663,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2664,
        "sentence": "@DRUG1$: Interaction with Drugs that Inhibit Metabolism via Cytochrome P450 3A (CYP3A): The metabolism of @DRUG2$ to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by CYP3A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2665,
        "sentence": "Rifampin: @DRUG1$ increases the metabolism of @DRUG2$ and some progestins (norethindrone) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2666,
        "sentence": "@DRUG1$: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of @DRUG2$, enhancing the toxicity of methotrexate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2667,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2668,
        "sentence": "In view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by CAMPTOSAR, the physician may wish to withhold @DRUG1$ during dosing with @DRUG2$ and, certainly, during periods of active vomiting or diarrhea.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2669,
        "sentence": "- Methyldopa (e.g., @DRUG1$) Use of methyldopa with @DRUG2$ may increase the chance of side effects affecting the liver and/or the blood",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2670,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2671,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG1$ [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2672,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2673,
        "sentence": "@DRUG1$ administered concurrently with @DRUG2$ reduced the urine volume in 4 healthy volunteers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2674,
        "sentence": "Consequently, it is recommended not to exceed a single 2.5 mg @DRUG1$ dose in a 72-hour period when used in combination with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2675,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2676,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG1$, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2677,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that sirolimus, in combination with cyclosporine or @DRUG1$, might have the potential to reduce the frequency of rejection episodes, permit reductions in @DRUG2$ or tacrolimus dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2678,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, @DRUG2$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2679,
        "sentence": "Pharmacokinetic studies indicate that administration of disulfiram or @DRUG1$ does not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2680,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of @DRUG1$, or the pharmacokinetics of propranolol (40 mg twice daily), @DRUG2$, theophylline, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2681,
        "sentence": "Methotrexate: Concomitant administration of methotrexate and some @DRUG1$ has been reported to reduce the clearance of methotrexate, enhancing the toxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2682,
        "sentence": "Other @DRUG1$ (including @DRUG2$) used in combination with anakinra may also result in similar toxicities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2683,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2684,
        "sentence": "No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with @DRUG1$ without coadministered @DRUG2$/dopa-decarboxylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2685,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, @DRUG1$, @DRUG2$, nelfinavir, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2686,
        "sentence": "@DRUG1$ is unlikely to interact with drugs that are substrates for the P-glycoprotein transporter, as demonstrated by the lack of interaction of @DRUG2$ with digoxin in a clinical drug interaction study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2687,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, @DRUG2$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2688,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2689,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG1$, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2690,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2691,
        "sentence": "@DRUG1$ (NSAIDS): Concomitant use of @DRUG2$ (or other nonsteroidal antiinflammatory agents) and corticosteroids increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2692,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2693,
        "sentence": "In order to examine some molecular mechanisms of PCP-induced behavioral changes, Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with PCP, @DRUG1$, and @DRUG2$ was carried out.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2694,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, @DRUG2$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2695,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2696,
        "sentence": "Limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50% for the first sixty (60) minutes following @DRUG1$ induction The concomitant use of erythromycin with ALFENTA can significantly inhibit @DRUG2$ clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2697,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG1$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2698,
        "sentence": "Such individuals are referred to as poor metabolizers of drugs such as @DRUG1$, dextromethorphan, the @DRUG2$, and clozapine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2699,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2700,
        "sentence": "@DRUG1$: @DRUG2$ may increase serum levels of phenytoin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2701,
        "sentence": "Antacids and @DRUG1$: Sucralfate and antacids containing magnesium or @DRUG2$, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2702,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2703,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2704,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG1$, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2705,
        "sentence": "Coadministration of oral contraceptives, @DRUG1$, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2706,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2707,
        "sentence": "On the basis of the metabolism of @DRUG1$ by cytochrome P450 3A4, @DRUG2$, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2708,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, @DRUG1$, flecainide, and @DRUG2$), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2709,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2710,
        "sentence": "@DRUG1$:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2711,
        "sentence": "Co-administration of @DRUG1$ and @DRUG2$ resulted in markedly increased plasma concentrations of bosentan in animals.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2712,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2713,
        "sentence": "@DRUG1$: @DRUG2$ may delay intestinal absorption of phenobarbital;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2714,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2715,
        "sentence": "@DRUG1$ and related drugs may increase the responsiveness to @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2716,
        "sentence": "In clinical studies, coadministration of @DRUG1$  with atorvastatin, @DRUG2$, or simvastatin did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2717,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2718,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2719,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most antidepressants (SSRIs, many @DRUG1$), beta-blockers, @DRUG2$, and antipsychotics are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2720,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2721,
        "sentence": "@DRUG1$: In vitro data indicate that @DRUG2$ and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2722,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered @DRUG1$, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate @DRUG2$ serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2723,
        "sentence": "Therefore, the potential exists for a drug interaction between @DRUG1$ and drugs that affect the CYP2B6 isoenzyme (e.g., @DRUG2$ and cyclophosphamide).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2724,
        "sentence": "Antacids: The concomitant administration of @DRUG1$ has no apparent effect on the extent of absorption of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2725,
        "sentence": "Ironically, @DRUG1$ are often used in the treatment of @DRUG2$ addiction while they cause much more severe withdrawal symptoms.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2726,
        "sentence": "Serum @DRUG1$ concentrations increase when @DRUG2$ is initiated in a patient maintained on theophylline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2727,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2728,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, @DRUG1$, cimetidine, metoclopramide, @DRUG2$, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2729,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, @DRUG1$ 200 mg QD) resulted in increases in Cmax of @DRUG2$ ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2730,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2731,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, @DRUG1$, phenytoin, @DRUG2$, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2732,
        "sentence": "@DRUG1$: Interaction with Drugs that Inhibit Metabolism via Cytochrome P450 3A (CYP3A): The metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other @DRUG2$ is catalyzed by CYP3A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2733,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2734,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2735,
        "sentence": "Capsules @DRUG1$ 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2736,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2737,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2738,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2739,
        "sentence": "Increasing the @DRUG1$ dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2740,
        "sentence": "Possible extrarenal mechanisms of action of @DRUG1$ on @DRUG2$ and iodamide transport were also examined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2741,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG2$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2742,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG1$ for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2743,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG1$, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2744,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral @DRUG2$, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2745,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2746,
        "sentence": "Oral @DRUG1$: @DRUG2$ does not alter glucose metabolism in normal subjects nor does it alter the effects of oral hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2747,
        "sentence": "The oral dexamethasone doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of @DRUG1$ similar to those obtained when it is given without @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2748,
        "sentence": "Probenecid or Cimetidine: Concomitant administration of probenecid or cimetidine decreases the elimination of @DRUG1$, most likely by inhibition of renal tubular secretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2749,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2750,
        "sentence": "@DRUG1$ can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2751,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2752,
        "sentence": "@DRUG1$, clonidine, lithium salts, and @DRUG2$ may either potentiate or weaken the blood-glucose-lowering effect of insulin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2753,
        "sentence": "In view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by @DRUG1$, the physician may wish to withhold @DRUG2$ during dosing with CAMPTOSAR and, certainly, during periods of active vomiting or diarrhea.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2754,
        "sentence": "@DRUG1$ such as spironolactone, triamterene, or @DRUG2$, or potassium supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2755,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of ZYVOX and serotonergic agents, including @DRUG1$ such as @DRUG2$ (SSRIs), have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2756,
        "sentence": "Certain drugs including thiazides, corticosteroids, thyroid products, and @DRUG1$ may reduce the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2757,
        "sentence": "@DRUG1$ potentiates other cholinesterase inhibitors such as succinylcholine or @DRUG2$s.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2758,
        "sentence": "The oral dexamethasone doses should be reduced by approximately 50% when coadministered with @DRUG1$, to achieve exposures of @DRUG2$ similar to those obtained when it is given without Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2759,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2760,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2761,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as @DRUG1$, telithromycin, @DRUG2$, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2762,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2763,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of @DRUG1$ (2 x 60 mg capsule) within 15 minutes of an @DRUG2$ and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2764,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG2$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2765,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2766,
        "sentence": "Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that @DRUG1$ may exacerbate the neutropenic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2767,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2768,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2769,
        "sentence": "Studies with @DRUG1$ in combination with diuretics indicate that the dose of the @DRUG2$ can be reduced when it is given with a diuretic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2770,
        "sentence": "This article looks at five commonly used @DRUG1$ in turn (corticosteroids, cyclosporin, @DRUG2$, methotrexate, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2771,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2772,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and @DRUG1$ (eg, propafenone, @DRUG2$, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2773,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG1$, coumarins, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2774,
        "sentence": "Inhibitors of CYP3A4 (eg, @DRUG1$) or CYP2D6 (eg, quinidine, fluoxetine, or @DRUG2$) can inhibit aripiprazole elimination and cause increased blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2775,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, @DRUG1$, @DRUG2$, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2776,
        "sentence": "@DRUG1$ may decrease renal tubular secretion of @DRUG2$ when used concurrently, resulting in increased and more prolonged cephalosporin blood levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2777,
        "sentence": "@DRUG1$: The combined use of @DRUG2$ and HMG-CoA reductase inhibitors should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2778,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2779,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2780,
        "sentence": "The oral @DRUG1$ doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of @DRUG2$ similar to those obtained when it is given without Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2781,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2782,
        "sentence": "@DRUG1$, enflurane, and @DRUG2$ decrease the ED50 of NUROMAX by 30% to 45%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2783,
        "sentence": "NaCMC at 1% (m/v) in the presence of free @DRUG1$ had no significant effect on the R-value of @DRUG2$ compared to NaCMC alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2784,
        "sentence": "When Bezalip or @DRUG1$ is used at the same time as other medicines or substances the following interactions must be taken into account: - @DRUG2$ and Bezalip retard may enhance the action of anticoagulants of the coumarin type.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2785,
        "sentence": "Administration of @DRUG1$ (100 mg kg(-1) body weight) to rats in vivo resulted in @DRUG2$ synthesis in the kidney, which was preceded by an elevation in fluoride levels and followed by citrate accumulation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2786,
        "sentence": "A clinical interaction study was also conducted with @DRUG1$ and the CYP3A4 substrate @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2787,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2788,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or @DRUG1$ (eg, @DRUG2$ and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2789,
        "sentence": "Effects of @DRUG1$ on Other Drugs @DRUG2$ does not inhibit the CYP450 isoenzymes (CYP1A2, 2C8, 2C9, 2C19, 2D6, 2E1, and CYP 3A) or induce CYP 3A4.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2790,
        "sentence": "Should it be decided to discontinue therapy in patients receiving beta-blockers and @DRUG1$ concurrently, the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2791,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2792,
        "sentence": "Interactions between treatments with @DRUG1$, bishydroxycoumarin (an anticoagulant), trichlorfon (an @DRUG2$), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2793,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG1$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2794,
        "sentence": "Thus, when @DRUG1$ and @DRUG2$ are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2795,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2796,
        "sentence": "Of over 3500 patients enrolled in the @DRUG1$ osteoporosis Treatment and Prevention Studies, 15% used anti-peptic agents (primarily H2 blockers and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2797,
        "sentence": "Most of the above effects concerning @DRUG1$ have been attributed, at least in part, to mechanisms involving inhibition of prostaglandin synthesis by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2798,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or @DRUG1$ did not affect @DRUG2$ pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2799,
        "sentence": "Because of its lack of platelet effects, @DRUG1$ is not a substitute for @DRUG2$ for cardiovascular prophylaxis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2800,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG1$ [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2801,
        "sentence": "Drug/Laboratory Test Interferences: Dicumarol and @DRUG1$, including @DRUG2$, or their metabolites may color alkaline urine red-orange, which may interfere with spectrophotometrically determined urinary laboratory tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2802,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2803,
        "sentence": "Potentiation of the hypotensive effects of @DRUG1$ for patients with ischemic heart disease has not been evaluated, and concomitant use of Vardenafil and @DRUG2$ is contraindicated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2804,
        "sentence": "Interactions between treatments with coumaphos, @DRUG1$ (an @DRUG2$), trichlorfon (an organophosphorous compound), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2805,
        "sentence": "H2-Receptor Antagonists: Co-administration of a single dose of intravenously administered @DRUG1$ (20 mg) reduced the oral absorption of a single 400 mg dose of @DRUG2$ administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2806,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG1$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2807,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other @DRUG2$, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2808,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2809,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant @DRUG1$ and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic @DRUG2$ concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2810,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. @DRUG1$ @DRUG2$ of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2811,
        "sentence": "@DRUG1$ Agents: Aspirin is contraindicated in patients who are hypersensitive to @DRUG2$ agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2812,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2813,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG1$ (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for @DRUG2$ in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2814,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG1$, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2815,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2816,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2817,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, @DRUG1$, itraconazole, erythromycin, grapefruit juice, @DRUG2$) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2818,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2819,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, @DRUG1$, orphenadrine, pyrilamine, @DRUG2$, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2820,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG1$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2821,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2822,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with @DRUG1$, antipyrine, @DRUG2$, erythromycin and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2823,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2824,
        "sentence": "Phospholine Iodide potentiates other cholinesterase inhibitors such as @DRUG1$ or organophosphate and @DRUG2$s.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2825,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2826,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2827,
        "sentence": "Such individuals are referred to as poor metabolizers of drugs such as @DRUG1$, dextromethorphan, the tricyclic antidepressants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2828,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, @DRUG1$, @DRUG2$, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2829,
        "sentence": "Anticonvulsants: @DRUG1$ @DRUG2$ Carbamazepine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2830,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2831,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2832,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2833,
        "sentence": "Lithium: Increased serum lithium levels and symptoms of @DRUG1$ toxicity have been reported in patients receiving ACE inhibitors during therapy with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2834,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2835,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of propranolol (40 mg twice daily), phenytoin, @DRUG1$, or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2836,
        "sentence": "A drug interaction study was performed in which @DRUG1$ was administered in combination with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2837,
        "sentence": "Propanolol: The pharmacokinetics of @DRUG1$ were not affected by coadministration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2838,
        "sentence": "A single dose of @DRUG1$ had no clinically important effect on the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2839,
        "sentence": "After prolonged administration of neuroleptics the displacing effect of @DRUG1$, an analog of cholecystokinin octapeptide, was replaced by the stimulant action on @DRUG2$ binding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2840,
        "sentence": "Protease Inhibitors: In vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of @DRUG1$ which can result in an increase in plasma @DRUG2$ levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2841,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2842,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic @DRUG1$ containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental @DRUG2$ reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2843,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2844,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2845,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2846,
        "sentence": "Limited clinical experience indicates that requirements for @DRUG1$ are reduced by 30 to 50% for the first sixty (60) minutes following ALFENTA induction The concomitant use of erythromycin with ALFENTA can significantly inhibit @DRUG2$ clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2847,
        "sentence": "Clinical experience with concomitant administration of @DRUG1$ and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among @DRUG2$- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2848,
        "sentence": "Methotrexate @DRUG1$ 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly @DRUG2$ doses of 7.5 to 20 mg for rheumatoid arthritis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2849,
        "sentence": "@DRUG1$ (18-MC) and @DRUG2$: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2850,
        "sentence": "In the experiments reported here, we examined the interactions between @DRUG1$ and the antiestrogen 4-hydroxytamoxifen (@DRUG2$), which also induces apoptosis in MCF-7 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2851,
        "sentence": "@DRUG1$: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of @DRUG2$ by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2852,
        "sentence": "@DRUG1$ and oral retinoids: Concomitant administration of vitamin A and/or other oral @DRUG2$ with acitretin must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2853,
        "sentence": "@DRUG1$ had no effect on plasma levels of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2854,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of @DRUG1$ are not altered by itraconazole, @DRUG2$, mycophenolate, nelfinavir, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2855,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2856,
        "sentence": "Antacids and @DRUG1$: Sucralfate and @DRUG2$ containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2857,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2858,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2859,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, @DRUG1$, mycophenolate, @DRUG2$, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2860,
        "sentence": "In the present study, evoked potentials were recorded at 5, 20, and 40 min following IP injections of saline, @DRUG1$ (2.0 g/kg), physostigmine (0.6 mg/kg) or @DRUG2$ (15.0 mg/kg) on separate days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2861,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG2$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2862,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG1$, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2863,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG1$, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2864,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2865,
        "sentence": "@DRUG1$: @DRUG2$-induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants (e.g., tubocurarine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2866,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of ergotamine-containing or ergot-type medications (like @DRUG1$ or @DRUG2$) and FROVA within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2867,
        "sentence": "Tablets: The benzodiazepines, including @DRUG1$, produce CNS-depressant effects when administered with such medications as @DRUG2$ or alcohol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2868,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2869,
        "sentence": "The results of a study of coadministration of @DRUG1$ (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of @DRUG2$ of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2870,
        "sentence": "Seizures have been reported in patients taking another @DRUG1$ and the nonsteroidal anti-inflammatory drug @DRUG2$ concurrently.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2871,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG1$, or with multivitamins containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2872,
        "sentence": "Concomitant treatment with @DRUG1$ (@DRUG2$, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2873,
        "sentence": "@DRUG1$, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other @DRUG2$-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2874,
        "sentence": "Because both of these drugs have negative inotropic properties and the effects of coadministration with TAMBOCOR are unknown, neither disopyramide nor @DRUG1$ should be administered concurrently with @DRUG2$ unless, in the judgment of the physician, the benefits of this combination outweigh the risks.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2875,
        "sentence": "MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of @DRUG1$ is enhanced by the MAO inhibitor @DRUG2$ .",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2876,
        "sentence": "@DRUG1$ and Foods Fortified With @DRUG2$ Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2877,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, @DRUG1$, rifapentine, phenytoin, @DRUG2$, phenobarbital and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2878,
        "sentence": "Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, @DRUG1$, @DRUG2$, or paroxetine) can inhibit aripiprazole elimination and cause increased blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2879,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2880,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2881,
        "sentence": "Ventricular tachycardia induced by @DRUG1$ was generally converted to sinus rhythm following administration of Innovar, ketamine, or droperidol but not after administration of @DRUG2$ alone or after pentobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2882,
        "sentence": "Increased toxicity (CNS depression): @DRUG1$, @DRUG2$, tricyclic antidepressants, phenothiazines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2883,
        "sentence": "While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, @DRUG1$, and @DRUG2$, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2884,
        "sentence": "An increase in serum @DRUG1$ concentration has been reported during concomitant administration of lithium with @DRUG2$, so careful monitoring of serum lithium levels is recommended during concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2885,
        "sentence": "Patients receiving other @DRUG1$, antipsychotics, antianxiety agents, or other @DRUG2$ (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2886,
        "sentence": "Beta-blockers, @DRUG1$, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2887,
        "sentence": "When @DRUG1$ and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because @DRUG2$ may potentiate the effect of atropine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2888,
        "sentence": "MAO inhibitors: MAOI antidepressants, as well as a metabolite of @DRUG1$, slow @DRUG2$ metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2889,
        "sentence": "Hypotension was more likely to occur if the @DRUG1$ were a @DRUG2$, e.g., nifedipine, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either verapamil or diltiazem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2890,
        "sentence": "When initiating a multi-day course of grepafloxacin in a patient maintained on @DRUG1$, the @DRUG2$ maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2891,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2892,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2893,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2894,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2895,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG2$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2896,
        "sentence": "If chlorprothixene is given concomitantly with @DRUG1$, the @DRUG2$ dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2897,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG1$), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2898,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, @DRUG1$, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of @DRUG2$, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2899,
        "sentence": "@DRUG1$ VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of @DRUG2$ as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2900,
        "sentence": "In simultaneous treatment with @DRUG1$ and @DRUG2$, the anticoagulant effect should be carefully titrated and monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2901,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG2$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2902,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an @DRUG1$ and magnesium containing @DRUG2$ (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2903,
        "sentence": "These include probenecid, cholestyramine, and some @DRUG1$ (e.g. @DRUG2$, rifamipicin, ampicillin and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2904,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of @DRUG1$, or the pharmacokinetics of propranolol (40 mg twice daily), phenytoin, theophylline, or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2905,
        "sentence": "@DRUG1$, @DRUG2$, Niacin (Nicotinic Acid, Erythromycin, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2906,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2907,
        "sentence": "Erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines @DRUG1$ and @DRUG2$ when taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2908,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2909,
        "sentence": "Drug Interactions, General: Although there have been no formal interaction studies, intravenous fenoldopam has been administered safely with drugs such as @DRUG1$ and sublingual @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2910,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2911,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2912,
        "sentence": "MAO inhibitors: @DRUG1$, as well as a metabolite of @DRUG2$, slow amphetamine metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2913,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with @DRUG2$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2914,
        "sentence": "In vitro, buspirone does not displace tightly bound drugs like @DRUG1$, @DRUG2$, and warfarin from serum proteins.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2915,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2916,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, @DRUG2$, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2917,
        "sentence": "Coadministration of @DRUG1$ and strong CYP3A4 inhibitors, such as @DRUG2$, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2918,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG1$), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2919,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2920,
        "sentence": "Concomitant administration of Kerlone with the oral @DRUG1$ warfarin has been shown not to potentiate the anticoagulant effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2921,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2922,
        "sentence": "@DRUG1$ (500 mg t.i.d) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax when co-administered with @DRUG2$ 5 mg in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2923,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2924,
        "sentence": "@DRUG1$, Ranitidine: In normal volunteers (n=9), pretreatment with @DRUG2$ or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2925,
        "sentence": "However, since aspirin, @DRUG1$, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of @DRUG2$ or NSAIDs with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2926,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG1$, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2927,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG1$, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2928,
        "sentence": "Tolbutamide: @DRUG1$, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of @DRUG2$ 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2929,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2930,
        "sentence": "The CNS effects of @DRUG1$ may be enhanced by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2931,
        "sentence": "The thiazolidinediones (@DRUG1$ and @DRUG2$), a new class of oral antidiabetic agents, are \"insulin sensitizers\"",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2932,
        "sentence": "Caution should be observed when @DRUG1$ is coadministered with other @DRUG2$, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2933,
        "sentence": "Therefore, the potential exists for a drug interaction between WELLBUTRIN and drugs that affect the CYP2B6 isoenzyme (e.g., @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2934,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2935,
        "sentence": "Repeated oral administration of @DRUG1$ in sheep: interactions of coumaphos with bishydroxycoumarin, trichlorfon, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2936,
        "sentence": "In patients taking an @DRUG1$ (eg, valproic acid, @DRUG2$, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2937,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG2$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2938,
        "sentence": "The benzodiazepines, including @DRUG1$, produce additive CNS depressant effects when co-administered with other @DRUG2$, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2939,
        "sentence": "Anticonvulsants (@DRUG1$, felbamate, phenobarbital, phenytoin, @DRUG2$): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2940,
        "sentence": "It may also interact with @DRUG1$ or other @DRUG2$ or MAOIs, which may intensify the anticholinergic action.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2941,
        "sentence": "Oral @DRUG1$ @DRUG2$ did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2942,
        "sentence": "@DRUG1$ has been reported to significantly alter the metabolism of nonsedating @DRUG2$ terfenadine and astemizole when taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2943,
        "sentence": "@DRUG1$: In a study of healthy volunteers, @DRUG2$ significantly reduced the bioavailability of ampicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2944,
        "sentence": "Risk of Anaphylactic Reaction: Although it is known that patients on @DRUG1$ may be refractory to @DRUG2$ in the treatment of anaphylactic shock, beta-blockers can, in addition, interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2945,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2946,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2947,
        "sentence": "@DRUG1$: Cimetidine does not affect the pharmacokinetics of @DRUG2$ when coadministered with MONUROL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2948,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2949,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local @DRUG1$ like lidocaine, procaine, beta-blockers, metaclopramide, lithium carbonate, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2950,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2951,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2952,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2953,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, alfentanil, cisapride, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2954,
        "sentence": "Because Anafranil is highly bound to serum protein, the administration of @DRUG1$ to patients taking other drugs that are highly bound to protein (e.g., @DRUG2$, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2955,
        "sentence": "in one man, the C max of terfenadine was 8.1 ng/mL with terfenadine alone and 7.2 ng/mL with @DRUG1$ plus @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2956,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2957,
        "sentence": "Comparison of @DRUG1$ pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without @DRUG2$ indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of cisplatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2958,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2959,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2960,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG1$ containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2961,
        "sentence": "Probenecid or @DRUG1$: Concomitant administration of @DRUG2$ or cimetidine decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2962,
        "sentence": "@DRUG1$ e.g., @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2963,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2964,
        "sentence": "Thus in order to avoid bleeding, reduced dosage of @DRUG1$ is recommended during treatment with @DRUG2$ (human).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2965,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG1$, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2966,
        "sentence": "@DRUG1$, @DRUG2$, cimetidine (consider Xanax dose reduction).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2967,
        "sentence": "@DRUG1$ or Primidone : No formal pharmacokinetic studies have been performed examining the addition of @DRUG2$ to regimens containing phenobarbital or primidone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2968,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG2$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2969,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2970,
        "sentence": "There has been too little experience with the coadministration of TAMBOCOR with @DRUG1$ or @DRUG2$ to recommend concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2971,
        "sentence": "Therapeutic drug monitoring can avoid iatrogenic alterations caused by @DRUG1$ (MDP)-@DRUG2$ interaction.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2972,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2973,
        "sentence": "Concomitant administration of FACTIVE and @DRUG1$, cimetidine, omeprazole, or an @DRUG2$/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2974,
        "sentence": "The percentage of neurons hyperpolarized by mu-, @DRUG-DRUG$ was significantly reduced when 1% but not <",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2975,
        "sentence": "In patients taking @DRUG1$, nifedipine, diltiazem, ACE inhibitors, @DRUG2$, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2976,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2977,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2978,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2979,
        "sentence": "Beta-blockers, clonidine, @DRUG1$ salts, and @DRUG2$ may either potentiate or weaken the blood-glucose-lowering effect of insulin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2980,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2981,
        "sentence": "There is no pharmacokinetic interaction between @DRUG1$ and @DRUG2$ following the administration of a single dose (10 mg and 50 mg, respectively) of each drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2982,
        "sentence": "Probenecid or @DRUG1$: Concomitant administration of probenecid or @DRUG2$ decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2983,
        "sentence": "In clinical studies, coadministration of @DRUG1$  with atorvastatin, lovastatin, or simvastatin did not interfere with the lipid-lowering activity of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2984,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2985,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/@DRUG1$ oral contraceptive produced minor changes in the pharmacokinetics of @DRUG2$, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2986,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2987,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing @DRUG1$ (@DRUG2$ ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2988,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or @DRUG1$ (eg, famotidine and omeprazole) is likely to reduce @DRUG2$ exposure.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2989,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG1$, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2990,
        "sentence": "@DRUG1$ (carbamazepine, @DRUG2$, phenobarbital, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2991,
        "sentence": "Effects of other Antiepilepsy Drugs (@DRUG1$) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG2$ with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2992,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2993,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2994,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2995,
        "sentence": "@DRUG1$ (@DRUG2$): Concomitant use of aspirin (or other nonsteroidal antiinflammatory agents) and corticosteroids increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2996,
        "sentence": "No significant interactions with @DRUG1$, hydrochlorothiazide, @DRUG2$, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2997,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2998,
        "sentence": "When @DRUG1$ dosing was separated from terazosin 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of @DRUG2$ experienced a decrease in standing systolic blood pressure below 85 mm Hg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2999,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3000,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, alfentanil, cisapride, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3001,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, @DRUG1$, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3002,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3003,
        "sentence": "The actions of the @DRUG1$ may be potentiated by @DRUG2$, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3004,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3005,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3006,
        "sentence": "The combination of therapeutic doses of intravenous dantrolene sodium and @DRUG1$ in @DRUG2$ a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3007,
        "sentence": "Hypotension was more likely to occur if the calcium antagonist were a @DRUG1$, e.g., nifedipine, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either @DRUG2$ or diltiazem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3008,
        "sentence": "These pharmacokinetic effects seen during @DRUG1$ coadministration can result in increased clinical effects (e.g., prolonged sodation)of both midazolam and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3009,
        "sentence": "In a study with concomitant administration of @DRUG1$ and fosinopril sodium, the bioavailability of unbound @DRUG2$ was not altered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3010,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3011,
        "sentence": "In patients taking @DRUG1$, nifedipine, diltiazem, ACE inhibitors, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3012,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, @DRUG2$, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3013,
        "sentence": "While it is not known whether this interaction occurs with @DRUG1$ other than gemfibrozil, myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3014,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3015,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG1$), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3016,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3017,
        "sentence": "and Videx , (@DRUG1$), chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of @DRUG2$, resulting in systemic levels considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3018,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG1$ (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3019,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3020,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3021,
        "sentence": "When @DRUG1$ or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and @DRUG2$ may enhance the action of anticoagulants of the coumarin type.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3022,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3023,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, @DRUG1$, @DRUG2$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3024,
        "sentence": "The thiazolidinediones (rosiglitazone and @DRUG1$), a new class of oral @DRUG2$, are \"insulin sensitizers\"",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3025,
        "sentence": "astemizole midazolam, @DRUG1$ @DRUG2$ ergot derivatives voriconazole",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3026,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3027,
        "sentence": "@DRUG1$: Cimetidine does not affect the pharmacokinetics of fosfomycin when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3028,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3029,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG1$, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3030,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of @DRUG1$ binding after the long-term administration of @DRUG2$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3031,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3032,
        "sentence": "A 21 (17)% decrease in the steady-state AUC of @DRUG1$ was observed when @DRUG2$ was administered 2 hours prior to ganciclovir, but not when the two drugs were administered simultaneously (n = 12).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3033,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like @DRUG1$, procaine, beta-blockers, metaclopramide, lithium carbonate, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3034,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3035,
        "sentence": "@DRUG1$: The concurrent administration of propoxyphene hydrochloride does not affect the bioavailability of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3036,
        "sentence": "Glibenclamide: In a study of 7 healthy male volunteers, @DRUG1$ treatment potentiated the blood glucose lowering effect of glibenclamide (a @DRUG2$ similar to chlorpropamide) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3037,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG1$, barbiturates, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3038,
        "sentence": "Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by @DRUG1$, since allopurinol and @DRUG2$ may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3039,
        "sentence": "When @DRUG1$ is co-administered with @DRUG2$ (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3040,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG2$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3041,
        "sentence": "While all the selective @DRUG1$ (SSRIs), e.g., @DRUG2$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3042,
        "sentence": "@DRUG1$: @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3043,
        "sentence": "No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including cyclosporine, @DRUG1$, and either azathioprine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3044,
        "sentence": "@DRUG1$: In vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of @DRUG2$ which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3045,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3046,
        "sentence": "Isoflurane, enflurane, and @DRUG1$ decrease the ED50 of @DRUG2$ by 30% to 45%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3047,
        "sentence": "Antacids or H 2 receptor antagonists: When @DRUG1$ is administered immediately following antacids or H 2 -receptor antagonists, the absorption of @DRUG2$ is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3048,
        "sentence": "@DRUG1$ decreased the binding of @DRUG2$ by a net change of 6.8% (percentage increase in FDF, 8.8%) at 277.5 micromol/L;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3049,
        "sentence": "In clinical studies, coadministration of WelChol  with atorvastatin, @DRUG1$, or @DRUG2$ did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3050,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3051,
        "sentence": "Several tricyclic antidepressants have been reported to block the pharmacologic effects of @DRUG1$, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3052,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3053,
        "sentence": "Serum concentration of digoxin and @DRUG1$ may increase when patients take @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3054,
        "sentence": "An adequate period of observation must be provided for any patient in whom either long-acting benzodiazepines (such as diazepam) or large doses of @DRUG1$ (such as  10 mg of @DRUG2$) have been used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3055,
        "sentence": "- Concomitant use of @DRUG1$ may reduce the efficacy of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3056,
        "sentence": "Pharmacokinetic interactions between @DRUG1$ and @DRUG2$ (atenolol, propranolol) were variable and not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3057,
        "sentence": "Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, @DRUG1$ (@DRUG2$ or ciprofloxacin) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3058,
        "sentence": "Pregnancy @DRUG1$ and estrogen-containing oral @DRUG2$ increase TBg concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3059,
        "sentence": "@DRUG1$: @DRUG2$ blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines, and can be used to treat amphetamine poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3060,
        "sentence": "Cimetidine: In the presence of @DRUG1$ at 300 mg QID (N=12) the mean apparent oral clearance of @DRUG2$ fell by 14% and creatinine clearance fell by 10%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3061,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with @DRUG1$ or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3062,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3063,
        "sentence": "In 5 other schizophrenic patients treated with oral @DRUG1$ and @DRUG2$, discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3064,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, @DRUG1$, lamivudine, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3065,
        "sentence": "Antacids and sucralfate: Sucralfate and @DRUG1$ containing @DRUG2$ or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3066,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3067,
        "sentence": "Coadministration of oral @DRUG1$, diazepam, phenytoin, or @DRUG2$ did not seem to change the pharmacokinetic profile of esomeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3068,
        "sentence": "The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when @DRUG1$ was coadministered, although the daily dosage of @DRUG2$ and other drugs had not changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3069,
        "sentence": "When initiating a multi-day course of @DRUG1$ in a patient maintained on theophylline, the @DRUG2$ maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3070,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, @DRUG2$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3071,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, @DRUG2$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3072,
        "sentence": "It may also interact with amantadine or other @DRUG1$ or @DRUG2$, which may intensify the anticholinergic action.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3073,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG2$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3074,
        "sentence": "Anticonvulsants (@DRUG1$, @DRUG2$, phenobarbital, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3075,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, @DRUG1$ 240 mg QD, @DRUG2$ 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3076,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3077,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3078,
        "sentence": "There have been a number of reports in the post-marketing experience of coma and death associated with the concomitant intravenous misuse of @DRUG1$ and @DRUG2$ by addicts.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3079,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3080,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3081,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG1$, and the Type 1C antiarrhythmics @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3082,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, @DRUG1$, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3083,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, terfenadine, ketoconazole, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3084,
        "sentence": "- @DRUG1$ (e.g., Aldomet) Use of methyldopa with @DRUG2$ may increase the chance of side effects affecting the liver and/or the blood",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3085,
        "sentence": "Oral Contraceptives @DRUG1$ did not have any clinically important effect on the pharmacokinetics of @DRUG2$ and norethindrone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3086,
        "sentence": "The concomitant use of @DRUG1$ with other @DRUG2$ is not recommended due to the increased possibility of gastrointestinal toxicity, with little or no increase in efficacy.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3087,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all @DRUG2$ (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3088,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the liver",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3089,
        "sentence": "The effect of a @DRUG1$ extract from bovine lung, Survanta, on the dissolution rate of aerosol particles of @DRUG2$ was determined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3090,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3091,
        "sentence": "Vitamin A and oral @DRUG1$: Concomitant administration of vitamin A and/or other oral @DRUG2$ with acitretin must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3092,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG1$, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3093,
        "sentence": "Intravenous infusion of @DRUG1$ had no effect on the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3094,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3095,
        "sentence": "@DRUG1$, like @DRUG2$, produced depletions of striatal dopamine but these actions were potentiated by pargyline pretreatment.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3096,
        "sentence": "Ethoxzolamide may increase the action of @DRUG1$, amphetamines, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3097,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3098,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3099,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3100,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG1$, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3101,
        "sentence": "However, the systemic administration of some @DRUG1$ has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of @DRUG2$, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3102,
        "sentence": "@DRUG1$: In normal volunteers, the concomitant administration of diflunisal and @DRUG2$ had no effect on the diuretic activity of furosemide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3103,
        "sentence": "Coadministration of oral contraceptives, @DRUG1$, phenytoin, or @DRUG2$ did not seem to change the pharmacokinetic profile of esomeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3104,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3105,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, @DRUG1$ (@DRUG2$), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3106,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3107,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3108,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3109,
        "sentence": "Itraconazole plasma concentrations should be monitored when @DRUG1$ and @DRUG2$ are coadministered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3110,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3111,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3112,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3113,
        "sentence": "Propoxyphene: In cases of @DRUG1$ overdosage, @DRUG2$ CNS stimulation is potentiated and fatal convulsions can occur.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3114,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3115,
        "sentence": "Amphotericin, Foscarnet, and @DRUG1$: Drugs such as @DRUG2$, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3116,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general @DRUG1$, local anesthetics like @DRUG2$, procaine, beta-blockers, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3117,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG1$, or with multivitamins containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3118,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3119,
        "sentence": "Warfarin, Digoxin, @DRUG1$, and Heparin The in vitro binding of @DRUG2$ to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3120,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, ACE inhibitors, @DRUG1$, @DRUG2$, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3121,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3122,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3123,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG1$, antianxiety agents, the phenothiazines, @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3124,
        "sentence": "however, as with other @DRUG1$, concomitant administration of @DRUG2$ and aspirin is not generally recommended because of the potential of increased adverse effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3125,
        "sentence": "Hypotension was more likely to occur if the calcium antagonist were a dihydropyridine derivative, e.g., @DRUG1$, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either @DRUG2$ or diltiazem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3126,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with @DRUG2$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3127,
        "sentence": "@DRUG1$: Amphetamines may counteract the sedative effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3128,
        "sentence": "Repeated oral administration of coumaphos in sheep: interactions of coumaphos with bishydroxycoumarin, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3129,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3130,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, @DRUG1$, @DRUG2$, pyrilamine, phenyltoloxamine, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3131,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3132,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3133,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3134,
        "sentence": "Diminished urinary excretion of @DRUG1$ has been reported during the concomitant administration of @DRUG2$ and norfloxacin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3135,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3136,
        "sentence": "Upon administration of 10 mg of @DRUG1$ with 800 mg TID @DRUG2$, the Cmax and AUC of indinavir were reduced by 40% and 30%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3137,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3138,
        "sentence": "Amphotericin, Foscarnet, and @DRUG1$: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of @DRUG2$ (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3139,
        "sentence": "Antacids and sucralfate: @DRUG1$ and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3140,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG1$ and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3141,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3142,
        "sentence": "@DRUG1$: In a study of 7 healthy male volunteers, @DRUG2$ treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3143,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3144,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3145,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3146,
        "sentence": "@DRUG1$ may increase the action of tricyclics, amphetamines, procainamide, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3147,
        "sentence": "Caution should be observed when anileridine is coadministered with other opioids, @DRUG1$, @DRUG2$, or anesthetics, as these agents may increase respiratory and circulatory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3148,
        "sentence": "Other: There appears to be no pharmacokinetic interaction between acitretin and @DRUG1$, digoxin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3149,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, @DRUG1$, ketoconazole, erythromycin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3150,
        "sentence": "Co-administration of multiple doses of 10 mg of @DRUG1$ had no effect on the single dose pharmacokinetics of R- and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3151,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3152,
        "sentence": "- @DRUG1$ (e.g., Dilantin) Use of phenytoin with @DRUG2$ may increase the chance of side effects affecting the liver and/or the side effects of phenytoin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3153,
        "sentence": "In vivo studies: Nitrates: The blood pressure lowering effects of sublingual @DRUG1$ (0.4 mg) taken 1 and 4 hours after @DRUG2$ and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3154,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3155,
        "sentence": "@DRUG1$: Cimetidine inhibits CYP3A4 and can increase serum @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3156,
        "sentence": "It is recommended that the combination of intravenous @DRUG1$ and @DRUG2$, such as verapamil, not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3157,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3158,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, @DRUG2$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3159,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, @DRUG1$ or @DRUG2$), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3160,
        "sentence": "Nafazodone, @DRUG1$, cimetidine (consider @DRUG2$ dose reduction).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3161,
        "sentence": "Serum concentration of @DRUG1$ and digitoxin may increase when patients take @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3162,
        "sentence": "Drug-Drug Interactions Albuterol - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other @DRUG1$) because the action of @DRUG2$ on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3163,
        "sentence": "Tacrolimus: Co-administration of @DRUG1$ and @DRUG2$ has not been studied in man.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3164,
        "sentence": "@DRUG1$: In vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma @DRUG2$ levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3165,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], @DRUG2$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3166,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3167,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3168,
        "sentence": "Co-administration of anastrozole and @DRUG1$ resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3169,
        "sentence": "Concomitant administration of @DRUG1$ with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3170,
        "sentence": "When digoxin and @DRUG1$ were concomitantly administered intravenously to normal volunteers, there was a 10-20% increase in @DRUG2$ blood levels at some time points.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3171,
        "sentence": "Concomitant treatment with @DRUG1$ (aminophylline, theophylline), steroids, or @DRUG2$ may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3172,
        "sentence": "and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including @DRUG1$ combined with local @DRUG2$, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3173,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, @DRUG1$, digoxin, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3174,
        "sentence": "Using in situ hybridization, we observed that METH caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist SCH-23390 but not by an @DRUG1$ @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3175,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, @DRUG1$, phenothiazines, sulfonamides and @DRUG2$ might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3176,
        "sentence": "Inhibitors of CYP3A4 (eg, @DRUG1$) or CYP2D6 (eg, @DRUG2$, fluoxetine, or paroxetine) can inhibit aripiprazole elimination and cause increased blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3177,
        "sentence": "@DRUG1$ or @DRUG2$: When dirithromycin is administered immediately following antacids or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3178,
        "sentence": "@DRUG1$: @DRUG2$ inhibits CYP3A4 and can increase serum amiodarone levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3179,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3180,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, @DRUG1$, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3181,
        "sentence": "Although specific drug interaction studies have not been conducted with @DRUG1$, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG2$, or anesthetics) should be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3182,
        "sentence": "A study in 14 normal male and female volunteers suggests that coadministration of @DRUG1$ and @DRUG2$ can result in prolongation of the QT interval on the ECG.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3183,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar, ketamine, or @DRUG1$ but not after administration of @DRUG2$ alone or after pentobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3184,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, @DRUG2$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3185,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG2$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3186,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3187,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3188,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3189,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3190,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3191,
        "sentence": "Sirolimus works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of @DRUG1$ does not appear to overlap to any great extent with that associated with cyclosporine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3192,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG2$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3193,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG1$), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3194,
        "sentence": "Skeletal muscle relaxants: @DRUG1$-induced hypokalemia may enhance the curariform effect of @DRUG2$ (e.g., tubocurarine).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3195,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3196,
        "sentence": "@DRUG1$: The concomitant administration of antacids has no apparent effect on the extent of absorption of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3197,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG1$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3198,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3199,
        "sentence": "Potential drug interactions for doxylamine include, increased sedation if @DRUG1$ is combined with other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3200,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3201,
        "sentence": "Interactions between treatments with coumaphos, bishydroxycoumarin (an @DRUG1$), trichlorfon (an organophosphorous compound), and @DRUG2$ (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3202,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG1$, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3203,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, @DRUG1$, @DRUG2$, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3204,
        "sentence": "In 5 other schizophrenic patients treated with oral haloperidol and rifampin, discontinuation of @DRUG1$ produced a mean 3.3-fold increase in @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3205,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG1$ containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3206,
        "sentence": "@DRUG1$ steady-state Cmax, A.C. and Cmin were decreased by 22%, 38%, and 27%, respectively, by concomitant @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3207,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG1$, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3208,
        "sentence": "No significant interactions with digoxin, @DRUG1$, hydralazine, @DRUG2$, oral contraceptives, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3209,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3210,
        "sentence": "and disulfiram When amitriptyline HCl is given with @DRUG1$ agents or sympathomimetic drugs, including @DRUG2$ combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3211,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3212,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of @DRUG1$ binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas @DRUG2$ binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3213,
        "sentence": "Therefore the, combination of @DRUG1$ with other @DRUG2$, including HUMIRA, may also result i n similar toxicities.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3214,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, @DRUG2$, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3215,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3216,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG1$ for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3217,
        "sentence": "Anesthetics/Sedatives/@DRUG1$/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, @DRUG2$, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3218,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (@DRUG1$), tolbutamide, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3219,
        "sentence": "@DRUG1$ attenuates, but @DRUG2$ potentiates, the acute locomotor effects of morphine;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3220,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3221,
        "sentence": "The @DRUG1$, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, @DRUG2$, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3222,
        "sentence": "These in vitro studies suggest that concomitant administration of @DRUG1$ and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine, which may lead to a decreased @DRUG2$ effect of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3223,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with @DRUG1$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3224,
        "sentence": "@DRUG1$: Sporadic cases of seizures have been reported during concomitant use of TORADOL and @DRUG2$ (phenytoin, carbamazepine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3225,
        "sentence": "@DRUG1$ is unlikely to interact with drugs that are substrates for the P-glycoprotein transporter, as demonstrated by the lack of interaction of Aprepitant with @DRUG2$ in a clinical drug interaction study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3226,
        "sentence": "These in vitro studies suggest that concomitant administration of @DRUG1$ and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated @DRUG2$, which may lead to a decreased antiretroviral effect of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3227,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3228,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG1$, probenecid, @DRUG2$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3229,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by @DRUG1$, @DRUG2$, mycophenolate, nelfinavir, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3230,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3231,
        "sentence": "Catecholamine-depleting drugs (e.g., @DRUG1$) may have an additive effect when given with @DRUG2$ agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3232,
        "sentence": "@DRUG1$: Coadministration of ketoconazole with VIRACEPT resulted in a 35% increase in @DRUG2$ plasma A.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3233,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and @DRUG1$ (eg, @DRUG2$, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3234,
        "sentence": "@DRUG1$ neutralized the increase of glycemia induced by oral @DRUG2$ overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3235,
        "sentence": "Meperidine: @DRUG1$ potentiate the analgesic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3236,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3237,
        "sentence": "Results from human in vitro metabolism studies and nonclinical studies show that REVLIMID  (@DRUG1$) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that @DRUG2$ is not likely to cause or be subject to P450-based metabolic drug interactions in man.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3238,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3239,
        "sentence": "Thus, when @DRUG1$ and lithium are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3240,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$ and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3241,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3242,
        "sentence": "When administered concurrently, the following drugs may interact with beta-adrenergic receptor blocking agents: @DRUG1$, general: exaggeration of the hypotension induced by general @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3243,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3244,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3245,
        "sentence": "Specific and aspecific treatments of magnesium depletion are tricky using for example magnesium sparing diuretics, pharmacological doses of @DRUG1$, physiological doses of vitamin D and of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3246,
        "sentence": "Noncardioselective beta-blockers (@DRUG1$,porpranolol,@DRUG2$) may exacerbate rebound hypertension when guanfacine is withdrawn.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3247,
        "sentence": "Potassium-sparing diuretics (@DRUG1$, amiloride, @DRUG2$, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3248,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3249,
        "sentence": "@DRUG1$: Weakness hyperreflexia, and incoordination have been reported rarely when @DRUG2$ have been co-administered with SSRIs (e. g.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3250,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3251,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3252,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3253,
        "sentence": "No significant interactions with @DRUG1$, hydrochlorothiazide, hydralazine, @DRUG2$, oral contraceptives, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3254,
        "sentence": "Should it be decided to discontinue therapy in patients receiving beta-blockers and @DRUG1$ concurrently, the @DRUG2$ should be discontinued slowly over several days before the gradual withdrawal of clonidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3255,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, alfentanil, @DRUG2$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3256,
        "sentence": "@DRUG1$: When fluvoxamine maleate (100 mg qd) and alprazolam (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of @DRUG2$ were approximately twice those observed when alprazolam was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3257,
        "sentence": "The gradual withdrawal of @DRUG1$ or a @DRUG2$ could be substituted.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3258,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with @DRUG2$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3259,
        "sentence": "Ketoconazole: Coadministration of ketoconazole with @DRUG1$ resulted in a 35% increase in @DRUG2$ plasma A.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3260,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3261,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3262,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG1$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3263,
        "sentence": "Although specific drug interaction studies have not been conducted with @DRUG1$, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG2$, sedatives, or anesthetics) should be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3264,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3265,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, @DRUG2$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3266,
        "sentence": "Therefore, concomitant use of @DRUG1$ and @DRUG2$ is contraindicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3267,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, @DRUG1$, beta-blockers, metaclopramide, lithium carbonate, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3268,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG1$, @DRUG2$, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3269,
        "sentence": "Concomitant administration of FACTIVE with @DRUG1$ resulted in a 45% increase in systemic exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3270,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, @DRUG2$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3271,
        "sentence": "@DRUG1$ or @DRUG2$: No significant differences were observed in the pharmacokinetics of triazolam (0.125 mg) and tiagabine (10 mg) when given together as a single dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3272,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG2$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3273,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG1$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3274,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing @DRUG1$ or aluminum, as well as formulations containing divalent and trivalent cations such as @DRUG2$  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3275,
        "sentence": "- a beta-blocker such as @DRUG1$ (Inderal), atenolol (Tenormin), acebutolol (@DRUG2$), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3276,
        "sentence": "Because oral @DRUG1$ may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and @DRUG2$ are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3277,
        "sentence": "Ketoconazole tablets may alter the metabolism of @DRUG1$, @DRUG2$, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3278,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, @DRUG1$, @DRUG2$ and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3279,
        "sentence": "An intravenous injection of @DRUG1$ given later also produces a complete and immediately beginning depletion of @DRUG2$ already accumulated in the thyroid, within a period of 195 min after 99m-TcO-4-injection with a corresponding increase in blood levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3280,
        "sentence": "Coadministration of @DRUG1$ and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, @DRUG2$, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3281,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG1$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3282,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3283,
        "sentence": "Certain drugs including thiazides, @DRUG1$, thyroid products, and sympathomimetics may reduce the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3284,
        "sentence": "When @DRUG1$ and BREVIBLOC were concomitantly administered intravenously to normal volunteers, there was a 10-20% increase in @DRUG2$ blood levels at some time points.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3285,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3286,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG1$, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3287,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3288,
        "sentence": "Ventricular tachycardia induced by @DRUG1$ was generally converted to sinus rhythm following administration of Innovar, ketamine, or droperidol but not after administration of fentayl alone or after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3289,
        "sentence": "Concomitant use of prophylactic low dose @DRUG1$ did not appear to affect safety, however, its effects on the efficacy of @DRUG2$ have not been evaluated in an adequate and well-controlled clinical trial.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3290,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3291,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3292,
        "sentence": "In vivo studies: Nitrates: The blood pressure lowering effects of sublingual @DRUG1$ (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of @DRUG2$ in healthy middle-aged subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3293,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3294,
        "sentence": "Acarbose may affect digoxin bioavailabillty and may require dose adjustment of @DRUG1$ by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of @DRUG2$ by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3295,
        "sentence": "@DRUG1$ or Triazolam: No significant differences were observed in the pharmacokinetics of @DRUG2$ (0.125 mg) and tiagabine (10 mg) when given together as a single dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3296,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3297,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3298,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, @DRUG2$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3299,
        "sentence": "Coadministration of ethoxzolamide with other @DRUG1$, @DRUG2$, and corticosteroids may cause hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3300,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG1$ may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3301,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, @DRUG1$ may elevate @DRUG2$ serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3302,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other @DRUG1$, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, @DRUG2$, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3303,
        "sentence": "The effects @DRUG1$ on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, phenytoin, @DRUG2$, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3304,
        "sentence": "@DRUG1$ or Primidone : No formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3305,
        "sentence": "Ketoconazole: Coadministration of @DRUG1$ with VIRACEPT resulted in a 35% increase in @DRUG2$ plasma A.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3306,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG1$, fluconazole, lamivudine, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3307,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3308,
        "sentence": "Alternatives to @DRUG1$, such as @DRUG2$, should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3309,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3310,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, @DRUG1$ 1200 mg TID, @DRUG2$ 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3311,
        "sentence": "@DRUG1$ @DRUG2$, triazolam cisapride ergot derivatives voriconazole",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3312,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG2$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3313,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3314,
        "sentence": "Use of PRINIVIL with potassium-sparing diuretics (e.g., spironolactone, @DRUG1$, or @DRUG2$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3315,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3316,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3317,
        "sentence": "Patients receiving other narcotic analgesics, @DRUG1$, antianxiety agents, or other @DRUG2$ (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3318,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, @DRUG1$, sulfonamides, @DRUG2$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3319,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, @DRUG1$, @DRUG2$ or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3320,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3321,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3322,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3323,
        "sentence": "@DRUG1$: @DRUG2$ does not affect the pharmacokinetics of fosfomycin when coadministered with MONUROL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3324,
        "sentence": "@DRUG1$s: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing @DRUG2$, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3325,
        "sentence": "Pharmacokinetic interaction studies with @DRUG1$ in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, @DRUG2$ and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3326,
        "sentence": "Oral @DRUG1$ Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG2$ and norethindrone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3327,
        "sentence": "MAO inhibitors: @DRUG1$, as well as a metabolite of furazolidone, slow @DRUG2$ metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3328,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3329,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, @DRUG1$, metoclopramide, @DRUG2$, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3330,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG1$, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3331,
        "sentence": "Coadministration of @DRUG1$ with oral @DRUG2$ or triazolam has resulted in elevated plasma concentrations of the latter two drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3332,
        "sentence": "The concurrent use of @DRUG1$ Injection with other anticholinergics or medications with anticholinergic activity, such as phenothiazines, antiparkinson drugs, or @DRUG2$, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3333,
        "sentence": "@DRUG1$ should be introduced at the lowest recommended dose in patients receiving @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3334,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3335,
        "sentence": "Intestinal adsorbents (e. g., charcoal) and @DRUG1$ containing carbohydrate-splitting enzymes (e. g., @DRUG2$, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3336,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3337,
        "sentence": "However, in a follow-up study in normal subjects, single-dose administration of @DRUG1$ and @DRUG2$ and twice-a-day administration for 5 days of both agents did not affect the extent of propranolol absorption, but had a small yet statistically significant effect on its rate of absorption;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3338,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3339,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3340,
        "sentence": "In normal volunteers receiving indomethacin, the administration of @DRUG1$ decreased the renal clearance and significantly increased the plasma levels of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3341,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an @DRUG1$-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and @DRUG2$/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3342,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3343,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG1$ (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3344,
        "sentence": "@DRUG1$: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that @DRUG2$ may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3345,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3346,
        "sentence": "@DRUG1$, atenolol, and @DRUG2$ (low hepatic clearance or no first-pass metabolism) are unlikely to be affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3347,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by @DRUG1$, amphotericin B, @DRUG2$, nelfinavir, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3348,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3349,
        "sentence": "This drug may interact with @DRUG1$ or other @DRUG2$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3350,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an @DRUG1$ containing @DRUG2$ to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3351,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG1$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3352,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3353,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral magnesium supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the magnesium intake and pharmacological @DRUG1$ therapy which may induce toxicity since it creates iatrogenic @DRUG2$ overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3354,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3355,
        "sentence": "Excessive neuromuscular weakness may be exacerbated by administration of another @DRUG1$ prior to the resolution of the effects of a previously administered @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3356,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3357,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3358,
        "sentence": "Morphine pharmacokinetic parameter values were not affected by administration of @DRUG1$  2 hours after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3359,
        "sentence": "Antihistamines: @DRUG1$ GI Motility Agents @DRUG2$ Antifungal",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3360,
        "sentence": "Antacids: Concomitant administration of @DRUG1$ and aluminum hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3361,
        "sentence": "Hydrochlorothiazide: A study in normal healthy volunteers has shown that concomitant administration of DynaCirc  (@DRUG1$) and @DRUG2$ does not result in altered pharmacoktnetics of either drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3362,
        "sentence": "In diabetic patients, the metabolic effects of @DRUG1$ may decrease blood glucose and therefore, @DRUG2$ requirements.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3363,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG2$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3364,
        "sentence": "Talk to your doctor if you are taking certain @DRUG1$ such as erythromycin, @DRUG2$ or azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3365,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG1$, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3366,
        "sentence": "Certain @DRUG1$, cisplatin, cyclosporine, diuretic, foscarnet, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3367,
        "sentence": "To avoid this interaction, @DRUG1$ or @DRUG2$ should be given 1 hour prior to dosing with VIDEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3368,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3369,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3370,
        "sentence": "Anticholinergics: Concurrent administration of certain anticholinergic compounds, such as belladonna alkaloids and @DRUG1$, would be expected to compromise the beneficial effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3371,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of @DRUG1$, interfere with the metabolism of @DRUG2$, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3372,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, @DRUG1$, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the @DRUG2$ for Topical Solution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3373,
        "sentence": "Cimetidine - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg/day @DRUG1$ for 8 days resulted in an increase in @DRUG2$ AUC and Cmax of 43% and 39%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3374,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., @DRUG1$, barbiturates, @DRUG2$, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3375,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3376,
        "sentence": "It is recommended that in patients taking @DRUG1$, prothrombin time be determined before starting @DRUG2$ and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3377,
        "sentence": "Protease Inhibitors: In vitro data indicate that @DRUG1$ and @DRUG2$ markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3378,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3379,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, @DRUG1$, @DRUG2$, erythromycin, and troleandomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3380,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or @DRUG1$) and @DRUG2$ within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3381,
        "sentence": "Glibenclamide: In a study of 7 healthy male volunteers, @DRUG1$ treatment potentiated the blood glucose lowering effect of @DRUG2$ (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3382,
        "sentence": "Since Zarontin (@DRUG1$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, @DRUG2$ may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3383,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3384,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3385,
        "sentence": "Warfarin, Digoxin, Salicylate, and @DRUG1$ The in vitro binding of warfarin to plasma proteins is only slightly reduced by @DRUG2$ (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3386,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG1$, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3387,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), @DRUG2$ (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3388,
        "sentence": "@DRUG1$/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, famotidine and omeprazole) is likely to reduce @DRUG2$ exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3389,
        "sentence": "@DRUG1$ or Cimetidine: Concomitant administration of @DRUG2$ or cimetidine decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3390,
        "sentence": "The use of @DRUG1$ before succinylcholine to attenuate some of the side effects of @DRUG2$ has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3391,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, @DRUG1$, @DRUG2$, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3392,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, @DRUG1$, nicotinic acid (@DRUG2$), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3393,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3394,
        "sentence": "Two different types of therapy with @DRUG1$ are used: physiological oral magnesium supplementation which is totally atoxic since it palliates @DRUG2$ deficiencies by simply normalizing the magnesium intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3395,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3396,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3397,
        "sentence": "@DRUG1$ or Triazolam: No significant differences were observed in the pharmacokinetics of triazolam (0.125 mg) and @DRUG2$ (10 mg) when given together as a single dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3398,
        "sentence": "In some patients, combined use of @DRUG1$ and @DRUG2$ has been associated with fatal gastrointestinal hemorrhage.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3399,
        "sentence": "Antacids and @DRUG1$: Sucralfate and antacids containing @DRUG2$ or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3400,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG1$, general anesthetics, barbiturates, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3401,
        "sentence": "Probenecid or Cimetidine: Concomitant administration of @DRUG1$ or cimetidine decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3402,
        "sentence": "Although not studied with @DRUG1$, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as @DRUG2$, procainamide, and hydralazine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3403,
        "sentence": "@DRUG1$ can interact with alcohol or other @DRUG2$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3404,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3405,
        "sentence": "@DRUG1$ works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with cyclosporine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3406,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG1$, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3407,
        "sentence": "@DRUG1$ may interact with @DRUG2$, butyrophenones, and certain other agents.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3408,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG1$, @DRUG2$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3409,
        "sentence": "The @DRUG1$ (@DRUG2$ and pioglitazone), a new class of oral antidiabetic agents, are \"insulin sensitizers\"",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3410,
        "sentence": "Certain concomitant medications (such as @DRUG1$, @DRUG2$, St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3411,
        "sentence": "It is, however, possible that concomitant use of other known @DRUG1$ such as griseofulvin, @DRUG2$, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3412,
        "sentence": "No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with @DRUG1$ without coadministered levodopa/@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3413,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG1$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3414,
        "sentence": "Potassium-sparing diuretics such as @DRUG1$, @DRUG2$, or amiloride, or potassium supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3415,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3416,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3417,
        "sentence": "Antiretroviral regimens consisted of two @DRUG1$ and one @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3418,
        "sentence": "Probenecid or Cimetidine: Concomitant administration of @DRUG1$ or cimetidine decreases the elimination of @DRUG2$, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3419,
        "sentence": "These include probenecid, cholestyramine, and some antibiotics (e.g. @DRUG1$, rifamipicin, ampicillin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3420,
        "sentence": "@DRUG1$: Combination hormonal contraceptives may increase the serum concentration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3421,
        "sentence": "The findings of these studies are summarized in the following table: Effects on steady-state @DRUG1$ pharmacokinetics after 7 days of co-administration with @DRUG2$ 120 mg every 12 hours (two times the recommended twice daily dose) in healthy volunteers (n=24)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3422,
        "sentence": "If chlorprothixene is given concomitantly with opioids, the @DRUG1$ dose should be reduced (by approx. 50%), because @DRUG2$ amplifies the therapeutic actions and side-effects of opioids massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3423,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3424,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3425,
        "sentence": "Hypotension was more likely to occur if the @DRUG1$ were a dihydropyridine derivative, e.g., @DRUG2$, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either verapamil or diltiazem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3426,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3427,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3428,
        "sentence": "In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of @DRUG1$ alone were compared to PRINIVIL given concomitantly with @DRUG2$, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3429,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3430,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3431,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3432,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3433,
        "sentence": "and disulfiram When @DRUG1$ is given with anticholinergic agents or sympathomimetic drugs, including @DRUG2$ combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3434,
        "sentence": "@DRUG1$: Ethinyl estradiol may inhibit the metabolism of @DRUG2$, leading to increased plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3435,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, @DRUG2$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3436,
        "sentence": "Oral Hypoglycemics: @DRUG1$ does not alter glucose metabolism in normal subjects nor does it alter the effects of oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3437,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3438,
        "sentence": "Repeated oral administration of @DRUG1$ in sheep: interactions of coumaphos with @DRUG2$, trichlorfon, and phenobarbital sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3439,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of ergotamine-containing or @DRUG1$ (like dihydroergotamine or methysergide) and @DRUG2$ within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3440,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, @DRUG1$, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the @DRUG2$ for Topical Solution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3441,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3442,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that @DRUG1$ may potentiate the vasoconstrictive action of @DRUG2$ by blocking the vasodilating property of epinephrine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3443,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3444,
        "sentence": "Some quinolones, including @DRUG1$, have been associated with transient elevations in serum creatinine in patients receiving @DRUG2$ concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3445,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3446,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG1$], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3447,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3448,
        "sentence": "In patients taking furosemide, @DRUG1$, diltiazem, @DRUG2$, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3449,
        "sentence": "MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of @DRUG1$ is enhanced by the @DRUG2$ phenelzine .",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3450,
        "sentence": "Combinations of these drugs have not been studied and coadministration of @DRUG1$ and @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3451,
        "sentence": "- a beta-blocker such as propranolol (Inderal), @DRUG1$ (@DRUG2$), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3452,
        "sentence": "However, since aspirin, NSAIDs, and @DRUG1$ are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3453,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3454,
        "sentence": "Thus, when @DRUG1$ and @DRUG2$ are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3455,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG1$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3456,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other opioids, general @DRUG2$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3457,
        "sentence": "Long Acting Nitrates: @DRUG1$ may be safely co-administered with @DRUG2$, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3458,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (@DRUG2$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3459,
        "sentence": "Pharmacokinetic studies indicate that administration of @DRUG1$ or @DRUG2$ does not affect the pharmacokinetics of acamprosate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3460,
        "sentence": "Drugs that may have their plasma concentration altered by @DRUG1$ Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3461,
        "sentence": "Other antiarrhythmic drugs (eg, @DRUG1$, procainamide, lidocaine, propranolol) have occasionally been used concurrently with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3462,
        "sentence": "Drug-Drug Interactions @DRUG1$ - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other @DRUG2$) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3463,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3464,
        "sentence": "HMG-CoA reductase inhibitors: The combined use of @DRUG1$ and @DRUG2$ should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3465,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3466,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3467,
        "sentence": "Such individuals are referred to as poor metabolizers of drugs such as @DRUG1$, @DRUG2$, the tricyclic antidepressants, and clozapine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3468,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, hydralazine, @DRUG1$, oral @DRUG2$, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3469,
        "sentence": "Nonsteroidal anti-inflammatory agents (NSAIDS): Concomitant use of aspirin (or other @DRUG1$) and @DRUG2$ increases the risk of gastrointestinal side effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3470,
        "sentence": "Antacids and sucralfate: @DRUG1$ and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as @DRUG2$  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3471,
        "sentence": "@DRUG1$ regimens consisted of two @DRUG2$ and one protease inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3472,
        "sentence": "Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of @DRUG1$ as measured by AUC0-24hr in patients receiving single weekly @DRUG2$ doses of 7.5 to 20 mg for rheumatoid arthritis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3473,
        "sentence": "Although the clinical significance is not known, it is not recommended that @DRUG1$ be taken concomitantly with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3474,
        "sentence": "@DRUG1$ (Oral): In patients receiving oral @DRUG2$, the coagulation times were increased in some cases.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3475,
        "sentence": "@DRUG1$: Coadministration of digoxin, a P-glycoprotein substrate, with oral @DRUG2$ resulted in a reduction in clearance and an increase in digoxin Cmax and AUC values.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3476,
        "sentence": "The administration of local @DRUG1$ containing @DRUG2$ or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3477,
        "sentence": "Animal experience indicates that @DRUG1$ prolongs the sleeping time after @DRUG2$ or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3478,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3479,
        "sentence": "When initiating a multi-day course of grepafloxacin in a patient maintained on @DRUG1$, the theophylline maintenance dose should be halved for the period of concurrent use of @DRUG2$ and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3480,
        "sentence": "With combined use, clinicians should be aware, when @DRUG1$ is added, of the potential for reexacerbation of pulmonary symptomatology due to lowered serum @DRUG2$ concentrations.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3481,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3482,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3483,
        "sentence": "@DRUG1$ should not be administered with other @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3484,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, @DRUG1$, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3485,
        "sentence": "Chlorpromazine: @DRUG1$ blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines, and can be used to treat @DRUG2$ poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3486,
        "sentence": "The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, @DRUG1$ or other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3487,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG2$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3488,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3489,
        "sentence": "Caution should be exercised when administering nabumetone with @DRUG1$ since interactions have been seen with other @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3490,
        "sentence": "If signs and symptoms suggestive of @DRUG1$ toxicity occur when @DRUG2$ and digoxin are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3491,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG1$, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3492,
        "sentence": "In patients receiving another @DRUG1$ in combination with @DRUG2$ (MAOI), there have been reports of serious, sometimes fatal, reactions including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3493,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3494,
        "sentence": "Studies with @DRUG1$ in combination with @DRUG2$ indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3495,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of @DRUG1$ were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, @DRUG2$, or phenobarbital) than in healthy volunteers.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3496,
        "sentence": "Ketoconazole/@DRUG1$, @DRUG2$, Including Erythromycin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3497,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3498,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3499,
        "sentence": "In patients taking an anticonvulsant (eg, @DRUG1$, carbamazepine, phenobarbital or @DRUG2$), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3500,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3501,
        "sentence": "Acebutolol, @DRUG1$, and @DRUG2$ (low hepatic clearance or no first-pass metabolism) are unlikely to be affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3502,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG2$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3503,
        "sentence": "In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free @DRUG1$ may be decreased when estrogens are started thus increasing @DRUG2$ requirements.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3504,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), @DRUG1$ antipsychotic agents (e.g. @DRUG2$), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3505,
        "sentence": "@DRUG1$ produced significantly increased vasoconstriction after a single administration of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3506,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3507,
        "sentence": "Using in situ hybridization, we observed that METH caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist @DRUG1$ but not by an atypical neuroleptic @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3508,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general @DRUG1$, local @DRUG2$ like lidocaine, procaine, beta-blockers, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3509,
        "sentence": "No drug interaction studies have been conducted for @DRUG1$, however the use of orally administered @DRUG2$ could, theoretically, interfere with the release of mesalamine in the colon.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3510,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3511,
        "sentence": "Because @DRUG1$ is highly bound to serum protein, the administration of Anafranil to patients taking other drugs that are highly bound to protein (e.g., @DRUG2$, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3512,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG1$, famotidine, @DRUG2$, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3513,
        "sentence": "No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including @DRUG1$, corticosteroids, and either azathioprine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3514,
        "sentence": "Studies in healthy volunteers have shown that @DRUG1$ has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, @DRUG2$, propranolol, or ranitidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3515,
        "sentence": "Pimozide and @DRUG1$ - In a controlled study, a single dose of @DRUG2$ 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3516,
        "sentence": "@DRUG1$: @DRUG2$ can be used with low dose aspirin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3517,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, @DRUG2$, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3518,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3519,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3520,
        "sentence": "No significant interactions with @DRUG1$, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3521,
        "sentence": "In patients taking an anticonvulsant (eg, @DRUG1$, carbamazepine, phenobarbital or phenytoin), the concomitant use of @DRUG2$ may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3522,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG2$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3523,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3524,
        "sentence": "The concomitant use of transdermal fentanyl with @DRUG1$ or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3525,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as @DRUG1$, thiazide diuretics, sulfonylureas, phenothiazines, @DRUG2$ and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3526,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (@DRUG1$), @DRUG2$, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3527,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, @DRUG2$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3528,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3529,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3530,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3531,
        "sentence": "Administration of @DRUG1$ with @DRUG2$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3532,
        "sentence": "When @DRUG1$ resin is given for long periods of time, concomitant supplementation with water-miscible (or parenteral) forms of @DRUG2$ should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3533,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, @DRUG2$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3534,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG1$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3535,
        "sentence": "Therefore, if @DRUG1$ is co-administered with fluvoxamine maleate, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of @DRUG2$ should to monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3536,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3537,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (@DRUG1$), tolbutamide, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3538,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3539,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3540,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (@DRUG2$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3541,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG1$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3542,
        "sentence": "Dexbrompheniramine can interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3543,
        "sentence": "@DRUG1$ should not be used concomitantly with other drugs known to prolong the QT interval: certain antiarrhythmics, including those of Class IA (such as @DRUG2$ and procainamide) and Class III (such as sotalol);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3544,
        "sentence": "Patients receiving other @DRUG1$, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and @DRUG2$ tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3545,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, @DRUG1$, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3546,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3547,
        "sentence": "Limited clinical experience indicates that requirements for @DRUG1$ are reduced by 30 to 50% for the first sixty (60) minutes following ALFENTA induction The concomitant use of @DRUG2$ with ALFENTA can significantly inhibit ALFENTA clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3548,
        "sentence": "@DRUG1$ (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., @DRUG2$, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3549,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, @DRUG1$, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3550,
        "sentence": "The actions of the benzodiazepines may be potentiated by @DRUG1$, narcotics, phenothiazines, monoamine oxidase inhibitors or other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3551,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3552,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3553,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and @DRUG1$ (eg, propafenone, flecainide, and @DRUG2$), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3554,
        "sentence": "@DRUG1$: Ibuprofen produced an elevation of plasma @DRUG2$ levels and a reduction in renal lithium clearance in a study of eleven normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3555,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3556,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine @DRUG1$ of class (e.g. @DRUG2$), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3557,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3558,
        "sentence": "Cimetidine: @DRUG1$ does not affect the pharmacokinetics of fosfomycin when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3559,
        "sentence": "In patients receiving a potent CYP3A4 inducer such as @DRUG1$ or @DRUG2$, a dose increase to 500 mg daily should be considered in the absence of severe adverse drug reaction, and clinical response and adverse events should be carefully monitored (see CLINICAL PHARMACOLOGY-Pharmacokinetics-Drug-Drug Interactions and DOSAGE AND ADMINISTRATION-Dosage Adjustment sections).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3560,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with @DRUG1$ or @DRUG2$ did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3561,
        "sentence": "@DRUG1$ and diphenoxylate, by decreasing gut motility, may increase @DRUG2$ absorption.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3562,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3563,
        "sentence": "Methotrexate: Concomitant administration of @DRUG1$ and some NSAIDs has been reported to reduce the clearance of @DRUG2$, enhancing the toxicity of methotrexate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3564,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3565,
        "sentence": "CIMETlDINE: @DRUG1$ plasma concentrations were not affected by co-administration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3566,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3567,
        "sentence": "@DRUG1$: Potential interaction of @DRUG2$ and Isoniazid may exist.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3568,
        "sentence": "Experience with @DRUG1$ (NSAIDs) suggests the potential for interactions with furosemide and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3569,
        "sentence": "Elevated plasma levels of @DRUG1$ have been reported with concomitant @DRUG2$ use.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3570,
        "sentence": "The concomitant administration of rifampin and @DRUG1$ resulted in the need for an unusually high maintenance dose of @DRUG2$ (20 mg per day) in order to produce a therapeutic effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3571,
        "sentence": "Anesthetics/@DRUG1$/Hypnotics/@DRUG2$: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3572,
        "sentence": "Clozapine may potentiate the hypotensive effects of @DRUG1$ and the anticholinergic effects of @DRUG2$-type drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3573,
        "sentence": "A pharmacokinetic study evaluating the administration of a single dose of @DRUG1$ 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3574,
        "sentence": "Doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving @DRUG1$, beta-blocking agents, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3575,
        "sentence": "Anticholinergics: Concurrent administration of certain anticholinergic compounds, such as @DRUG1$ and @DRUG2$, would be expected to compromise the beneficial effects of cisapride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3576,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG1$, and the @DRUG2$ propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3577,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3578,
        "sentence": "Studies with @DRUG1$ in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3579,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (@DRUG1$) Injection, USP to subjects already receiving @DRUG2$, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3580,
        "sentence": "An oral @DRUG1$ overload of 1 ml of a 50% @DRUG2$ solution was given to rats and blood glucose was determined after 30, 60 and 90 min.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3581,
        "sentence": "Pregnancy @DRUG1$ and @DRUG2$-containing oral contraceptives increase TBg concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3582,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG1$ [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3583,
        "sentence": "@DRUG1$ (e. g., @DRUG2$) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3584,
        "sentence": "Cyclosporine, @DRUG1$ and @DRUG2$ concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3585,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3586,
        "sentence": "However, patients receiving infusions of @DRUG1$ in clinical trials were maintained on @DRUG2$ without evidence of increased bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3587,
        "sentence": "Therefore the, combination of @DRUG1$ with other TNF-blocking agents, including @DRUG2$, may also result i n similar toxicities.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3588,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG1$, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3589,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3590,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3591,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3592,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, @DRUG1$, @DRUG2$, phenyltoloxamine, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3593,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other @DRUG1$, @DRUG2$, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3594,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3595,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, procaine, @DRUG1$, @DRUG2$, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3596,
        "sentence": "Prospective, long-term studies on concomitant administration of @DRUG1$ and @DRUG2$ have not been conducted.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3597,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, @DRUG2$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3598,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, @DRUG1$, chloramphenicol, @DRUG2$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3599,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3600,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3601,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3602,
        "sentence": "In order to examine some molecular mechanisms of PCP-induced behavioral changes, Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with @DRUG1$, @DRUG2$, and L-CCG-1 was carried out.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3603,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, @DRUG1$) with @DRUG2$ may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3604,
        "sentence": "Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of @DRUG1$ 500 mg was admini,stered orally prior to the administration of the 3-day regimen of @DRUG2$ and on Days 4,8, and 15.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3605,
        "sentence": "Warfarin: Co-administration of @DRUG1$ 500 mg b.i.d. for 6 days decreased the plasma concentrations of both @DRUG2$ (a CYP2C9 substrate) and R-warfarin (a CYP3A4 substrate) by 29 and 38%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3606,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3607,
        "sentence": "An intravenous dose of 50 mg perchlorate was in respect of competitive suppression of organs actively concentrating @DRUG1$ as effective as intravenous 1000 mg ClO-4- simultaneously or 1000 mg orally 30 min before the injection of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3608,
        "sentence": "Certain drugs including thiazides, @DRUG1$, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3609,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3610,
        "sentence": "Other: Coadministration of grapefruit juice with @DRUG1$ increases the bioavailability of @DRUG2$ and concomitant use should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3611,
        "sentence": "@DRUG1$ at 10(-10) M or retinyl acetate at about 3 X 10(-9) M inhibits proliferation stimulated by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3612,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3613,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3614,
        "sentence": "Phenobarbital (@DRUG1$): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (@DRUG2$) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3615,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3616,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3617,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG2$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3618,
        "sentence": "@DRUG1$: When administered to patients on a thyroid preparation, this parenteral @DRUG2$ may cause hypertension and tachycardia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3619,
        "sentence": "Those for which effectiveness is reported includes @DRUG1$, hydroxyzine, orphenadrine, pyrilamine, @DRUG2$, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3620,
        "sentence": "Dexbrompheniramine can interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG2$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3621,
        "sentence": "Concurrent administration of @DRUG1$ and @DRUG2$ significantly reduces the level of exposure to indinavir, but it is unclear how soon after didanosine administration indinavir may be given safely.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3622,
        "sentence": "Interactions between treatments with @DRUG1$, @DRUG2$ (an anticoagulant), trichlorfon (an organophosphorous compound), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3623,
        "sentence": "Hypotension was more likely to occur if the calcium antagonist were a @DRUG1$, e.g., nifedipine, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either verapamil or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3624,
        "sentence": "Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., @DRUG1$, pancreatin) may reduce the effect of @DRUG2$ and should not be taken concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3625,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3626,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3627,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3628,
        "sentence": "and @DRUG1$ e.g., verapamil), CYP1A2 inducers (omeprazole) and CYP1A2 inhibitors (@DRUG2$ and clarithromycin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3629,
        "sentence": "The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG1$ or @DRUG2$ may produce severe, prolonged hypertension.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3630,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG1$, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3631,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, @DRUG2$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3632,
        "sentence": "Because oral anticoagulants may interfere with the hepatic metabolism of @DRUG1$, toxic levels of the @DRUG2$ may occur when an oral anticoagulant and phenytoin are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3633,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3634,
        "sentence": "@DRUG1$s: In a small clinical trial in which @DRUG2$ was administered to warfarin treated patients, no effect on prothrombin time was detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3635,
        "sentence": "If concomitant treatment with @DRUG1$ and an @DRUG2$ is clinically warranted, appropriate observation of the patient is advised.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3636,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG2$ (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3637,
        "sentence": "Although there was no effect of @DRUG1$ on the plasma AUC of @DRUG2$ determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3638,
        "sentence": "As with other @DRUG1$, the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3639,
        "sentence": "Additive depressant effect when used with general anesthetics, sedatives, antianxiety drugs, @DRUG1$, @DRUG2$, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3640,
        "sentence": "To avoid this interaction, @DRUG1$ or indinavir should be given 1 hour prior to dosing with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3641,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, @DRUG2$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3642,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3643,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3644,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3645,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (@DRUG1$), @DRUG2$ (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3646,
        "sentence": "Rifampicin: In a study in healthy volunteers, a six-day course of @DRUG1$ at 600 mg/day followed by a single 5 mg dose of isradipine resulted in a reduction in @DRUG2$ levels to below detectable limits.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3647,
        "sentence": "Although there was no effect of Aprepitant on the plasma AUC of R(+) or S(-) warfarin determined on Day 3, there was a 34% decrease in @DRUG1$ (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3648,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3649,
        "sentence": "Concurrent administration of @DRUG1$ and didanosine significantly reduces the level of exposure to indinavir, but it is unclear how soon after didanosine administration @DRUG2$ may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3650,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3651,
        "sentence": "The 20% v/v solution of @DRUG1$ was prepared in water from a stock solution of 95% @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3652,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3653,
        "sentence": "@DRUG1$: @DRUG2$ may counteract the sedative effect of antihistamines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3654,
        "sentence": "However, 10 patients who switched from therapy with @DRUG1$ to @DRUG2$  did not report any serious and unexpected adverse reactions thought to be related to treatment.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3655,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3656,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG1$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3657,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3658,
        "sentence": "Specific and aspecific treatments of magnesium depletion are tricky using for example magnesium sparing diuretics, pharmacological doses of @DRUG1$, physiological doses of @DRUG2$ and of selenium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3659,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3660,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, clindamycin, clofibrate, @DRUG2$, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3661,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG1$ may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3662,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3663,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3664,
        "sentence": "@DRUG1$: Ibuprofen produced an elevation of plasma lithium levels and a reduction in renal @DRUG2$ clearance in a study of eleven normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3665,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (@DRUG1$, cyclosporin, azathioprine, @DRUG2$, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3666,
        "sentence": "In another drug interaction study, co-administration of orally inhaled @DRUG1$ and oral @DRUG2$, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3667,
        "sentence": "Experience with @DRUG1$ (NSAIDs) suggests the potential for interactions with @DRUG2$ and ACE inhibitors.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3668,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3669,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, @DRUG1$, and @DRUG2$ has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3670,
        "sentence": "Patients receiving other @DRUG1$, antipsychotics, antianxiety agents, or other CNS depressants (including @DRUG2$) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3671,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3672,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by @DRUG1$ or proton pump inhibitors (eg, famotidine and @DRUG2$) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3673,
        "sentence": "The serum concentration of @DRUG1$ increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of phenytoin and other @DRUG2$ had not changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3674,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, isosorbide dinitrate, @DRUG2$, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3675,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3676,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3677,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, @DRUG1$, pyrilamine, phenyltoloxamine, promethazine, @DRUG2$, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3678,
        "sentence": "Videx (@DRUG1$) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG2$, because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3679,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, @DRUG2$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3680,
        "sentence": "Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the @DRUG1$ may occur when an oral @DRUG2$ and phenytoin are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3681,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3682,
        "sentence": "Potential drug interactions for @DRUG1$ include, increased sedation if @DRUG2$ is combined with other CNS depressant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3683,
        "sentence": "Additive depressant effect when used with general anesthetics, @DRUG1$, antianxiety drugs, @DRUG2$, alcohol, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3684,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG1$, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3685,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most antidepressants (SSRIs, many @DRUG1$), @DRUG2$, antiarrhythmics, and antipsychotics are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3686,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: Cyclosporine (CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of @DRUG1$ resulting in elevated creatinine, despite reduction in dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3687,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3688,
        "sentence": "@DRUG1$: When administered to patients on a @DRUG2$, this parenteral anesthetic may cause hypertension and tachycardia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3689,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or @DRUG2$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3690,
        "sentence": "In a controlled clinical trial, a 20% reduction of the @DRUG1$ dose at the initiation of Felbatol  therapy resulted in phenytoin levels comparable to those prior to @DRUG2$  administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3691,
        "sentence": "@DRUG1$ or Cimetidine: Concomitant administration of probenecid or @DRUG2$ decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3692,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG2$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3693,
        "sentence": "@DRUG1$, @DRUG2$, sirolimus",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3694,
        "sentence": "@DRUG1$, Foscarnet, and Aminoglycosides: Drugs such as @DRUG2$, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3695,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3696,
        "sentence": "Immunosuppressants: cyclosporine, @DRUG1$, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3697,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG1$, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3698,
        "sentence": "May lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of @DRUG1$ or other coadministered @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3699,
        "sentence": "No dose adjustment is necessary when @DRUG1$ is added to triple-immunosuppression regimens including cyclosporine, corticosteroids, and either azathioprine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3700,
        "sentence": "@DRUG1$ should not be used in patients who have previously received the recommended maximum cumulative doses of doxorubicin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3701,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, @DRUG1$, @DRUG2$ (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3702,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of @DRUG1$, phenazepam, phenibut and amizyl and reduces the action of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3703,
        "sentence": "Erythromycin has been reported to significantly alter the metabolism of nonsedating @DRUG1$ terfenadine and @DRUG2$ when taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3704,
        "sentence": "therefore, coadministration of @DRUG1$ with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, @DRUG2$) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3705,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, @DRUG1$, beta-blockers, metaclopramide, @DRUG2$, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3706,
        "sentence": "@DRUG1$: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both @DRUG2$ and paroxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3707,
        "sentence": "Coadministration of @DRUG1$ and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and @DRUG2$ has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3708,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3709,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, @DRUG1$, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3710,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3711,
        "sentence": "@DRUG1$/@DRUG2$: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, famotidine and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3712,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3713,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, @DRUG2$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3714,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3715,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3716,
        "sentence": "The emerging roles of @DRUG1$ in @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3717,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3718,
        "sentence": "Effects of Erythromycin on @DRUG1$  The coadministration of @DRUG2$ (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax, Cmin, AUC, CI/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3719,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG1$, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3720,
        "sentence": "Thus, when NSAIDs and @DRUG1$ are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3721,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3722,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3723,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3724,
        "sentence": "In vitro, @DRUG1$ does not displace tightly bound drugs like phenytoin, @DRUG2$, and warfarin from serum proteins.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3725,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3726,
        "sentence": "Quinolone Antibiotics: @DRUG1$ should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with @DRUG2$ containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3727,
        "sentence": "In a placebo-controlled trial in normal volunteers, the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral @DRUG1$ (400 mg twice daily) resulted in a 10% increase in mean AUC of doxazosin (p=0.006), and a slight but not statistically significant increase in mean Cmax and mean half-life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3728,
        "sentence": "@DRUG1$/@DRUG2$/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3729,
        "sentence": "Concomitant administration of @DRUG1$ with @DRUG2$ resulted in a 45% increase in systemic exposure to gemifloxacin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3730,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3731,
        "sentence": "In patients taking furosemide, @DRUG1$, diltiazem, ACE inhibitors, verapamil, glyburide, @DRUG2$, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3732,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3733,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, @DRUG1$ (niacin), @DRUG2$, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3734,
        "sentence": "@DRUG1$s: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, @DRUG2$, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3735,
        "sentence": "Acarbose may affect @DRUG1$ bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of @DRUG2$ by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3736,
        "sentence": "Antacids and @DRUG1$: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3737,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3738,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3739,
        "sentence": "Using in situ hybridization, we observed that @DRUG1$ caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist @DRUG2$ but not by an atypical neuroleptic clozapine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3740,
        "sentence": "Rat kidney homogenates supplemented with coenzyme A, ATP, oxaloacetate, and Mg2+ converted @DRUG1$ to @DRUG2$ in vitro.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3741,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, @DRUG2$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3742,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3743,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3744,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG1$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3745,
        "sentence": "The extent to which SSRI-@DRUG1$ interactions may pose clinical problems will depend on the degree of inhibition, and the pharmacokinetics of the @DRUG2$ involved.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3746,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, @DRUG1$, erythromycin, grapefruit juice, cimetidine) with @DRUG2$ may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3747,
        "sentence": "Hydrochlorothiazide: A study in normal healthy volunteers has shown that concomitant administration of @DRUG1$  (@DRUG2$) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3748,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: @DRUG1$ (CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of @DRUG2$ resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3749,
        "sentence": "@DRUG1$, Digoxin, Salicylate, and @DRUG2$ The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3750,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3751,
        "sentence": "Pharmacological/Pharmacodynamic Interactions with Carbamazepine Concomitant administration of @DRUG1$ and @DRUG2$ may increase the risk of neurotoxic side effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3752,
        "sentence": "Certain antibiotic, cisplatin, cyclosporine, @DRUG1$, @DRUG2$, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3753,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG1$, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3754,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral @DRUG1$ supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the @DRUG2$ intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3755,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3756,
        "sentence": "Coadministration of @DRUG1$ with oral midazolam or @DRUG2$ has resulted in elevated plasma concentrations of the latter two drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3757,
        "sentence": "Digoxin: Concomitant administration of @DRUG1$ did not affect the steady-state pharmacokinetics of @DRUG2$ or the mean daily trough serum level of digoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3758,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, cannabinoids, @DRUG2$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3759,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including @DRUG2$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3760,
        "sentence": "Increased toxicity (CNS depression): CNS depressants, @DRUG1$, @DRUG2$, phenothiazines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3761,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3762,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3763,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3764,
        "sentence": "Antacids or H 2 receptor antagonists: When dirithromycin is administered immediately following @DRUG1$ or @DRUG2$, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3765,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3766,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG2$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3767,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG1$, and the Type 1C antiarrhythmics propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3768,
        "sentence": "When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because @DRUG1$ may potentiate the effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3769,
        "sentence": "@DRUG1$ (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3770,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3771,
        "sentence": "Administration of quinolones with @DRUG1$ containing @DRUG2$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3772,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG1$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3773,
        "sentence": "Although there was no effect of Aprepitant on the plasma AUC of R(+) or @DRUG1$ determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3774,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, @DRUG2$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3775,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3776,
        "sentence": "The mechanism for this interaction probably is adsorption of @DRUG1$ onto the surface of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3777,
        "sentence": "Netilmicin should not be administered concomitantly with potent @DRUG1$ such as furosemide and @DRUG2$ as the potential for ototoxicity is enhanced by the combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3778,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, pyrilamine, @DRUG1$, promethazine, methdilazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3779,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG2$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3780,
        "sentence": "Because both of these drugs have negative inotropic properties and the effects of coadministration with @DRUG1$ are unknown, neither disopyramide nor @DRUG2$ should be administered concurrently with TAMBOCOR unless, in the judgment of the physician, the benefits of this combination outweigh the risks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3781,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, cannabinoids, diltiazem, grapefruit juice, @DRUG2$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3782,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3783,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG1$ @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3784,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG1$, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3785,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3786,
        "sentence": "During @DRUG1$ and fluvoxamine treatment, ataxia, a typical side effect of @DRUG2$, was observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3787,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (@DRUG2$), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3788,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3789,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3790,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3791,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3792,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG1$, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3793,
        "sentence": "Although specific drug interaction studies have not been conducted with @DRUG1$, the possibility of an additive or potentiating effect with CNS depressants (@DRUG2$, barbiturates, opiates, sedatives, or anesthetics) should be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3794,
        "sentence": "@DRUG1$, Foscarnet, and @DRUG2$: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3795,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3796,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG1$, @DRUG2$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3797,
        "sentence": "Reported examples of this interaction include the following: @DRUG1$s: Cyclosporine (CYP3A4 substrate) administered in combination with oral @DRUG2$ has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3798,
        "sentence": "While all the selective serotonin reuptake inhibitors (@DRUG1$), e.g., fluoxetine, @DRUG2$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3799,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, @DRUG2$, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3800,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG1$, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3801,
        "sentence": "Rhabdomyolysis secondary to a drug interaction between @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3802,
        "sentence": "Oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents, eg, @DRUG1$ and @DRUG2$, by inhibiting their metabolism in the liver.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3803,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, @DRUG1$, nelfinavir, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3804,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3805,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3806,
        "sentence": "Anticoagulants: @DRUG1$ like other nonsteroidal anti-inflammatory drugs, has been shown to affect bleeding parameters in patients receiving @DRUG2$, and serious clinical bleeding has been reported.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3807,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3808,
        "sentence": "HMG-CoA Reductase Inhibitors: @DRUG1$, @DRUG2$ WARNING potential for serious reactions such as risk of myopathy including rhabdomyolysis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3809,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3810,
        "sentence": "Interactions between treatments with coumaphos, bishydroxycoumarin (an @DRUG1$), trichlorfon (an @DRUG2$), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3811,
        "sentence": "Antacids or @DRUG1$: When dirithromycin is administered immediately following antacids or H 2 -receptor antagonists, the absorption of @DRUG2$ is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3812,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, @DRUG2$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3813,
        "sentence": "Cimetidine: Cimetidine does not affect the pharmacokinetics of @DRUG1$ when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3814,
        "sentence": "Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving @DRUG1$ during therapy with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3815,
        "sentence": "Phenobarbital or Primidone : No formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3816,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3817,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3818,
        "sentence": "Carbamazepine: Coadministration of @DRUG1$ (200 mg BID), a potent CYP3A4 inducer, with @DRUG2$ (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite, dehydro-aripiprazole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3819,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, hydralazine, @DRUG1$, oral contraceptives, @DRUG2$, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3820,
        "sentence": "SINCE CHOLESTYRAMINE @DRUG1$ MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER @DRUG2$ RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3821,
        "sentence": "Cyclosporin, @DRUG1$, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3822,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3823,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG2$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3824,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3825,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3826,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, @DRUG1$, or an @DRUG2$/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3827,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3828,
        "sentence": "@DRUG1$ significantly decreases clearance of @DRUG2$ and 25-O-desacetylrifabutin, and the combination is poorly tolerated.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3829,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3830,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3831,
        "sentence": "Serum @DRUG1$ concentrations increase when grepafloxacin is initiated in a patient maintained on @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3832,
        "sentence": "In order to maintain @DRUG1$ levels, limit adverse experiences, and achieve the @DRUG2$ dose of 3600 mg/day, a phenytoin dose reduction of approximately 40% was necessary for eight of these 10 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3833,
        "sentence": "@DRUG1$: Amphetamines may delay intestinal absorption of @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3834,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3835,
        "sentence": "Rifampin: Rifampin increases the metabolism of @DRUG1$ and some progestins (@DRUG2$) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3836,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG1$, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3837,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3838,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG1$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3839,
        "sentence": "Literature reports indicate that coadministration of @DRUG1$ may reduce the natriuretic and antihypertensive effects of @DRUG2$ in some patients by inhibiting prostaglandin synthesis.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3840,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3841,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of benzodiazepines other than @DRUG2$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3842,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3843,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3844,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3845,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and @DRUG1$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3846,
        "sentence": "H2 Blockers/@DRUG1$: Long-term suppression of gastric acid secretion by H2 blockers or @DRUG2$ (eg, famotidine and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3847,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG1$, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3848,
        "sentence": "Concomitant use of @DRUG1$ with alcohol, @DRUG2$, barbiturates, or other central nervous system depressants may have an additive effect.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3849,
        "sentence": "In 5 other schizophrenic patients treated with oral @DRUG1$ and rifampin, discontinuation of @DRUG2$ produced a mean 3.3-fold increase in haloperidol concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3850,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, @DRUG1$, @DRUG2$, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3851,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3852,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG1$, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3853,
        "sentence": "and @DRUG1$ e.g., verapamil), CYP1A2 inducers (@DRUG2$) and CYP1A2 inhibitors (furafylline and clarithromycin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3854,
        "sentence": "Although the mechanism of interaction between @DRUG1$ and aspirin is not totally known, enzyme induction and displacement of @DRUG2$ from plasma albumin binding sites are possibilities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3855,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for @DRUG2$ in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3856,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, @DRUG2$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3857,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3858,
        "sentence": "Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of @DRUG1$ by 19% on Day 8 relative to the dosing of @DRUG2$ on Days 1 through 3.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3859,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3860,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3861,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3862,
        "sentence": "Since @DRUG1$ in high doses has been associated with hepatotoxicity, concomitant administration of diflunisal and @DRUG2$ should be used cautiously, with careful monitoring of patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3863,
        "sentence": "Because Anafranil is highly bound to serum protein, the administration of @DRUG1$ to patients taking other drugs that are highly bound to protein (e.g., warfarin, @DRUG2$) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3864,
        "sentence": "@DRUG1$ : Antipyrine pharmacokinetics were not significantly different before and after @DRUG2$ multiple-dose regimens.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3865,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG1$, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3866,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG1$, morphine, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3867,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3868,
        "sentence": "No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including @DRUG1$, @DRUG2$, and either azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3869,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (@DRUG1$), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3870,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3871,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., @DRUG2$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3872,
        "sentence": "@DRUG1$: The effect of flurbiprofen on blood pressure response to @DRUG2$ and atenolol was evaluated in men with mild uncomplicated hypertension (n = 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3873,
        "sentence": "Hydrochlorothiazide: A study in normal healthy volunteers has shown that concomitant administration of @DRUG1$  (isradipine) and @DRUG2$ does not result in altered pharmacoktnetics of either drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3874,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3875,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and @DRUG1$, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3876,
        "sentence": "Talk to your doctor if you are taking certain @DRUG1$ such as erythromycin, clarithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3877,
        "sentence": "@DRUG1$: Isoniazid may increase serum levels of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3878,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3879,
        "sentence": "It is, however, possible that concomitant use of other known @DRUG1$ such as griseofulvin, thiazide diuretics, @DRUG2$, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3880,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, @DRUG1$, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3881,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an @DRUG1$ and magnesium containing antacid (@DRUG2$ ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3882,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3883,
        "sentence": "@DRUG1$: The effect of flurbiprofen on blood pressure response to propranolol and @DRUG2$ was evaluated in men with mild uncomplicated hypertension (n = 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3884,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3885,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3886,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3887,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG1$, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3888,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3889,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG1$, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3890,
        "sentence": "Butyrophenones (such as @DRUG1$) and @DRUG2$ can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3891,
        "sentence": "Differential actions of intrathecal @DRUG1$ on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and @DRUG2$ in rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3892,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3893,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3894,
        "sentence": "Since acetaminophen in high doses has been associated with hepatotoxicity, concomitant administration of @DRUG1$ and @DRUG2$ should be used cautiously, with careful monitoring of patients.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3895,
        "sentence": "@DRUG1$ Supplements and @DRUG2$ Lotensin can attenuate potassium loss caused by thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3896,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG1$, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3897,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3898,
        "sentence": "@DRUG1$: @DRUG2$ has been reported to increase the plasma levels and cardiovascular effects of adenosine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3899,
        "sentence": "@DRUG1$ contains @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3900,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3901,
        "sentence": "Certain drugs, including @DRUG1$ (NSAIDs), @DRUG2$, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3902,
        "sentence": "In vitro, buspirone does not displace tightly bound drugs like @DRUG1$, propranolol, and @DRUG2$ from serum proteins.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3903,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG1$, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3904,
        "sentence": "Lithium: Increased serum lithium levels and symptoms of @DRUG1$ toxicity have been reported in patients receiving @DRUG2$ during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3905,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of @DRUG1$ with anesthetics, sedatives, hypnotics, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3906,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG1$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG2$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3907,
        "sentence": "Pimozide and @DRUG1$ - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic @DRUG2$ 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3908,
        "sentence": "@DRUG1$: The effect of @DRUG2$ on blood pressure response to propranolol and atenolol was evaluated in men with mild uncomplicated hypertension (n = 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3909,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG1$, @DRUG2$, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3910,
        "sentence": "Clearance of @DRUG1$ decreased by about 27% when @DRUG2$ was administered intravenously concomitantly with atenolol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3911,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with @DRUG1$ containing magnesium, calcium, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3912,
        "sentence": "Warfarin, Digoxin, Salicylate, and @DRUG1$ The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when @DRUG2$ plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3913,
        "sentence": "@DRUG1$, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when @DRUG2$ plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3914,
        "sentence": "@DRUG1$ at 400 mg daily (the maximum approved prescription dose) co-administered with TIKOSYN (500 mcg BID) for 7 days has been shown to increase @DRUG2$ Cmax by 53% in males and 97% in females, and AUC by 41% in males and 69% in females.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3915,
        "sentence": "Agents Increasing Serum Potassium: @DRUG1$ and @DRUG2$ IV attenuate potassium loss caused by thiazide-type diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3916,
        "sentence": "When initiating a multi-day course of grepafloxacin in a patient maintained on theophylline, the @DRUG1$ maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum @DRUG2$ concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3917,
        "sentence": "Concomitant administration of @DRUG1$ and calcium carbonate, cimetidine, @DRUG2$, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3918,
        "sentence": "As with other @DRUG1$, the antihypertensive effect of losartan may be blunted by the @DRUG2$ indomethacin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3919,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, @DRUG2$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3920,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG1$], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3921,
        "sentence": "Two studies were conducted in HIV-infected subjects to assess the potential for @DRUG1$ to interact with zidovudine and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3922,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., Nardil), @DRUG2$ (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3923,
        "sentence": "Drug Interactions, General: Although there have been no formal interaction studies, intravenous @DRUG1$ has been administered safely with drugs such as @DRUG2$ and sublingual nitroglycerin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3924,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3925,
        "sentence": "Because oral @DRUG1$ may interfere with the hepatic metabolism of phenytoin, toxic levels of the @DRUG2$ may occur when an oral anticoagulant and phenytoin are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3926,
        "sentence": "In the experiments reported here, we examined the interactions between 1,25(OH)2D3 and the antiestrogen @DRUG1$ (@DRUG2$), which also induces apoptosis in MCF-7 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3927,
        "sentence": "While the effects of chronic phenytoin or @DRUG1$ therapy on the action of @DRUG2$ are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3928,
        "sentence": "Tablet If a patient receiving @DRUG1$ is also taking tricyclic antidepressants, the effect of @DRUG2$ may be reduced, thus necessitating an increase in dosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3929,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3930,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3931,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, @DRUG1$, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3932,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for @DRUG1$ in subcortical structures, whereas @DRUG2$ binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3933,
        "sentence": "In clinical trials, similar changes in @DRUG1$ and @DRUG2$ were seen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3934,
        "sentence": "@DRUG1$ has no effect on the pharmacokinetics of @DRUG2$, amphotericin B, or the active metabolite of mycophenolate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3935,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG1$, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3936,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of @DRUG1$, or the pharmacokinetics of propranolol (40 mg twice daily), phenytoin, @DRUG2$, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3937,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3938,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, @DRUG1$, @DRUG2$, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3939,
        "sentence": "Iron Supplements and Foods Fortified With @DRUG1$ Concomitant administration of @DRUG2$ with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3940,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3941,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3942,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3943,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG1$ (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3944,
        "sentence": "Concomitant single dose administration of valdecoxib 20 mg with multiple doses of @DRUG1$ and @DRUG2$ produced a significant increase in exposure of valdecoxib.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3945,
        "sentence": "Concomitant administration of @DRUG1$ with probenecid resulted in a 45% increase in systemic exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3946,
        "sentence": "In the experiments reported here, we examined the interactions between 1,25(OH)2D3 and the @DRUG1$ 4-hydroxytamoxifen (@DRUG2$), which also induces apoptosis in MCF-7 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3947,
        "sentence": "Cyclosporine: Modest increases in mean trough @DRUG1$ concentrations were observed following initiation of @DRUG2$ treatment in 21 renal transplant patients suffering from chronic vascular rejection.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3948,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG1$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3949,
        "sentence": "Similarly, the effects of phenytoin on phenobarbital, @DRUG1$ and sodium plasma @DRUG2$ concentrations are unpredictable",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3950,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and @DRUG1$ may potentiate the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3951,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3952,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3953,
        "sentence": "Chlorpropamide: @DRUG1$s plasma half-life may be prolonged by allopurinol, since allopurinol and @DRUG2$ may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3954,
        "sentence": "Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG1$ (primidone) with or without other enzyme-inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3955,
        "sentence": "When Bezalip or @DRUG1$ is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and @DRUG2$ may enhance the action of anticoagulants of the coumarin type.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3956,
        "sentence": "@DRUG1$ may also interfere with the absorption of oral @DRUG2$ supplements and hydrocortisone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3957,
        "sentence": "In patients taking @DRUG1$, nifedipine, @DRUG2$, ACE inhibitors, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3958,
        "sentence": "Intestinal adsorbents (e. g., @DRUG1$) and @DRUG2$ containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3959,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3960,
        "sentence": "Since apraclonidine may reduce pulse and blood pressure, caution in using drugs such as @DRUG1$ (ophthalmic and systemic), @DRUG2$, and cardiac glycosides is advised.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3961,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3962,
        "sentence": "@DRUG1$: In cases of propoxyphene overdosage, @DRUG2$ CNS stimulation is potentiated and fatal convulsions can occur.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3963,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, @DRUG1$, tolbutamide, and @DRUG2$ have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3964,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3965,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3966,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, @DRUG1$ (niacin), tolbutamide, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3967,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3968,
        "sentence": "@DRUG1$ and oral @DRUG2$: Concomitant administration of vitamin A and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3969,
        "sentence": "@DRUG1$ markedly increases the metabolic clearance of @DRUG2$, and coadministration is contraindicated.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3970,
        "sentence": "Ethoxzolamide may increase the action of tricyclics, @DRUG1$, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3971,
        "sentence": "THE POTENTIATING ACTION OF @DRUG1$ MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS, @DRUG2$ AND BARBITURATES.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3972,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, @DRUG2$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3973,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG2$ propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3974,
        "sentence": "Sirolimus works differently from the @DRUG1$ currently available, and except for increased lipid levels, the adverse reaction profile of @DRUG2$ does not appear to overlap to any great extent with that associated with cyclosporine or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3975,
        "sentence": "@DRUG1$ such as @DRUG2$ (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3976,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3977,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3978,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and @DRUG2$ (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3979,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3980,
        "sentence": "Since Zarontin (@DRUG1$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease @DRUG2$ levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3981,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG1$, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3982,
        "sentence": "Caution should be observed when anileridine is coadministered with other @DRUG1$, sedatives, @DRUG2$, or anesthetics, as these agents may increase respiratory and circulatory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3983,
        "sentence": "In the experiments reported here, we examined the interactions between @DRUG1$ and the antiestrogen @DRUG2$ (TAM), which also induces apoptosis in MCF-7 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3984,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3985,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3986,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG1$ and other drugs that are highly protein bound, @DRUG2$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3987,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG1$, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3988,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3989,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3990,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered @DRUG1$, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and @DRUG2$ has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3991,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3992,
        "sentence": "@DRUG1$: Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3993,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect @DRUG1$ pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3994,
        "sentence": "On the contrary, @DRUG1$ and @DRUG2$ were agonists in induction of analgesia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3995,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, @DRUG1$, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3996,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3997,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG1$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3998,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, @DRUG1$, pyrilamine, phenyltoloxamine, promethazine, methdilazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3999,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, pyrilamine, phenyltoloxamine, @DRUG1$, methdilazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4000,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG2$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4001,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4002,
        "sentence": "@DRUG1$ and Ketoconazole: Ketoconazole and @DRUG2$ are predominantly CYP 3A4 and 2C9 inhibitors, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4003,
        "sentence": "@DRUG1$ has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and @DRUG2$ when taken concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4004,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4005,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4006,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG2$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4007,
        "sentence": "Antiepileptic Drugs: Sporadic cases of seizures have been reported during concomitant use of @DRUG1$ and antiepileptic drugs (phenytoin, @DRUG2$).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4008,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4009,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and @DRUG1$/@DRUG2$/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4010,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with @DRUG1$, with metal cations such as iron, or with @DRUG2$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4011,
        "sentence": "Simultaneous use of @DRUG1$ or @DRUG2$ should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4012,
        "sentence": "@DRUG1$: Coadministration of carbamazepine (200 mg BID), a potent CYP3A4 inducer, with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both @DRUG2$ and its active metabolite, dehydro-aripiprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4013,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4014,
        "sentence": "@DRUG1$ (NSAIDs): The concomitant administration of a nonsteroidal anti inflammatory drug with a @DRUG2$ may increase the risks of CNS stimulation and convulsions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4015,
        "sentence": "In a placebo-controlled trial in normal volunteers, the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral cimetidine (400 mg twice daily) resulted in a 10% increase in mean AUC of @DRUG1$ (p=0.006), and a slight but not statistically significant increase in mean Cmax and mean half-life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4016,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (corticosteroids, cyclosporin, @DRUG1$, methotrexate, @DRUG2$), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4017,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4018,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4019,
        "sentence": "Ketoconazole: @DRUG1$ has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to increased risk of @DRUG2$ side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4020,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as @DRUG1$, terfenadine, ketoconazole, @DRUG2$, and troleandomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4021,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, @DRUG2$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4022,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as @DRUG1$, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4023,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4024,
        "sentence": "Administration of @DRUG1$ to patients receiving @DRUG2$ has been reported to lead to hypotension and bradycardia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4025,
        "sentence": "@DRUG1$: Furosemide administered concurrently with @DRUG2$ does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4026,
        "sentence": "The effect of @DRUG1$ on @DRUG2$ was not evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4027,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4028,
        "sentence": "Anticholinergics: Concurrent administration of certain anticholinergic compounds, such as @DRUG1$ and dicyclomine, would be expected to compromise the beneficial effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4029,
        "sentence": "Doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide diuretics, @DRUG1$s, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4030,
        "sentence": "@DRUG1$: Coadministration of carbamazepine (200 mg BID), a potent CYP3A4 inducer, with @DRUG2$ (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite, dehydro-aripiprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4031,
        "sentence": "Coadministration of @DRUG1$ did not have effects on either the safety or efficacy of @DRUG2$ in the clinical trials.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4032,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4033,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4034,
        "sentence": "An increase in serum @DRUG1$ concentration has been reported during concomitant administration of @DRUG2$ with ATACAND, so careful monitoring of serum lithium levels is recommended during concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4035,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4036,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4037,
        "sentence": "A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with @DRUG1$ 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of @DRUG2$ and a 5.4-fold increase in AUC of eplerenone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4038,
        "sentence": "@DRUG1$ or H 2 receptor antagonists: When dirithromycin is administered immediately following antacids or H 2 -receptor antagonists, the absorption of @DRUG2$ is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4039,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4040,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4041,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG1$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4042,
        "sentence": "@DRUG1$ (123I and 131I), @DRUG2$: Uptake of radiolabeled ions may be decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4043,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an @DRUG1$-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/@DRUG2$-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4044,
        "sentence": "Clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or @DRUG1$ dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among @DRUG2$- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4045,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, @DRUG2$, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4046,
        "sentence": "When atropine and @DRUG1$ are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when @DRUG2$ is used alone because pralidoxime may potentiate the effect of atropine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4047,
        "sentence": "@DRUG1$: @DRUG2$ may increase the clearance of corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4048,
        "sentence": "Oral @DRUG1$: @DRUG2$ has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4049,
        "sentence": "Administration of 0.1-mg/kg (2 x ED95) @DRUG1$ at 10% or 95% recovery following an intubating dose of @DRUG2$ (1 mg/kg) produced  95% neuromuscular block.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4050,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, @DRUG1$, phenyltoloxamine, promethazine, @DRUG2$, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4051,
        "sentence": "Certain @DRUG1$, @DRUG2$, cyclosporine, diuretic, foscarnet, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4052,
        "sentence": "Other antiarrhythmic drugs (eg, @DRUG1$, procainamide, @DRUG2$, propranolol) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4053,
        "sentence": "Concomitant single dose administration of @DRUG1$ 20 mg with multiple doses of @DRUG2$ and fluconazole produced a significant increase in exposure of valdecoxib.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4054,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG2$, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4055,
        "sentence": "Dexbrompheniramine can interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4056,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4057,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4058,
        "sentence": "However, since @DRUG1$, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4059,
        "sentence": "Drugs that inhibit cytochrome P450IID6, such as quinidine , might increase the plasma concentrations of @DRUG1$ in patients that are on chronic @DRUG2$ therapy;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4060,
        "sentence": "@DRUG1$: The safety and effectiveness of Argatroban with @DRUG2$ have not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4061,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4062,
        "sentence": "Use of @DRUG1$ with potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG2$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4063,
        "sentence": "Since photic evoked potential components are representations of neural pathways which are activated during photic stimulation, study of the effects of @DRUG1$ on these components may help to trace pathways which are affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4064,
        "sentence": "Drug/Laboratory Test Interferences: @DRUG1$ and indanedione anticoagulants, including @DRUG2$, or their metabolites may color alkaline urine red-orange, which may interfere with spectrophotometrically determined urinary laboratory tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4065,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4066,
        "sentence": "@DRUG1$: @DRUG2$ potentiate the analgesic effect of meperidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4067,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4068,
        "sentence": "No dose adjustment is necessary when @DRUG1$ is added to triple-immunosuppression regimens including cyclosporine, corticosteroids, and either @DRUG2$ or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4069,
        "sentence": "While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG1$, @DRUG2$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4070,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4071,
        "sentence": "While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG1$, sertraline, and @DRUG2$, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4072,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG1$ propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4073,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, terfenadine, @DRUG1$, erythromycin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4074,
        "sentence": "Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a @DRUG1$ similar to @DRUG2$) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4075,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral @DRUG1$ warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic @DRUG2$ concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4076,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (corticosteroids, @DRUG1$, azathioprine, methotrexate, @DRUG2$), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4077,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG2$, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4078,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, hydrochlorothiazide, @DRUG2$, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4079,
        "sentence": "Several @DRUG1$ have been reported to block the pharmacologic effects of guanethidine, @DRUG2$, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4080,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, @DRUG2$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4081,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., @DRUG1$, @DRUG2$, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4082,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : @DRUG1$: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG2$ with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4083,
        "sentence": "Griseofulvin: @DRUG1$ may induce the metabolism of @DRUG2$ causing menstrual changes;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4084,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, @DRUG2$, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4085,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4086,
        "sentence": "Since @DRUG1$ is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and @DRUG2$ or inhibitors of CYP2C19 such as omeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4087,
        "sentence": "Other @DRUG1$ (including REMICADE) used in combination with @DRUG2$ may also result in similar toxicities.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4088,
        "sentence": "@DRUG1$ (such as @DRUG2$) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4089,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4090,
        "sentence": "@DRUG1$, oral: Co-administration of corticosteroids and @DRUG2$ usually results in inhibition of response to warfarin, although there have been some conflicting reports.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4091,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4092,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX on the concomitant anesthetic, @DRUG1$, @DRUG2$ or opioid may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4093,
        "sentence": "Reported examples of this interaction include the following: Antibiotics: @DRUG1$ is a potent inducer of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4094,
        "sentence": "Simvastatin and Other Statins: Co-administration of @DRUG1$ decreased the plasma concentrations of @DRUG2$ (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4095,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4096,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG2$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4097,
        "sentence": "therefore, coadministration of @DRUG1$ with drugs that strongly induce CYP3A4 activity (e.g., rifampin, @DRUG2$, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4098,
        "sentence": "Tablet If a patient receiving @DRUG1$ is also taking @DRUG2$, the effect of clonidine may be reduced, thus necessitating an increase in dosage.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4099,
        "sentence": "Chlorpromazine: Chlorpromazine blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of @DRUG1$, and can be used to treat @DRUG2$ poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4100,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and @DRUG1$ may increase the risk of developing peripheral neuropathy or other @DRUG2$-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4101,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4102,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4103,
        "sentence": "Plasma @DRUG1$ concentrations may need to be monitored and the dose of the @DRUG2$ may need to be reduced if a TCA is co-administered with Duloxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4104,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4105,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of ergotamine-containing or @DRUG1$ (like @DRUG2$ or methysergide) and FROVA within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4106,
        "sentence": "The effect of @DRUG1$ on the steady-state pharmacokinetics of @DRUG2$ was evaluated in a randomized, double-blind study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4107,
        "sentence": "Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4108,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of @DRUG1$ was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4109,
        "sentence": "The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of @DRUG1$ and other @DRUG2$ had not changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4110,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4111,
        "sentence": "Drugs that may have their plasma concentration altered by @DRUG1$ CYP3A4 Substrates: @DRUG2$ is a time-dependent inhibitor of CYP3A4.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4112,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4113,
        "sentence": "Concurrent use of @DRUG1$ with @DRUG2$ (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4114,
        "sentence": "Concomitant use of antihistamines with @DRUG1$, tricyclic antidepressants, barbiturates, or other @DRUG2$ may have an additive effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4115,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and @DRUG1$) may result in increased @DRUG2$ effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4116,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4117,
        "sentence": "Radioligand binding experiments using the uptake inhibitor hydrogen-3 @DRUG1$ revealed a significant decrease by approximately 30% in @DRUG2$ uptake-1 carrier density in functional classes II to III and IV myocardium versus nonfailing myocardium (p < 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4118,
        "sentence": "Repeated oral administration of coumaphos in sheep: interactions of @DRUG1$ with bishydroxycoumarin, @DRUG2$, and phenobarbital sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4119,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of @DRUG1$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between @DRUG2$ and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4120,
        "sentence": "Tablet If a patient receiving clonidine hydrochloride is also taking @DRUG1$, the effect of @DRUG2$ may be reduced, thus necessitating an increase in dosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4121,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4122,
        "sentence": "Antihistamines: @DRUG1$ GI Motility Agents Anti-Migraine @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4123,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4124,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4125,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of @DRUG2$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4126,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, phenobarbital, phenytoin, topiramate): Increase the metabolism of @DRUG1$ and/or some @DRUG2$, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4127,
        "sentence": "Use of PRINIVIL with potassium-sparing diuretics (e.g., @DRUG1$, triamterene, or amiloride), @DRUG2$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4128,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines @DRUG1$ (e.g. @DRUG2$), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4129,
        "sentence": "Hypotension was more likely to occur if the calcium antagonist were a @DRUG1$, e.g., @DRUG2$, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either verapamil or diltiazem.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4130,
        "sentence": "Plasma was analyzed for @DRUG1$, and urine was analyzed for tolbutamide and its two metabolites, 4-hydroxytolbutamide and @DRUG2$ by means of HPLC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4131,
        "sentence": "Thrombolytic agents: The safety and effectiveness of @DRUG1$ with @DRUG2$ have not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4132,
        "sentence": "Bromocriptine mesylate may interact with @DRUG1$, @DRUG2$, and certain other agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4133,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4134,
        "sentence": "@DRUG1$s: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4135,
        "sentence": "@DRUG1$ (@DRUG2$) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4136,
        "sentence": "@DRUG1$: @DRUG2$ administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4137,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4138,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4139,
        "sentence": "Potential drug interactions for @DRUG1$ include, increased sedation if doxylamine is combined with other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4140,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4141,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4142,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4143,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of @DRUG1$ with anesthetics, @DRUG2$, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4144,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4145,
        "sentence": "@DRUG1$: Concurrent use of erythromycin and ergotamine or @DRUG2$ has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4146,
        "sentence": "As with other agents with b-blocking properties, if COREG is to be administered orally with calcium channel blockers of the @DRUG1$ or @DRUG2$ type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4147,
        "sentence": "Coadministration of @DRUG1$ with phenytoin or any known CYP3A4 inducer should be avoided and alternative @DRUG2$ therapy should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4148,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, @DRUG2$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4149,
        "sentence": "Although not studied with alosetron, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4150,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4151,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4152,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4153,
        "sentence": "in one man, the C max of terfenadine was 8.1 ng/mL with @DRUG1$ alone and 7.2 ng/mL with terfenadine plus @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4154,
        "sentence": "and disulfiram When @DRUG1$ is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local @DRUG2$, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4155,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4156,
        "sentence": "Potassium-sparing diuretics such as @DRUG1$, triamterene, or @DRUG2$, or potassium supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4157,
        "sentence": "(@DRUG1$ may decrease arterial responsiveness to @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4158,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], @DRUG2$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4159,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4160,
        "sentence": "The beneficial effects on arterial thrombus formation from combined therapy with @DRUG-DRUG$ must be weighed against an increased risk of inducing hemorrhage.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4161,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG2$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4162,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG1$, barbiturates, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4163,
        "sentence": "Certain antibiotic, @DRUG1$, cyclosporine, diuretic, foscarnet, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4164,
        "sentence": "@DRUG1$ tablets may alter the metabolism of cyclosporine, tacrolimus, and @DRUG2$, resulting in elevated plasma concentrations of the latter drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4165,
        "sentence": "Paroxetine: Coadministration of once daily doses of @DRUG1$, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with @DRUG2$ 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and paroxetine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4166,
        "sentence": "Oral Hypoglycemics: @DRUG1$ has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for @DRUG2$ or oral hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4167,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the @DRUG1$, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4168,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4169,
        "sentence": "The rate of metabolism and the leukopenic activity of @DRUG1$ reportedly are increased by chronic administration of high doses of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4170,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4171,
        "sentence": "In this study we investigated the effect of ginsenosides on high threshold voltage-dependent Ca(2+) channel subtypes using their @DRUG1$ nimodipine (L-type), omega-conotoxin GVIA (N-type), or @DRUG2$ (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4172,
        "sentence": "Pharmacokinetic interaction studies with @DRUG1$ in adults were conducted with pseudoephedrine, @DRUG2$, ketoconazole, erythromycin and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4173,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other @DRUG2$, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4174,
        "sentence": "Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (@DRUG1$) with or without other enzyme-inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4175,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG1$, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4176,
        "sentence": "Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4177,
        "sentence": "If signs and symptoms suggestive of @DRUG1$ toxicity occur when enoxacin and @DRUG2$ are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4178,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG1$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4179,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, @DRUG2$, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4180,
        "sentence": "Both @DRUG1$ and @DRUG2$ ameliorate opioid withdrawal signs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4181,
        "sentence": "Twelve strains of Staphylococcus aureus (a frequent cause of infection in @DRUG1$, but not in pentazocine and @DRUG2$, addicts) were completely inhibited by the drug combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4182,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4183,
        "sentence": "May interact with wthionamide (@DRUG1$) and @DRUG2$ (Nydrazid).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4184,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, @DRUG2$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4185,
        "sentence": "Patients receiving other @DRUG1$, @DRUG2$, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4186,
        "sentence": "18-Methoxycoronaridine (@DRUG1$) and @DRUG2$: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4187,
        "sentence": "Lithium: Increased serum @DRUG1$ levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4188,
        "sentence": "If @DRUG1$ is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because @DRUG2$ amplifies the therapeutic actions and side-effects of opioids massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4189,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4190,
        "sentence": "@DRUG1$: @DRUG2$ may delay intestinal absorption of phenobarbital;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4191,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG2$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4192,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4193,
        "sentence": "@DRUG1$ has shown no clinically important potentiation of the pharmacodynamic effects of triazo lam or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4194,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and @DRUG1$ containing antacid (@DRUG2$ ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4195,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4196,
        "sentence": "The objective of this study was to determine if there is a pharmacokinetic interaction when @DRUG1$ is given with rifabutin or @DRUG2$ and to determine the effects of these drugs on the erythromycin breath test (ERMBT).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4197,
        "sentence": "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH @DRUG1$ SUCH AS NARCOTICS, @DRUG2$ AND BARBITURATES.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4198,
        "sentence": "Pharmacokinetic interactions between nisoldipine and @DRUG1$ (atenolol, @DRUG2$) were variable and not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4199,
        "sentence": "In a controlled clinical trial, a 20% reduction of the phenytoin dose at the initiation of Felbatol  therapy resulted in @DRUG1$ levels comparable to those prior to @DRUG2$  administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4200,
        "sentence": "The use of NIMBEX before @DRUG1$ to attenuate some of the side effects of @DRUG2$ has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4201,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4202,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4203,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4204,
        "sentence": "Furosemide: Clinical studies, as well as post-marketing observations, have shown that @DRUG1$ can reduce the natriuretic effect of furosemide and @DRUG2$ in some patients.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4205,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4206,
        "sentence": "May interact with wthionamide (@DRUG1$) and isoniazid (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4207,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4208,
        "sentence": "@DRUG1$ and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4209,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4210,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG1$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4211,
        "sentence": "Concomitant use of @DRUG1$ and @DRUG2$ increases the risk of cardiac arrhythmias.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4212,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4213,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4214,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG1$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4215,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, @DRUG1$, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4216,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4217,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4218,
        "sentence": "On the basis of the estimated number of regular users of intravenous @DRUG1$ in Ontario, the mortality rate in such users is at least four times as high as in the general population of the same age, and is comparable to that in alcoholics and @DRUG2$ addicts.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4219,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, @DRUG1$, mycophenolate, nelfinavir, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4220,
        "sentence": "Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of @DRUG1$, @DRUG2$, propranolol, or ranitidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4221,
        "sentence": "Specific and aspecific treatments of @DRUG1$ depletion are tricky using for example magnesium sparing diuretics, pharmacological doses of vitamin B6, physiological doses of @DRUG2$ and of selenium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4222,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4223,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4224,
        "sentence": "@DRUG1$ taken concomitantly with @DRUG2$ increases the serum digoxin concentration by 70% after one day.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4225,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as @DRUG1$  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4226,
        "sentence": "Since @DRUG1$ is coadministered with @DRUG2$, the ritonavir label should be reviewed for additional drugs that should not be coadministered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4227,
        "sentence": "@DRUG1$: Benzodiazepines GI Motility Agents Anti-Migraine @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4228,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most antidepressants (SSRIs, many @DRUG1$), beta-blockers, antiarrhythmics, and @DRUG2$ are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4229,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4230,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG1$, antianxiety agents, the phenothiazines, thioxanthene and @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4231,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4232,
        "sentence": "NaCMC at 1% (m/v) in the presence of free @DRUG1$ had no significant effect on the R-value of NaFlu compared to @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4233,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of @DRUG1$ were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, @DRUG2$, carbamazepine, or phenobarbital) than in healthy volunteers.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4234,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG1$ or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4235,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4236,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other @DRUG1$, phenothiazines, @DRUG2$, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4237,
        "sentence": "@DRUG1$: Co-administration of linezolid and @DRUG2$ was not associated with serotonin syndrome in Phase 1, 2 or 3 studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4238,
        "sentence": "Post-marketing reports of changes in prothrombin measures have been received among patients on concomitant @DRUG1$ and @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4239,
        "sentence": "In patients taking an @DRUG1$ (eg, valproic acid, carbamazepine, phenobarbital or @DRUG2$), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4240,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4241,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar, @DRUG1$, or @DRUG2$ but not after administration of fentayl alone or after pentobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4242,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4243,
        "sentence": "@DRUG1$ (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of @DRUG2$ and should not be taken concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4244,
        "sentence": "Co-administration of @DRUG1$ and tamoxifen resulted in a reduction of @DRUG2$ plasma levels by 27% compared with those achieved with anastrozole alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4245,
        "sentence": "BROVANA, as with other @DRUG1$, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of @DRUG2$ on the cardiovascular system may be potentiated by these agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4246,
        "sentence": "Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus @DRUG1$ to those in patients treated with 100 mg/m2 without @DRUG2$ indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of cisplatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4247,
        "sentence": "An adequate period of observation must be provided for any patient in whom either @DRUG1$ (such as diazepam) or large doses of @DRUG2$ (such as  10 mg of midazolam) have been used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4248,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4249,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate @DRUG1$ serum levels and valproic acid has been reported to both increase and decrease @DRUG2$ levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4250,
        "sentence": "Inhibitors or substrates of CYP2D6 (i.e., quinidine, selective serotonin reuptake inhibitors [@DRUG1$]) may increase the plasma concentration of @DRUG2$ when administered concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4251,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4252,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4253,
        "sentence": "@DRUG1$: Sporadic cases of seizures have been reported during concomitant use of TORADOL and antiepileptic drugs (@DRUG2$, carbamazepine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4254,
        "sentence": "@DRUG1$ should either be temporarily discontinued or decreased by 50% when coadministered with probenecid on the day of @DRUG2$ infusion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4255,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4256,
        "sentence": "Intestinal adsorbents (e. g., charcoal) and @DRUG1$ containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of @DRUG2$ and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4257,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG2$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4258,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4259,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4260,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4261,
        "sentence": "Other @DRUG1$ (eg, @DRUG2$, procainamide, lidocaine, propranolol) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4262,
        "sentence": "Concomitant administration of @DRUG1$ and calcium carbonate, @DRUG2$, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4263,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4264,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and @DRUG1$ might increase the photosensitivity reaction of actinic keratoses treated with the @DRUG2$ for Topical Solution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4265,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, @DRUG2$, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4266,
        "sentence": "Data from a randomized trial of @DRUG1$ and @DRUG2$ plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4267,
        "sentence": "Effects of Erythromycin on @DRUG1$  The coadministration of erythromycin (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax, Cmin, AUC, CI/kg or tmax at @DRUG2$ daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4268,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4269,
        "sentence": "Increases in prothrombin time have been noted in patients receiving long- term @DRUG1$ therapy after @DRUG2$ was initiated.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4270,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG2$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4271,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of @DRUG1$ (e.g., spironolactone, triamterene, @DRUG2$), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4272,
        "sentence": "@DRUG1$ (spironolactone, @DRUG2$,triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4273,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, @DRUG2$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4274,
        "sentence": "Zidovudine should either be temporarily discontinued or decreased by 50% when coadministered with @DRUG1$ on the day of @DRUG2$ infusion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4275,
        "sentence": "@DRUG1$: Multiple oral doses of Sonata (20 mg q24h for 13 days) did not affect the pharmacokinetics of warfarin (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4276,
        "sentence": "Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when @DRUG1$ is coadministered with inhibitors of C.P.A. such as ketoconazole and @DRUG2$ or inhibitors of CYP2C19 such as omeprazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4277,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4278,
        "sentence": "@DRUG1$: Coadministration of rifampin and MEPRON Suspension results in a significant decrease in average steady- state plasma @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4279,
        "sentence": "@DRUG1$: Multiple oral doses of Sonata (20 mg q24h for 13 days) did not affect the pharmacokinetics of @DRUG2$ (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4280,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, @DRUG1$ may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease @DRUG2$ levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4281,
        "sentence": "@DRUG1$/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, famotidine and @DRUG2$) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4282,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4283,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG1$, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4284,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with @DRUG1$ (alcohol, @DRUG2$, opiates, sedatives, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4285,
        "sentence": "However, there were 16% and 32% increases in the AUC and Cmax, respectively, of the combined moieties of @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4286,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4287,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4288,
        "sentence": "Repeating the study with 6 healthy male volunteers in the absence of @DRUG1$ did not detect an effect of @DRUG2$ on glucose tolerance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4289,
        "sentence": "Lithium: Increased serum @DRUG1$ levels and symptoms of @DRUG2$ toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4290,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4291,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4292,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4293,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, @DRUG1$, protease inhibitors, @DRUG2$, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4294,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4295,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: @DRUG2$, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4296,
        "sentence": "Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using @DRUG1$ but not with those using @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4297,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4298,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4299,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4300,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG1$, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4301,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: Cyclosporine (CYP3A4 substrate) administered in combination with oral @DRUG1$ has been reported to produce persistently elevated plasma concentrations of @DRUG2$ resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4302,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4303,
        "sentence": "Like @DRUG1$, @DRUG2$ does not predispose to premature ventricular arrhythmias in the presence of exogenously infused epinephrine in swine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4304,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, @DRUG2$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4305,
        "sentence": "However, since aspirin, @DRUG1$, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4306,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4307,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4308,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4309,
        "sentence": "In @DRUG1$-treated patients who require additional @DRUG2$ therapy, the initial dose of such agents should be approximately half of the usual recommended dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4310,
        "sentence": "@DRUG1$ Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of @DRUG2$ with ACE inhibitors, and with some angiotensin II receptor antagonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4311,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4312,
        "sentence": "@DRUG1$: Flurbiprofen like other @DRUG2$, has been shown to affect bleeding parameters in patients receiving anti-coagulants, and serious clinical bleeding has been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4313,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4314,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG2$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4315,
        "sentence": "The concurrent use of Robinul Injection with other anticholinergics or medications with anticholinergic activity, such as @DRUG1$, antiparkinson drugs, or @DRUG2$, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4316,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4317,
        "sentence": "Additive depressant effect when used with general @DRUG1$, sedatives, antianxiety drugs, @DRUG2$, alcohol, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4318,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, @DRUG1$, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4319,
        "sentence": "@DRUG1$: When atorvastatin and Maalox TC suspension were coadministered, plasma concentrations of @DRUG2$ decreased approximately 35%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4320,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, @DRUG1$, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4321,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other @DRUG2$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4322,
        "sentence": "Phase II clinical trial data, where IRESSA and @DRUG1$ have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4323,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4324,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) Use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4325,
        "sentence": "If signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly, physicians are advised to obtain serum @DRUG1$ levels and adjust @DRUG2$ doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4326,
        "sentence": "Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal @DRUG1$ clearance in psychiatric patients and normal subjects with steady state plasma @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4327,
        "sentence": "Cimetidine Co-administration of @DRUG1$ with cimetidine (a non-specific CYP-450 inhibitor) resulted in an increase of approximately 50% in the AUC and the Cmax, of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4328,
        "sentence": "If signs and symptoms suggestive of @DRUG1$ toxicity occur when enoxacin and digoxin are given concomitantly, physicians are advised to obtain serum @DRUG2$ levels and adjust digoxin doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4329,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4330,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG1$, morphine, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4331,
        "sentence": "Dexbrompheniramine can interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or @DRUG2$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4332,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4333,
        "sentence": "@DRUG1$ should not be administered concomitantly with potent @DRUG2$ such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4334,
        "sentence": "Concomitant administration of @DRUG1$ and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of @DRUG2$/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4335,
        "sentence": "METHODS: Clinical studies, case reports, and commentaries and editorials concerning @DRUG1$ published in the international literature between January 1999 and August 2000 were identified through searches of MEDLINE, PREMEDLINE, and International Pharmaceutical Abstracts, using the terms sildenafil, @DRUG2$, and erectile dysfunction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4336,
        "sentence": "These data suggest that @DRUG1$ are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/@DRUG2$-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4337,
        "sentence": "@DRUG1$ levels may be decreased; increased dosages may be required to prevent symptoms of @DRUG2$ withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4338,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, @DRUG2$, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4339,
        "sentence": "Potassium-sparing diuretics such as @DRUG1$, triamterene, or amiloride, or @DRUG2$ supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4340,
        "sentence": "Coadministration of oral @DRUG1$, @DRUG2$, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4341,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4342,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4343,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other @DRUG2$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4344,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4345,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4346,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4347,
        "sentence": "Ketoconazole: Co-administration of @DRUG1$ 125 mg b.i.d. and ketoconazole, a potent CYP3A4 inhibitor, increased the plasma concentrations of @DRUG2$ by approximately 2-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4348,
        "sentence": "Because oral @DRUG1$ may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral @DRUG2$ and phenytoin are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4349,
        "sentence": "In clinical studies, coadministration of WelChol  with atorvastatin, @DRUG1$, or simvastatin did not interfere with the lipid-lowering activity of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4350,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG1$, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4351,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG1$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4352,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4353,
        "sentence": "Co-administration of @DRUG1$ resulted in about a 50% increase in @DRUG2$ Cmax and AUC after multiple dosing.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4354,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4355,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4356,
        "sentence": "Using in situ hybridization, we observed that METH caused a rapid and transient dose-dependent increase in arc mRNA level in the striatum and cortex that was abolished by pretreatment with the specific dopamine D1 receptor antagonist @DRUG1$ but not by an @DRUG2$ clozapine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4357,
        "sentence": "It is recommended that serum @DRUG1$ levels be monitored frequently if @DRUG2$ is administered concomitantly with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4358,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4359,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4360,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4361,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4362,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4363,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG2$, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4364,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4365,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4366,
        "sentence": "@DRUG1$ (Oral): The hypoprothrombinemic effect of @DRUG2$ may be potentiated, apparently by increased catabloism of vitamin K-dependent clotting factors.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4367,
        "sentence": "@DRUG1$ has been administered without any evidence of an adverse drug interaction to patients receiving thiazide diuretics, beta-blocking agents, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4368,
        "sentence": "CNS-Active Drugs Ethanol An additive effect on psychomotor performance was seen with coadministration of eszopiclone and @DRUG1$ 0.70 g/kg for up to 4 hours after @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4369,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4370,
        "sentence": "However, because higher doses (up to 360 mg QD) of @DRUG1$ are tolerated in Zollinger-Ellison (ZE) patients, no dose adjustment for @DRUG2$ is recommended at current doses.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4371,
        "sentence": "Carbamazepine: Coadministration of @DRUG1$ (200 mg BID), a potent CYP3A4 inducer, with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both @DRUG2$ and its active metabolite, dehydro-aripiprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4372,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4373,
        "sentence": "@DRUG1$: The effects of @DRUG2$ and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4374,
        "sentence": "At 24 hours postdose, a similar proportion of patients treated with @DRUG1$ alone (94%) and subsequently treated with @DRUG2$ co-administered with 75 mg of rofecoxib (88%) had methotrexate plasma concentrations below the measurable limit (5 ng/mL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4375,
        "sentence": "The actions of the @DRUG1$ may be potentiated by barbiturates, @DRUG2$, phenothiazines, monoamine oxidase inhibitors or other antidepressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4376,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. @DRUG1$ antiarrhythmic agents of class (e.g. quinidine), antihistamines @DRUG2$ (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4377,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (Tenormin), acebutolol (@DRUG1$), @DRUG2$ (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4378,
        "sentence": "Both 18-MC and ibogaine are sequestered in fat and, like @DRUG1$, @DRUG2$ probably has an active metabolite.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4379,
        "sentence": "In vitro mixing of an @DRUG1$ with beta-lactamtype antibiotics (@DRUG2$ or cephalosporins) may result in a significant mutual inactivation.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4380,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of @DRUG1$, @DRUG2$, methotrexate, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4381,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG1$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4382,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4383,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, @DRUG1$, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of @DRUG2$ (thereby raising systemic exposure).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4384,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG2$, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4385,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4386,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG2$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4387,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4388,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG1$, the phenothiazines, thioxanthene and @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4389,
        "sentence": "There is one report of cardiopulmonary arrest, with full recovery, in a patient who was taking a @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4390,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4391,
        "sentence": "Cyclosporine: Elevated serum levels of @DRUG1$ have been reported with concomitant use of @DRUG2$ with other members of the quinolone class.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4392,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4393,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4394,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4395,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, @DRUG1$, troleandomycin, clarithromycin, @DRUG2$, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4396,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on @DRUG1$ : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4397,
        "sentence": "This decrease in absorption results in a 36% and 50% lower AUC for @DRUG1$ and @DRUG2$, respectively, which could cause clinical failures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4398,
        "sentence": "The urinary excretion of @DRUG1$ is unaffected by @DRUG2$, indicating no change in meclofenamate sodium absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4399,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, @DRUG1$, @DRUG2$, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4400,
        "sentence": "Due to wide interindividual variability in the dose adjustment required, it is recommended that @DRUG1$ concentrations be monitored closely after initiation of @DRUG2$ therapy and that the dose of cyclosporine be adjusted as appropriate.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4401,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG1$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4402,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4403,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4404,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4405,
        "sentence": "The concurrent administration of allopurinol and @DRUG1$ increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4406,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or @DRUG1$ did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4407,
        "sentence": "- a beta-blocker such as propranolol (Inderal), @DRUG1$ (Tenormin), acebutolol (@DRUG2$), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4408,
        "sentence": "Anesthetics/Sedatives/Hypnotics/@DRUG1$: Co-administration of @DRUG2$ with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4409,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG1$), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4410,
        "sentence": "Coadministration of @DRUG1$ with other @DRUG2$, amphotericin B, and corticosteroids may cause hypokalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4411,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, @DRUG2$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4412,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4413,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG2$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4414,
        "sentence": "Concomitant administration of Kerlone with the oral @DRUG1$ @DRUG2$ has been shown not to potentiate the anticoagulant effect of warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4415,
        "sentence": "Therefore, if @DRUG1$ is co-administered with @DRUG2$, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4416,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG1$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4417,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4418,
        "sentence": "- a beta-blocker such as propranolol (Inderal), @DRUG1$ (Tenormin), acebutolol (Sectral), metoprolol (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4419,
        "sentence": "The effects of coadministration of @DRUG1$ with other drugs that are renally eliminated or are known to affect renal function have not been evaluated, and patients should be monitored closely for adverse events when @DRUG2$ is coadministered with such drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4420,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4421,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG1$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG2$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4422,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4423,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, @DRUG1$, @DRUG2$), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4424,
        "sentence": "@DRUG1$: Co-administration with high doses of cimetidine [800 mg twice daily] increased the Cmax of @DRUG2$ by 21%, the AUC0-120hr by 23% and the t1/2 by 15%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4425,
        "sentence": "Inhibitors of CYP3A4 (eg, @DRUG1$) or CYP2D6 (eg, quinidine, @DRUG2$, or paroxetine) can inhibit aripiprazole elimination and cause increased blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4426,
        "sentence": "The urinary excretion of meclofenamate sodium is unaffected by @DRUG1$, indicating no change in @DRUG2$ absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4427,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG1$, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4428,
        "sentence": "Antacids and @DRUG1$: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as @DRUG2$  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4429,
        "sentence": "Use of PRINIVIL with @DRUG1$ (e.g., spironolactone, triamterene, or amiloride), @DRUG2$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4430,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, @DRUG1$, flecainide, and encainide), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4431,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term @DRUG1$ therapy (eg, phenytoin, @DRUG2$, or phenobarbital) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4432,
        "sentence": "Co-administration of @DRUG1$ and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4433,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), @DRUG1$ antipsychotic agents (e.g. phenothiazines), @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4434,
        "sentence": "Certain antibiotic, cisplatin, @DRUG1$, diuretic, foscarnet, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4435,
        "sentence": "Both @DRUG1$ and ibogaine are sequestered in fat and, like ibogaine, @DRUG2$ probably has an active metabolite.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4436,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4437,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4438,
        "sentence": "When coadministered with @DRUG1$ in treatment-naive patients, the recommended dose of atazanavir is 300 mg with ritonavir 100 mg and @DRUG2$ 600 mg (all once daily).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4439,
        "sentence": "Concomitant administration of Kerlone with the oral anticoagulant @DRUG1$ has been shown not to potentiate the anticoagulant effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4440,
        "sentence": "@DRUG1$: Griseofulvin may induce the metabolism of @DRUG2$ causing menstrual changes;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4441,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, @DRUG1$, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4442,
        "sentence": "When concomitant treatment with @DRUG1$ and @DRUG2$ is to be terminated, the b-blocking agent should be discontinued first.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4443,
        "sentence": "Ketoconazole: Co-administration of @DRUG1$ 125 mg b.i.d. and @DRUG2$, a potent CYP3A4 inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4444,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG1$, @DRUG2$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4445,
        "sentence": "However, in a follow-up study in normal subjects, single-dose administration of @DRUG1$ and propranolol and twice-a-day administration for 5 days of both agents did not affect the extent of @DRUG2$ absorption, but had a small yet statistically significant effect on its rate of absorption;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4446,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4447,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4448,
        "sentence": "In some cases where serious ventricular arrhythmias, QT prolongation, and torsades de pointes have occurred when @DRUG1$ was taken in conjunction with one of the cytochrome P450 3A4 inhibitors, elevated blood @DRUG2$ levels were noted at the time of the QT prolongation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4449,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, @DRUG1$, carbamazepine, and Type 1C antiarrhythmics (eg, @DRUG2$, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4450,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4451,
        "sentence": "The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, @DRUG1$, antihistaminics, @DRUG2$, and other drugs which themselves produce CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4452,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with @DRUG2$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4453,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4454,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4455,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4456,
        "sentence": "Concomitant treatment with @DRUG1$ (@DRUG2$) and drugs that affect platelet function may also increase the risk of bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4457,
        "sentence": "The fraction of @DRUG1$ absorbed is unaffected by the concomitant administration of a nasal vasoconstrictor (@DRUG2$), but the rate of absorption is decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4458,
        "sentence": "Interactions between treatments with coumaphos, bishydroxycoumarin (an anticoagulant), @DRUG1$ (an organophosphorous compound), and @DRUG2$ (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4459,
        "sentence": "Anticonvulsants (carbamazepine, @DRUG1$, phenobarbital, @DRUG2$, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4460,
        "sentence": "Anticoagulants, oral: Co-administration of @DRUG1$ and warfarin usually results in inhibition of response to @DRUG2$, although there have been some conflicting reports.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4461,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, ACE inhibitors, verapamil, @DRUG1$, propranolol, and various chemotherapy agents, no effect was shown on the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4462,
        "sentence": "The percentage of neurons hyperpolarized by @DRUG-DRUG$ was significantly reduced when 1% but not <",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4463,
        "sentence": "Drugs that may have their plasma concentration altered by Gleevec @DRUG1$ increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4464,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4465,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG1$, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4466,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4467,
        "sentence": "@DRUG1$: Since heparin is contraindicated in patients with heparin-induced thrombocytopenia, the co-administration of @DRUG2$ and heparin is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4468,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4469,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, @DRUG2$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4470,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG2$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4471,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG1$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4472,
        "sentence": "These include @DRUG1$, cholestyramine, and some @DRUG2$ (e.g. erythromycin, rifamipicin, ampicillin and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4473,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of @DRUG1$  (@DRUG2$) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4474,
        "sentence": "@DRUG1$ or Corticosteroids or Corticotropin (@DRUG2$)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4475,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG2$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4476,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4477,
        "sentence": "RESULTS: The geometric mean (90% confidence interval) whole blood sirolimus area under the plasma concentration time-curve increased 60% (35%-90%), from 736 to 1178 ng x h/mL, and maximum concentration increased 43% (14%-81%), from 67 to 96 ng/mL, with @DRUG1$ coadministration, whereas the mean elimination half-life of @DRUG2$ decreased slightly, from 79 to 67 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4478,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4479,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4480,
        "sentence": "Certain drugs including @DRUG1$, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4481,
        "sentence": "When @DRUG1$ is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4482,
        "sentence": "The administration of local @DRUG1$ containing epinephrine or norepinephrine to patients receiving @DRUG2$ or tricyclic antidepressants may produce severe, prolonged hypertension.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4483,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4484,
        "sentence": "@DRUG1$, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and @DRUG2$ may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4485,
        "sentence": "The concurrent use of @DRUG1$ Injection with other anticholinergics or medications with anticholinergic activity, such as @DRUG2$, antiparkinson drugs, or tricyclic antidepressants, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4486,
        "sentence": "However, coadministration of @DRUG1$ (20 mg) and ritonavir (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4487,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4488,
        "sentence": "Concomitant use of @DRUG1$ with other drugs metabolized by cytochrome P450IID6 may require lower doses than usually prescribed for either the @DRUG2$ or the other drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4489,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of @DRUG1$-containing or ergot-type medications (like dihydroergotamine or methysergide) and @DRUG2$ within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4490,
        "sentence": "Consider doubling the @DRUG1$ dose in regimens where @DRUG2$ is given 2 or 3 times a week.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4491,
        "sentence": "Thus, careful monitoring of clinical status is warranted when @DRUG1$ is administered or discontinued in @DRUG2$-treated patients.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4492,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4493,
        "sentence": "@DRUG1$: When healthy subjects were administered @DRUG2$ 120 mg three times daily before meals for four days in combination with a single dose of warfarin 30 mg on day 2, there were no alterations in the pharmacokinetics of either agent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4494,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4495,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4496,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4497,
        "sentence": "Certain drugs including thiazides, corticosteroids, @DRUG1$, and @DRUG2$ may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4498,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, @DRUG1$, tranquilizers, and antihistamines) may result in increased @DRUG2$ effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4499,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4500,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of ZYVOX and @DRUG1$, including @DRUG2$ such as selective serotonin reuptake inhibitors (SSRIs), have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4501,
        "sentence": "@DRUG1$ (SSRIs) (e.g., @DRUG2$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4502,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4503,
        "sentence": "Probenecid or Cimetidine: Concomitant administration of probenecid or @DRUG1$ decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4504,
        "sentence": "@DRUG1$, Fibric Acid Derivatives, Niacin (@DRUG2$, Erythromycin, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4505,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4506,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, @DRUG2$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4507,
        "sentence": "@DRUG1$: Clinical studies, as well as random observations, have shown that ibuprofen can reduce the natriuretic effect of @DRUG2$ and thiazides in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4508,
        "sentence": "Since Zarontin (@DRUG1$) may interact with concurrently administered @DRUG2$, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4509,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4510,
        "sentence": "Nevertheless, the possibility of additive negative inotropic effects of @DRUG1$ and @DRUG2$ should be recognized.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4511,
        "sentence": "The concomitant use of @DRUG1$ with digitalis and @DRUG2$s may have additive effects on prolonging atrioventricular conduction time.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4512,
        "sentence": "Certain drugs including @DRUG1$, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4513,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of @DRUG1$ are decreased when administered with antacids containing magnesium, calcium, or @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4514,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG1$, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4515,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/@DRUG1$/@DRUG2$-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4516,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG1$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4517,
        "sentence": "Carbamazepine - Combined administration of racemic @DRUG1$ (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of @DRUG2$, a CYP3A4 substrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4518,
        "sentence": "Concomitant treatment with methylxanthines (aminophylline, theophylline), @DRUG1$, or @DRUG2$ may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4519,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4520,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4521,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that sirolimus, in combination with @DRUG1$ or @DRUG2$, might have the potential to reduce the frequency of rejection episodes, permit reductions in cyclosporine or tacrolimus dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4522,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4523,
        "sentence": "Agents Increasing Serum Potassium: @DRUG1$ and enalapril IV attenuate potassium loss caused by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4524,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4525,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG1$ such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4526,
        "sentence": "@DRUG1$: Sporadic cases of seizures have been reported during concomitant use of @DRUG2$ and antiepileptic drugs (phenytoin, carbamazepine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4527,
        "sentence": "Long Acting @DRUG1$: @DRUG2$ may be safely co-administered with nitrates, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4528,
        "sentence": "@DRUG1$: When healthy subjects were administered Starlix 120 mg three times daily before meals for four days in combination with a single dose of @DRUG2$ 30 mg on day 2, there were no alterations in the pharmacokinetics of either agent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4529,
        "sentence": "Oral @DRUG1$ may enhance the effect of coumarin in @DRUG2$ by decreasing vitamin K availability.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4530,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG1$, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4531,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4532,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4533,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, @DRUG1$ or phenytoin), the concomitant use of @DRUG2$ may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4534,
        "sentence": "Antacids and sucralfate: @DRUG1$ and antacids containing magnesium or @DRUG2$, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4535,
        "sentence": "In a study in diabetics with microalbuminuria @DRUG1$ 200 mg combined with the @DRUG2$ enalapril 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on enalapril alone to 38%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4536,
        "sentence": "Antacids containing @DRUG1$, @DRUG2$, or calcium;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4537,
        "sentence": "Chlorpropamide: @DRUG1$s plasma half-life may be prolonged by @DRUG2$, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4538,
        "sentence": "The administration of lower doses of @DRUG1$ with @DRUG2$ has not been completely evaluated to determine if they can be safely administered together.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4539,
        "sentence": "Based on clinical and pharmacokinetic results from the ATAC trial, @DRUG1$ should not be administered with @DRUG2$ (see CLINICAL PHARMACOLOGY   Drug Interactions and CLINICAL PHARMACOLOGY - Clinical Studies - Adjuvant Treatment of Breast Cancer in Postmenopausal Women subsections).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4540,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4541,
        "sentence": "@DRUG1$: Amphetamines potentiate the analgesic effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4542,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4543,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, @DRUG1$, nicotinic acid (niacin), tolbutamide, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4544,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4545,
        "sentence": "Coadministration of oral @DRUG1$, diazepam, @DRUG2$, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4546,
        "sentence": "No interaction with the @DRUG1$ imipramine was shown in a single-dose study with @DRUG2$ without coadministered levodopa/dopa-decarboxylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4547,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4548,
        "sentence": "Ethoxzolamide may increase the action of tricyclics, amphetamines, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4549,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4550,
        "sentence": "Anticoagulants, oral: Co-administration of @DRUG1$ and @DRUG2$ usually results in inhibition of response to warfarin, although there have been some conflicting reports.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4551,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4552,
        "sentence": "Additive depressant effect when used with general @DRUG1$, sedatives, antianxiety drugs, hypnotics, alcohol, and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4553,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with @DRUG1$, a reduction in dosage of PRECEDEX on the concomitant @DRUG2$, sedative, hypnotic or opioid may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4554,
        "sentence": "Ketoconazole tablets may alter the metabolism of @DRUG1$, tacrolimus, and @DRUG2$, resulting in elevated plasma concentrations of the latter drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4555,
        "sentence": "@DRUG1$: The pharmacokinetics of almotriptan were not affected by coadministration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4556,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, @DRUG1$, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4557,
        "sentence": "Furthermore, @DRUG1$, phenytoin, @DRUG2$, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4558,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, @DRUG1$, chloramphenicol, probenecid, @DRUG2$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4559,
        "sentence": "The @DRUG1$, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, @DRUG2$, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4560,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4561,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving @DRUG1$, there have been reports that @DRUG2$ may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4562,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, @DRUG1$, digoxin, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4563,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4564,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4565,
        "sentence": "Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, @DRUG1$, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4566,
        "sentence": "It may also interact with @DRUG1$ or other anticholinergic drugs or @DRUG2$, which may intensify the anticholinergic action.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4567,
        "sentence": "@DRUG1$: Chlorpromazine blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines, and can be used to treat @DRUG2$ poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4568,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4569,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG1$ suggest a possible drug interaction with alprazolam for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4570,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4571,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG1$, morphine, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4572,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, @DRUG2$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4573,
        "sentence": "Lithium Reversible increases in serum @DRUG1$ concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4574,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, @DRUG1$, and @DRUG2$), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4575,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4576,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4577,
        "sentence": "Oral @DRUG1$ Interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4578,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4579,
        "sentence": "Hypotension was more likely to occur if the calcium antagonist were a dihydropyridine derivative, e.g., nifedipine, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4580,
        "sentence": "Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, @DRUG1$ (metronidazole or @DRUG2$) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4581,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, @DRUG2$, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4582,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, @DRUG2$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4583,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, @DRUG1$, and encainide), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4584,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, @DRUG2$, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4585,
        "sentence": "@DRUG1$ can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4586,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that @DRUG1$ (1 mg/kg) removes the antiedematous action of @DRUG2$, phenazepam, phenibut and amizyl and reduces the action of phentolamine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4587,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4588,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, @DRUG1$, @DRUG2$, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4589,
        "sentence": "Antiepileptic Drugs: Sporadic cases of seizures have been reported during concomitant use of TORADOL and @DRUG1$ (phenytoin, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4590,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4591,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4592,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4593,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of @DRUG1$-containing or ergot-type medications (like @DRUG2$ or methysergide) and FROVA within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4594,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG1$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4595,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4596,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4597,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4598,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4599,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, @DRUG2$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4600,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of @DRUG1$ may be reduced by these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4601,
        "sentence": "@DRUG1$: In a study in healthy volunteers, a six-day course of rifampicin at 600 mg/day followed by a single 5 mg dose of @DRUG2$ resulted in a reduction in isradipine levels to below detectable limits.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4602,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4603,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4604,
        "sentence": "The biochemical toxicology of @DRUG1$, a known metabolite of the major ingredient of the pesticide @DRUG2$ (1,3-difluoro-2-propanol), was investigated in vivo and in vitro.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4605,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4606,
        "sentence": "@DRUG1$, @DRUG2$: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4607,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4608,
        "sentence": "@DRUG1$: Sporadic cases of seizures have been reported during concomitant use of TORADOL and antiepileptic drugs (phenytoin, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4609,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG1$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4610,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4611,
        "sentence": "This drug may interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG2$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4612,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with @DRUG1$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4613,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4614,
        "sentence": "@DRUG1$: Modest increases in mean trough @DRUG2$ concentrations were observed following initiation of carvedilol treatment in 21 renal transplant patients suffering from chronic vascular rejection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4615,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG1$, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4616,
        "sentence": "When @DRUG1$ or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4617,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4618,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4619,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4620,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4621,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of @DRUG1$ with a therapeutic @DRUG2$ containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4622,
        "sentence": "In patients who have been reported to be well controlled on @DRUG1$ receiving concurrent @DRUG2$ therapy, discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic antidepressant levels and compromise their therapeutic effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4623,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG1$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4624,
        "sentence": "@DRUG1$, @DRUG2$ and carbamazepine are ge nerally classified as enzyme inducers;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4625,
        "sentence": "Skeletal muscle relaxants: @DRUG1$-induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants (e.g., @DRUG2$).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4626,
        "sentence": "The results from a study in which eight HIV-infected individuals were treated with @DRUG1$, 8 +/- 0.4 mg/kg/day, showed that the pharmacokinetics of @DRUG2$ were not affected during concomitant administration of Itraconazole, 100 mg b.i.d.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4627,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG1$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4628,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4629,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, @DRUG1$, @DRUG2$, erythromycin and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4630,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG1$, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4631,
        "sentence": "Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of @DRUG1$ to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when @DRUG2$ plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4632,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4633,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4634,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4635,
        "sentence": "Following oral administration of two 150-mg sustained-release tablets with and without 800 mg of @DRUG1$, the pharmacokinetics of @DRUG2$ and hydroxybupropion were unaffected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4636,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4637,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4638,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and @DRUG1$ (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, @DRUG2$), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4639,
        "sentence": "Anticonvulsants (@DRUG1$, felbamate, @DRUG2$, phenytoin, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4640,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4641,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), @DRUG2$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4642,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of @DRUG1$ and @DRUG2$, including antidepressants such as selective serotonin reuptake inhibitors (SSRIs), have been reported.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4643,
        "sentence": "Although acid-base and electrolyte disturbances were not reported in the clinical trials with @DRUG1$, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose @DRUG2$ therapy).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4644,
        "sentence": "Drugs Metabolized by Cytochrome P450IID6 (CYP2D6): Many drugs, including most @DRUG1$ (SSRIs, many @DRUG2$), beta-blockers, antiarrhythmics, and antipsychotics are metabolized by the CYP2D6 isoenzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4645,
        "sentence": "Consequently, the effect of @DRUG1$ on the retention of @DRUG2$ was lower than on absorption.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4646,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4647,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other @DRUG2$, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4648,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4649,
        "sentence": "Additive depressant effect when used with general anesthetics, @DRUG1$, antianxiety drugs, hypnotics, @DRUG2$, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4650,
        "sentence": "Doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving @DRUG1$, @DRUG2$s, and nonsteroidal anti-inflammatory drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4651,
        "sentence": "In patients taking @DRUG1$, nifedipine, diltiazem, ACE inhibitors, verapamil, glyburide, @DRUG2$, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4652,
        "sentence": "Lithium: @DRUG1$ produced an elevation of plasma lithium levels and a reduction in renal @DRUG2$ clearance in a study of eleven normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4653,
        "sentence": "d-amphetamine with desipramine or protriptyline and possibly other @DRUG1$ cause striking and sustained increases in the concentration of @DRUG2$ in the brain;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4654,
        "sentence": "However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of @DRUG1$ or @DRUG2$ with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4655,
        "sentence": "Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of @DRUG1$ (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of @DRUG2$ 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4656,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4657,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG1$, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4658,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, @DRUG2$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4659,
        "sentence": "Agents Causing Renin Release @DRUG1$'s effect will be augmented by @DRUG2$ that cause renin release.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4660,
        "sentence": "@DRUG1$/Sedatives/Hypnotics/Opioids: Co-administration of @DRUG2$ with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4661,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4662,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, @DRUG2$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4663,
        "sentence": "As with other @DRUG1$, if COREG is to be administered orally with calcium channel blockers of the @DRUG2$ or diltiazem type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4664,
        "sentence": "Beta-adrenergic Blocking Agents: The effect of flurbiprofen on blood pressure response to @DRUG1$ and @DRUG2$ was evaluated in men with mild uncomplicated hypertension (n = 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4665,
        "sentence": "As with other antihypertensive agents, the antihypertensive effect of losartan may be blunted by the @DRUG1$ @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4666,
        "sentence": "METHODS: Clinical studies, case reports, and commentaries and editorials concerning @DRUG1$ published in the international literature between January 1999 and August 2000 were identified through searches of MEDLINE, PREMEDLINE, and International Pharmaceutical Abstracts, using the terms @DRUG2$, Viagra, and erectile dysfunction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4667,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4668,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG2$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4669,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, @DRUG1$, @DRUG2$, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4670,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4671,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (Tenormin), acebutolol (Sectral), @DRUG1$ (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4672,
        "sentence": "Of over 3500 patients enrolled in the Ibandronate osteoporosis Treatment and Prevention Studies, 15% used anti-peptic agents (primarily @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4673,
        "sentence": "@DRUG1$: In normal volunteers, the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4674,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4675,
        "sentence": "Concomitant use of @DRUG1$ with other drugs metabolized by cytochrome P450 2D6 may require lower doses than usually prescribed for either @DRUG2$ or the other drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4676,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4677,
        "sentence": "Drugs that may have their plasma concentration altered by Gleevec @DRUG1$ increases the mean cmax and AUC of @DRUG2$ (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4678,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG1$, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4679,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4680,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG1$, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4681,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4682,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4683,
        "sentence": "Potassium-sparing diuretics (@DRUG1$, amiloride,@DRUG2$, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4684,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, phenobarbital, phenytoin, @DRUG1$): Increase the metabolism of @DRUG2$ and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4685,
        "sentence": "It is unknown whether the concomitant administration of @DRUG1$ affects @DRUG2$ absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4686,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4687,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4688,
        "sentence": "Nevertheless, plasma @DRUG1$ levels should be monitored with appropriate adjustment to the @DRUG2$ dose in accordance with standard clinical practice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4689,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4690,
        "sentence": "@DRUG1$ @DRUG2$ 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4691,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4692,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG1$ [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4693,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4694,
        "sentence": "@DRUG1$, phenobarbital and @DRUG2$ are ge nerally classified as enzyme inducers;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4695,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4696,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, @DRUG2$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4697,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG1$, and the Type 1C antiarrhythmics @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4698,
        "sentence": "Limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50% for the first sixty (60) minutes following ALFENTA induction The concomitant use of erythromycin with @DRUG1$ can significantly inhibit @DRUG2$ clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4699,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG1$, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4700,
        "sentence": "Other @DRUG1$ (eg, quinidine, @DRUG2$, lidocaine, propranolol) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4701,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, @DRUG2$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4702,
        "sentence": "However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or @DRUG1$ with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4703,
        "sentence": "Pharmacokinetic interaction between single oral doses of @DRUG1$ and @DRUG2$ in healthy volunteers.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4704,
        "sentence": "Furosemide: Clinical studies, as well as random observations, have shown that ibuprofen can reduce the natriuretic effect of @DRUG1$ and @DRUG2$ in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4705,
        "sentence": "@DRUG1$: amphotericin B-induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants (e.g., @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4706,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG1$, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4707,
        "sentence": "Limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50% for the first sixty (60) minutes following ALFENTA induction The concomitant use of @DRUG1$ with ALFENTA can significantly inhibit @DRUG2$ clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4708,
        "sentence": "Warfarin: Co-administration of bosentan 500 mg b.i.d. for 6 days decreased the plasma concentrations of both @DRUG1$ (a CYP2C9 substrate) and @DRUG2$ (a CYP3A4 substrate) by 29 and 38%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4709,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4710,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4711,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4712,
        "sentence": "Dexbrompheniramine can interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4713,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4714,
        "sentence": "It has been reported that the addition of @DRUG1$ to a maintenance schedule of @DRUG2$ resulted in reversible acute renal failure in two of four healthy volunteers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4715,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG2$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4716,
        "sentence": "Phenobarbital (@DRUG1$): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4717,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4718,
        "sentence": "Other strong selective CYP3A4 inhibitors such as @DRUG1$ can also be expected to increase the exposure of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4719,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as @DRUG1$, @DRUG2$, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4720,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG-DRUG$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4721,
        "sentence": "While it is not known whether this interaction occurs with @DRUG1$ other than gemfibrozil, myopathy and rhabdomyolysis have occasionally been associated with the use of @DRUG2$ alone, including clofibrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4722,
        "sentence": "Pharmacokinetic interactions between nisoldipine and @DRUG1$ (@DRUG2$, propranolol) were variable and not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4723,
        "sentence": "@DRUG1$ at 400 mg daily (the maximum approved prescription dose) co-administered with @DRUG2$ (500 mcg BID) for 7 days has been shown to increase dofetilide Cmax by 53% in males and 97% in females, and AUC by 41% in males and 69% in females.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4724,
        "sentence": "@DRUG1$ exposure was significantly decreased by @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4725,
        "sentence": "@DRUG1$: When atorvastatin and @DRUG2$ suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4726,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, @DRUG2$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4727,
        "sentence": "@DRUG1$: Concomitant administration of magnesium hydroxide and aluminum hydroxide does not interfere with the rate or extent of the absorption of @DRUG2$ administered as Orudis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4728,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4729,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4730,
        "sentence": "Cimetidine - In subjects who had received 21 days of 40 mg/day racemic @DRUG1$, combined administration of 400 mg/day @DRUG2$ for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4731,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4732,
        "sentence": "Although it has not been definitively demonstrated that @DRUG1$ is a potent IIIA4 inhibitor, it is likely to be, given the substantial interaction of @DRUG2$ with alprazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4733,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4734,
        "sentence": "In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with @DRUG1$, the use of @DRUG2$ was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4735,
        "sentence": "The biochemical toxicology of 1,3-difluoroacetone, a known metabolite of the major ingredient of the pesticide @DRUG1$ (@DRUG2$), was investigated in vivo and in vitro.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4736,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4737,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving @DRUG1$, there have been reports that propranolol may potentiate the vasoconstrictive action of @DRUG2$ by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4738,
        "sentence": "therefore, coadministration of @DRUG1$ with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of @DRUG2$ that may result in decreased efficacy of Aprepitant.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4739,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4740,
        "sentence": "Furosemide: Clinical studies, as well as random observations, have shown that @DRUG1$ can reduce the natriuretic effect of @DRUG2$ and thiazides in some patients.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4741,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG1$, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4742,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of ZYVOX and @DRUG1$, including antidepressants such as selective serotonin reuptake inhibitors (@DRUG2$), have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4743,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4744,
        "sentence": "Probenecid or @DRUG1$: Concomitant administration of probenecid or cimetidine decreases the elimination of @DRUG2$, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4745,
        "sentence": "CNS-Active Drugs Ethanol An additive effect on psychomotor performance was seen with coadministration of @DRUG1$ and @DRUG2$ 0.70 g/kg for up to 4 hours after ethanol administration.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4746,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG1$ (e.g., @DRUG2$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4747,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate @DRUG1$ serum levels and @DRUG2$ has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4748,
        "sentence": "Caution should be exercised when administering @DRUG1$ with warfarin since interactions have been seen with other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4749,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4750,
        "sentence": "Although it has not been definitively demonstrated that @DRUG1$ is a potent IIIA4 inhibitor, it is likely to be, given the substantial interaction of fluvoxamine with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4751,
        "sentence": "May lead to loss of virologic response and possible resistance to @DRUG1$ or to the class of @DRUG2$ or other coadministered antiretroviral agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4752,
        "sentence": "Anesthetics/Sedatives/@DRUG1$/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4753,
        "sentence": "- @DRUG1$ (e.g., Dilantin) Use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4754,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG2$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4755,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4756,
        "sentence": "NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of @DRUG1$ compared to @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4757,
        "sentence": "Phenobarbital (@DRUG1$): Population pharmacokinetic analyses indicate that @DRUG2$ clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4758,
        "sentence": "@DRUG1$ (such as haloperidol) and @DRUG2$ can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4759,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4760,
        "sentence": "Although not studied with @DRUG1$, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid, procainamide, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4761,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between @DRUG1$ and low affinity binding sites for apomorphine in subcortical structures, whereas @DRUG2$ binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4762,
        "sentence": "Drugs which induce CYP3A4 activity (eg, phenobarbital, rifampin, @DRUG1$) would be expected to increase the clearance of @DRUG2$ resulting in lowered plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4763,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (Tenormin), acebutolol (@DRUG1$), metoprolol (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4764,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4765,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4766,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4767,
        "sentence": "Clinical experience with concomitant administration of bosentan and @DRUG1$ in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or @DRUG2$ dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4768,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4769,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4770,
        "sentence": "Oral Anticoagulants Interaction studies with @DRUG1$ and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4771,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, @DRUG1$, and @DRUG2$ may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4772,
        "sentence": "Two studies were conducted in HIV-infected subjects to assess the potential for azithromycin to interact with @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4773,
        "sentence": "The pharmacokinetic variables for @DRUG1$ were determined after a 1.0 mg intravenous dose of digoxin in each subject, before and after oral @DRUG2$, 400 mg daily for 3 weeks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4774,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, cetirizine, famotidine, @DRUG2$, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4775,
        "sentence": "While all the selective @DRUG1$ (@DRUG2$), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4776,
        "sentence": "@DRUG1$, Oral Contraceptives: @DRUG2$ tend to increase serum thyroxine-binding globulin (TBg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4777,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4778,
        "sentence": "Drug Interactions with @DRUG1$ Administration of 120 mg of @DRUG2$ (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4779,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4780,
        "sentence": "In another drug interaction study, co-administration of orally inhaled ciclesonide and oral @DRUG1$, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of @DRUG2$ by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4781,
        "sentence": "Anticholinergics: Concurrent administration of certain @DRUG1$, such as belladonna alkaloids and dicyclomine, would be expected to compromise the beneficial effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4782,
        "sentence": "Ketoconazole: @DRUG1$ 400 mg daily did not have any clinically important effect on the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4783,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4784,
        "sentence": "Additive depressant effect when used with general @DRUG1$, sedatives, antianxiety drugs, hypnotics, @DRUG2$, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4785,
        "sentence": "@DRUG1$ should either be temporarily discontinued or decreased by 50% when coadministered with @DRUG2$ on the day of VISTIDE infusion.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4786,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4787,
        "sentence": "Coadministration of gly-buride and @DRUG1$ did not result in any changes in either @DRUG2$ pharmacokinetics or pharmaco-dynamics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4788,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4789,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4790,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, @DRUG1$, carbamazepine, or @DRUG2$) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4791,
        "sentence": "@DRUG1$, like MPTP, produced depletions of striatal dopamine but these actions were potentiated by @DRUG2$ pretreatment.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4792,
        "sentence": "- a beta-blocker such as propranolol (@DRUG1$), atenolol (Tenormin), acebutolol (Sectral), @DRUG2$ (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4793,
        "sentence": "No drug interaction studies have been conducted for COLAZAL, however the use of orally administered @DRUG1$ could, theoretically, interfere with the release of @DRUG2$ in the colon.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4794,
        "sentence": "Oral Anticoagulants Interaction studies with @DRUG1$ and @DRUG2$ failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4795,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4796,
        "sentence": "@DRUG1$: @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4797,
        "sentence": "Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a @DRUG1$ is co-administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4798,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4799,
        "sentence": "Drug Interactions with @DRUG1$: Concomitant use of @DRUG2$ with beta-blockers should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4800,
        "sentence": "@DRUG1$ and butyrophenones may reduce or reverse the pressor effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4801,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, @DRUG1$, @DRUG2$, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4802,
        "sentence": "@DRUG1$ or Cimetidine: Concomitant administration of probenecid or cimetidine decreases the elimination of @DRUG2$, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4803,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), @DRUG1$, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4804,
        "sentence": "In patients taking furosemide, @DRUG1$, diltiazem, ACE inhibitors, verapamil, @DRUG2$, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4805,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4806,
        "sentence": "@DRUG1$: Coadministration of a single dose of @DRUG2$ 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4807,
        "sentence": "@DRUG1$/@DRUG2$, Macrolides, Including Erythromycin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4808,
        "sentence": "Phenobarbital or Primidone : No formal pharmacokinetic studies have been performed examining the addition of @DRUG1$ to regimens containing phenobarbital or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4809,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG1$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4810,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4811,
        "sentence": "@DRUG1$ attenuated the heart rate increase following administration of immediate release @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4812,
        "sentence": "Results with @DRUG1$ wshow no evidence of interaction with either single or repeated doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4813,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some azoles and other drugs that are highly protein bound, @DRUG2$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4814,
        "sentence": "Clinical experience with concomitant administration of @DRUG1$ and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or @DRUG2$ dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among bosentan- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4815,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4816,
        "sentence": "The disposition of @DRUG1$ was not altered by concomitant @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4817,
        "sentence": "The effects @DRUG1$ on the pharmacokinetics and/or pharmacodynamics of glyburide, @DRUG2$, methotrexate, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4818,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4819,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4820,
        "sentence": "Increasing the @DRUG1$ dose to 1000 mg every 8 hours does not compensate for the increased @DRUG2$ metabolism due to efavirenz.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4821,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4822,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, @DRUG2$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4823,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, @DRUG1$, orphenadrine, pyrilamine, phenyltoloxamine, @DRUG2$, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4824,
        "sentence": "@DRUG1$: @DRUG2$ may induce the metabolism of combination hormonal contraceptives causing menstrual changes;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4825,
        "sentence": "Certain antibiotic, @DRUG1$, @DRUG2$, diuretic, foscarnet, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4826,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4827,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (@DRUG1$, @DRUG2$, opiates, sedatives, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4828,
        "sentence": "Probenecid: Concomitant administration of TORADOL ORAL and @DRUG1$ resulted in decreased clearance of ketorolac and significant increases in @DRUG2$ plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4829,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4830,
        "sentence": "Drug Interaction with @DRUG1$: A multiple-dose study was conducted to assess the effect of fluoxetine 20 mg BID on the pharmacokinetics of @DRUG2$ 2 mg QHS after seven days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4831,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG1$, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4832,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: @DRUG1$ (CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4833,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4834,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, @DRUG2$, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4835,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4836,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4837,
        "sentence": "Because both of these drugs have negative inotropic properties and the effects of coadministration with @DRUG1$ are unknown, neither disopyramide nor verapamil should be administered concurrently with @DRUG2$ unless, in the judgment of the physician, the benefits of this combination outweigh the risks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4838,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4839,
        "sentence": "Methotrexate: Concomitant administration of @DRUG1$ and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4840,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, @DRUG1$, phenyltoloxamine, @DRUG2$, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4841,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4842,
        "sentence": "In this study we investigated the effect of @DRUG1$ on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers nimodipine (L-type), @DRUG2$ (N-type), or omega-agatoxin IVA (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4843,
        "sentence": "Laboratory Tests: The combination of @DRUG1$ and low-dose @DRUG2$ has been associated with elevations of cholesterol and triglycerides, SGOT (AST), and SGPT (ALT) in some patients.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4844,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG2$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4845,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4846,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4847,
        "sentence": "There has been too little experience with the coadministration of @DRUG1$ with nifedipine or @DRUG2$ to recommend concomitant use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4848,
        "sentence": "Certain antibiotic, cisplatin, @DRUG1$, diuretic, @DRUG2$, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4849,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4850,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, phenobarbital, phenytoin, @DRUG1$): Increase the metabolism of ethinyl estradiol and/or some @DRUG2$, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4851,
        "sentence": "Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of @DRUG1$ and other oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4852,
        "sentence": "@DRUG1$: Phenytoin @DRUG2$ Carbamazepine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4853,
        "sentence": "Therefore, 4 to 5 hours should elapse between administration of @DRUG1$ and @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4854,
        "sentence": "Diminished urinary excretion of @DRUG1$ has been reported during the concomitant administration of probenecid and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4855,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4856,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4857,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG2$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4858,
        "sentence": "@DRUG1$ and @DRUG2$: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4859,
        "sentence": "Specific and aspecific treatments of @DRUG1$ depletion are tricky using for example magnesium sparing diuretics, pharmacological doses of vitamin B6, physiological doses of vitamin D and of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4860,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4861,
        "sentence": "Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG1$ and @DRUG2$ in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4862,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4863,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4864,
        "sentence": "- a beta-blocker such as propranolol (@DRUG1$), @DRUG2$ (Tenormin), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4865,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4866,
        "sentence": "While it is not known whether this interaction occurs with fibrates other than @DRUG1$, myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4867,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG2$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4868,
        "sentence": "Oral @DRUG1$: Diclofenac does not alter glucose metabolism in normal subjects nor does it alter the effects of oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4869,
        "sentence": "@DRUG1$ VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma @DRUG2$ concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4870,
        "sentence": "However, since @DRUG1$, NSAIDs, and @DRUG2$ are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4871,
        "sentence": "- a beta-blocker such as @DRUG1$ (Inderal), atenolol (Tenormin), @DRUG2$ (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4872,
        "sentence": "@DRUG1$ (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG2$ (primidone) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4873,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with @DRUG1$ because plasma concentrations of ciprofloxacin are decreased when administered with @DRUG2$ containing magnesium, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4874,
        "sentence": "Interactions between treatments with coumaphos, bishydroxycoumarin (an anticoagulant), trichlorfon (an @DRUG1$), and @DRUG2$ (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4875,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG1$, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4876,
        "sentence": "- @DRUG1$: Pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4877,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG1$ (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4878,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG1$, antianxiety agents, the @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4879,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4880,
        "sentence": "Antacid: When @DRUG1$ and Maalox TC suspension were coadministered, plasma concentrations of @DRUG2$ decreased approximately 35%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4881,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4882,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4883,
        "sentence": "Rifampin: @DRUG1$ increases the metabolism of ethinyl estradiol and some @DRUG2$ (norethindrone) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4884,
        "sentence": "Anticonvulsants (carbamazepine, @DRUG1$, phenobarbital, phenytoin, topiramate): Increase the metabolism of @DRUG2$ and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4885,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4886,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG1$, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4887,
        "sentence": "Capsules @DRUG1$ 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal @DRUG2$ clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4888,
        "sentence": "- Valproic acid (e.g., @DRUG1$) Use of @DRUG2$ with these medicines may increase the chance of side effects affecting the liver",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4889,
        "sentence": "@DRUG1$ works differently from the @DRUG2$ currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with cyclosporine or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4890,
        "sentence": "@DRUG1$: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, carbamazepine, or @DRUG2$) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4891,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4892,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4893,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4894,
        "sentence": "Metoclopramide: When coadministered with @DRUG1$, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4895,
        "sentence": "Drug Interactions with @DRUG1$ Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased @DRUG2$ AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4896,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or @DRUG1$ supplemented with 10 mg of elemental @DRUG2$ reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4897,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that sirolimus, in combination with @DRUG1$ or tacrolimus, might have the potential to reduce the frequency of rejection episodes, permit reductions in @DRUG2$ or tacrolimus dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4898,
        "sentence": "@DRUG1$: Clinical studies, as well as random observations, have shown that @DRUG2$ can reduce the natriuretic effect of furosemide and thiazides in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4899,
        "sentence": "Interaction between @DRUG1$ and @DRUG2$ has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4900,
        "sentence": "In a study with concomitant administration of aspirin and @DRUG1$, the bioavailability of unbound @DRUG2$ was not altered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4901,
        "sentence": "Although specific drug interaction studies have not been conducted with @DRUG1$, the possibility of an additive or potentiating effect with @DRUG2$ (alcohol, barbiturates, opiates, sedatives, or anesthetics) should be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4902,
        "sentence": "there was no effect on the 3 major metabolites (@DRUG1$, @DRUG2$ and FBAL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4903,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4904,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4905,
        "sentence": "In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of @DRUG1$ alone were compared to @DRUG2$ given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4906,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4907,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG1$], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4908,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4909,
        "sentence": "Nucleoside Analogues Didanosine Co-administration of @DRUG1$ and @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4910,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing magnesium or @DRUG1$, as well as formulations containing divalent and trivalent cations such as Videx  (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4911,
        "sentence": "When @DRUG1$ or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - @DRUG2$ and Bezalip retard may enhance the action of anticoagulants of the coumarin type.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4912,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., @DRUG1$ 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of @DRUG2$ ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4913,
        "sentence": "Diminished urinary excretion of norfloxacin has been reported during the concomitant administration of @DRUG1$ and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4914,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4915,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG2$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4916,
        "sentence": "@DRUG1$ containing magnesium, @DRUG2$, or calcium;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4917,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4918,
        "sentence": "Reported examples of this interaction include the following: @DRUG1$s: Cyclosporine (@DRUG2$ substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4919,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental @DRUG1$ (as FeSO4) or vitamins supplemented with 10 mg of elemental @DRUG2$ reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4920,
        "sentence": "@DRUG1$: Amphetamines may delay intestinal absorption of @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4921,
        "sentence": "Antacids and sucralfate: @DRUG1$ and @DRUG2$ containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4922,
        "sentence": "Such individuals are referred to as  poor metabolizers  of drugs such as @DRUG1$, dextromethorphan, and the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4923,
        "sentence": "Drug Interaction with Fluoxetine: A multiple-dose study was conducted to assess the effect of @DRUG1$ 20 mg BID on the pharmacokinetics of @DRUG2$ 2 mg QHS after seven days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4924,
        "sentence": "Although @DRUG1$ may increase the bioavailability of @DRUG2$ by increasing gastric emptying, metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4925,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4926,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG1$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4927,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4928,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, @DRUG1$, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4929,
        "sentence": "@DRUG1$: The mean steady-state trough serum @DRUG2$ concentrations prior to and during concomitant gabapentin administration (400 mg TID;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4930,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4931,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4932,
        "sentence": "Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning @DRUG1$ therapy should be monitored forevidence of withdrawal and @DRUG2$ dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4933,
        "sentence": "@DRUG1$ (20 mg QD) increased the concentration of @DRUG2$ (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4934,
        "sentence": "Phospholine Iodide potentiates other cholinesterase inhibitors such as succinylcholine or @DRUG-DRUG$s.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4935,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4936,
        "sentence": "Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. @DRUG1$ maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and @DRUG2$ dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4937,
        "sentence": "Quinolone Antibiotics: @DRUG1$ should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing @DRUG2$, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4938,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4939,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4940,
        "sentence": "The oral @DRUG1$ doses should be reduced by approximately 50% when coadministered with @DRUG2$, to achieve exposures of dexamethasone similar to those obtained when it is given without Aprepitant.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4941,
        "sentence": "@DRUG1$ and Ketoconazole: @DRUG2$ and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4942,
        "sentence": "@DRUG1$: Concomitant administration of aluminum and @DRUG2$s does not interfere with absorption of meclofenamate sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4943,
        "sentence": "Antacids and sucralfate: Sucralfate and @DRUG1$ containing magnesium or @DRUG2$, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4944,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4945,
        "sentence": "While it is not known whether this interaction occurs with fibrates other than gemfibrozil, myopathy and rhabdomyolysis have occasionally been associated with the use of @DRUG1$ alone, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4946,
        "sentence": "@DRUG1$: Chlorpropamides plasma half-life may be prolonged by allopurinol, since @DRUG2$ and chlorpropamide may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4947,
        "sentence": "@DRUG1$: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either @DRUG2$ or venlafaxine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4948,
        "sentence": "@DRUG1$ may increase the action of tricyclics, amphetamines, @DRUG2$, and quinidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4949,
        "sentence": "@DRUG1$: The concomitant administration of @DRUG2$ has no apparent effect on the extent of absorption of Lodine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4950,
        "sentence": "In patients who have been reported to be well controlled on @DRUG1$ receiving concurrent cimetidine therapy, discontinuation of cimetidine has been reported to decrease established steady-state serum @DRUG2$ levels and compromise their therapeutic effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4951,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4952,
        "sentence": "@DRUG1$ may have life-threatening interactions with @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4953,
        "sentence": "@DRUG1$ increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of @DRUG2$ by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4954,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, @DRUG1$, and the @DRUG2$ propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4955,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4956,
        "sentence": "The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other @DRUG1$, anticonvulsants, @DRUG2$, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4957,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, @DRUG2$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4958,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4959,
        "sentence": "Caution should be observed when anileridine is coadministered with other opioids, sedatives, @DRUG1$, or @DRUG2$, as these agents may increase respiratory and circulatory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4960,
        "sentence": "Heparin: Since heparin is contraindicated in patients with @DRUG1$-induced thrombocytopenia, the co-administration of Argatroban and @DRUG2$ is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4961,
        "sentence": "The concomitant use of transdermal fentanyl with @DRUG1$ or other potent 3A4 inhibitors such as @DRUG2$, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4962,
        "sentence": "@DRUG1$: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with @DRUG2$ 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and paroxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4963,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of @DRUG1$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG2$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4964,
        "sentence": "Adenosine: @DRUG1$ has been reported to increase the plasma levels and cardiovascular effects of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4965,
        "sentence": "Although the mechanism of interaction between @DRUG1$ and @DRUG2$ is not totally known, enzyme induction and displacement of fenoprofen from plasma albumin binding sites are possibilities.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4966,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, @DRUG2$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4967,
        "sentence": "@DRUG1$ may also interact with @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4968,
        "sentence": "In vivo studies: @DRUG1$: The blood pressure lowering effects of sublingual @DRUG2$ (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4969,
        "sentence": "If antacids are required during @DRUG1$ therapy, @DRUG2$ should be taken at least 2 hours before or after the antacid.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4970,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG1$ (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4971,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4972,
        "sentence": "@DRUG1$ (NSAIDS): Concomitant use of aspirin (or other nonsteroidal antiinflammatory agents) and @DRUG2$ increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4973,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with @DRUG1$ (alcohol, barbiturates, @DRUG2$, sedatives, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4974,
        "sentence": "@DRUG1$: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, @DRUG2$, carbamazepine, or phenobarbital) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4975,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4976,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4977,
        "sentence": "Warfarin: Multiple oral doses of Sonata (20 mg q24h for 13 days) did not affect the pharmacokinetics of @DRUG1$ (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4978,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4979,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4980,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4981,
        "sentence": "@DRUG1$: Concomitant administration of TORADOL ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in @DRUG2$ plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4982,
        "sentence": "Phenytoin, @DRUG1$ and @DRUG2$ are ge nerally classified as enzyme inducers;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4983,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG1$, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4984,
        "sentence": "Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4985,
        "sentence": "injection of vehicle (corn oil, 0.1 mL/day), @DRUG1$ (10 microg/kg/day or 4 mg/kg/day) and/or @DRUG2$ (20 mg/kg/day), for eight days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4986,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG1$, grapefruit juice, nefazadone, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4987,
        "sentence": "Therefore the, combination of anakinra with other @DRUG1$, including @DRUG2$, may also result i n similar toxicities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4988,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG2$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4989,
        "sentence": "@DRUG1$: When @DRUG2$ (100 mg qd) and alprazolam (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of alprazolam were approximately twice those observed when alprazolam was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4990,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4991,
        "sentence": "For a 4-fold range of @DRUG1$ doses there were no differential effects on @DRUG2$ dosing or pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4992,
        "sentence": "The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, @DRUG1$, @DRUG2$ or other antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4993,
        "sentence": "Certain other antibiotics (@DRUG1$ and @DRUG2$) have also been reported to interfere with the nerve transmission at the neuromuscular junction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4994,
        "sentence": "Alprazolam: When @DRUG1$ (100 mg qd) and alprazolam (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of alprazolam were approximately twice those observed when @DRUG2$ was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4995,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. @DRUG1$ antiarrhythmic agents of class (e.g. @DRUG2$), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4996,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, @DRUG2$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4997,
        "sentence": "Possible extrarenal mechanisms of action of @DRUG1$ on verografine and @DRUG2$ transport were also examined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4998,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4999,
        "sentence": "Sirolimus works differently from the @DRUG1$ currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with cyclosporine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5000,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5001,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, @DRUG1$, phenobarbital or phenytoin), the concomitant use of @DRUG2$ may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5002,
        "sentence": "- @DRUG1$: Pretreatment with @DRUG2$ reduces both the natriuresis and hyperreninemia produced by bumetanide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5003,
        "sentence": "Antacids: Concomitant administration of @DRUG1$s does not interfere with absorption of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5004,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5005,
        "sentence": "Furthermore, rifampin, phenytoin, @DRUG1$, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5006,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin and @DRUG2$ may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5007,
        "sentence": "Immunosuppressive Drugs, Fibric Acid Derivatives, @DRUG1$ (@DRUG2$, Erythromycin, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5008,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5009,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: Cyclosporine (CYP3A4 substrate) administered in combination with oral @DRUG1$ has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5010,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered @DRUG1$, periodic serum level determinations of these drugs may be necessary (eg, @DRUG2$ may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5011,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG1$(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5012,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, @DRUG1$ and omeprazole) is likely to reduce @DRUG2$ exposure.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5013,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, @DRUG1$ (niacin), tolbutamide, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5014,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, isosorbide dinitrate, @DRUG2$, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5015,
        "sentence": "Plasma @DRUG1$ concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5016,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing @DRUG1$ to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of @DRUG2$ of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5017,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with @DRUG1$ because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, @DRUG2$, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5018,
        "sentence": "Several clinically important interactions have previously been reported for other @DRUG1$ that are metabolized by the same enzyme and for @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5019,
        "sentence": "In this study we investigated the effect of @DRUG1$ on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers nimodipine (L-type), omega-conotoxin GVIA (N-type), or @DRUG2$ (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5020,
        "sentence": "Amphotericin B or Corticosteroids or @DRUG1$ (@DRUG2$)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5021,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG1$, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5022,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with @DRUG1$, with metal cations such as iron, or with multivitamins containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5023,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG2$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5024,
        "sentence": "In clinical studies, coadministration of WelChol  with @DRUG1$, lovastatin, or simvastatin did not interfere with the lipid-lowering activity of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5025,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG2$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5026,
        "sentence": "and disulfiram When @DRUG1$ is given with anticholinergic agents or @DRUG2$ drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5027,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, @DRUG2$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5028,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing @DRUG1$ to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5029,
        "sentence": "@DRUG1$ may decrease renal tubular secretion of cephalosporins when used concurrently, resulting in increased and more prolonged @DRUG2$ blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5030,
        "sentence": "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS, @DRUG1$ AND @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5031,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5032,
        "sentence": "Additive depressant effect when used with general anesthetics, @DRUG1$, antianxiety drugs, hypnotics, alcohol, and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5033,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5034,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5035,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5036,
        "sentence": "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH @DRUG1$ SUCH AS @DRUG2$, NON-NARCOTIC ANALGESICS AND BARBITURATES.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5037,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$ and rifampin may increase the clearance of @DRUG2$ and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5038,
        "sentence": "Additive depressant effect when used with general anesthetics, sedatives, antianxiety drugs, hypnotics, @DRUG1$, and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5039,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5040,
        "sentence": "Thus, when @DRUG1$ and lithium are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5041,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5042,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5043,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5044,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: Cyclosporine (@DRUG1$ substrate) administered in combination with oral @DRUG2$ has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5045,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. @DRUG1$ antiarrhythmic agents of class (e.g. quinidine), @DRUG2$ antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5046,
        "sentence": "Other antiarrhythmic drugs (eg, quinidine, @DRUG1$, @DRUG2$, propranolol) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5047,
        "sentence": "@DRUG1$: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of @DRUG2$ and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5048,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, @DRUG1$, @DRUG2$, or phenobarbital) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5049,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5050,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5051,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, @DRUG1$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5052,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with @DRUG1$, with metal cations such as @DRUG2$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5053,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG2$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5054,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG2$, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5055,
        "sentence": "Administration of quinolones with antacids containing aluminum, @DRUG1$, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5056,
        "sentence": "@DRUG1$ is unlikely to have a significant effect on @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5057,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5058,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5059,
        "sentence": "@DRUG1$: Co-administration of bosentan 500 mg b.i.d. for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and @DRUG2$ (a CYP3A4 substrate) by 29 and 38%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5060,
        "sentence": "@DRUG1$: Nicotine may provoke vasoconstriction in some patients, predisposing to a greater ischemic response to @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5061,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5062,
        "sentence": "In vitro mixing of an aminoglycoside with beta-lactamtype @DRUG1$ (penicillins or @DRUG2$) may result in a significant mutual inactivation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5063,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5064,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5065,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG2$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5066,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5067,
        "sentence": "Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after @DRUG1$, increases the inhibitory effects of @DRUG2$, but does not exhibit monoamine oxidase inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5068,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG1$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5069,
        "sentence": "Concomitant administration of @DRUG1$ and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/@DRUG2$) resulted in greater gastrointestinal toxicity than when either drug was administered alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5070,
        "sentence": "Potassium-sparing diuretics (spironolactone, @DRUG1$, @DRUG2$, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5071,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of @DRUG1$ (e.g., spironolactone, @DRUG2$, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5072,
        "sentence": "The @DRUG1$ Cmax values were not significantly affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5073,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5074,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral @DRUG1$ produced minor changes in the pharmacokinetics of @DRUG2$, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5075,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar, ketamine, or droperidol but not after administration of @DRUG1$ alone or after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5076,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5077,
        "sentence": "In vitro studies have shown that the metabolism of @DRUG1$ may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as @DRUG2$, terfenadine, ketoconazole, erythromycin, and troleandomycin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5078,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, @DRUG2$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5079,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5080,
        "sentence": "Phenobarbital: @DRUG1$ may delay intestinal absorption of @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5081,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5082,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5083,
        "sentence": "@DRUG1$, @DRUG2$, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5084,
        "sentence": "The extent to which @DRUG1$-@DRUG2$ interactions may pose clinical problems will depend on the degree of inhibition, and the pharmacokinetics of the SSRI involved.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5085,
        "sentence": "Other TNFa-blocking agents (including @DRUG1$) used in combination with @DRUG2$ may also result in similar toxicities.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5086,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5087,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5088,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5089,
        "sentence": "[Stimulation by @DRUG1$--an analog of the octapeptide cholecystokinin--of @DRUG2$ binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5090,
        "sentence": "and @DRUG1$ e.g., @DRUG2$), CYP1A2 inducers (omeprazole) and CYP1A2 inhibitors (furafylline and clarithromycin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5091,
        "sentence": "Drug-Drug Interactions @DRUG1$ - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other beta2 agonists) because the action of @DRUG2$ on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5092,
        "sentence": "Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, @DRUG1$, fluoxetine, or @DRUG2$) can inhibit aripiprazole elimination and cause increased blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5093,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5094,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5095,
        "sentence": "Concomitant administration of Norpace and @DRUG1$ resulted in slight increases in plasma @DRUG2$ levels and slight decreases in plasma quinidine levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5096,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that @DRUG1$ clearance is 60% greater in patients taking @DRUG2$ with or without other enzyme- inducing AEDs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5097,
        "sentence": "@DRUG1$ also has no significant effect on the intracellular phosphorylation of @DRUG2$, as shown in vitro in peripheral blood mononuclear cells or in two other cell lines (U937 and Molt-4).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5098,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5099,
        "sentence": "Studies in healthy volunteers have shown that @DRUG1$ has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, @DRUG2$, or ranitidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5100,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, @DRUG2$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5101,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG1$, famotidine, fluconazole, lamivudine, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5102,
        "sentence": "In addition, under the influence of sympatholytic medicinal products such as @DRUG1$, clonidine, @DRUG2$, and reserpine, the signs of hypoglycemia may be reduced or absent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5103,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5104,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5105,
        "sentence": "@DRUG1$: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5106,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5107,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of @DRUG1$ and other oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5108,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that @DRUG1$ clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5109,
        "sentence": "Specific and aspecific treatments of @DRUG1$ depletion are tricky using for example @DRUG2$, pharmacological doses of vitamin B6, physiological doses of vitamin D and of selenium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5110,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5111,
        "sentence": "Since bacteriostatic drugs may interfere with the bactericidal action of @DRUG1$, it is advisable to avoid giving @DRUG2$ in conjunction with penicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5112,
        "sentence": "No interaction with the tricyclic antidepressant @DRUG1$ was shown in a single-dose study with entacapone without coadministered @DRUG2$/dopa-decarboxylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5113,
        "sentence": "Ventricular tachycardia induced by @DRUG1$ was generally converted to sinus rhythm following administration of @DRUG2$, ketamine, or droperidol but not after administration of fentayl alone or after pentobarbital.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5114,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5115,
        "sentence": "@DRUG1$ should not be administered concomitantly with potent loop diuretics such as furosemide and @DRUG2$ as the potential for ototoxicity is enhanced by the combination.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5116,
        "sentence": "With oral @DRUG1$ treatment, @DRUG2$ such as pyrimethamine have been noted to possibly increase the likelihood of hematologic reactions",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5117,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG1$, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5118,
        "sentence": "@DRUG1$: Concomitant administration of TORADOL ORAL and probenecid resulted in decreased clearance of @DRUG2$ and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5119,
        "sentence": "Because of the low dietary @DRUG1$ concentration as compared to the iron contents of the diets, no effect of cobalt on @DRUG2$ absorption and excretion occurred.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5120,
        "sentence": "No significant interactions with @DRUG1$, @DRUG2$, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5121,
        "sentence": "Thus, when NSAIDs and @DRUG1$ are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5122,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG2$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5123,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5124,
        "sentence": "When @DRUG1$ HCl is administered concomitantly with an @DRUG2$, the risk of hyperkalemia may be increased.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5125,
        "sentence": "Interactions between treatments with @DRUG1$, bishydroxycoumarin (an @DRUG2$), trichlorfon (an organophosphorous compound), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5126,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5127,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5128,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, @DRUG2$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5129,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5130,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5131,
        "sentence": "A smaller 24-week study has suggested nevirapine may be superior to the @DRUG1$ @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5132,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG1$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5133,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5134,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5135,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (@DRUG2$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5136,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5137,
        "sentence": "@DRUG1$ may decrease thyroidal uptake of sodium iodide I131, a rebound in uptake may occur up to 5 days after sudden withdrawal of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5138,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5139,
        "sentence": "However, appropriate monitoring of blood glucose should be performed when initiating @DRUG1$ in diabetic patients and @DRUG2$ dosage should be adjusted if needed.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5140,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5141,
        "sentence": "Interactions between treatments with coumaphos, @DRUG1$ (an anticoagulant), trichlorfon (an organophosphorous compound), and @DRUG2$ (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5142,
        "sentence": "Therefore, patients receiving @DRUG1$ will have erroneously low ERPF and Tm @DRUG2$ values.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5143,
        "sentence": "Drugs that may decrease @DRUG1$ plasma concentrations: Substances that are inducers of CYP3A4 activity may increase metabolism and decrease @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5144,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5145,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5146,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by @DRUG1$ or proton pump inhibitors (eg, @DRUG2$ and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5147,
        "sentence": "Warfarin, Digoxin, @DRUG1$, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by @DRUG2$ (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5148,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (corticosteroids, cyclosporin, @DRUG1$, @DRUG2$, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5149,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5150,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG2$, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5151,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG1$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5152,
        "sentence": "Amphotericin B or @DRUG1$ or @DRUG2$ (ACTH)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5153,
        "sentence": "Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of @DRUG1$/@DRUG2$) resulted in greater gastrointestinal toxicity than when either drug was administered alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5154,
        "sentence": "@DRUG1$: @DRUG2$ may increase the serum concentration of selegiline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5155,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of @DRUG1$ were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, carbamazepine, or @DRUG2$) than in healthy volunteers.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5156,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5157,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5158,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5159,
        "sentence": "@DRUG1$ pretreatment augmented the depressant effect of alcohol on the early components P1 and N1, while attenuating @DRUG2$'s influence on components P2 and P3.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5160,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG1$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5161,
        "sentence": "Some @DRUG1$, including @DRUG2$, have been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5162,
        "sentence": "When initiating a multi-day course of grepafloxacin in a patient maintained on theophylline, the theophylline maintenance dose should be halved for the period of concurrent use of @DRUG1$ and monitoring of serum @DRUG2$ concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5163,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., @DRUG2$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5164,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5165,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5166,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5167,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5168,
        "sentence": "There have been reports of @DRUG1$-related side effects in patients on concomitant therapy with quinolones and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5169,
        "sentence": "Use of @DRUG1$ with potassium-sparing diuretics (e.g., @DRUG2$, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5170,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5171,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, @DRUG1$, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5172,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5173,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5174,
        "sentence": "Oral @DRUG1$ Interaction studies with @DRUG2$ and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5175,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG1$ (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5176,
        "sentence": "@DRUG1$: @DRUG2$ is a competitive inhibitor of the metabolism of theophylline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5177,
        "sentence": "Cimetidine, @DRUG1$: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect @DRUG2$ pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5178,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of @DRUG1$, interfere with the metabolism of caffeine, and enhance the effects of the oral @DRUG2$ warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5179,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, phenobarbital, @DRUG1$, @DRUG2$): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5180,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG1$, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5181,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5182,
        "sentence": "@DRUG1$: @DRUG2$, tacrolimus, sirolimus",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5183,
        "sentence": "Coadministration of oral contraceptives, diazepam, @DRUG1$, or quinidine did not seem to change the pharmacokinetic profile of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5184,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5185,
        "sentence": "d-amphetamine with @DRUG1$ or @DRUG2$ and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5186,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5187,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5188,
        "sentence": "@DRUG1$, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of @DRUG2$ resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5189,
        "sentence": "Although there was no effect of @DRUG1$ on the plasma AUC of R(+) or S(-) warfarin determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5190,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5191,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5192,
        "sentence": "Concomitant treatment with methylxanthines (aminophylline, theophylline), @DRUG1$, or diuretics may potentiate any hypokalemic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5193,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG1$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5194,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5195,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG1$, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5196,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5197,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG1$ containing @DRUG2$ or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5198,
        "sentence": "@DRUG1$ inhibited @DRUG2$ phosphorylation at high concentration ratios (10 and 100);",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5199,
        "sentence": "Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when @DRUG1$ was given concomitantly with @DRUG2$ or spironolactone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5200,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG1$, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5201,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and @DRUG1$ (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas @DRUG2$ binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5202,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5203,
        "sentence": "SSRIs: Weakness hyperreflexia, and incoordination have been reported rarely when @DRUG1$ have been co-administered with @DRUG2$ (e. g.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5204,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of @DRUG1$ with @DRUG2$, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5205,
        "sentence": "Known drug interactions include @DRUG1$, tranquilizers, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5206,
        "sentence": "Concomitant treatment with methylxanthines (@DRUG1$, theophylline), steroids, or @DRUG2$ may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5207,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5208,
        "sentence": "Nevertheless, the prothrombin time or other suitable coagulation test should be monitored when @DRUG1$ or its derivatives and @DRUG2$ are given concomitantly.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5209,
        "sentence": "Similarly, the effects of @DRUG1$ on @DRUG2$, valproic acid and sodium plasma valproate concentrations are unpredictable",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5210,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and @DRUG1$, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5211,
        "sentence": "@DRUG1$: CELEBREX can be used with low dose @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5212,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5213,
        "sentence": "Concomitant treatment with @DRUG1$ (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5214,
        "sentence": "Administration of @DRUG1$ with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, @DRUG2$ 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5215,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of @DRUG1$ (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (@DRUG2$ ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5216,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG1$, @DRUG2$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5217,
        "sentence": "After prolonged administration of @DRUG1$ the displacing effect of @DRUG2$, an analog of cholecystokinin octapeptide, was replaced by the stimulant action on 3H-spiroperidol binding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5218,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG1$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5219,
        "sentence": "This drug may interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5220,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, hydrochlorothiazide, cimetidine, @DRUG2$, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5221,
        "sentence": "@DRUG1$ may enhance the toxicity of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5222,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5223,
        "sentence": "When coadministered with SUSTIVA in treatment-naive patients, the recommended dose of @DRUG1$ is 300 mg with ritonavir 100 mg and @DRUG2$ 600 mg (all once daily).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5224,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG1$ may result in increased CNS depressant effects), divalproex sodium, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5225,
        "sentence": "Co-administration of tacrolimus and @DRUG1$ resulted in markedly increased plasma concentrations of @DRUG2$ in animals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5226,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5227,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG1$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5228,
        "sentence": "Because oral anticoagulants may interfere with the hepatic metabolism of @DRUG1$, toxic levels of the anticonvulsant may occur when an oral anticoagulant and @DRUG2$ are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5229,
        "sentence": "@DRUG1$ such as @DRUG2$, triamterene, or amiloride, or potassium supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5230,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5231,
        "sentence": "Concurrent administration of indinavir and @DRUG1$ significantly reduces the level of exposure to @DRUG2$, but it is unclear how soon after didanosine administration indinavir may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5232,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5233,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5234,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of @DRUG1$ binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and @DRUG2$ (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5235,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG1$, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5236,
        "sentence": "Phenobarbital: @DRUG1$ may delay intestinal absorption of @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5237,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5238,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5239,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5240,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5241,
        "sentence": "Catecholamine-depleting drugs (eg, @DRUG1$) may have an additive effect when given with @DRUG2$s.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5242,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5243,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5244,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5245,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5246,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG2$, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5247,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5248,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5249,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5250,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of @DRUG1$, ketoconazole, methotrexate, phenytoin, tolbutamide, and @DRUG2$ have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5251,
        "sentence": "Certain drugs, including @DRUG1$ (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5252,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5253,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5254,
        "sentence": "In patients who have been reported to be well controlled on @DRUG1$ receiving concurrent cimetidine therapy, discontinuation of @DRUG2$ has been reported to decrease established steady-state serum tricyclic antidepressant levels and compromise their therapeutic effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5255,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, @DRUG1$, methyldopa, nicotinic acid (niacin), tolbutamide, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5256,
        "sentence": "Alcohol: It should be borne in mind that @DRUG1$ ingestion may increase the danger inherent in any intentional or unintentional @DRUG2$ overdosage.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5257,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5258,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5259,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5260,
        "sentence": "Pharmacokinetic interactions between nisoldipine and beta-blockers (@DRUG1$, @DRUG2$) were variable and not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5261,
        "sentence": "It was concluded that, although @DRUG1$ did augment the neuromuscular blockade of @DRUG2$, the effect was minimal.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5262,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, @DRUG1$, clofibrate, @DRUG2$, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5263,
        "sentence": "@DRUG1$, @DRUG2$, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5264,
        "sentence": "Methadone levels may be decreased; increased dosages may be required to prevent symptoms of @DRUG1$ withdrawal. Methadone maintained patients beginning @DRUG2$ therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5265,
        "sentence": "Quinolone Antibiotics: @DRUG1$ should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, @DRUG2$, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5266,
        "sentence": "Furthermore, rifampin, @DRUG1$, @DRUG2$, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5267,
        "sentence": "@DRUG1$ (e. g., charcoal) and @DRUG2$ containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5268,
        "sentence": "AIMS/HYPOTHESIS: There is evidence that @DRUG1$ and @DRUG2$ cause renal and ocular vasodilation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5269,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, @DRUG1$, sulfonamides, chloramphenicol, @DRUG2$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5270,
        "sentence": "- a beta-blocker such as @DRUG1$ (Inderal), atenolol (Tenormin), acebutolol (Sectral), metoprolol (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5271,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, @DRUG1$, @DRUG2$, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5272,
        "sentence": "Both @DRUG1$ and @DRUG2$ are sequestered in fat and, like ibogaine, 18-MC probably has an active metabolite.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5273,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and @DRUG2$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5274,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5275,
        "sentence": "Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular @DRUG1$ and @DRUG2$ in rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5276,
        "sentence": "When initiating a multi-day course of @DRUG1$ in a patient maintained on theophylline, the theophylline maintenance dose should be halved for the period of concurrent use of @DRUG2$ and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5277,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG1$ and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5278,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (@DRUG1$, @DRUG2$, azathioprine, methotrexate, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5279,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: @DRUG2$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5280,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, @DRUG1$, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5281,
        "sentence": "Caution should be observed when anileridine is coadministered with other @DRUG1$, @DRUG2$, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5282,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of @DRUG1$]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5283,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with @DRUG1$ (@DRUG2$, barbiturates, opiates, sedatives, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5284,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5285,
        "sentence": "@DRUG1$ or Primidone : No formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing @DRUG2$ or primidone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5286,
        "sentence": "Pharmacokinetic interaction studies with @DRUG1$ in adults were conducted with @DRUG2$, antipyrine, ketoconazole, erythromycin and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5287,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5288,
        "sentence": "- a beta-blocker such as propranolol (@DRUG1$), atenolol (Tenormin), acebutolol (Sectral), metoprolol (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5289,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5290,
        "sentence": "Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an @DRUG1$ or @DRUG2$ potentiated the risk of bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5291,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5292,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5293,
        "sentence": "In seven experiments reactions to norepinephrine and @DRUG1$ were @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5294,
        "sentence": "Patients on oral @DRUG1$ receiving VELCADE treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5295,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other opioids, general anesthetics, @DRUG2$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5296,
        "sentence": "Potassium Supplements and @DRUG1$ Lotensin can attenuate potassium loss caused by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5297,
        "sentence": "This drug may interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or @DRUG2$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5298,
        "sentence": "@DRUG1$ dose should not exceed a maximum of 2.5 mg in a 24-hour period in patients receiving concomitant @DRUG2$ therapy.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5299,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG1$, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5300,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general @DRUG1$, @DRUG2$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5301,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing @DRUG1$ or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5302,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: @DRUG1$ (@DRUG2$ substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5303,
        "sentence": "@DRUG1$: @DRUG2$ may inhibit both synthetic and catabolic enzymes of vitamin D.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5304,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5305,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, @DRUG2$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5306,
        "sentence": "WelChol  decreased the Cmax and AUC of sustained-release @DRUG1$ (@DRUG2$ ) by approximately 31% and 11%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5307,
        "sentence": "Therefore, when @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5308,
        "sentence": "Since @DRUG1$ may raise the serum uric acid level, dosage adjustment of @DRUG2$ may be necessary",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5309,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5310,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, @DRUG2$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5311,
        "sentence": "When Bezalip or @DRUG1$ is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5312,
        "sentence": "Coadministration of @DRUG1$ with these drugs or other drugs that are known to be metabolized by CYP2C9, such as @DRUG2$, may result in lower plasma concentrations of these drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5313,
        "sentence": "@DRUG1$ and oral retinoids: Concomitant administration of @DRUG2$ and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5314,
        "sentence": "Antacids or @DRUG1$: When dirithromycin is administered immediately following @DRUG2$ or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5315,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5316,
        "sentence": "Inhibitors or substrates of CYP2D6 (i.e., quinidine, @DRUG1$ [SSRIs]) may increase the plasma concentration of @DRUG2$ when administered concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5317,
        "sentence": "Several tricyclic antidepressants have been reported to block the pharmacologic effects of @DRUG1$, clonidine, or similar agents, and such an effect may be anticipated with @DRUG2$ because of its structural similarity to other tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5318,
        "sentence": "Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma @DRUG1$ and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5319,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5320,
        "sentence": "Rifampicin: In a study in healthy volunteers, a six-day course of @DRUG1$ at 600 mg/day followed by a single 5 mg dose of @DRUG2$ resulted in a reduction in isradipine levels to below detectable limits.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5321,
        "sentence": "- Phenytoin (e.g., @DRUG1$) Use of @DRUG2$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5322,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5323,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG1$, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5324,
        "sentence": "Repeated oral administration of coumaphos in sheep: interactions of @DRUG1$ with bishydroxycoumarin, trichlorfon, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5325,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG1$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5326,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG1$, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5327,
        "sentence": "@DRUG1$: In the presence of cimetidine at 300 mg QID (N=12) the mean apparent oral clearance of @DRUG2$ fell by 14% and creatinine clearance fell by 10%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5328,
        "sentence": "It is desirable to monitor @DRUG1$plasma levels whenever an agent of the tricyclic antidepressant class including @DRUG2$ is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5329,
        "sentence": "Repeated oral administration of coumaphos in sheep: interactions of @DRUG1$ with @DRUG2$, trichlorfon, and phenobarbital sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5330,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5331,
        "sentence": "@DRUG1$: Cerivastatin plasma concentrations were not affected by co-administration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5332,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5333,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, @DRUG2$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5334,
        "sentence": "Many people use both @DRUG1$ and @DRUG2$ (i.e., cigarettes and other tobacco products).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5335,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, @DRUG1$, phenobarbital or @DRUG2$), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5336,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5337,
        "sentence": "Carbamazepine: Coadministration of carbamazepine (200 mg BID), a potent CYP3A4 inducer, with @DRUG1$ (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both @DRUG2$ and its active metabolite, dehydro-aripiprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5338,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with @DRUG1$, a reduction in dosage of PRECEDEX on the concomitant anesthetic, sedative, hypnotic or @DRUG2$ may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5339,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5340,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG1$ [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5341,
        "sentence": "These include probenecid, @DRUG1$, and some @DRUG2$ (e.g. erythromycin, rifamipicin, ampicillin and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5342,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5343,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5344,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including @DRUG1$) concomitantly with hydrocodone and @DRUG2$ tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5345,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5346,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, @DRUG2$, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5347,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5348,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5349,
        "sentence": "Drugs That Inhibit CYP3A4 CYP3A4 is a minor metabolic pathway for the elimination of @DRUG1$ because the sum of desethylzaleplon (formed via CYP3A4 in vitro) and its metabolites, 5-oxo-desethylzaleplon and @DRUG2$, account for only 9% of the urinary recovery of a zaleplon dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5350,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5351,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5352,
        "sentence": "@DRUG1$: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5353,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, clofibrate, @DRUG1$, nicotinic acid (niacin), tolbutamide, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5354,
        "sentence": "The concomitant use of beta-adrenergic blocking agents with @DRUG1$ and @DRUG2$s may have additive effects on prolonging atrioventricular conduction time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5355,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: @DRUG2$, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5356,
        "sentence": "In a study in diabetics with microalbuminuria @DRUG1$ 200 mg combined with the ACE inhibitor @DRUG2$ 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on enalapril alone to 38%.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5357,
        "sentence": "@DRUG1$ such as spironolactone, @DRUG2$, or amiloride, or potassium supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5358,
        "sentence": "Combination @DRUG1$ may also decrease the plasma concentration of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5359,
        "sentence": "Effects of @DRUG1$ on Felbatol  The coadministration of @DRUG2$ (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax, Cmin, AUC, CI/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5360,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, @DRUG1$, pyrilamine, @DRUG2$, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5361,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5362,
        "sentence": "@DRUG1$ - Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of @DRUG2$, a CYP3A4 substrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5363,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5364,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5365,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, @DRUG1$, the @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5366,
        "sentence": "No interaction with the tricyclic antidepressant @DRUG1$ was shown in a single-dose study with @DRUG2$ without coadministered levodopa/dopa-decarboxylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5367,
        "sentence": "While all the selective serotonin reuptake inhibitors (@DRUG1$), e.g., @DRUG2$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5368,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5369,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5370,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5371,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG2$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5372,
        "sentence": "In the experiments reported here, we examined the interactions between 1,25(OH)2D3 and the @DRUG1$ @DRUG2$ (TAM), which also induces apoptosis in MCF-7 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5373,
        "sentence": "When given concomitantly with @DRUG1$, the @DRUG2$ blood concentration should be followed and the tacrolimus dose may need to be adjusted.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5374,
        "sentence": "@DRUG1$ tablets may alter the metabolism of @DRUG2$, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5375,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5376,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with @DRUG1$ because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing @DRUG2$, calcium, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5377,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5378,
        "sentence": "As with other @DRUG1$, high concentrations of @DRUG2$ may interfere with measurement of serum and urine creatinine levels by Jaffe  reaction and produce false increases in the levels of creatinine reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5379,
        "sentence": "Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., @DRUG1$, @DRUG2$) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5380,
        "sentence": "In patients taking furosemide, @DRUG1$, diltiazem, ACE inhibitors, @DRUG2$, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5381,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, @DRUG2$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5382,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, @DRUG2$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5383,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5384,
        "sentence": "Antiepileptic Drugs: Sporadic cases of seizures have been reported during concomitant use of @DRUG1$ and antiepileptic drugs (@DRUG2$, carbamazepine).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5385,
        "sentence": "Probenecid: Concomitant administration of @DRUG1$ ORAL and probenecid resulted in decreased clearance of @DRUG2$ and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5386,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5387,
        "sentence": "(See CLINICAL PHARMACOLOGY) Coadministration of @DRUG1$ and @DRUG2$ 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5388,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG1$ other than @DRUG2$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5389,
        "sentence": "Immunosuppressants: @DRUG1$, tacrolimus, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5390,
        "sentence": "Because prostaglandina play an important role in hemostasis and ketoprofen has an effect on platelet function as well, concurent therapy with @DRUG1$ and @DRUG2$ requires close monitoring of patients on both drugs.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5391,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5392,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5393,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5394,
        "sentence": "With oral dapsone treatment, @DRUG1$ such as @DRUG2$ have been noted to possibly increase the likelihood of hematologic reactions",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5395,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG2$), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5396,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG1$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5397,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5398,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., @DRUG1$, carbamazepine, @DRUG2$) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5399,
        "sentence": "Caution in using concomitant drugs such as @DRUG1$ (ophthalmic and systemic), @DRUG2$ and/or cardiac glycosides is advised.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5400,
        "sentence": "@DRUG1$ doses of up to 300 mg b.i.d. have been safely used concomitantly with sustained-release calcium channel blockers (sustained-release @DRUG2$) with no clinically significant adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5401,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG1$, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5402,
        "sentence": "If @DRUG1$ is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of @DRUG2$ massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5403,
        "sentence": "Coumarin Anticoagulants: In a small clinical trial in which @DRUG1$ was administered to @DRUG2$ treated patients, no effect on prothrombin time was detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5404,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5405,
        "sentence": "Results from human in vitro metabolism studies and nonclinical studies show that @DRUG1$  (@DRUG2$) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that lenalidomide is not likely to cause or be subject to P450-based metabolic drug interactions in man.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5406,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5407,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG1$), procarbazine (e.g., Matulane), @DRUG2$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5408,
        "sentence": "An intravenous dose of 50 mg @DRUG1$ was in respect of competitive suppression of organs actively concentrating pertechnetate as effective as intravenous 1000 mg ClO-4- simultaneously or 1000 mg orally 30 min before the injection of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5409,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5410,
        "sentence": "@DRUG1$/Sedatives/Hypnotics/@DRUG2$: Co-administration of PRECEDEX with anesthetics, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5411,
        "sentence": "Therefore, intake of supplemental @DRUG1$ should not exceed 1000 micrograms ( g, sometimes mcg) per day to prevent @DRUG2$ from masking symptoms of vitamin B12 deficiency.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5412,
        "sentence": "In a placebo-controlled trial in normal volunteers, the administration of a single 1 mg dose of @DRUG1$ on day 1 of a four-day regimen of oral @DRUG2$ (400 mg twice daily) resulted in a 10% increase in mean AUC of doxazosin (p=0.006), and a slight but not statistically significant increase in mean Cmax and mean half-life of doxazosin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5413,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5414,
        "sentence": "Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, @DRUG1$ 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of @DRUG2$ ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5415,
        "sentence": "Since @DRUG1$ is coadministered with ritonavir, the @DRUG2$ label should be reviewed for additional drugs that should not be coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5416,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5417,
        "sentence": "Potassium-sparing diuretics (spironolactone, @DRUG1$,@DRUG2$, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5418,
        "sentence": "Since @DRUG1$ may reduce pulse and blood pressure, caution in using drugs such as beta-blockers (ophthalmic and systemic), antihypertensives, and @DRUG2$ is advised.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5419,
        "sentence": "No interaction with the @DRUG1$ imipramine was shown in a single-dose study with entacapone without coadministered levodopa/@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5420,
        "sentence": "Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of @DRUG1$ (a @DRUG2$ similar to chlorpropamide) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5421,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an @DRUG1$ and @DRUG2$ containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5422,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5423,
        "sentence": "In view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by @DRUG1$, the physician may wish to withhold diuretics during dosing with @DRUG2$ and, certainly, during periods of active vomiting or diarrhea.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5424,
        "sentence": "If chlorprothixene is given concomitantly with @DRUG1$, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of @DRUG2$ massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5425,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5426,
        "sentence": "@DRUG1$ or @DRUG2$ : No formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5427,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5428,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5429,
        "sentence": "Talk to your doctor if you are taking certain @DRUG1$ such as @DRUG2$, clarithromycin or azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5430,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX on the concomitant @DRUG1$, sedative, @DRUG2$ or opioid may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5431,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5432,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5433,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG1$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5434,
        "sentence": "Cyclosporine: Elevated serum levels of @DRUG1$ have been reported with concomitant use of cyclosporine with other members of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5435,
        "sentence": "@DRUG1$ (@DRUG2$,porpranolol,timolol) may exacerbate rebound hypertension when guanfacine is withdrawn.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5436,
        "sentence": "- a beta-blocker such as @DRUG1$ (Inderal), @DRUG2$ (Tenormin), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5437,
        "sentence": "Phenothiazines and @DRUG1$ may reduce or reverse the pressor effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5438,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG1$, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5439,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG1$, lovastatin, bromocriptine, valproate, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5440,
        "sentence": "Coadministration of @DRUG1$ and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, @DRUG2$, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5441,
        "sentence": "As with other agents with b-blocking properties, if COREG is to be administered orally with @DRUG1$ of the verapamil or @DRUG2$ type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5442,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and @DRUG1$ containing antacid (Maalox ) decreased @DRUG2$ AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5443,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG2$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5444,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other @DRUG2$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5445,
        "sentence": "@DRUG1$: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to @DRUG2$) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5446,
        "sentence": "Evoked hind limb digital extensor tension (hoof twitch) was maintained at 40% of baseline for 1 h by @DRUG1$ infusion in 7 horses anaesthetised with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5447,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5448,
        "sentence": "Several @DRUG1$ have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5449,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5450,
        "sentence": "Caution should be observed when @DRUG1$ is coadministered with other opioids, sedatives, phenothiazines, or @DRUG2$, as these agents may increase respiratory and circulatory depression.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5451,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG1$, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5452,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5453,
        "sentence": "Concomitant administration of FACTIVE and @DRUG1$, cimetidine, omeprazole, or an estrogen/@DRUG2$ oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5454,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG1$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5455,
        "sentence": "The absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies, @DRUG1$ or @DRUG2$ supplements.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5456,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG1$), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5457,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG1$, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5458,
        "sentence": "@DRUG1$: Ketoconazole has been reported to decrease the metabolism of certain @DRUG2$ by up to 60%, leading to increased risk of corticosteroid side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5459,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., @DRUG2$), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5460,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG2$, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5461,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5462,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5463,
        "sentence": "@DRUG1$: Coadministration of a single dose of zaleplon 10 mg and multiple doses of @DRUG2$ ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5464,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG1$, fluconazole, lamivudine, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5465,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG2$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5466,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5467,
        "sentence": "Repeated oral administration of coumaphos in sheep: interactions of coumaphos with @DRUG1$, trichlorfon, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5468,
        "sentence": "@DRUG1$: @DRUG2$ like other nonsteroidal anti-inflammatory drugs, has been shown to affect bleeding parameters in patients receiving anti-coagulants, and serious clinical bleeding has been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5469,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5470,
        "sentence": "@DRUG1$: Since @DRUG2$ is contraindicated in patients with heparin-induced thrombocytopenia, the co-administration of Argatroban and heparin is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5471,
        "sentence": "Thus, when VIOXX and @DRUG1$ are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5472,
        "sentence": "Such individuals are referred to as  poor metabolizers  of drugs such as debrisoquin, @DRUG1$, and the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5473,
        "sentence": "Since there have been conflicting results regarding the effect of digoxin levels, it is recommended that @DRUG1$ levels be monitored when initiating, adjusting, and discontinuing @DRUG2$ therapy to avoid possible over- or under-digitalization.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5474,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5475,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, @DRUG1$, and @DRUG2$) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5476,
        "sentence": "@DRUG1$ enhanced possibility of arrhythmias or @DRUG2$ toxicity associated with hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5477,
        "sentence": "Coadministration of oral @DRUG1$, diazepam, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5478,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG1$, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5479,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5480,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5481,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5482,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, @DRUG2$, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5483,
        "sentence": "The effect may be mediated by @DRUG1$s known inhibition of hepatic cytochrome P-450, the enzyme system responsible for the first-pass metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5484,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5485,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an @DRUG1$-sensitive (P-type) channel and nimodipine/@DRUG2$/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5486,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of @DRUG1$ are decreased when administered with antacids containing @DRUG2$, calcium, or aluminum.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5487,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5488,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG1$, probenecid, coumarins, @DRUG2$, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5489,
        "sentence": "@DRUG1$ such as spironolactone, triamterene, or amiloride, or @DRUG2$ supplements should be given only for documented hypokalemia, and then with caution, since they may lead to a significant increase of serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5490,
        "sentence": "No interaction with the tricyclic antidepressant @DRUG1$ was shown in a single-dose study with entacapone without coadministered levodopa/@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5491,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5492,
        "sentence": "Concomitant administration of diflunisal and @DRUG1$ in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of @DRUG2$/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5493,
        "sentence": "An adequate period of observation must be provided for any patient in whom either long-acting benzodiazepines (such as @DRUG1$) or large doses of short-acting benzodiazepines (such as  10 mg of @DRUG2$) have been used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5494,
        "sentence": "Clearance of hydrodolasetron decreased by about 27% when @DRUG1$ was administered intravenously concomitantly with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5495,
        "sentence": "In vitro studies have shown that the metabolism of @DRUG1$ may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, terfenadine, ketoconazole, @DRUG2$, and troleandomycin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5496,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG2$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5497,
        "sentence": "Caution should be observed when anileridine is coadministered with other opioids, @DRUG1$, phenothiazines, or @DRUG2$, as these agents may increase respiratory and circulatory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5498,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5499,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, @DRUG2$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5500,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5501,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5502,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other @DRUG1$, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and @DRUG2$), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5503,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG2$, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5504,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5505,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, @DRUG1$, phenytoin) may result in reduced plasma concentrations of @DRUG2$ that may result in decreased efficacy of Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5506,
        "sentence": "Drug/Laboratory Tests Interactions Because false positive readings were reported with the Ames N-Multistix SG dipstick test for urinary protein when @DRUG1$ was added to other @DRUG2$, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5507,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG2$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5508,
        "sentence": "Caution should be observed when @DRUG1$ is coadministered with other opioids, sedatives, @DRUG2$, or anesthetics, as these agents may increase respiratory and circulatory depression.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5509,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5510,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5511,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5512,
        "sentence": "@DRUG1$ significantly prolonged the half-life of @DRUG2$ to 26 hours.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5513,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5514,
        "sentence": "@DRUG1$ (Didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG2$, because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5515,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, @DRUG2$, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5516,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5517,
        "sentence": "Use of PRINIVIL with @DRUG1$ (e.g., spironolactone, triamterene, or @DRUG2$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5518,
        "sentence": "Iron Supplements and Foods Fortified With @DRUG1$ Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or @DRUG2$ supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5519,
        "sentence": "Since Zarontin (@DRUG1$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate @DRUG2$ serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5520,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG1$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5521,
        "sentence": "Reported examples of this interaction include the following: @DRUG1$s: @DRUG2$ (CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5522,
        "sentence": "- Probenecid: Pretreatment with @DRUG1$ reduces both the natriuresis and hyperreninemia produced by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5523,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, @DRUG1$, lamivudine, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5524,
        "sentence": "METHODS: Clinical studies, case reports, and commentaries and editorials concerning sildenafil published in the international literature between January 1999 and August 2000 were identified through searches of MEDLINE, PREMEDLINE, and International Pharmaceutical Abstracts, using the terms @DRUG1$, @DRUG2$, and erectile dysfunction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5525,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (@DRUG1$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5526,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, @DRUG2$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5527,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$. amantadine antiarrhythmic agents of class (e.g. quinidine), @DRUG2$ antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5528,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5529,
        "sentence": "@DRUG1$ has been found to temporarily raise serum concentrations of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5530,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5531,
        "sentence": "@DRUG1$ may potentially interfere with CYP2C19, the major @DRUG2$ metabolizing enzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5532,
        "sentence": "If @DRUG1$ are required during @DRUG2$ therapy, OMNICEF should be taken at least 2 hours before or after the supplement.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5533,
        "sentence": "@DRUG1$: Coadministration of @DRUG2$ (200 mg BID), a potent CYP3A4 inducer, with aripiprazole (30 mg QD) resulted in an approximate 70% decrease in Cmax and AUC values of both aripiprazole and its active metabolite, dehydro-aripiprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5534,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with @DRUG1$, nifedipine, propanolol, @DRUG2$, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5535,
        "sentence": "Do not mix @DRUG1$ and @DRUG2$ in the same syringe.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5536,
        "sentence": "Oral Anticoagulants: In some normal volunteers, the concomitant administration of diflunisal and @DRUG1$, acenocoumarol, or @DRUG2$ resulted in prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5537,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5538,
        "sentence": "If signs and symptoms suggestive of digoxin toxicity occur when @DRUG1$ and digoxin are given concomitantly, physicians are advised to obtain serum @DRUG2$ levels and adjust digoxin doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5539,
        "sentence": "As with other @DRUG1$, if COREG is to be administered orally with @DRUG2$ of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5540,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5541,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5542,
        "sentence": "Studies showed that @DRUG1$ increased the AUC of midazolam and @DRUG2$ by 3-4 fold and the Cmax by 2-fold, compared to placebo.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5543,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5544,
        "sentence": "Steroids enhance the renal toxicity of @DRUG1$ in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the @DRUG2$. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5545,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG2$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5546,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5547,
        "sentence": "@DRUG1$: In a study of healthy volunteers, chloroquine significantly reduced the bioavailability of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5548,
        "sentence": "Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after @DRUG1$ or after ethyl alcohol, increases the inhibitory effects of @DRUG2$, but does not exhibit monoamine oxidase inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5549,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5550,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5551,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5552,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG1$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5553,
        "sentence": "@DRUG1$: In the fed state, praziquantel (40 mg/kg) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5554,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG2$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5555,
        "sentence": "Caution should be observed when @DRUG1$ is coadministered with other opioids, @DRUG2$, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5556,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG1$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5557,
        "sentence": "Since @DRUG1$ is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5558,
        "sentence": "Effects of @DRUG1$ on Felbatol  The coadministration of erythromycin (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax, Cmin, AUC, CI/kg or tmax at @DRUG2$ daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5559,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5560,
        "sentence": "Phenobarbital or Primidone : No formal pharmacokinetic studies have been performed examining the addition of @DRUG1$ to regimens containing @DRUG2$ or primidone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5561,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5562,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, ACE inhibitors, verapamil, glyburide, @DRUG1$, and various chemotherapy agents, no effect was shown on the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5563,
        "sentence": "In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to @DRUG1$ given concomitantly with indomethacin, the use of @DRUG2$ was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5564,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5565,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5566,
        "sentence": "Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, quinidine, @DRUG1$, or paroxetine) can inhibit @DRUG2$ elimination and cause increased blood levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5567,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, @DRUG2$, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5568,
        "sentence": "Praziquantel: In the fed state, praziquantel (40 mg/kg) increased mean maximum plasma concentration and area under the curve of @DRUG1$ by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5569,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5570,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral @DRUG1$ supplementation which is totally atoxic since it palliates @DRUG2$ deficiencies by simply normalizing the magnesium intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5571,
        "sentence": "Nucleoside Analogues @DRUG1$ Co-administration of @DRUG2$ and didanosine is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5572,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5573,
        "sentence": "therefore, coadministration of @DRUG1$ with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5574,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG1$(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5575,
        "sentence": "The pharmacokinetic variables for digoxin were determined after a 1.0 mg intravenous dose of @DRUG1$ in each subject, before and after oral @DRUG2$, 400 mg daily for 3 weeks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5576,
        "sentence": "Because prostaglandina play an important role in hemostasis and @DRUG1$ has an effect on platelet function as well, concurent therapy with ketoprofen and @DRUG2$ requires close monitoring of patients on both drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5577,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG1$, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5578,
        "sentence": "@DRUG1$ increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of @DRUG2$ on Days 1 through 3.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5579,
        "sentence": "The actions of the benzodiazepines may be potentiated by barbiturates, @DRUG1$, phenothiazines, monoamine oxidase inhibitors or other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5580,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG1$ [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5581,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of @DRUG1$ with anesthetics, sedatives, @DRUG2$, and opioids is likely to lead to an enhancement of effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5582,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5583,
        "sentence": "Known drug interactions include barbiturates, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5584,
        "sentence": "@DRUG1$: Co-administration of tacrolimus and @DRUG2$ has not been studied in man.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5585,
        "sentence": "Amiodarone taken concomitantly with @DRUG1$ increases the serum @DRUG2$ concentration by 70% after one day.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5586,
        "sentence": "@DRUG1$: cyclosporine, tacrolimus, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5587,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5588,
        "sentence": "The concurrent administration of @DRUG1$ and @DRUG2$ increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving ampicillin alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5589,
        "sentence": "@DRUG1$ at 10(-10) M or @DRUG2$ at about 3 X 10(-9) M inhibits proliferation stimulated by EGF.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5590,
        "sentence": "Alprazolam: When @DRUG1$ (100 mg qd) and @DRUG2$ (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of alprazolam were approximately twice those observed when alprazolam was administered alone;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5591,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, @DRUG2$, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5592,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, @DRUG1$, or other @DRUG2$ (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5593,
        "sentence": "@DRUG1$: When @DRUG2$ and Maalox TC suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5594,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5595,
        "sentence": "Immunosuppressive Drugs, @DRUG1$, @DRUG2$ (Nicotinic Acid, Erythromycin, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5596,
        "sentence": "The effects @DRUG1$ on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, phenytoin, tolbutamide, and @DRUG2$ have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5597,
        "sentence": "@DRUG1$ should be used with caution in patients with creatinine clearance  50 mL/min and @DRUG2$ should not be administered to patients with creatinine clearance  50 mL/min",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5598,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5599,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. @DRUG1$ antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5600,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5601,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5602,
        "sentence": "Amphotericin, @DRUG1$, and Aminoglycosides: Drugs such as @DRUG2$, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5603,
        "sentence": "Although in vivo studies have not been done to see if @DRUG1$ clearance is changed by coadministration of @DRUG2$, it is not recommended that they be coadministered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5604,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5605,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, @DRUG1$, @DRUG2$, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5606,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5607,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5608,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, @DRUG1$, sulfinpyrazone, oral @DRUG2$, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5609,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (corticosteroids, @DRUG1$, @DRUG2$, methotrexate, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5610,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5611,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5612,
        "sentence": "Co-administration of @DRUG1$ decreased the plasma concentrations of @DRUG2$ (a CYP3A4 substrate) by approximately 50%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5613,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5614,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5615,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5616,
        "sentence": "@DRUG1$ (@DRUG2$) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5617,
        "sentence": "@DRUG1$ pharmacokinetic parameter values were not affected by administration of @DRUG2$  2 hours after morphine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5618,
        "sentence": "In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of @DRUG1$ by approximately 3.6-fold at steady state, while levels of @DRUG2$ remained unchanged.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5619,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, @DRUG1$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5620,
        "sentence": "Certain drugs including thiazides, @DRUG1$, @DRUG2$, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5621,
        "sentence": "Phenobarbital or @DRUG1$ : No formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5622,
        "sentence": "In patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent @DRUG1$ therapy, discontinuation of cimetidine has been reported to decrease established steady-state serum @DRUG2$ levels and compromise their therapeutic effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5623,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as @DRUG1$, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the @DRUG2$ for Topical Solution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5624,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5625,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5626,
        "sentence": "@DRUG1$: A study in normal healthy volunteers has shown that concomitant administration of @DRUG2$  (isradipine) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5627,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, @DRUG1$, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5628,
        "sentence": "Clinical experience with concomitant administration of bosentan and @DRUG1$ in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among @DRUG2$- and placebo-treated patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5629,
        "sentence": "Antacids containing magnesium, @DRUG1$, or @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5630,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5631,
        "sentence": "Use of PRINIVIL with potassium-sparing diuretics (e.g., @DRUG1$, triamterene, or @DRUG2$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5632,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, @DRUG2$, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5633,
        "sentence": "@DRUG1$ (carbamazepine, felbamate, phenobarbital, phenytoin, topiramate): Increase the metabolism of @DRUG2$ and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5634,
        "sentence": "Increases of 22% with @DRUG1$ and 47% with @DRUG2$ were observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5635,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5636,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX on the concomitant anesthetic, @DRUG1$, hypnotic or @DRUG2$ may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5637,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5638,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5639,
        "sentence": "Oral @DRUG1$ may potentiate the hypoglycemic action of hypoglycemic agents, eg, @DRUG2$ and chlorpropamide, by inhibiting their metabolism in the liver.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5640,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, @DRUG1$, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5641,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, @DRUG1$, @DRUG2$, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5642,
        "sentence": "Upon administration of 10 mg of Vardenafil with 800 mg TID @DRUG1$, the Cmax and AUC of @DRUG2$ were reduced by 40% and 30%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5643,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5644,
        "sentence": "@DRUG1$/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, @DRUG2$ and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5645,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, clindamycin, clofibrate, methyldopa, @DRUG2$ (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5646,
        "sentence": "The potential effects of @DRUG1$ on the fertility of male animals were not studied but in a 6-month toxicology study, male rats treated with intramuscular doses of 15 mg/kg/30 days, 10 mg/rat/30 days, or 10 mg/rat/15 days @DRUG2$ showed a loss of spermatozoa from the seminiferous tubules, seminiferous tubular atrophy, and degenerative changes in the epididymides.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5647,
        "sentence": "Due to wide interindividual variability in the dose adjustment required, it is recommended that cyclosporine concentrations be monitored closely after initiation of @DRUG1$ therapy and that the dose of @DRUG2$ be adjusted as appropriate.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5648,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5649,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG1$, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5650,
        "sentence": "The actions of the @DRUG1$ may be potentiated by barbiturates, narcotics, @DRUG2$, monoamine oxidase inhibitors or other antidepressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5651,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5652,
        "sentence": "@DRUG1$: It should be borne in mind that @DRUG2$ ingestion may increase the danger inherent in any intentional or unintentional SINEQUAN overdosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5653,
        "sentence": "Patients on oral antidiabetic agents receiving @DRUG1$ treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5654,
        "sentence": "Drug/Laboratory Test Interferences: @DRUG1$ and @DRUG2$, including anisindione, or their metabolites may color alkaline urine red-orange, which may interfere with spectrophotometrically determined urinary laboratory tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5655,
        "sentence": "- a beta-blocker such as propranolol (@DRUG1$), atenolol (Tenormin), @DRUG2$ (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5656,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5657,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or @DRUG1$, or with formulations containing divalent and trivalent cations such as VIDEX (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5658,
        "sentence": "@DRUG1$, Oral @DRUG2$: Estrogens tend to increase serum thyroxine-binding globulin (TBg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5659,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG2$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5660,
        "sentence": "In order to examine some molecular mechanisms of @DRUG1$-induced behavioral changes, Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with @DRUG2$, DCG-IV, and L-CCG-1 was carried out.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5661,
        "sentence": "and @DRUG1$ , (Didanosine), chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of @DRUG2$, resulting in systemic levels considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5662,
        "sentence": "Although acid-base and electrolyte disturbances were not reported in the clinical trials with @DRUG1$, these disturbances have been reported with oral @DRUG2$ and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5663,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG1$, or with @DRUG2$ containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5664,
        "sentence": "When initiating a multi-day course of @DRUG1$ in a patient maintained on theophylline, the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum @DRUG2$ concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5665,
        "sentence": "astemizole midazolam, triazolam @DRUG1$ ergot derivatives @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5666,
        "sentence": "In healthy volunteers, @DRUG1$ had no effect on the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5667,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG1$, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5668,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5669,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5670,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5671,
        "sentence": "Results of preliminary studies in humans and rats suggest that nonabsorbable @DRUG1$ given concurrently with lactulose may inhibit the desired @DRUG2$-induced drop in colonic pH.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5672,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG2$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5673,
        "sentence": "Cimetidine, @DRUG1$: In normal volunteers (n=9), pretreatment with @DRUG2$ or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5674,
        "sentence": "Because of the low dietary cobalt concentration as compared to the @DRUG1$ contents of the diets, no effect of cobalt on @DRUG2$ absorption and excretion occurred.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5675,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG1$, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5676,
        "sentence": "Patients receiving other narcotic analgesics, @DRUG1$, antianxiety agents, or other CNS depressants (including @DRUG2$) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5677,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5678,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5679,
        "sentence": "Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when @DRUG1$ is coadministered with inhibitors of C.P.A. such as @DRUG2$ and erythromycin or inhibitors of CYP2C19 such as omeprazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5680,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$ and rifampin may increase the clearance of corticosteroids and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5681,
        "sentence": "The intestinal absorption of @DRUG1$(@DRUG2$) has been investigated in the chick by means of the in situ ligated duodenal loop technique.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5682,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or @DRUG1$), the concomitant use of @DRUG2$ may reduce seizure control by lowering the plasma levels of the anticonvulsant.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5683,
        "sentence": "Co-administration of anastrozole and tamoxifen resulted in a reduction of @DRUG1$ plasma levels by 27% compared with those achieved with @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5684,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], @DRUG1$ [e.g., Thorazine], fluphenazine [e.g., @DRUG2$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5685,
        "sentence": "@DRUG1$: Combination hormonal contraceptives may increase or decrease the effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5686,
        "sentence": "Concomitant administration of @DRUG1$ and digoxin has been reported to result in elevated @DRUG2$ serum levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5687,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5688,
        "sentence": "@DRUG1$ (NSAIDS): Concomitant use of aspirin (or other @DRUG2$) and corticosteroids increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5689,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5690,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5691,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5692,
        "sentence": "Drug Interactions with Beta-Blockers: Concomitant use of @DRUG1$ with @DRUG2$ should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5693,
        "sentence": "@DRUG1$ (spironolactone, amiloride,triamterene, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5694,
        "sentence": "Plasma was analyzed for tolbutamide, and urine was analyzed for @DRUG1$ and its two metabolites, @DRUG2$ and carboxytolbutamide by means of HPLC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5695,
        "sentence": "@DRUG1$ : @DRUG2$ pharmacokinetics were not significantly different before and after tiagabine multiple-dose regimens.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5696,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$ resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5697,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5698,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG1$ containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5699,
        "sentence": "Twelve strains of Staphylococcus aureus (a frequent cause of infection in heroin, but not in @DRUG1$ and @DRUG2$, addicts) were completely inhibited by the drug combination.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5700,
        "sentence": "The concomitant administration of quinolones including @DRUG1$ with glyburide (a @DRUG2$) has, on rare occasions, resulted in severe hypoglycemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5701,
        "sentence": "Amphotericin, @DRUG1$, and @DRUG2$: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5702,
        "sentence": "@DRUG1$ should not be used concomitantly with other drugs known to prolong the QT interval: certain antiarrhythmics, including those of Class IA (such as quinidine and @DRUG2$) and Class III (such as sotalol);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5703,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5704,
        "sentence": "In patients taking @DRUG1$, nifedipine, diltiazem, @DRUG2$, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5705,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5706,
        "sentence": "Certain other @DRUG1$ (aminoglycosides and @DRUG2$) have also been reported to interfere with the nerve transmission at the neuromuscular junction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5707,
        "sentence": "The data presented here demonstrate that with serial pharmacokinetic dosing of @DRUG1$, the iatrogenic alteration caused by @DRUG2$ therapy can be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5708,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, @DRUG1$, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5709,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and @DRUG1$ may increase the clearance of corticosteroids and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5710,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5711,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5712,
        "sentence": "Two different types of therapy with @DRUG1$ are used: physiological oral magnesium supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the magnesium intake and pharmacological @DRUG2$ therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5713,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, @DRUG1$, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5714,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5715,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5716,
        "sentence": "May interact with wthionamide (Trecator-SC) and @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5717,
        "sentence": "The effects of @DRUG1$ on @DRUG2$s analgesic actions are not known.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5718,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, @DRUG2$, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5719,
        "sentence": "Antacids: Concomitant administration of magnesium hydroxide and @DRUG1$ does not interfere with the rate or extent of the absorption of ketoprofen administered as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5720,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], thioridazine [e.g., @DRUG2$], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5721,
        "sentence": "Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the @DRUG1$ may occur when an oral anticoagulant and @DRUG2$ are administered concurrently.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5722,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5723,
        "sentence": "Ketoconazole: @DRUG1$ has been reported to decrease the metabolism of certain @DRUG2$ by up to 60%, leading to increased risk of corticosteroid side effects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5724,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, @DRUG2$, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5725,
        "sentence": "In patients taking furosemide, nifedipine, @DRUG1$, @DRUG2$, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5726,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5727,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, @DRUG2$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5728,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5729,
        "sentence": "No dose adjustment is necessary when @DRUG1$ is added to triple-immunosuppression regimens including @DRUG2$, corticosteroids, and either azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5730,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5731,
        "sentence": "The fraction of STADOL NS absorbed is unaffected by the concomitant administration of a @DRUG1$ (@DRUG2$), but the rate of absorption is decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5732,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG2$, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5733,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG2$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5734,
        "sentence": "Other compounds that are substrates of CYP3A4 may have decreased plasma concentrations when coadministered with @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5735,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5736,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5737,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG2$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5738,
        "sentence": "Coadministration of @DRUG1$ with other diuretics, amphotericin B, and @DRUG2$ may cause hypokalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5739,
        "sentence": "Since @DRUG1$ (ethosuximide) may interact with concurrently administered @DRUG2$, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5740,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, @DRUG1$, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5741,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG1$ such as @DRUG2$ and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5742,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (Tenormin), @DRUG1$ (@DRUG2$), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5743,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5744,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5745,
        "sentence": "@DRUG1$: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of @DRUG2$ (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5746,
        "sentence": "Potentiation of the hypotensive effects of @DRUG1$ for patients with ischemic heart disease has not been evaluated, and concomitant use of @DRUG2$ and nitrates is contraindicated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5747,
        "sentence": "Antacids: Concomitant administration of @DRUG1$ and @DRUG2$ does not interfere with the rate or extent of the absorption of ketoprofen administered as Orudis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5748,
        "sentence": "@DRUG1$ treatment, which causes a marked and persistent inhibition of cholinesterase activity, potentiates the effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5749,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG2$ for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5750,
        "sentence": "@DRUG1$: Concomitant administration of nicardipine and @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5751,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5752,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5753,
        "sentence": "therefore, coadministration of @DRUG1$ with drugs that inhibit CYP3A4 activity may result in increased plasma concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5754,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5755,
        "sentence": "Amphotericin, @DRUG1$, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of @DRUG2$ (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5756,
        "sentence": "Both ibogaine and @DRUG1$ ameliorate @DRUG2$ withdrawal signs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5757,
        "sentence": "Drug Interaction with @DRUG1$ and Ketoconazole @DRUG2$ has been shown to exhibit minimal (ca. 5%) metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5758,
        "sentence": "@DRUG1$: The mean steady-state trough serum valproic acid concentrations prior to and during concomitant @DRUG2$ administration (400 mg TID;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5759,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, @DRUG1$, methotrexate, phenytoin, @DRUG2$, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5760,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5761,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5762,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5763,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5764,
        "sentence": "@DRUG1$: Studies in animals demonstrate that the acute toxicity of @DRUG2$ is enhanced by the MAO inhibitor phenelzine .",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5765,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, @DRUG1$, methyldopa, @DRUG2$ (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5766,
        "sentence": "there was no effect on the 3 major metabolites (5-DFUR, @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5767,
        "sentence": "Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5768,
        "sentence": "In a study in diabetics with microalbuminuria @DRUG1$ 200 mg combined with the ACE inhibitor enalapril 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on @DRUG2$ alone to 38%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5769,
        "sentence": "@DRUG1$: Clinical studies, as well as post-marketing observations, have shown that @DRUG2$ can reduce the natriuretic effect of furosemide and thiazides in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5770,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that @DRUG1$, in combination with cyclosporine or @DRUG2$, might have the potential to reduce the frequency of rejection episodes, permit reductions in cyclosporine or tacrolimus dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5771,
        "sentence": "@DRUG1$: @DRUG2$ produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5772,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, @DRUG2$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5773,
        "sentence": "Antipyrine : @DRUG1$ pharmacokinetics were not significantly different before and after @DRUG2$ multiple-dose regimens.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5774,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. @DRUG1$), antihistamines antipsychotic agents (e.g. phenothiazines), @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5775,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG1$, disopyramide, lovastatin, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5776,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral magnesium supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the @DRUG1$ intake and pharmacological @DRUG2$ therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5777,
        "sentence": "As with other agents with b-blocking properties, if @DRUG1$ is to be administered orally with @DRUG2$ of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5778,
        "sentence": "Anticonvulsants (carbamazepine, felbamate, @DRUG1$, @DRUG2$, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5779,
        "sentence": "@DRUG1$ (spironolactone, @DRUG2$, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5780,
        "sentence": "Warfarin, @DRUG1$, @DRUG2$, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5781,
        "sentence": "This drug may interact with @DRUG1$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5782,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5783,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, @DRUG2$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5784,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5785,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5786,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG2$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5787,
        "sentence": "On the basis of the metabolism of @DRUG1$ by cytochrome P450 3A4, ketoconazole, @DRUG2$, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5788,
        "sentence": "It is desirable to monitor @DRUG1$plasma levels whenever an agent of the @DRUG2$ including Anafranil is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5789,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG1$, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5790,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5791,
        "sentence": "Because fluvoxamine reduces the clearance of both @DRUG1$ and its active metabolite, @DRUG2$, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5792,
        "sentence": "Since @DRUG1$ (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and @DRUG2$ has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5793,
        "sentence": "Anticonvulsants: Phenytoin @DRUG1$ @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5794,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, pyrilamine, @DRUG1$, @DRUG2$, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5795,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, @DRUG1$, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5796,
        "sentence": "@DRUG1$ enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the @DRUG2$. 7",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5797,
        "sentence": "Oral @DRUG1$: In some normal volunteers, the concomitant administration of @DRUG2$ and warfarin, acenocoumarol, or phenprocoumon resulted in prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5798,
        "sentence": "@DRUG1$: Concurrent use of erythromycin and @DRUG2$ or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5799,
        "sentence": "Since @DRUG1$ in high doses has been associated with hepatotoxicity, concomitant administration of @DRUG2$ and acetaminophen should be used cautiously, with careful monitoring of patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5800,
        "sentence": "Concurrent use of @DRUG1$ with central nervous system depressants (e.g., @DRUG2$, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5801,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that sirolimus, in combination with cyclosporine or @DRUG1$, might have the potential to reduce the frequency of rejection episodes, permit reductions in cyclosporine or @DRUG2$ dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5802,
        "sentence": "Drug Interaction with @DRUG1$: A multiple-dose study was conducted to assess the effect of @DRUG2$ 20 mg BID on the pharmacokinetics of estazolam 2 mg QHS after seven days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5803,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5804,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, @DRUG1$, @DRUG2$ and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5805,
        "sentence": "May interact with addictive medications, especially central nervous system (CNS) depressants with habituating potential (prolonged concurrent use may increase the risk of habituation), @DRUG1$ or CNS depression producing medications (concurrent use may increase the CNS depressant effects of either these medications or @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5806,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, procaine, @DRUG1$, metaclopramide, lithium carbonate, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5807,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG1$ (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5808,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG1$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5809,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5810,
        "sentence": "CNS-Active Drugs @DRUG1$ An additive effect on psychomotor performance was seen with coadministration of @DRUG2$ and ethanol 0.70 g/kg for up to 4 hours after ethanol administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5811,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5812,
        "sentence": "@DRUG1$ VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly @DRUG2$ doses of 7.5 to 20 mg for rheumatoid arthritis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5813,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG1$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5814,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5815,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5816,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with PRECEDEX, a reduction in dosage of PRECEDEX on the concomitant anesthetic, sedative, @DRUG1$ or @DRUG2$ may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5817,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, @DRUG1$, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5818,
        "sentence": "Drug Interactions with @DRUG1$ Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (@DRUG2$ ) decreased fexofenadine AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5819,
        "sentence": "H2 Blockers/@DRUG1$: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, famotidine and @DRUG2$) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5820,
        "sentence": "Specific and aspecific treatments of magnesium depletion are tricky using for example @DRUG1$, pharmacological doses of @DRUG2$, physiological doses of vitamin D and of selenium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5821,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5822,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5823,
        "sentence": "Phase II clinical trial data, where IRESSA and @DRUG1$ have been used concomitantly, indicate that @DRUG2$ may exacerbate the neutropenic effect of vinorelbine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5824,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5825,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5826,
        "sentence": "Drug Interaction with Erythromycin and @DRUG1$ @DRUG2$ has been shown to exhibit minimal (ca. 5%) metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5827,
        "sentence": "Anticoagulants: Combination @DRUG1$ may increase or decrease the effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5828,
        "sentence": "There have been reports of theophylline-related side effects in patients on concomitant therapy with @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5829,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5830,
        "sentence": "Furosemide: Clinical studies, as well as random observations, have shown that @DRUG1$ can reduce the natriuretic effect of furosemide and @DRUG2$ in some patients.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5831,
        "sentence": "Inhibitors of CYP2D6: Because CYP2D6 is involved in duloxetine metabolism, concomitant use of @DRUG1$ with potent inhibitors of CYP2D6 may result in higher concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5832,
        "sentence": "@DRUG1$: Modest increases in mean trough cyclosporine concentrations were observed following initiation of @DRUG2$ treatment in 21 renal transplant patients suffering from chronic vascular rejection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5833,
        "sentence": "When initiating a multi-day course of grepafloxacin in a patient maintained on theophylline, the @DRUG1$ maintenance dose should be halved for the period of concurrent use of @DRUG2$ and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5834,
        "sentence": "@DRUG1$: Rifampin increases the metabolism of ethinyl estradiol and some progestins (@DRUG2$) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5835,
        "sentence": "In addition, under the influence of sympatholytic medicinal products such as beta-blockers, @DRUG1$, @DRUG2$, and reserpine, the signs of hypoglycemia may be reduced or absent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5836,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5837,
        "sentence": "Heparin: Since @DRUG1$ is contraindicated in patients with heparin-induced thrombocytopenia, the co-administration of @DRUG2$ and heparin is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5838,
        "sentence": "Immunosuppressive Drugs, Fibric Acid Derivatives, @DRUG1$ (Nicotinic Acid, @DRUG2$, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5839,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5840,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5841,
        "sentence": "In patients taking an anticonvulsant (eg, valproic acid, @DRUG1$, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5842,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5843,
        "sentence": "We examined the effect of exogenous @DRUG1$ on the changes in serum steroid hormone levels induced by a nonlethal dose of Escherichia coli @DRUG2$ in male rats and the deaths due to nonlethal and lethal doses of endotoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5844,
        "sentence": "Because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of @DRUG1$, @DRUG2$ and thioridazine should not be co-administered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5845,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5846,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5847,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5848,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that @DRUG1$, in combination with @DRUG2$ or tacrolimus, might have the potential to reduce the frequency of rejection episodes, permit reductions in cyclosporine or tacrolimus dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5849,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG1$, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5850,
        "sentence": "Administration of quinolones with antacids containing @DRUG1$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG2$ (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5851,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5852,
        "sentence": "@DRUG1$ concentrations were similar in patients receiving bolus-IFL alone and in combination with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5853,
        "sentence": "@DRUG1$: In the presence of @DRUG2$ at 300 mg QID (N=12) the mean apparent oral clearance of gabapentin fell by 14% and creatinine clearance fell by 10%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5854,
        "sentence": "Observe the patient for possible diminished effect of @DRUG1$ and increase the @DRUG2$ dosage accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5855,
        "sentence": "@DRUG1$ pretreatment attenuated the hypotensive effect of a single dose of @DRUG2$ but not atenolol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5856,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5857,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5858,
        "sentence": "Both @DRUG1$ and 18-MC ameliorate @DRUG2$ withdrawal signs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5859,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG1$, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5860,
        "sentence": "Antacids: Concomitant administration of aluminum and @DRUG1$s does not interfere with absorption of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5861,
        "sentence": "However, coadministration of escitalopram (20 mg) and @DRUG1$ (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5862,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], @DRUG2$ [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5863,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5864,
        "sentence": "In diabetic patients, the metabolic effects of @DRUG1$ may decrease blood glucose and therefore, @DRUG2$ requirements.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5865,
        "sentence": "Therefore, monitoring of @DRUG1$ plasma levels should be considered and dosage of @DRUG2$ adjusted as required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5866,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5867,
        "sentence": "Pimozide and Celexa - In a controlled study, a single dose of @DRUG1$ 2 mg co-administered with racemic @DRUG2$ 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5868,
        "sentence": "Effects of other Antiepilepsy Drugs (@DRUG1$) on GABITRIL : @DRUG2$: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5869,
        "sentence": "However, @DRUG1$ pretreatment did not affect any of the physiological, behavioral, or subjective effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5870,
        "sentence": "In a study with concomitant administration of @DRUG1$ and @DRUG2$, the bioavailability of unbound fosinoprilat was not altered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5871,
        "sentence": "As with other @DRUG1$, if @DRUG2$ is to be administered orally with calcium channel blockers of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5872,
        "sentence": "@DRUG1$ (Primidone): Population pharmacokinetic analyses indicate that @DRUG2$ clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5873,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5874,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG2$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5875,
        "sentence": "Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of @DRUG1$ ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5876,
        "sentence": "@DRUG1$ such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5877,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, @DRUG1$, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, @DRUG2$, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5878,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, nonbarbiturate hypnotics, antianxiety agents, the @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5879,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., @DRUG1$, @DRUG2$, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5880,
        "sentence": "@DRUG1$: The pharmacokinetics of @DRUG2$ were not affected by coadministration of propranolol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5881,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like lidocaine, @DRUG1$, @DRUG2$, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5882,
        "sentence": "Therefore, @DRUG1$ should be administered with caution with intranasal @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5883,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5884,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5885,
        "sentence": "@DRUG1$ and Other @DRUG2$: Co-administration of bosentan decreased the plasma concentrations of simvastatin (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5886,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, @DRUG1$, orphenadrine, pyrilamine, phenyltoloxamine, promethazine, methdilazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5887,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5888,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of @DRUG1$ binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5889,
        "sentence": "This interaction should be given consideration in patients taking @DRUG1$ concomitantly with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5890,
        "sentence": "@DRUG1$: If @DRUG2$ is given concurrently with phenytoin, the protein binding of phenytoin may be reduced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5891,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5892,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5893,
        "sentence": "Because @DRUG1$, @DRUG2$, or Activase may cause bleeding complications, careful monitoring for bleeding is advised, especially at arterial puncture sites.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5894,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, @DRUG2$, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5895,
        "sentence": "Concomitant administration of diflunisal and @DRUG1$ in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/@DRUG2$) resulted in greater gastrointestinal toxicity than when either drug was administered alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5896,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG1$, @DRUG2$, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5897,
        "sentence": "Coadministration of entecavir with @DRUG1$, adefovir dipivoxil,or @DRUG2$ did not result in significant drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5898,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG1$, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5899,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5900,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5901,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, @DRUG1$ (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5902,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$ and @DRUG2$ may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5903,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, @DRUG2$, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5904,
        "sentence": "There have been reports of interactions of @DRUG1$ with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5905,
        "sentence": "Other antiarrhythmic drugs (eg, quinidine, procainamide, lidocaine, @DRUG1$) have occasionally been used concurrently with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5906,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, cetirizine, @DRUG2$, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5907,
        "sentence": "When coadministered with @DRUG1$ in treatment-naive patients, the recommended dose of @DRUG2$ is 300 mg with ritonavir 100 mg and SUSTIVA 600 mg (all once daily).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5908,
        "sentence": "If @DRUG1$ are required during OMNICEF therapy, @DRUG2$ should be taken at least 2 hours before or after the supplement.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5909,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5910,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, @DRUG1$, and aminoglycosides may increase the risk of developing peripheral neuropathy or other @DRUG2$-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5911,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG1$, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5912,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5913,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5914,
        "sentence": "Cimetidine, @DRUG1$: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5915,
        "sentence": "No interaction with the @DRUG1$ imipramine was shown in a single-dose study with entacapone without coadministered @DRUG2$/dopa-decarboxylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5916,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5917,
        "sentence": "Specific and aspecific treatments of @DRUG1$ depletion are tricky using for example magnesium sparing diuretics, pharmacological doses of @DRUG2$, physiological doses of vitamin D and of selenium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5918,
        "sentence": "Anesthetics/@DRUG1$/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, sedatives, @DRUG2$, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5919,
        "sentence": "Concomitant use of antihistamines with @DRUG1$, @DRUG2$, barbiturates, or other central nervous system depressants may have an additive effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5920,
        "sentence": "Tablets: The @DRUG1$, including lorazepam, produce CNS-depressant effects when administered with such medications as @DRUG2$ or alcohol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5921,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5922,
        "sentence": "Estazolam: Interaction with Drugs that Inhibit Metabolism via Cytochrome P450 3A (CYP3A): The metabolism of @DRUG1$ to the major circulating metabolite @DRUG2$ and the metabolism of other triazolobenzodiazepines is catalyzed by CYP3A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5923,
        "sentence": "Carbamazepine - Combined administration of racemic citalopram (40 mg/day for 14 days) and @DRUG1$ (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of @DRUG2$, a CYP3A4 substrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5924,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5925,
        "sentence": "@DRUG1$: When fluvoxamine maleate (100 mg qd) and alprazolam (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of alprazolam were approximately twice those observed when @DRUG2$ was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5926,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, @DRUG1$, phenyltoloxamine, promethazine, methdilazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5927,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (@DRUG1$), @DRUG2$, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5928,
        "sentence": "If chlorprothixene is given concomitantly with @DRUG1$, the opioid dose should be reduced (by approx. 50%), because @DRUG2$ amplifies the therapeutic actions and side-effects of opioids massively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5929,
        "sentence": "Certain drugs including thiazides, corticosteroids, @DRUG1$, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5930,
        "sentence": "Amphotericin, @DRUG1$, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other @DRUG2$-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5931,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5932,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5933,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG1$ may change the amount of either medicine that you need to take), and oral contraceptives containing @DRUG2$ (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5934,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, @DRUG1$, cimetidine, metoclopramide, propantheline, @DRUG2$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5935,
        "sentence": "@DRUG1$: When fluvoxamine maleate (100 mg qd) and @DRUG2$ (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of alprazolam were approximately twice those observed when alprazolam was administered alone;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5936,
        "sentence": "Oral Hypoglycemics: @DRUG1$ has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5937,
        "sentence": "Renal function should be carefully monitored, especially if higher dosages of the @DRUG1$ are to be administered or if therapy is prolonged, because of the potential nephrotoxicity and ototoxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5938,
        "sentence": "@DRUG1$: Enoxacin is a potent inhibitor of the cytochrome P-450 isozymes responsible for the metabolism of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5939,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG1$, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5940,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with @DRUG1$ may lead to several- fold increases in the plasma levels of @DRUG2$, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5941,
        "sentence": "The effect of concomitant administration of @DRUG1$ and @DRUG2$ has been demonstrated in a placebo-controlled crossover study in normal volunteers.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5942,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG2$, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5943,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an @DRUG1$-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/@DRUG2$-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5944,
        "sentence": "Of particular importance, sufficient time must elapse before initiating @DRUG1$treatment in a patient being withdrawn from @DRUG2$, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5945,
        "sentence": "In clinical studies, coadministration of @DRUG1$  with atorvastatin, lovastatin, or @DRUG2$ did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5946,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG1$, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5947,
        "sentence": "The absorption of @DRUG1$ may be affected by the simultaneous administration of indigestion remedies, iron or @DRUG2$ supplements.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5948,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5949,
        "sentence": "Lithium: Ibuprofen produced an elevation of plasma @DRUG1$ levels and a reduction in renal @DRUG2$ clearance in a study of eleven normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5950,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5951,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5952,
        "sentence": "Inhibitors or substrates of CYP2D6 (i.e., @DRUG1$, selective serotonin reuptake inhibitors [@DRUG2$]) may increase the plasma concentration of doxepin when administered concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5953,
        "sentence": "Dose reduction of @DRUG1$ to 600 mg every 8 hours is recommended when administering @DRUG2$ concurrently.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5954,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG1$, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5955,
        "sentence": "The results of a study of coadministration of @DRUG1$ (50 mg/kg) with an aluminum hydroxide containing @DRUG2$ to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5956,
        "sentence": "When cholestyramine @DRUG1$ is given for long periods of time, concomitant supplementation with water-miscible (or parenteral) forms of @DRUG2$ should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5957,
        "sentence": "Co-administration with @DRUG1$ or fluconazole had a modest effect on the pharmacokinetics of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5958,
        "sentence": "No clinically relevant pharmacokinetic interactions between @DRUG1$ and @DRUG2$ were observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5959,
        "sentence": "Our data suggest that @DRUG1$ significantly potentiates the reduction in cell number induced by @DRUG2$ alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5960,
        "sentence": "@DRUG1$/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by @DRUG2$ or proton pump inhibitors (eg, famotidine and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5961,
        "sentence": "Some @DRUG1$, including ciprofloxacin, have been associated with transient elevations in serum creatinine in patients receiving @DRUG2$ concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5962,
        "sentence": "Antacids: Concomitant administration of @DRUG1$ and aluminum hydroxide does not interfere with the rate or extent of the absorption of @DRUG2$ administered as Orudis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5963,
        "sentence": "in one man, the C max of @DRUG1$ was 8.1 ng/mL with terfenadine alone and 7.2 ng/mL with terfenadine plus @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5964,
        "sentence": "Some @DRUG1$, including @DRUG2$, have also been shown to interfere with the metabolism of caffeine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5965,
        "sentence": "No interaction trials have been conducted with @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5966,
        "sentence": "Potential for Other Drugs to Affect @DRUG1$: Both CYP1A2 and CYP2D6 are responsible for @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5967,
        "sentence": "@DRUG1$) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5968,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5969,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5970,
        "sentence": "Because both of these drugs have negative inotropic properties and the effects of coadministration with @DRUG1$ are unknown, neither @DRUG2$ nor verapamil should be administered concurrently with TAMBOCOR unless, in the judgment of the physician, the benefits of this combination outweigh the risks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5971,
        "sentence": "Antihistamines: @DRUG1$ may counteract the sedative effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5972,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG2$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5973,
        "sentence": "Chlorpromazine: @DRUG1$ blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of @DRUG2$, and can be used to treat amphetamine poisoning.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5974,
        "sentence": "Estazolam: Interaction with Drugs that Inhibit Metabolism via Cytochrome P450 3A (CYP3A): The metabolism of @DRUG1$ to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other @DRUG2$ is catalyzed by CYP3A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5975,
        "sentence": "In patients taking furosemide, nifedipine, @DRUG1$, ACE inhibitors, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5976,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5977,
        "sentence": "Single dose bioavailability studies in normal volunteers have failed to wshow an effect of @DRUG1$ on @DRUG2$ blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5978,
        "sentence": "@DRUG1$, @DRUG2$, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5979,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, @DRUG1$, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5980,
        "sentence": "@DRUG1$: In the fed state, praziquantel (40 mg/kg) increased mean maximum plasma concentration and area under the curve of @DRUG2$ by about 50% in healthy subjects (n=10) compared with a separate group of subjects (n=6) given albendazole alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5981,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG1$, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5982,
        "sentence": "Potassium-sparing diuretics (spironolactone, @DRUG1$, triamterene, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5983,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5984,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG2$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5985,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG1$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5986,
        "sentence": "Ethanol:Clinical evidence has shown that @DRUG1$ can be formed with concurrent ingestion of @DRUG2$ and ethanol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5987,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5988,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5989,
        "sentence": "@DRUG1$, an inducer of drug metabolism, decreased the concentrations of @DRUG2$ and its active metabolite.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5990,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5991,
        "sentence": "@DRUG1$ (@DRUG2$): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5992,
        "sentence": "Protease Inhibitors: In vitro data indicate that indinavir and @DRUG1$ markedly inhibit the metabolism of cisapride which can result in an increase in plasma @DRUG2$ levels and prolongation of the QT interval on the ECG.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5993,
        "sentence": "- a beta-blocker such as @DRUG1$ (Inderal), atenolol (Tenormin), acebutolol (Sectral), @DRUG2$ (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5994,
        "sentence": "@DRUG1$: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (@DRUG2$) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5995,
        "sentence": "@DRUG1$: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5996,
        "sentence": "Videx (@DRUG1$) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because these products may interfere with absorption resulting in lower serum and urine levels of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5997,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5998,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5999,
        "sentence": "Although not studied with @DRUG1$, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid, @DRUG2$, and hydralazine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6000,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6001,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, @DRUG1$, @DRUG2$, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6002,
        "sentence": "@DRUG1$: A recent case study has shown a possible increase in the plasma level of valproate when co administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6003,
        "sentence": "@DRUG1$ and Other Statins: Co-administration of bosentan decreased the plasma concentrations of @DRUG2$ (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6004,
        "sentence": "Other antiarrhythmic drugs (eg, quinidine, procainamide, @DRUG1$, @DRUG2$) have occasionally been used concurrently with Norpace.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6005,
        "sentence": "@DRUG1$ (spironolactone, amiloride, @DRUG2$, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6006,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG1$, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6007,
        "sentence": "Serum @DRUG1$ concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including @DRUG2$, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6008,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6009,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6010,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, @DRUG1$, methyldopa, nicotinic acid (@DRUG2$), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6011,
        "sentence": "@DRUG1$ (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (@DRUG2$) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6012,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6013,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6014,
        "sentence": "@DRUG1$: Concomitant administration of methotrexate and some @DRUG2$ has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6015,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6016,
        "sentence": "Coadministration of oral contraceptives, diazepam, @DRUG1$, or @DRUG2$ did not seem to change the pharmacokinetic profile of esomeprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6017,
        "sentence": "- Phenytoin (e.g., Dilantin) Use of @DRUG1$ with @DRUG2$ may increase the chance of side effects affecting the liver and/or the side effects of phenytoin",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6018,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6019,
        "sentence": "When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - @DRUG1$ and @DRUG2$ may enhance the action of anticoagulants of the coumarin type.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6020,
        "sentence": "Furthermore, @DRUG1$, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6021,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other @DRUG2$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6022,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6023,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6024,
        "sentence": "@DRUG1$ (5-35 micromol/l) induced concentration-dependent relaxation of mesenteric arteries preconstricted with @DRUG2$ (8 micromol/l) or KCl (125 mmol/l) from both lean and dietary-obese rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6025,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG1$), @DRUG2$ (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6026,
        "sentence": "Noncardioselective beta-blockers (@DRUG1$,porpranolol,timolol) may exacerbate rebound hypertension when @DRUG2$ is withdrawn.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6027,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6028,
        "sentence": "astemizole @DRUG1$, triazolam cisapride ergot derivatives @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6029,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6030,
        "sentence": "Simvastatin and Other @DRUG1$: Co-administration of bosentan decreased the plasma concentrations of @DRUG2$ (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6031,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, @DRUG1$, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6032,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6033,
        "sentence": "@DRUG1$, as with other @DRUG2$, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6034,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., @DRUG1$), @DRUG2$ (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6035,
        "sentence": "Flurbiprofen pretreatment attenuated the hypotensive effect of a single dose of @DRUG1$ but not @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6036,
        "sentence": "The anxiogenic effects of theophylline were reduced by pretreatment with @DRUG1$, an A2-selective agonist, but not by @DRUG2$ (CPA), an A1-selective agonist.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6037,
        "sentence": "Ventricular tachycardia induced by @DRUG1$ was generally converted to sinus rhythm following administration of Innovar, ketamine, or @DRUG2$ but not after administration of fentayl alone or after pentobarbital.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6038,
        "sentence": "Anesthetics/Sedatives/@DRUG1$/Opioids: Co-administration of PRECEDEX with @DRUG2$, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6039,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG1$ (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6040,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, clindamycin, @DRUG2$, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6041,
        "sentence": "THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS @DRUG1$, @DRUG2$ AND BARBITURATES.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6042,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, @DRUG2$, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6043,
        "sentence": "Talk to your doctor if you are taking certain antibiotics such as @DRUG1$, clarithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6044,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, @DRUG1$, grapefruit juice, @DRUG2$) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6045,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6046,
        "sentence": "Concomitant treatment with methylxanthines (@DRUG1$, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6047,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), @DRUG1$ (e.g., Matulane), @DRUG2$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6048,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6049,
        "sentence": "Additive depressant effect when used with general @DRUG1$, sedatives, @DRUG2$, hypnotics, alcohol, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6050,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of @DRUG1$ of approximately 20% and 13%, respectively, suggesting that the oral absorption of @DRUG2$ may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6051,
        "sentence": "(See CLINICAL PHARMACOLOGY) Coadministration of @DRUG1$ and tamoxifen 20 mg daily resulted in a reduction of @DRUG2$ plasma levels by 38% on average.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6052,
        "sentence": "The @DRUG1$, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, @DRUG2$, ethanol, and other drugs which themselves produce CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6053,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of @DRUG1$ and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6054,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6055,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6056,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, @DRUG2$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6057,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of @DRUG1$, ketoconazole, @DRUG2$, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6058,
        "sentence": "Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with @DRUG1$ containing magnesium, @DRUG2$, or aluminum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6059,
        "sentence": "Oxytocin or other @DRUG1$ (concurrent use with @DRUG2$ may result in uterine hypertonus, possibly causing uterine rupture or cervical laceration, especially in the absence of adequate cervical dilatation;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6060,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6061,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6062,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6063,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6064,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6065,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, @DRUG2$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6066,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6067,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, hydrochlorothiazide, cimetidine, metoclopramide, @DRUG2$, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6068,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6069,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6070,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of @DRUG1$ (e.g., @DRUG2$, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6071,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, @DRUG1$, @DRUG2$, oral contraceptives, tolbutamide, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6072,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of @DRUG1$ (40 mg twice daily), @DRUG2$, theophylline, or oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6073,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6074,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, @DRUG1$, @DRUG2$) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6075,
        "sentence": "Lithium Reversible increases in serum @DRUG1$ concentrations and toxicity have been reported during concomitant administration of @DRUG2$ with ACE inhibitors, and with some angiotensin II receptor antagonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6076,
        "sentence": "When administered concurrently, the following drugs may interact with @DRUG1$: @DRUG2$: may enhance the potential for renal toxicity, bronchospasm and hypotension.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6077,
        "sentence": "Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by @DRUG1$ (99.5% control vs 99.3%) when @DRUG2$ plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6078,
        "sentence": "The actions of the @DRUG1$ may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6079,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6080,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6081,
        "sentence": "Talk to your doctor if you are taking certain antibiotics such as @DRUG1$, @DRUG2$ or azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6082,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6083,
        "sentence": "Protease Inhibitors: In vitro data indicate that @DRUG1$ and ritonavir markedly inhibit the metabolism of @DRUG2$ which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6084,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as @DRUG1$, itraconazole, @DRUG2$, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6085,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6086,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, @DRUG1$, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6087,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG1$, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6088,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. @DRUG1$), @DRUG2$ antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6089,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6090,
        "sentence": "The safety of using STADOL NS and @DRUG1$ (@DRUG2$) Nasal Spray during the same episode of migraine has not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6091,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6092,
        "sentence": "In patients taking furosemide, @DRUG1$, @DRUG2$, ACE inhibitors, verapamil, glyburide, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6093,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, @DRUG2$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6094,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG2$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6095,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6096,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6097,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6098,
        "sentence": "Vitamin A and oral retinoids: Concomitant administration of vitamin A and/or other oral @DRUG1$ with @DRUG2$ must be avoided because of the risk of hypervitaminosis A.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6099,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of @DRUG1$ with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or @DRUG2$ supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6100,
        "sentence": "Also, there were no clinically significant differences in adverse events when @DRUG1$ was administered with or without @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6101,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG1$, @DRUG2$, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6102,
        "sentence": "Because of the low dietary cobalt concentration as compared to the @DRUG1$ contents of the diets, no effect of @DRUG2$ on iron absorption and excretion occurred.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6103,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6104,
        "sentence": "@DRUG1$ concentration   @DRUG2$ concentration",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6105,
        "sentence": "Drugs which induce CYP3A4 activity (eg, @DRUG1$, rifampin, rifabutin) would be expected to increase the clearance of @DRUG2$ resulting in lowered plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6106,
        "sentence": "Because oral @DRUG1$ may interfere with the hepatic metabolism of @DRUG2$, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6107,
        "sentence": "- a beta-blocker such as propranolol (@DRUG1$), atenolol (Tenormin), acebutolol (@DRUG2$), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6108,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, @DRUG1$, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6109,
        "sentence": "At 24 hours postdose, a similar proportion of patients treated with @DRUG1$ alone (94%) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib (88%) had @DRUG2$ plasma concentrations below the measurable limit (5 ng/mL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6110,
        "sentence": "Antacids and sucralfate: Sucralfate and @DRUG1$ containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6111,
        "sentence": "Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. @DRUG1$ maintained patients beginning @DRUG2$ therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6112,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6113,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6114,
        "sentence": "Concurrent use of @DRUG1$ with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased @DRUG2$ effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6115,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6116,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG2$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6117,
        "sentence": "The mean clearances of @DRUG1$ were 16% and 15% lower in patients on @DRUG2$ and inhibitors of tubular organic cation transport, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6118,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG1$), selegiline (e.g., @DRUG2$), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6119,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG1$, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6120,
        "sentence": "Thus, when @DRUG1$ and lithium are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6121,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG1$ may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6122,
        "sentence": "Antacids or H 2 receptor antagonists: When dirithromycin is administered immediately following antacids or @DRUG1$, the absorption of @DRUG2$ is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6123,
        "sentence": "Propoxyphene: In cases of @DRUG1$ overdosage, @DRUG2$ CNS stimulation is potentiated and fatal convulsions can occur.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6124,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6125,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6126,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, @DRUG2$, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6127,
        "sentence": "@DRUG1$ has no effect on the blood pressure or metabolic responses to @DRUG2$ in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6128,
        "sentence": "@DRUG1$: Clinical studies, as well as random observations, have shown that ibuprofen can reduce the natriuretic effect of furosemide and @DRUG2$ in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6129,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6130,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with @DRUG1$ or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of @DRUG2$ resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6131,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, @DRUG1$, @DRUG2$, phenytoin, carbamazepine, phenobarbital and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6132,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG1$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6133,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG2$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6134,
        "sentence": "Antiepileptic Drugs: Sporadic cases of seizures have been reported during concomitant use of TORADOL and @DRUG1$ (@DRUG2$, carbamazepine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6135,
        "sentence": "in one man, the C max of @DRUG1$ was 8.1 ng/mL with @DRUG2$ alone and 7.2 ng/mL with terfenadine plus dirithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6136,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG2$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6137,
        "sentence": "Because @DRUG1$ is metabolized by a variety of hepatic CYP drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6138,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6139,
        "sentence": "Antacids containing @DRUG1$, aluminum, or @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6140,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6141,
        "sentence": "In order to maintain @DRUG1$ levels, limit adverse experiences, and achieve the felbamate dose of 3600 mg/day, a @DRUG2$ dose reduction of approximately 40% was necessary for eight of these 10 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6142,
        "sentence": "Concomitant treatment with @DRUG1$ (aminophylline, @DRUG2$), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6143,
        "sentence": "Aprepitant increased the AUC of @DRUG1$ by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of @DRUG2$ on Days 1 through 3.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6144,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6145,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6146,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6147,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an @DRUG1$ containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of @DRUG2$ of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6148,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, bumetanide, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6149,
        "sentence": "@DRUG1$ (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6150,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG2$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6151,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG2$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6152,
        "sentence": "- a @DRUG1$ such as propranolol (@DRUG2$), atenolol (Tenormin), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6153,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6154,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6155,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6156,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, cetirizine, famotidine, fluconazole, @DRUG2$, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6157,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6158,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6159,
        "sentence": "Probenecid may decrease renal tubular secretion of @DRUG1$ when used concurrently, resulting in increased and more prolonged @DRUG2$ blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6160,
        "sentence": "These results suggest that the analgesic effect of @DRUG1$ may be diminished when it is administered shortly after @DRUG2$ nasal spray, but by 30 minutes any such reduction in effect should be minimal.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6161,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to @DRUG2$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6162,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6163,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, @DRUG1$, troleandomycin, @DRUG2$, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6164,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG2$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6165,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6166,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6167,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6168,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6169,
        "sentence": "- Methyldopa (e.g., @DRUG1$) Use of @DRUG2$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6170,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, @DRUG1$, propantheline, digoxin, and @DRUG2$, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6171,
        "sentence": "@DRUG1$  decreased the Cmax and AUC of sustained-release verapamil (@DRUG2$ ) by approximately 31% and 11%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6172,
        "sentence": "Because of the possible additive effects of drugs that may depress the nervous system, @DRUG1$ or triazolam should be used cautiously in combination with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6173,
        "sentence": "As with other antihypertensive agents, the antihypertensive effect of @DRUG1$ may be blunted by the @DRUG2$ indomethacin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6174,
        "sentence": "Coadministration of alosetron and strong CYP3A4 inhibitors, such as @DRUG1$, telithromycin, protease inhibitors, voriconazole, and @DRUG2$ has not been evaluated but should be undertaken with caution because of similar potential drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6175,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG1$, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6176,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6177,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6178,
        "sentence": "When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - @DRUG1$ and Bezalip retard may enhance the action of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6179,
        "sentence": "Co-administration of multiple doses of 10 mg of @DRUG1$ had no effect on the single dose pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6180,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG1$, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6181,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6182,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6183,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6184,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG1$, morphine, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6185,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG1$, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6186,
        "sentence": "@DRUG1$, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, @DRUG2$, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6187,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6188,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG1$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6189,
        "sentence": "Immunosuppressive Drugs, @DRUG1$, Niacin (@DRUG2$, Erythromycin, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6190,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG1$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6191,
        "sentence": "and disulfiram When amitriptyline HCl is given with @DRUG1$ agents or sympathomimetic drugs, including epinephrine combined with local @DRUG2$, close supervision and careful adjustment of dosages are required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6192,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6193,
        "sentence": "Patients taking @DRUG1$ may not benefit from opioid containing medicines, such as cough and cold preparations, antidiarrheal preparations, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6194,
        "sentence": "No dose adjustment is necessary when Simulect is added to triple-immunosuppression regimens including cyclosporine, @DRUG1$, and either @DRUG2$ or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6195,
        "sentence": "Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, @DRUG1$, fluoxetine, or paroxetine) can inhibit @DRUG2$ elimination and cause increased blood levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6196,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$. @DRUG2$ antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6197,
        "sentence": "Of over 3500 patients enrolled in the @DRUG1$ osteoporosis Treatment and Prevention Studies, 15% used anti-peptic agents (primarily @DRUG2$ and PPIs).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6198,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that @DRUG1$, in combination with cyclosporine or tacrolimus, might have the potential to reduce the frequency of rejection episodes, permit reductions in cyclosporine or @DRUG2$ dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6199,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6200,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, @DRUG1$, isosorbide dinitrate, morphine, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6201,
        "sentence": "Anticholinergics: Concurrent administration of certain @DRUG1$, such as belladonna alkaloids and @DRUG2$, would be expected to compromise the beneficial effects of cisapride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6202,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6203,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG2$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6204,
        "sentence": "@DRUG1$ interferes with the therapeutic action of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6205,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, @DRUG1$, clofibrate, methyldopa, nicotinic acid (niacin), @DRUG2$, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6206,
        "sentence": "@DRUG1$ and @DRUG2$ may reduce or reverse the pressor effect of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6207,
        "sentence": "These in vitro studies suggest that concomitant administration of zalcitabine and @DRUG1$ in humans may result in sub-therapeutic concentrations of active phosphorylated @DRUG2$, which may lead to a decreased antiretroviral effect of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6208,
        "sentence": "Antithyroid agents may decrease thyroidal uptake of @DRUG1$, a rebound in uptake may occur up to 5 days after sudden withdrawal of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6209,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG2$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6210,
        "sentence": "Some @DRUG1$ have also been shown to interfere with the metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6211,
        "sentence": "Immunosuppressive Drugs, Fibric Acid Derivatives, @DRUG1$ (Nicotinic Acid, Erythromycin, @DRUG2$: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6212,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG1$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6213,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG1$, famotidine, fluconazole, lamivudine, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6214,
        "sentence": "A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of @DRUG1$ and a 5.4-fold increase in AUC of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6215,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6216,
        "sentence": "Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, @DRUG1$, propranolol, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6217,
        "sentence": "@DRUG1$, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by @DRUG2$ (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6218,
        "sentence": "Reported examples of this interaction include the following: @DRUG1$s: Cyclosporine (CYP3A4 substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of @DRUG2$ resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6219,
        "sentence": "However, since aspirin, @DRUG1$, and @DRUG2$ are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6220,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other @DRUG1$-associated adverse events by interfering with the renal clearance of @DRUG2$ (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6221,
        "sentence": "There does not appear to be an increase in adverse events in subjects who received oral @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6222,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and @DRUG1$ may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of @DRUG2$ (thereby raising systemic exposure).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6223,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6224,
        "sentence": "Isoflurane, @DRUG1$, and halothane decrease the ED50 of @DRUG2$ by 30% to 45%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6225,
        "sentence": "@DRUG1$ should not be used concomitantly with other drugs known to prolong the QT interval: certain @DRUG2$, including those of Class IA (such as quinidine and procainamide) and Class III (such as sotalol);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6226,
        "sentence": "Antacids: Concomitant administration of @DRUG-DRUG$s does not interfere with absorption of meclofenamate sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6227,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG1$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6228,
        "sentence": "Cimetidine: @DRUG1$ can inhibit the metabolism of @DRUG2$, increasing its plasma level.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6229,
        "sentence": "The concomitant use of transdermal fentanyl with @DRUG1$ or other potent 3A4 inhibitors such as ketoconazole, itraconazole, @DRUG2$, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6230,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6231,
        "sentence": "Although @DRUG1$ may increase the bioavailability of levodopa by increasing gastric emptying, @DRUG2$ may also adversely affect disease control by its dopamine receptor antagonistic properties.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6232,
        "sentence": "In addition, the beneficial effects of levodopa in Parkinsons disease have been reported to be reversed by @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6233,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., @DRUG1$), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6234,
        "sentence": "Concomitant administration of FACTIVE and @DRUG1$, @DRUG2$, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6235,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6236,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with @DRUG1$ (alcohol, barbiturates, opiates, sedatives, or @DRUG2$) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6237,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6238,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, @DRUG1$, amiloride), @DRUG2$ supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6239,
        "sentence": "For example, since cholestyramine may reduce the gastrointestinal absorption of both the oral @DRUG1$ and @DRUG2$, the net effects are unpredictable.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6240,
        "sentence": "If signs and symptoms suggestive of @DRUG1$ toxicity occur when enoxacin and digoxin are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust @DRUG2$ doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6241,
        "sentence": "Rifampin: @DRUG1$ increases the metabolism of ethinyl estradiol and some progestins (@DRUG2$) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6242,
        "sentence": "The oral @DRUG1$ doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of dexamethasone similar to those obtained when it is given without @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6243,
        "sentence": "@DRUG1$  decreased the Cmax and AUC of sustained-release @DRUG2$ (Calan SR ) by approximately 31% and 11%, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6244,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$ has been reported to result in elevated digoxin serum levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6245,
        "sentence": "@DRUG1$, Fibric Acid Derivatives, @DRUG2$ (Nicotinic Acid, Erythromycin, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6246,
        "sentence": "Such individuals are referred to as  poor metabolizers  of drugs such as @DRUG1$, @DRUG2$, and the tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6247,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6248,
        "sentence": "The pharmacokinetic variables for @DRUG1$ were determined after a 1.0 mg intravenous dose of @DRUG2$ in each subject, before and after oral amiodarone, 400 mg daily for 3 weeks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6249,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6250,
        "sentence": "Phospholine Iodide potentiates other @DRUG1$ such as succinylcholine or organophosphate and @DRUG2$s.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6251,
        "sentence": "If signs and symptoms suggestive of digoxin toxicity occur when enoxacin and @DRUG1$ are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust @DRUG2$ doses appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6252,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than @DRUG1$ suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6253,
        "sentence": "@DRUG1$ pharmacokinetic parameter values were not affected by administration of Neurontin  2 hours after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6254,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6255,
        "sentence": "Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by @DRUG1$, since @DRUG2$ and chlorpropamide may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6256,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6257,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., @DRUG1$, barbiturates, tranquilizers, and @DRUG2$) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6258,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], @DRUG2$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6259,
        "sentence": "- a @DRUG1$ such as propranolol (Inderal), atenolol (Tenormin), acebutolol (Sectral), metoprolol (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6260,
        "sentence": "Plasma TCA concentrations may need to be monitored and the dose of the @DRUG1$ may need to be reduced if a TCA is co-administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6261,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6262,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of @DRUG1$, phenazepam, phenibut and @DRUG2$ and reduces the action of phentolamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6263,
        "sentence": "Antacids and @DRUG1$: @DRUG2$ and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6264,
        "sentence": "In vitro, @DRUG1$ does not displace tightly bound drugs like @DRUG2$, propranolol, and warfarin from serum proteins.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6265,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some @DRUG2$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6266,
        "sentence": "Vitamin A and oral retinoids: Concomitant administration of @DRUG1$ and/or other oral @DRUG2$ with acitretin must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6267,
        "sentence": "Due to a theoretical risk of a pharmacodynamic interaction, use of @DRUG1$-containing or ergot-type medications (like dihydroergotamine or @DRUG2$) and FROVA within 24 hours of each other should be avoided (see  a href= frova_od.htm#CI CONTRAINDICATIONS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6268,
        "sentence": "Methamphetamine, like @DRUG1$, produced depletions of striatal dopamine but these actions were potentiated by @DRUG2$ pretreatment.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6269,
        "sentence": "This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6270,
        "sentence": "Drug-Drug Interactions Albuterol - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) @DRUG1$ (or other @DRUG2$) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6271,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of @DRUG1$ binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for @DRUG2$ in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6272,
        "sentence": "Drug-Drug Interactions Albuterol - @DRUG1$ should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other beta2 agonists) because the action of @DRUG2$ on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6273,
        "sentence": "Coadministration of @DRUG1$ with lamivudine, adefovir dipivoxil,or @DRUG2$ did not result in significant drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6274,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, @DRUG1$, orphenadrine, pyrilamine, phenyltoloxamine, promethazine, @DRUG2$, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6275,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6276,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG1$, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6277,
        "sentence": "In the present study, evoked potentials were recorded at 5, 20, and 40 min following IP injections of saline, ethanol (2.0 g/kg), @DRUG1$ (0.6 mg/kg) or @DRUG2$ (15.0 mg/kg) on separate days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6278,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG1$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6279,
        "sentence": "Anticonvulsants: @DRUG1$ Phenobarbital @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6280,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6281,
        "sentence": "Netilmicin should not be administered concomitantly with potent @DRUG1$ such as @DRUG2$ and ethacrynic acid as the potential for ototoxicity is enhanced by the combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6282,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6283,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6284,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG1$ [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6285,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : @DRUG1$: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6286,
        "sentence": "Oral Anticoagulants: In some normal volunteers, the concomitant administration of @DRUG1$ and @DRUG2$, acenocoumarol, or phenprocoumon resulted in prolongation of prothrombin time.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6287,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6288,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with sucralfate, with metal cations such as @DRUG2$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6289,
        "sentence": "Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that @DRUG1$ clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6290,
        "sentence": "This information should be considered when changing from intravenous @DRUG1$ to oral @DRUG2$ .",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6291,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. @DRUG1$), antihistamines antipsychotic agents (e.g. @DRUG2$), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6292,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6293,
        "sentence": "Elevated serum levels of cyclosporine have been reported with the concomitant use of some @DRUG1$ and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6294,
        "sentence": "Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of @DRUG1$, nifedipine, propranolol, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6295,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6296,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6297,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, @DRUG1$, sulfonamides, chloramphenicol, probenecid, @DRUG2$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6298,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6299,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6300,
        "sentence": "Potassium-sparing diuretics (@DRUG1$, @DRUG2$,triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6301,
        "sentence": "Oral Hypoglycemics: Bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for @DRUG1$ or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6302,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$ and aluminum hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as Orudis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6303,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6304,
        "sentence": "The anxiogenic effects of theophylline were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by @DRUG1$ (@DRUG2$), an A1-selective agonist.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6305,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6306,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG1$, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6307,
        "sentence": "The concomitant use of transdermal @DRUG1$ with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6308,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6309,
        "sentence": "This drug may interact with alcohol or other @DRUG1$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6310,
        "sentence": "Following oral administration of two 150-mg sustained-release tablets with and without 800 mg of cimetidine, the pharmacokinetics of @DRUG1$ and @DRUG2$ were unaffected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6311,
        "sentence": "@DRUG1$ may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of @DRUG2$ by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6312,
        "sentence": "In addition, under the influence of sympatholytic medicinal products such as @DRUG1$, @DRUG2$, guanethidine, and reserpine, the signs of hypoglycemia may be reduced or absent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6313,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, @DRUG2$, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6314,
        "sentence": "Similarly, the effects of phenytoin on @DRUG1$, @DRUG2$ and sodium plasma valproate concentrations are unpredictable",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6315,
        "sentence": "Capsules @DRUG1$ 50 mg t.i.d. produced a clinically relevant elevation of plasma @DRUG2$ and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6316,
        "sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic @DRUG1$ containing 60 mg of elemental iron (as FeSO4) or @DRUG2$ supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6317,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general @DRUG1$, local anesthetics like lidocaine, procaine, beta-blockers, @DRUG2$, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6318,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), @DRUG1$, @DRUG2$, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6319,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, @DRUG1$, sulfonamides and @DRUG2$ might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6320,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6321,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6322,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6323,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, @DRUG1$, propantheline, digoxin, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6324,
        "sentence": "@DRUG1$ therapy should be monitored, particularly during the first few weeks, after initiating therapy with @DRUG2$ in patients receiving warfarin or similar agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6325,
        "sentence": "Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6326,
        "sentence": "Oral @DRUG1$: In some normal volunteers, the concomitant administration of diflunisal and warfarin, acenocoumarol, or @DRUG2$ resulted in prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6327,
        "sentence": "@DRUG1$: If acitretin is given concurrently with @DRUG2$, the protein binding of phenytoin may be reduced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6328,
        "sentence": "Although not studied with alosetron, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as @DRUG1$, @DRUG2$, and hydralazine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6329,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), @DRUG2$, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6330,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as @DRUG1$, foscarnet, and @DRUG2$ may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6331,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6332,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with @DRUG1$, sedatives, hypnotics, and @DRUG2$ is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6333,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], @DRUG1$ [e.g., Trilafon], prochlorperazine [e.g., @DRUG2$], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6334,
        "sentence": "Tissue culture and animal studies indicate that @DRUG1$ can diminish or abolish the effect of @DRUG2$ on malignant cells.14 This effect on methotrexate activity persists as long as plasma asparagine levels are suppressed.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6335,
        "sentence": "No significant interactions with digoxin, @DRUG1$, hydralazine, sulfinpyrazone, oral contraceptives, @DRUG2$, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6336,
        "sentence": "The adverse experience profile seen with @DRUG1$ was similar to that seen with @DRUG2$ tablets.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6337,
        "sentence": "Coadministration of @DRUG1$ with @DRUG2$, adefovir dipivoxil,or tenofovir disoproxil fumarate did not result in significant drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6338,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the @DRUG1$ of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6339,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6340,
        "sentence": "The antimicrobial combinations of @DRUG1$ with four @DRUG2$ resulted in additive effect in most instances, synergism in two instances, and antagonism in two instances.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6341,
        "sentence": "Antacids and sucralfate: Sucralfate and @DRUG1$ containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (@DRUG2$), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6342,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, @DRUG1$, or other CNS depressants (including alcohol) concomitantly with @DRUG2$ and acetaminophen tablets may exhibit an additive CNS depression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6343,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, @DRUG1$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6344,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6345,
        "sentence": "Coadministration of ethoxzolamide with other @DRUG1$, amphotericin B, and @DRUG2$ may cause hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6346,
        "sentence": "In patients taking furosemide, nifedipine, @DRUG1$, ACE inhibitors, verapamil, glyburide, @DRUG2$, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6347,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG1$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6348,
        "sentence": "Heparin: Since @DRUG1$ is contraindicated in patients with @DRUG2$-induced thrombocytopenia, the co-administration of Argatroban and heparin is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6349,
        "sentence": "Concomitant administration of @DRUG1$ and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral @DRUG2$ produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6350,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, @DRUG1$, lamivudine, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6351,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of @DRUG1$, phenazepam, @DRUG2$ and amizyl and reduces the action of phentolamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6352,
        "sentence": "Concurrent administration of indinavir and @DRUG1$ significantly reduces the level of exposure to indinavir, but it is unclear how soon after didanosine administration @DRUG2$ may be given safely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6353,
        "sentence": "Elevated serum levels of @DRUG1$ have been reported with the concomitant use of some @DRUG2$ and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6354,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG2$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6355,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, @DRUG1$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6356,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, aminosalicylic acid, @DRUG2$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6357,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6358,
        "sentence": "@DRUG1$ (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6359,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG1$ (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6360,
        "sentence": "@DRUG1$ steady state plasma concentrations (40 mg BID) were not affected significantly with multiple doses of @DRUG2$ (40 mg QD).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6361,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, @DRUG2$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6362,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, @DRUG1$, grapefruit juice, cimetidine) with @DRUG2$ may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6363,
        "sentence": "Phenobarbital (@DRUG1$): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG2$ (primidone) with or without other enzyme-inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6364,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6365,
        "sentence": "@DRUG1$: Combination @DRUG2$ may increase or decrease the effects of coumarin derivatives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6366,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG2$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6367,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG1$, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG2$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6368,
        "sentence": "For example, since @DRUG1$ may reduce the gastrointestinal absorption of both the oral @DRUG2$ and vitamin K, the net effects are unpredictable.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6369,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6370,
        "sentence": "Antacids: Concomitant administration of magnesium hydroxide and @DRUG1$ does not interfere with the rate or extent of the absorption of @DRUG2$ administered as Orudis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6371,
        "sentence": "therefore, coadministration of @DRUG1$ with drugs that strongly induce CYP3A4 activity (e.g., @DRUG2$, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6372,
        "sentence": "Concomitant single dose administration of valdecoxib 20 mg with multiple doses of ketoconazole and @DRUG1$ produced a significant increase in exposure of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6373,
        "sentence": "Amphotericin, @DRUG1$, and Aminoglycosides: Drugs such as amphotericin, foscarnet, and @DRUG2$ may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6374,
        "sentence": "@DRUG1$: Potential interaction of Ketoconazole and @DRUG2$ may exist.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6375,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/@DRUG1$ oral @DRUG2$ produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6376,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6377,
        "sentence": "Antacids or @DRUG1$: When dirithromycin is administered immediately following antacids or @DRUG2$, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6378,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG2$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6379,
        "sentence": "At 24 hours postdose, a similar proportion of patients treated with methotrexate alone (94%) and subsequently treated with @DRUG1$ co-administered with 75 mg of @DRUG2$ (88%) had methotrexate plasma concentrations below the measurable limit (5 ng/mL).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6380,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6381,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral @DRUG1$ supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the magnesium intake and pharmacological @DRUG2$ therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6382,
        "sentence": "The adverse effects of @DRUG1$, such as myelosuppression and diarrhea, would be expected to be exacerbated by other @DRUG2$ having similar adverse effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6383,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6384,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, @DRUG1$, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and @DRUG2$) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6385,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6386,
        "sentence": "In patients taking furosemide, nifedipine, diltiazem, @DRUG1$, verapamil, @DRUG2$, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6387,
        "sentence": "@DRUG1$ (carbamazepine, felbamate, phenobarbital, phenytoin, @DRUG2$): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6388,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG1$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6389,
        "sentence": "In vitro, buspirone does not displace tightly bound drugs like phenytoin, @DRUG1$, and @DRUG2$ from serum proteins.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6390,
        "sentence": "Anesthetics/Sedatives/Hypnotics/Opioids: Co-administration of PRECEDEX with @DRUG1$, sedatives, @DRUG2$, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6391,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6392,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine @DRUG1$ of class (e.g. quinidine), antihistamines @DRUG2$ (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6393,
        "sentence": "RESULTS: The geometric mean (90% confidence interval) whole blood @DRUG1$ area under the plasma concentration time-curve increased 60% (35%-90%), from 736 to 1178 ng x h/mL, and maximum concentration increased 43% (14%-81%), from 67 to 96 ng/mL, with @DRUG2$ coadministration, whereas the mean elimination half-life of sirolimus decreased slightly, from 79 to 67 hours.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6394,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, @DRUG1$, famotidine, fluconazole, @DRUG2$, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6395,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6396,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG1$, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6397,
        "sentence": "In controlled clinical trials, however, beta blockers including @DRUG1$ were concurrently administered with @DRUG2$ and were well tolerated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6398,
        "sentence": "@DRUG1$: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the @DRUG2$ phenelzine .",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6399,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6400,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6401,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, @DRUG1$, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of @DRUG2$, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6402,
        "sentence": "The effect of a pulmonary surfactant extract from bovine lung, @DRUG1$, on the dissolution rate of aerosol particles of @DRUG2$ was determined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6403,
        "sentence": "Two different types of therapy with @DRUG1$ are used: physiological oral @DRUG2$ supplementation which is totally atoxic since it palliates magnesium deficiencies by simply normalizing the magnesium intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic magnesium overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6404,
        "sentence": "Long Acting @DRUG1$: Nifedipine may be safely co-administered with @DRUG2$, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6405,
        "sentence": "- Phenytoin (e.g., @DRUG1$) Use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6406,
        "sentence": "Oral @DRUG1$ may potentiate the hypoglycemic action of hypoglycemic agents, eg, tolbutamide and @DRUG2$, by inhibiting their metabolism in the liver.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6407,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, @DRUG1$, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6408,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, @DRUG1$, metoclopramide, propantheline, @DRUG2$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6409,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, @DRUG1$, lorazepam, nelfinavir, paroxetine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6410,
        "sentence": "Anticonvulsants (@DRUG1$, felbamate, phenobarbital, phenytoin, topiramate): Increase the metabolism of @DRUG2$ and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6411,
        "sentence": "Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max @DRUG1$ by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of @DRUG2$ by 9% (90% confidence limit: 19% decrease to 2% increase).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6412,
        "sentence": "If the usual amounts of nondepolarizing relaxants are given, the time for recovery from neuromuscular blockade will be longer in the presence of Enflurane than when @DRUG1$ or @DRUG2$ with a balanced technique are used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6413,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6414,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG2$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6415,
        "sentence": "Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of @DRUG1$ (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6416,
        "sentence": "A case report of one patient taking amiodarone 200 mg and @DRUG1$ 800 mg three times a day resulted in increases in @DRUG2$ concentrations from 0.9 mg/L to 1.3 mg/L.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6417,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, famotidine and @DRUG1$) is likely to reduce @DRUG2$ exposure.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6418,
        "sentence": "BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with @DRUG1$, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of @DRUG2$ on the cardiovascular system may be potentiated by these agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6419,
        "sentence": "Because of the possible additive effects of drugs that may depress the nervous system, @DRUG1$ or @DRUG2$ should be used cautiously in combination with tiagabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6420,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or @DRUG2$, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6421,
        "sentence": "@DRUG1$ at 1% (m/v) in the presence of free @DRUG2$ had no significant effect on the R-value of NaFlu compared to NaCMC alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6422,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6423,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6424,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6425,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of @DRUG1$, @DRUG2$, phenibut and amizyl and reduces the action of phentolamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6426,
        "sentence": "Histamine H2 antagonists: @DRUG1$ inhibits CYP3A4 and can increase serum @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6427,
        "sentence": "When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when @DRUG1$ is used alone because @DRUG2$ may potentiate the effect of atropine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6428,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6429,
        "sentence": "Spontaneous reports of serotonin syndrome associated with co-administration of ZYVOX and @DRUG1$, including antidepressants such as @DRUG2$ (SSRIs), have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6430,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of @DRUG1$, ketamine, or droperidol but not after administration of @DRUG2$ alone or after pentobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6431,
        "sentence": "Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with @DRUG1$ because of its structural similarity to other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6432,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6433,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of @DRUG1$ (e.g., spironolactone, triamterene, amiloride), @DRUG2$ supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6434,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6435,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG1$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6436,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6437,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of @DRUG1$ are not altered by @DRUG2$, amphotericin B, mycophenolate, nelfinavir, or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6438,
        "sentence": "@DRUG1$: @DRUG2$, simvastatin WARNING potential for serious reactions such as risk of myopathy including rhabdomyolysis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6439,
        "sentence": "@DRUG1$ plasma concentrations were also not affected by co-administration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6440,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG2$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6441,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6442,
        "sentence": "Patients on oral @DRUG1$ receiving @DRUG2$ treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6443,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6444,
        "sentence": "@DRUG1$: Elevated serum levels of @DRUG2$ have been reported with concomitant use of cyclosporine with other members of the quinolone class.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6445,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between @DRUG1$ and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for @DRUG2$ increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6446,
        "sentence": "This interaction should be given consideration in patients taking @DRUG1$ concomitantly with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6447,
        "sentence": "Because of the low dietary @DRUG1$ concentration as compared to the iron contents of the diets, no effect of @DRUG2$ on iron absorption and excretion occurred.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6448,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of @DRUG1$, ketoconazole, methotrexate, phenytoin, @DRUG2$, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6449,
        "sentence": "@DRUG1$ potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and @DRUG2$s.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6450,
        "sentence": "Certain antibiotic, @DRUG1$, cyclosporine, diuretic, @DRUG2$, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6451,
        "sentence": "@DRUG1$: Furosemide administered concurrently with captopril does not alter the pharmacokinetics of @DRUG2$ in renally impaired hypertensive patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6452,
        "sentence": "Potassium-sparing diuretics (@DRUG1$, @DRUG2$, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6453,
        "sentence": "Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking @DRUG1$ with or without other enzyme- inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6454,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG2$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6455,
        "sentence": "Iron Supplements and Foods Fortified With @DRUG1$ Concomitant administration of cefdinir with a therapeutic @DRUG2$ containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6456,
        "sentence": "Antacids or @DRUG1$: When @DRUG2$ is administered immediately following antacids or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6457,
        "sentence": "Those for which effectiveness is reported includes @DRUG1$, hydroxyzine, orphenadrine, @DRUG2$, phenyltoloxamine, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6458,
        "sentence": "The combination of therapeutic doses of intravenous @DRUG1$ and @DRUG2$ in halothane a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6459,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6460,
        "sentence": "Methotrexate @DRUG1$ 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of @DRUG2$ as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6461,
        "sentence": "The oral dexamethasone doses should be reduced by approximately 50% when coadministered with @DRUG1$, to achieve exposures of dexamethasone similar to those obtained when it is given without @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6462,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6463,
        "sentence": "and phase 3 (days 45-52): @DRUG1$ 10 mg 4 times/day (days 45-51) plus @DRUG2$ 20 mg/day (days 45-52).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6464,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6465,
        "sentence": "However, due to possible pharmacodynamic interactions, when co-administered with @DRUG1$, a reduction in dosage of @DRUG2$ on the concomitant anesthetic, sedative, hypnotic or opioid may be required.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6466,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6467,
        "sentence": "The effect of a @DRUG1$ extract from bovine lung, @DRUG2$, on the dissolution rate of aerosol particles of budesonide was determined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6468,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, @DRUG2$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6469,
        "sentence": "Interactions between treatments with @DRUG1$, bishydroxycoumarin (an anticoagulant), trichlorfon (an organophosphorous compound), and @DRUG2$ (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6470,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6471,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6472,
        "sentence": "Both 18-MC and @DRUG1$ are sequestered in fat and, like @DRUG2$, 18-MC probably has an active metabolite.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6473,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6474,
        "sentence": "Venlafaxine: Coadministration of a single dose of @DRUG1$ 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either @DRUG2$ or venlafaxine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6475,
        "sentence": "@DRUG1$: The safety and effectiveness of @DRUG2$ with thrombolytic agents have not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6476,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6477,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, @DRUG1$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, @DRUG2$, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6478,
        "sentence": "@DRUG1$ produced a decrease of 20% [90% CI: 18-27] of the plasma levels of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6479,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6480,
        "sentence": "Cimetidine, @DRUG1$: In normal volunteers (n=9), pretreatment with cimetidine or @DRUG2$ did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6481,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, @DRUG1$, phenytoin, tolbutamide, and @DRUG2$ have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6482,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG1$, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6483,
        "sentence": "Sirolimus works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of @DRUG1$ does not appear to overlap to any great extent with that associated with @DRUG2$ or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6484,
        "sentence": "On the other hand, intrathecal @DRUG1$ (12-120 micrograms) had only a very weak effect on the tail-flick inhibition induced by intraventricular @DRUG2$ (40 micrograms).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6485,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6486,
        "sentence": "Ketoconazole: Coadministration of @DRUG1$ with @DRUG2$ resulted in a 35% increase in nelfinavir plasma A.C.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6487,
        "sentence": "Isoflurane, @DRUG1$, and @DRUG2$ decrease the ED50 of NUROMAX by 30% to 45%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6488,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), @DRUG2$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6489,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, @DRUG1$, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6490,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6491,
        "sentence": "Patients receiving other narcotic analgesics, @DRUG1$, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and @DRUG2$ tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6492,
        "sentence": "Warfarin, @DRUG1$, Salicylate, and Heparin The in vitro binding of @DRUG2$ to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6493,
        "sentence": "@DRUG1$ Agents: @DRUG2$ is contraindicated in patients who are hypersensitive to nonsteroidal anti-inflammatory agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6494,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6495,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6496,
        "sentence": "Inhibitors or substrates of CYP2D6 (i.e., @DRUG1$, selective serotonin reuptake inhibitors [SSRIs]) may increase the plasma concentration of @DRUG2$ when administered concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6497,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, bumetanide, clofibrate, @DRUG2$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6498,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of diazepam, @DRUG1$, @DRUG2$ and amizyl and reduces the action of phentolamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6499,
        "sentence": "Because both of these drugs have negative inotropic properties and the effects of coadministration with TAMBOCOR are unknown, neither @DRUG1$ nor verapamil should be administered concurrently with @DRUG2$ unless, in the judgment of the physician, the benefits of this combination outweigh the risks.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6500,
        "sentence": "Use of PRINIVIL with @DRUG1$ (e.g., spironolactone, @DRUG2$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6501,
        "sentence": "Certain antibiotic, cisplatin, @DRUG1$, @DRUG2$, foscarnet, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6502,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6503,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6504,
        "sentence": "@DRUG1$: Co-administration of @DRUG2$ 125 mg b.i.d. and ketoconazole, a potent CYP3A4 inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6505,
        "sentence": "Ethoxzolamide may increase the action of tricyclics, @DRUG1$, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6506,
        "sentence": "Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., @DRUG1$, @DRUG2$), patients should be observed closely for development of hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6507,
        "sentence": "Hypotension was more likely to occur if the calcium antagonist were a dihydropyridine derivative, e.g., @DRUG1$, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either verapamil or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6508,
        "sentence": "Such individuals are referred to as poor metabolizers of drugs such as debrisoquin, @DRUG1$, the tricyclic antidepressants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6509,
        "sentence": "@DRUG1$: Cimetidine can inhibit the metabolism of @DRUG2$, increasing its plasma level.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6510,
        "sentence": "Methotrexate: Concomitant administration of @DRUG1$ and some @DRUG2$ has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6511,
        "sentence": "Concomitant use of @DRUG1$ with @DRUG2$, tricyclic antidepressants, barbiturates, or other central nervous system depressants may have an additive effect.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6512,
        "sentence": "and calcium channel antagonists e.g., @DRUG1$), CYP1A2 inducers (omeprazole) and CYP1A2 inhibitors (@DRUG2$ and clarithromycin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6513,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, @DRUG1$, itraconazole, erythromycin, grapefruit juice, cimetidine) with @DRUG2$ may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6514,
        "sentence": "In clinical studies, coadministration of WelChol  with @DRUG1$, @DRUG2$, or simvastatin did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6515,
        "sentence": "Anesthetics/Sedatives/@DRUG1$/Opioids: Co-administration of PRECEDEX with anesthetics, @DRUG2$, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6516,
        "sentence": "Nonsteroidal anti-inflammatory agents (NSAIDS): Concomitant use of @DRUG1$ (or other @DRUG2$) and corticosteroids increases the risk of gastrointestinal side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6517,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6518,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6519,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG1$, diltiazem, grapefruit juice, @DRUG2$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6520,
        "sentence": "@DRUG1$: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and @DRUG2$ in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6521,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6522,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG1$, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6523,
        "sentence": "Use of PRINIVIL with potassium-sparing diuretics (e.g., spironolactone, @DRUG1$, or amiloride), @DRUG2$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6524,
        "sentence": "The anxiogenic effects of @DRUG1$ were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by @DRUG2$ (CPA), an A1-selective agonist.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6525,
        "sentence": "Nucleoside Analogues @DRUG1$ Co-administration of COPEGUS and @DRUG2$ is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6526,
        "sentence": "@DRUG1$s: In a small clinical trial in which lovastatin was administered to @DRUG2$ treated patients, no effect on prothrombin time was detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6527,
        "sentence": "Sirolimus works differently from the @DRUG1$ currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with @DRUG2$ or tacrolimus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6528,
        "sentence": "H2 Blockers/@DRUG1$: Long-term suppression of gastric acid secretion by H2 blockers or proton pump inhibitors (eg, famotidine and omeprazole) is likely to reduce @DRUG2$ exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6529,
        "sentence": "Because @DRUG1$, aspirin, or @DRUG2$ may cause bleeding complications, careful monitoring for bleeding is advised, especially at arterial puncture sites.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6530,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6531,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6532,
        "sentence": "A 21 (17)% decrease in the steady-state AUC of ganciclovir was observed when @DRUG1$ was administered 2 hours prior to @DRUG2$, but not when the two drugs were administered simultaneously (n = 12).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6533,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, @DRUG1$, sulfonylureas, phenothiazines, @DRUG2$ and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6534,
        "sentence": "In this study we investigated the effect of @DRUG1$ on high threshold voltage-dependent Ca(2+) channel subtypes using their @DRUG2$ nimodipine (L-type), omega-conotoxin GVIA (N-type), or omega-agatoxin IVA (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6535,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG2$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6536,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG1$ @DRUG2$ and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6537,
        "sentence": "Several @DRUG1$ have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with @DRUG2$ because of its structural similarity to other tricyclic antidepressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6538,
        "sentence": "Drugs That Inhibit CYP3A4 CYP3A4 is a minor metabolic pathway for the elimination of @DRUG1$ because the sum of desethylzaleplon (formed via CYP3A4 in vitro) and its metabolites, 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon glucuronide, account for only 9% of the urinary recovery of a @DRUG2$ dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6539,
        "sentence": "In vitro studies have shown that the metabolism of @DRUG1$ may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, terfenadine, @DRUG2$, erythromycin, and troleandomycin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6540,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., @DRUG2$], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6541,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG1$), procarbazine (e.g., @DRUG2$), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6542,
        "sentence": "The resulting increase in @DRUG1$ serum levels may increase toxicity, and the decreased urinary levels could lessen its efficacy as a urinary tract @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6543,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6544,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, @DRUG1$, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of @DRUG2$ was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6545,
        "sentence": "Phenobarbital or @DRUG1$ : No formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing @DRUG2$ or primidone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6546,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG1$, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6547,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, clindamycin, clofibrate, @DRUG2$, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6548,
        "sentence": "Additive depressant effect when used with general anesthetics, sedatives, @DRUG1$, @DRUG2$, alcohol, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6549,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6550,
        "sentence": "The time to onset of maximum block following @DRUG1$ is approximately 2 minutes faster with prior administration of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6551,
        "sentence": "@DRUG1$ (@DRUG2$, amiloride,triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6552,
        "sentence": "In this study, the effects of @DRUG1$ upon chylomicron metabolism was tested by determination of the plasma kinetics of a chylomicron-like emulsion model in 12 patients with coronary artery disease, aged 59+/-11 years, (total cholesterol: 240+/-41 mg/dl; triglycerides: 188+/-42 mg/dl) submitted to a randomized, crossover, double-blind, placebo-controlled study with administration of 1 g per day @DRUG2$ or placebo for 1-month.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6553,
        "sentence": "Cimetidine, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of @DRUG1$ resulted with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6554,
        "sentence": "The concomitant use of transdermal @DRUG1$ with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, @DRUG2$, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6555,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, @DRUG1$, lovastatin, bromocriptine, @DRUG2$, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6556,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6557,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6558,
        "sentence": "Therefore, co-administration of @DRUG1$ with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, @DRUG2$, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6559,
        "sentence": "Drugs which induce CYP3A4 activity (eg, @DRUG1$, rifampin, @DRUG2$) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6560,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, @DRUG1$, hydrochlorothiazide, @DRUG2$, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6561,
        "sentence": "@DRUG1$ increase the rate of absorption of pseudoephedrine, while @DRUG2$ decreases it.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6562,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG2$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6563,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6564,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG1$, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6565,
        "sentence": "The concomitant use of H2 blockers or @DRUG1$ with @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6566,
        "sentence": "Concomitant administration of FACTIVE and @DRUG1$, cimetidine, @DRUG2$, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6567,
        "sentence": "Coadministration of @DRUG1$ with lamivudine, @DRUG2$,or tenofovir disoproxil fumarate did not result in significant drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6568,
        "sentence": "A dose adjustment is not needed when @DRUG1$ is administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6569,
        "sentence": "In a study of 12 schizophrenic patients coadministered oral @DRUG1$ and rifampin, plasma @DRUG2$ levels were decreased by a mean of 70% and mean scores on the Brief Psychiatric Rating Scale were increased from baseline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6570,
        "sentence": "CANCIDAS has no effect on the pharmacokinetics of @DRUG1$, @DRUG2$, or the active metabolite of mycophenolate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6571,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6572,
        "sentence": "Coadministration of entecavir with @DRUG1$, @DRUG2$,or tenofovir disoproxil fumarate did not result in significant drug interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6573,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of @DRUG1$, ketamine, or @DRUG2$ but not after administration of fentayl alone or after pentobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6574,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6575,
        "sentence": "In the present study, evoked potentials were recorded at 5, 20, and 40 min following IP injections of saline, @DRUG1$ (2.0 g/kg), @DRUG2$ (0.6 mg/kg) or atropine (15.0 mg/kg) on separate days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6576,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG1$, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6577,
        "sentence": "Because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine, @DRUG1$ and @DRUG2$ should not be co-administered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6578,
        "sentence": "While all the selective serotonin reuptake inhibitors (@DRUG1$), e.g., fluoxetine, sertraline, and @DRUG2$, inhibit P450 2D6, they may vary in the extent of inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6579,
        "sentence": "Probenecid or Cimetidine: Concomitant administration of @DRUG1$ or @DRUG2$ decreases the elimination of zalcitabine, most likely by inhibition of renal tubular secretion of zalcitabine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6580,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6581,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an @DRUG1$/progesterone oral @DRUG2$ produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6582,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, @DRUG1$, alfentanil, @DRUG2$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6583,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6584,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6585,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG1$, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6586,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6587,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6588,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: @DRUG1$ (CYP3A4 substrate) administered in combination with oral @DRUG2$ has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6589,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG1$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6590,
        "sentence": "Lithium Reversible increases in serum @DRUG1$ concentrations and toxicity have been reported during concomitant administration of lithium with @DRUG2$, and with some angiotensin II receptor antagonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6591,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG1$, @DRUG2$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6592,
        "sentence": "Cisapride should not be used concomitantly with other drugs known to prolong the QT interval: certain antiarrhythmics, including those of Class IA (such as @DRUG1$ and @DRUG2$) and Class III (such as sotalol);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6593,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, nonbarbiturate hypnotics, @DRUG2$, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6594,
        "sentence": "RESULTS: The geometric mean (90% confidence interval) whole blood @DRUG1$ area under the plasma concentration time-curve increased 60% (35%-90%), from 736 to 1178 ng x h/mL, and maximum concentration increased 43% (14%-81%), from 67 to 96 ng/mL, with diltiazem coadministration, whereas the mean elimination half-life of @DRUG2$ decreased slightly, from 79 to 67 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6595,
        "sentence": "In a parallel group drug interaction study comparing the intravenous prodrug form of @DRUG1$ at 40 mg BID (n=10) vs placebo (n=9), @DRUG2$ had no effect on in vitro aspirin-mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6596,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6597,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, @DRUG1$, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6598,
        "sentence": "@DRUG1$ and @DRUG2$ - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6599,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG2$, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6600,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6601,
        "sentence": "SINCE @DRUG1$ RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE @DRUG2$ (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6602,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., @DRUG1$), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6603,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG1$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG2$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6604,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, @DRUG1$, @DRUG2$, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6605,
        "sentence": "Studies with ACE inhibitors in combination with @DRUG1$ indicate that the dose of the ACE inhibitor can be reduced when it is given with a @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6606,
        "sentence": "If the usual amounts of nondepolarizing relaxants are given, the time for recovery from neuromuscular blockade will be longer in the presence of @DRUG1$ than when @DRUG2$ or nitrous oxide with a balanced technique are used.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6607,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local @DRUG1$ like lidocaine, procaine, beta-blockers, metaclopramide, @DRUG2$, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6608,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, @DRUG1$, @DRUG2$, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6609,
        "sentence": "@DRUG1$ and oral retinoids: Concomitant administration of vitamin A and/or other oral retinoids with @DRUG2$ must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6610,
        "sentence": "@DRUG1$: @DRUG2$, as well as a metabolite of furazolidone, slow amphetamine metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6611,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, @DRUG1$, omeprazole, or an estrogen/@DRUG2$ oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6612,
        "sentence": "@DRUG1$: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of @DRUG2$ (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6613,
        "sentence": "Carbamazepine - Combined administration of racemic @DRUG1$ (40 mg/day for 14 days) and @DRUG2$ (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6614,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (corticosteroids, cyclosporin, azathioprine, @DRUG1$, @DRUG2$), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6615,
        "sentence": "There are reports of enhanced as well as diminished effects of @DRUG1$ when given concurrently with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6616,
        "sentence": "Probenecid: Concomitant administration of @DRUG1$ ORAL and @DRUG2$ resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6617,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6618,
        "sentence": "@DRUG1$ and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic @DRUG2$ containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6619,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, hydralazine, @DRUG1$, oral contraceptives, tolbutamide, or @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6620,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with @DRUG1$ or other benzodiazepines (caution is recommended during coadministration with @DRUG2$): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6621,
        "sentence": "Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including @DRUG1$, antibiotics (@DRUG2$ or ciprofloxacin) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6622,
        "sentence": "@DRUG1$ should not be used in patients who have previously received the recommended maximum cumulative doses of @DRUG2$ or Cerubidine.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6623,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG1$, perphenazine, phenylbutazone, @DRUG2$, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6624,
        "sentence": "These in vitro studies suggest that concomitant administration of @DRUG1$ and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine, which may lead to a decreased antiretroviral effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6625,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that @DRUG1$ (1 mg/kg) removes the antiedematous action of diazepam, phenazepam, phenibut and amizyl and reduces the action of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6626,
        "sentence": "Other @DRUG1$ should be used with caution in patients taking @DRUG2$, since the effects may be additive.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6627,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6628,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6629,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6630,
        "sentence": "@DRUG1$, Ranitidine: In normal volunteers (n=9), pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small (13 %) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6631,
        "sentence": "Certain drugs, including @DRUG1$ (NSAIDs), salicylates, monoamine oxidase inhibitors, and @DRUG2$ may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6632,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, @DRUG1$, sulfonylureas, phenothiazines, sulfonamides and @DRUG2$ might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6633,
        "sentence": "Other: There appears to be no pharmacokinetic interaction between @DRUG1$ and @DRUG2$, digoxin, or glyburide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6634,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6635,
        "sentence": "Results of preliminary studies in humans and rats suggest that nonabsorbable @DRUG1$ given concurrently with @DRUG2$ may inhibit the desired lactulose-induced drop in colonic pH.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6636,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and @DRUG2$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6637,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., @DRUG1$], @DRUG2$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6638,
        "sentence": "In patients taking furosemide, nifedipine, @DRUG1$, ACE inhibitors, verapamil, @DRUG2$, propranolol, and various chemotherapy agents, no effect was shown on the clearance of hydrodolasetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6639,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6640,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6641,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6642,
        "sentence": "@DRUG1$: @DRUG2$ GI Motility Agents Anti-Migraine Antifungal",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6643,
        "sentence": "Those for which effectiveness is reported includes @DRUG1$, @DRUG2$, orphenadrine, pyrilamine, phenyltoloxamine, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6644,
        "sentence": "@DRUG1$, Fibric Acid Derivatives, Niacin (Nicotinic Acid, @DRUG2$, Azole Antifungals: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6645,
        "sentence": "Although there was no effect of Aprepitant on the plasma AUC of @DRUG1$ determined on Day 3, there was a 34% decrease in @DRUG2$ (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6646,
        "sentence": "@DRUG1$ - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in @DRUG2$ AUC and Cmax of 43% and 39%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6647,
        "sentence": "In contrast, preliminary results from an 8-week controlled study suggested @DRUG1$ 2 to 6 mg/day was superior to @DRUG2$ 5 to 20 mg/day against positive and anxiety/depressive symptoms (p < 0.05), although consistent with the first study, both agents demonstrated similar efficacy on measures of overall psychopathology.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6648,
        "sentence": "In addition, the beneficial effects of @DRUG1$ in Parkinsons disease have been reported to be reversed by phenytoin and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6649,
        "sentence": "Warfarin, @DRUG1$, Salicylate, and @DRUG2$ The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6650,
        "sentence": "Such individuals are referred to as poor metabolizers of drugs such as debrisoquin, dextromethorphan, the @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6651,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6652,
        "sentence": "An increase in serum lithium concentration has been reported during concomitant administration of @DRUG1$ with @DRUG2$, so careful monitoring of serum lithium levels is recommended during concomitant use.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6653,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6654,
        "sentence": "Limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50% for the first sixty (60) minutes following @DRUG1$ induction The concomitant use of @DRUG2$ with ALFENTA can significantly inhibit ALFENTA clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6655,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, phenothiazines, and the Type 1C antiarrhythmics propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6656,
        "sentence": "Since Zarontin (ethosuximide) may interact with concurrently administered @DRUG1$, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease @DRUG2$ levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6657,
        "sentence": "@DRUG1$: In one study of 10 healthy volunteers, administration of PRECEDEX for 45 minutes at a plasma concentration of 1 (one) ng/mL resulted in no clinically meaningful increases in the magnitude or neuromuscular blockade associated with @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6658,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, @DRUG1$, and Type 1C antiarrhythmics (eg, @DRUG2$, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6659,
        "sentence": "This article looks at five commonly used immunosuppressive drugs in turn (corticosteroids, @DRUG1$, azathioprine, @DRUG2$, cyclophosphamide), discussing the main, non-infection, unwanted effects, ways to avoid them and what to do if problems arise.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6660,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6661,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of propranolol (40 mg twice daily), @DRUG1$, theophylline, or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6662,
        "sentence": "Intestinal adsorbents (e. g., @DRUG1$) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, @DRUG2$) may reduce the effect of Acarbose and should not be taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6663,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, @DRUG2$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6664,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6665,
        "sentence": "Interactions between treatments with coumaphos, @DRUG1$ (an anticoagulant), @DRUG2$ (an organophosphorous compound), and phenobarbital sodium (an inducer of microsomal enzymes) were investigated in sheep.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6666,
        "sentence": "It is, however, possible that concomitant use of other known photosensitizing agents such as @DRUG1$, thiazide diuretics, @DRUG2$, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6667,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, cetirizine, @DRUG2$, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6668,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], promazine [e.g., Sparine], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6669,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG2$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6670,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG1$, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6671,
        "sentence": "Those for which effectiveness is reported includes @DRUG1$, hydroxyzine, @DRUG2$, pyrilamine, phenyltoloxamine, promethazine, methdilazine, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6672,
        "sentence": "@DRUG1$ (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6673,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6674,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), @DRUG2$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6675,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6676,
        "sentence": "Vitamin A and oral @DRUG1$: Concomitant administration of @DRUG2$ and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6677,
        "sentence": "@DRUG1$ used concurrently with @DRUG2$ may also result in increased cardiotoxicity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6678,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6679,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG1$, famotidine, furosemide, nonsteroidal anti-inflammatory agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6680,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, @DRUG1$, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma @DRUG2$ concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6681,
        "sentence": "In vitro, @DRUG1$ appears to be displaced from its binding sites by @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6682,
        "sentence": "Cyclosporine, tacrolimus and @DRUG1$ concentrations should be monitored at the initiation of @DRUG2$ therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6683,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), @DRUG1$, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral @DRUG2$ containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6684,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6685,
        "sentence": "Although the clinical significance of these effects is not known, caution is advised in the co-administration of @DRUG1$ with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6686,
        "sentence": "Plasma @DRUG1$ concentrations may need to be monitored and the dose of the TCA may need to be reduced if a @DRUG2$ is co-administered with Duloxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6687,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, @DRUG2$, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6688,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG2$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6689,
        "sentence": "@DRUG1$ attenuates, but 18-MC potentiates, the acute locomotor effects of @DRUG2$;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6690,
        "sentence": "H2 Blockers/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or @DRUG1$ (eg, famotidine and @DRUG2$) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6691,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6692,
        "sentence": "Potassium-sparing diuretics (@DRUG1$, amiloride, triamterene, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6693,
        "sentence": "As with other agents with b-blocking properties, if @DRUG1$ is to be administered orally with calcium channel blockers of the @DRUG2$ or diltiazem type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6694,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG1$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6695,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, @DRUG2$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6696,
        "sentence": "@DRUG1$ and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental @DRUG2$ (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6697,
        "sentence": "- Phenytoin (e.g., @DRUG1$) Use of phenytoin with @DRUG2$ may increase the chance of side effects affecting the liver and/or the side effects of phenytoin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6698,
        "sentence": "@DRUG1$, fluvoxamine, @DRUG2$ (consider Xanax dose reduction).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6699,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG1$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6700,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, @DRUG1$, hypnotics, other @DRUG2$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6701,
        "sentence": "In normal volunteers receiving @DRUG1$, the administration of diflunisal decreased the renal clearance and significantly increased the plasma levels of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6702,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6703,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, @DRUG1$, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6704,
        "sentence": "Oral @DRUG1$: Bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for @DRUG2$ or oral hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6705,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6706,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of @DRUG1$  (dihydroergotamine mesylate) Injection, USP to subjects already receiving @DRUG2$, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6707,
        "sentence": "While additional research is needed, the initial clinical data in kidney recipients suggest that @DRUG1$, in combination with cyclosporine or tacrolimus, might have the potential to reduce the frequency of rejection episodes, permit reductions in @DRUG2$ or tacrolimus dosage, and permit steroid withdrawal (Kelly, 1999).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6708,
        "sentence": "Pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33% when @DRUG1$ was administered following @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6709,
        "sentence": "In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of @DRUG1$ (40 mg twice daily), phenytoin, theophylline, or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6710,
        "sentence": "As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene, @DRUG1$), @DRUG2$ supplements, or salt substitutes containing potassium may lead to increases in serum potassium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6711,
        "sentence": "Nonsteroidal Anti-inflammatory Drugs (NSAIDs): The concomitant administration of a @DRUG1$ with a @DRUG2$ may increase the risks of CNS stimulation and convulsions.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6712,
        "sentence": "Pharmacokinetic interaction studies with @DRUG1$ in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6713,
        "sentence": "Antacids: Concomitant administration of magnesium hydroxide and aluminum hydroxide does not interfere with the rate or extent of the absorption of @DRUG1$ administered as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6714,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$ and cyclosporine levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6715,
        "sentence": "@DRUG1$: Ketoconazole 400 mg daily did not have any clinically important effect on the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6716,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$s does not interfere with absorption of meclofenamate sodium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6717,
        "sentence": "Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of @DRUG1$ that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or @DRUG2$ potentiated the risk of bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6718,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, hydrochlorothiazide, @DRUG1$, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of @DRUG2$ with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6719,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG1$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6720,
        "sentence": "Because of the low dietary @DRUG1$ concentration as compared to the @DRUG2$ contents of the diets, no effect of cobalt on iron absorption and excretion occurred.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6721,
        "sentence": "Concomitant administration of FACTIVE and calcium carbonate, @DRUG1$, omeprazole, or an @DRUG2$/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6722,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, @DRUG2$, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6723,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general @DRUG1$, local anesthetics like lidocaine, @DRUG2$, beta-blockers, metaclopramide, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6724,
        "sentence": "In addition, most @DRUG1$ are contraindicated in patients receiving @DRUG2$ therapy who have pre-existing cardiac abnormalities (arrhythmia, bradycardia, QT c interval prolongation, ischemic heart disease, congestive heart failure, etc.) or electrolyte disturbances.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6725,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other @DRUG1$, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6726,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of diazepam, phenazepam, @DRUG1$ and @DRUG2$ and reduces the action of phentolamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6727,
        "sentence": "The concomitant use of @DRUG1$ or @DRUG2$ with SPRYCEL is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6728,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6729,
        "sentence": "In 5 other schizophrenic patients treated with oral @DRUG1$ and rifampin, discontinuation of rifampin produced a mean 3.3-fold increase in @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6730,
        "sentence": "In patients taking an @DRUG1$ (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6731,
        "sentence": "Although not studied with alosetron, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as @DRUG1$, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6732,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG1$, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6733,
        "sentence": "Although it has not been definitively demonstrated that fluvoxamine is a potent IIIA4 inhibitor, it is likely to be, given the substantial interaction of @DRUG1$ with @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 6734,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: @DRUG1$, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6735,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG1$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6736,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6737,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6738,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6739,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6740,
        "sentence": "In patients taking an anticonvulsant (eg, @DRUG1$, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6741,
        "sentence": "Pregnancy estrogens and @DRUG1$-containing oral @DRUG2$ increase TBg concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6742,
        "sentence": "With oral @DRUG1$ treatment, folic acid antagonists such as @DRUG2$ have been noted to possibly increase the likelihood of hematologic reactions",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6743,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6744,
        "sentence": "Anticonvulsants (carbamazepine, @DRUG1$, phenobarbital, phenytoin, @DRUG2$): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6745,
        "sentence": "Drug-Drug Interactions @DRUG1$ - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) @DRUG2$ (or other beta2 agonists) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6746,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, @DRUG2$, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6747,
        "sentence": "@DRUG1$ may interact with dopamine antagonists, @DRUG2$, and certain other agents.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 6748,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6749,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6750,
        "sentence": "@DRUG1$ can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG2$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6751,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, @DRUG1$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6752,
        "sentence": "An intravenous dose of 50 mg @DRUG1$ was in respect of competitive suppression of organs actively concentrating @DRUG2$ as effective as intravenous 1000 mg ClO-4- simultaneously or 1000 mg orally 30 min before the injection of radiopertechnetate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6753,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the @DRUG1$ propafenone and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6754,
        "sentence": "The behavioral effects of the stereoisomers of N-allylnormetazocine (NANM) were compared with those of @DRUG1$ (@DRUG2$) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6755,
        "sentence": "A possible interaction has been suggested with @DRUG1$ and the herbal supplement St. Johns Wort based on some reports of oral @DRUG2$ users experiencing breakthrough bleeding shortly after starting St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6756,
        "sentence": "At least 3 weeks should elapse between discontinuation of @DRUG1$ and initiation of treatment with a @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6757,
        "sentence": "However, since @DRUG1$, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or @DRUG2$ with Ibandronate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6758,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], @DRUG2$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6759,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, @DRUG2$, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6760,
        "sentence": "In vitro mixing of an aminoglycoside with beta-lactamtype @DRUG1$ (@DRUG2$ or cephalosporins) may result in a significant mutual inactivation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6761,
        "sentence": "Phospholine Iodide potentiates other cholinesterase inhibitors such as @DRUG1$ or @DRUG2$s.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6762,
        "sentence": "Although there was no effect of @DRUG1$ on the plasma AUC of R(+) or S(-) warfarin determined on Day 3, there was a 34% decrease in @DRUG2$ (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6763,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and @DRUG1$, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6764,
        "sentence": "(Concurrent use with @DRUG1$ is not recommended, as they may provoke @DRUG2$ toxicity because of reduced renal clearance.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6765,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6766,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, clindamycin, clofibrate, methyldopa, nicotinic acid (@DRUG2$), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6767,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, @DRUG1$, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6768,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, @DRUG2$, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6769,
        "sentence": "In this study we investigated the effect of @DRUG1$ on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers @DRUG2$ (L-type), omega-conotoxin GVIA (N-type), or omega-agatoxin IVA (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6770,
        "sentence": "Anesthetics/Sedatives/Hypnotics/@DRUG1$: Co-administration of PRECEDEX with anesthetics, @DRUG2$, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6771,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6772,
        "sentence": "Warfarin: The effects of @DRUG1$ and @DRUG2$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6773,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG2$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6774,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG2$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6775,
        "sentence": "Although there was no effect of Aprepitant on the plasma AUC of @DRUG1$ determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6776,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6777,
        "sentence": "Coadministration of @DRUG1$ and @DRUG2$ had no clinically significant effects on blood pressure or heart rate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6778,
        "sentence": "The concurrent use of @DRUG1$ with @DRUG2$ may produce paralytic ileus.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6779,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (@DRUG1$ may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral @DRUG2$, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6780,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of @DRUG1$, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic @DRUG2$ concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6781,
        "sentence": "Anticonvulsants: In a pharmacokinetic study, maximum plasma concentrations of @DRUG1$ were considerably lower in epileptic patients on long-term @DRUG2$ therapy (eg, phenytoin, carbamazepine, or phenobarbital) than in healthy volunteers.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6782,
        "sentence": "Risk of Anaphylactic Reaction: Although it is known that patients on @DRUG1$ may be refractory to epinephrine in the treatment of anaphylactic shock, @DRUG2$ can, in addition, interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6783,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, @DRUG1$, and nefazadone may result in an increase in @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6784,
        "sentence": "Drugs That Inhibit CYP3A4 CYP3A4 is a minor metabolic pathway for the elimination of @DRUG1$ because the sum of desethylzaleplon (formed via CYP3A4 in vitro) and its metabolites, @DRUG2$ and 5-oxo-desethylzaleplon glucuronide, account for only 9% of the urinary recovery of a zaleplon dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6785,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6786,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG2$, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6787,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, @DRUG2$, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6788,
        "sentence": "The action of @DRUG1$ is potentiated by @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6789,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with @DRUG1$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of @DRUG2$, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6790,
        "sentence": "Limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50% for the first sixty (60) minutes following @DRUG1$ induction The concomitant use of erythromycin with @DRUG2$ can significantly inhibit ALFENTA clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6791,
        "sentence": "Anesthetics/@DRUG1$/Hypnotics/Opioids: Co-administration of PRECEDEX with anesthetics, @DRUG2$, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6792,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG1$, @DRUG2$, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6793,
        "sentence": "Quinolone Antibiotics: @DRUG1$ should be administered at least 2 hours after or 6 hours before dosing with @DRUG2$ because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6794,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6795,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6796,
        "sentence": "Because the @DRUG1$ have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their @DRUG2$ dosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6797,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, @DRUG2$, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6798,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6799,
        "sentence": "Cisapride should not be used concomitantly with other drugs known to prolong the QT interval: certain @DRUG1$, including those of Class IA (such as @DRUG2$ and procainamide) and Class III (such as sotalol);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6800,
        "sentence": "When @DRUG1$ or @DRUG2$ is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6801,
        "sentence": "Phase II clinical trial data, where @DRUG1$ and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6802,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit @DRUG1$ binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, @DRUG2$, tamoxifen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6803,
        "sentence": "Amphotericin, @DRUG1$, and Aminoglycosides: Drugs such as amphotericin, @DRUG2$, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6804,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6805,
        "sentence": "Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and @DRUG1$ may potentiate the hypoglycemic action of @DRUG2$ and other oral antidiabetic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6806,
        "sentence": "The percentage of neurons hyperpolarized by @DRUG-DRUG$ was significantly reduced when 1% but not <",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6807,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing @DRUG1$ to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of @DRUG2$ may be reduced by these antacid products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6808,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6809,
        "sentence": "Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6810,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG1$ [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6811,
        "sentence": "Concurrent use of butorphanol with central nervous system depressants (e.g., @DRUG1$, @DRUG2$, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6812,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, @DRUG2$, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6813,
        "sentence": "Although specific drug interaction studies have not been conducted with ALPHAGAN P, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG1$, @DRUG2$, sedatives, or anesthetics) should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6814,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG1$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6815,
        "sentence": "@DRUG1$, tacrolimus and @DRUG2$ concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6816,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: @DRUG1$, clindamycin, clofibrate, methyldopa, nicotinic acid (niacin), tolbutamide, @DRUG2$ or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6817,
        "sentence": "Caution should be exercised when administering @DRUG1$ with @DRUG2$ since interactions have been seen with other NSAIDs.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6818,
        "sentence": "@DRUG1$ and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental @DRUG2$ reduced extent of absorption by 80% and 31%, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6819,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6820,
        "sentence": "If signs and symptoms suggestive of digoxin toxicity occur when @DRUG1$ and @DRUG2$ are given concomitantly, physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6821,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), @DRUG1$ (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and @DRUG2$ (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6822,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, @DRUG2$, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6823,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, clonazepam, clozapine, cyclosporin, @DRUG2$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6824,
        "sentence": "However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of @DRUG1$, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant @DRUG2$ and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6825,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG1$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6826,
        "sentence": "The administration of local @DRUG1$ containing epinephrine or @DRUG2$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6827,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and @DRUG2$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6828,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6829,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG2$, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6830,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and @DRUG1$, @DRUG2$, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6831,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6832,
        "sentence": "No depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs: aspirin, clindamycin, @DRUG1$, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6833,
        "sentence": "Administration of @DRUG1$ with antacids containing aluminum, magnesium, or calcium, with @DRUG2$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6834,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6835,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of @DRUG1$ binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and pyreneperone (0.25 mg/kg) resulted in the reduced interaction between @DRUG2$ and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6836,
        "sentence": "Concomitant use of @DRUG1$ and @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6837,
        "sentence": "Butyrophenones (such as haloperidol) and @DRUG1$ can suppress the @DRUG2$rgic renal and mesenteric vasodilation induced with low dose dopamine infusion.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6838,
        "sentence": "- Phenothiazines (@DRUG1$ [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG2$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6839,
        "sentence": "Hypotension was more likely to occur if the @DRUG1$ were a dihydropyridine derivative, e.g., nifedipine, while left ventricular failure and AV conduction disturbances, including complete heart block, were more likely to occur with either verapamil or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6840,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG1$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6841,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6842,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, @DRUG1$, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6843,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local @DRUG1$ like lidocaine, procaine, beta-blockers, @DRUG2$, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6844,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, @DRUG1$, @DRUG2$, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6845,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: @DRUG1$ and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, @DRUG2$, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6846,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, phenothiazines, and the @DRUG2$ propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6847,
        "sentence": "Pimozide and Celexa - In a controlled study, a single dose of @DRUG1$ 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to @DRUG2$ given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6848,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$ ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6849,
        "sentence": "@DRUG1$/Proton Pump Inhibitors: Long-term suppression of gastric acid secretion by H2 blockers or @DRUG2$ (eg, famotidine and omeprazole) is likely to reduce dasatinib exposure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6850,
        "sentence": "In patients receiving @DRUG1$ alone, @DRUG2$ AUC increased by 27% and Cmax by 21%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6851,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, @DRUG1$ and @DRUG2$, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6852,
        "sentence": "Rifampin: Coadministration of @DRUG1$ and @DRUG2$ Suspension results in a significant decrease in average steady- state plasma atovaquone concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6853,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, @DRUG1$, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6854,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG2$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6855,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6856,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG1$, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6857,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6858,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, @DRUG2$, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6859,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6860,
        "sentence": "@DRUG1$ with @DRUG2$ or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6861,
        "sentence": "Concomitant administration of Norpace and @DRUG1$ resulted in slight increases in plasma disopyramide levels and slight decreases in plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6862,
        "sentence": "@DRUG1$, enflurane, and halothane decrease the ED50 of @DRUG2$ by 30% to 45%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6863,
        "sentence": "Following oral administration of two 150-mg sustained-release tablets with and without 800 mg of @DRUG1$, the pharmacokinetics of bupropion and @DRUG2$ were unaffected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6864,
        "sentence": "In 5 other schizophrenic patients treated with oral haloperidol and @DRUG1$, discontinuation of @DRUG2$ produced a mean 3.3-fold increase in haloperidol concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6865,
        "sentence": "The results of a study of coadministration of ethambutol (50 mg/kg) with an @DRUG1$ containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6866,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., @DRUG1$, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG2$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6867,
        "sentence": "@DRUG1$ and @DRUG2$: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6868,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6869,
        "sentence": "Phospholine Iodide potentiates other @DRUG1$ such as succinylcholine or @DRUG2$s.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6870,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., @DRUG1$], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., @DRUG2$], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6871,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, @DRUG2$, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6872,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6873,
        "sentence": "Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (@DRUG1$ ) decreased @DRUG2$ AUC by 41% and cmax by 43%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6874,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6875,
        "sentence": "@DRUG1$: Co-administration of @DRUG2$ and bosentan has not been studied in man.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6876,
        "sentence": "@DRUG1$, @DRUG2$: intensified electrolyte depletion, particularly hypokalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6877,
        "sentence": "Reported examples of this interaction include the following: Immunosuppressives: Cyclosporine (@DRUG1$ substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of @DRUG2$ resulting in elevated creatinine, despite reduction in dose of cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6878,
        "sentence": "Protease Inhibitors: In vitro data indicate that indinavir and @DRUG1$ markedly inhibit the metabolism of @DRUG2$ which can result in an increase in plasma cisapride levels and prolongation of the QT interval on the ECG.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6879,
        "sentence": "@DRUG1$ therapy has not been associated with bleeding or with changes in prothrombin time in patients not taking @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6880,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to @DRUG1$ or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, @DRUG2$, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6881,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related @DRUG1$, @DRUG2$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6882,
        "sentence": "@DRUG1$ can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6883,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all @DRUG1$ (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, @DRUG2$ and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6884,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of diazepam, @DRUG1$, phenibut and amizyl and reduces the action of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6885,
        "sentence": "Approximately 2/3 of the patients in the Phase 3 study received either prophylactic low dose heparin (@DRUG1$ up to 15,000 units/day) or prophylactic doses of @DRUG2$ as indicated in the prescribing information for the specific products.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6886,
        "sentence": "Certain @DRUG1$, cisplatin, cyclosporine, @DRUG2$, foscarnet, and vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6887,
        "sentence": "@DRUG1$: Concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6888,
        "sentence": "Sirolimus works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6889,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6890,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG1$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6891,
        "sentence": "Administration of @DRUG1$ with antacids containing @DRUG2$, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6892,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG1$, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6893,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6894,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6895,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of haloperidol (0.25 mg/kg) and @DRUG1$ (0.25 mg/kg) resulted in the reduced interaction between @DRUG2$ and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6896,
        "sentence": "Immunosuppressive Drugs, @DRUG1$, Niacin (Nicotinic Acid, Erythromycin, @DRUG2$: Skeletal Muscle.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6897,
        "sentence": "Because of the low dietary cobalt concentration as compared to the iron contents of the diets, no effect of @DRUG1$ on @DRUG2$ absorption and excretion occurred.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6898,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6899,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6900,
        "sentence": "Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other @DRUG1$ (including alcohol) concomitantly with hydrocodone and @DRUG2$ tablets may exhibit an additive CNS depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6901,
        "sentence": "Co-administration of CYP3A4 inhibitors (eg, ketoconazole, @DRUG1$, @DRUG2$, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6902,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as @DRUG1$, foscarnet, and aminoglycosides may increase the risk of developing peripheral neuropathy or other @DRUG2$-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6903,
        "sentence": "@DRUG1$ tablets may alter the metabolism of cyclosporine, @DRUG2$, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6904,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, @DRUG2$, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6905,
        "sentence": "@DRUG1$: @DRUG2$, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6906,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, @DRUG2$, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6907,
        "sentence": "@DRUG1$: Chlorpropamides plasma half-life may be prolonged by @DRUG2$, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6908,
        "sentence": "A case report of one patient taking @DRUG1$ 200 mg and indinavir 800 mg three times a day resulted in increases in @DRUG2$ concentrations from 0.9 mg/L to 1.3 mg/L.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6909,
        "sentence": "- a @DRUG1$ such as @DRUG2$ (Inderal), atenolol (Tenormin), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6910,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (@DRUG1$, @DRUG2$, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6911,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, @DRUG1$, glyceryl trinitrate, isosorbide dinitrate, morphine, @DRUG2$, heparin, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6912,
        "sentence": "Rifampin: Rifampin increases the metabolism of @DRUG1$ and some @DRUG2$ (norethindrone) resulting in decreased contraceptive effectiveness and increased menstrual irregularities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6913,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (Tenormin), @DRUG1$ (Sectral), metoprolol (@DRUG2$), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6914,
        "sentence": "Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some @DRUG1$ and other drugs that are highly protein bound, salicylates, @DRUG2$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6915,
        "sentence": "Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, quinidine, @DRUG1$, or @DRUG2$) can inhibit aripiprazole elimination and cause increased blood levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6916,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG2$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6917,
        "sentence": "In normal volunteers receiving @DRUG1$, the administration of @DRUG2$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6918,
        "sentence": "@DRUG1$: A recent case study has shown a possible increase in the plasma level of @DRUG2$ when co administered with isoniazid.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6919,
        "sentence": "No dose adjustment is necessary when @DRUG1$ is added to triple-immunosuppression regimens including cyclosporine, @DRUG2$, and either azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6920,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, alfentanil, cisapride, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6921,
        "sentence": "@DRUG1$ requirements (i.e., @DRUG2$) may be altered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6922,
        "sentence": "Amphotericin, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, @DRUG1$, and @DRUG2$ may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6923,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: @DRUG1$, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, @DRUG2$, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6924,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with @DRUG2$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6925,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with @DRUG2$ may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6926,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, @DRUG1$, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6927,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), @DRUG2$, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6928,
        "sentence": "Concomitant administration of an aluminum-containing @DRUG1$ had no significant effect in the bioavailability of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6929,
        "sentence": "The behavioral effects of the stereoisomers of @DRUG1$ (NANM) were compared with those of phencyclidine (@DRUG2$) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6930,
        "sentence": "No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered @DRUG1$/@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6931,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, @DRUG1$(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6932,
        "sentence": "Clinical studies in healthy volunteers show that the pharmacokinetics of @DRUG1$ are not altered by itraconazole, amphotericin B, mycophenolate, nelfinavir, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6933,
        "sentence": "cimetidine) and many that are substrates for P450 2D6 (many other @DRUG1$, @DRUG2$, and the Type 1C antiarrhythmics propafenone and flecainide).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6934,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, pyrilamine, phenyltoloxamine, @DRUG1$, @DRUG2$, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6935,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG1$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6936,
        "sentence": "Oral Anticoagulants Interaction studies with warfarin and @DRUG1$ failed to identify any clinically important effects on the serum concentrations or clinical effects of these @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6937,
        "sentence": "As with other agents with b-blocking properties, if @DRUG1$ is to be administered orally with calcium channel blockers of the verapamil or @DRUG2$ type, it is recommended that ECG and blood pressure be monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6938,
        "sentence": "- a beta-blocker such as @DRUG1$ (Inderal), atenolol (@DRUG2$), acebutolol (Sectral), metoprolol (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6939,
        "sentence": "Thus, when ibuprofen and @DRUG1$ are administered concurrently, subjects should be observed carefully for signs of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6940,
        "sentence": "Drugs which induce CYP3A4 activity (eg, phenobarbital, @DRUG1$, rifabutin) would be expected to increase the clearance of @DRUG2$ resulting in lowered plasma concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6941,
        "sentence": "@DRUG1$ and @DRUG2$, by decreasing gut motility, may increase digoxin absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6942,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, @DRUG2$, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6943,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6944,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, @DRUG1$, sulfinpyrazone, oral contraceptives, @DRUG2$, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6945,
        "sentence": "@DRUG1$ and sucralfate: @DRUG2$ and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6946,
        "sentence": "Heparin: Since @DRUG1$ is contraindicated in patients with heparin-induced thrombocytopenia, the co-administration of Argatroban and @DRUG2$ is unlikely for this indication.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6947,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6948,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], @DRUG2$ [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6949,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, @DRUG2$, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6950,
        "sentence": "The vasodilating effects of @DRUG1$ may be additive with those of other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6951,
        "sentence": "Interactions with Other CNS Agents: Concurrent use of @DRUG1$ with all central nervous system depressants (eg, alcohol, sedatives, @DRUG2$, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6952,
        "sentence": "Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 @DRUG1$ interferes with the action of @DRUG2$ preparations by chelating the zinc. 7",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 6953,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: @DRUG1$, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6954,
        "sentence": "Patients who are treated with @DRUG1$ and concomitant @DRUG2$ should be closely observed for signs and symptoms of serotonin syndrome (e.g., cognitive dysfunction, hyperpyrexia, hyperreflexia, incoordination).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6955,
        "sentence": "Antacid: When atorvastatin and @DRUG1$ suspension were coadministered, plasma concentrations of @DRUG2$ decreased approximately 35%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6956,
        "sentence": "The effects @DRUG1$ on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, @DRUG2$, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6957,
        "sentence": "Drugs that inhibit cytochrome P450IID6, such as @DRUG1$ , might increase the plasma concentrations of flecainide in patients that are on chronic @DRUG2$ therapy;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6958,
        "sentence": "Effects of other Antiepilepsy Drugs (@DRUG1$) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6959,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other @DRUG1$, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, @DRUG2$, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6960,
        "sentence": "@DRUG1$: Co-administration of a single dose of intravenously administered famotidine (20 mg) reduced the oral absorption of a single 400 mg dose of @DRUG2$ administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6961,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, @DRUG1$, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6962,
        "sentence": "Because @DRUG1$ is coadministered, prescribers should also refer to the prescribing information for @DRUG2$ regarding drug interactions associated with this agent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6963,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as isocarboxazid (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., @DRUG1$), @DRUG2$ (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6964,
        "sentence": "No significant interactions with @DRUG1$, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, @DRUG2$, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6965,
        "sentence": "@DRUG1$, Foscarnet, and Aminoglycosides: Drugs such as amphotericin, @DRUG2$, and aminoglycosides may increase the risk of developing peripheral neuropathy or other HIVID-associated adverse events by interfering with the renal clearance of zalcitabine (thereby raising systemic exposure).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6966,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG1$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6967,
        "sentence": "Anticoagulants, oral: Co-administration of corticosteroids and @DRUG1$ usually results in inhibition of response to @DRUG2$, although there have been some conflicting reports.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6968,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, @DRUG1$, phenytoin, alfentanil, @DRUG2$, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6969,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the @DRUG1$, monoamine oxidase inhibitors and the @DRUG2$, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6970,
        "sentence": "Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, pyrilamine, @DRUG1$, promethazine, @DRUG2$, and tripelennamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6971,
        "sentence": "The concomitant use of transdermal fentanyl with @DRUG1$ or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, @DRUG2$, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6972,
        "sentence": "Oral Anticoagulants: In some normal volunteers, the concomitant administration of diflunisal and @DRUG1$, @DRUG2$, or phenprocoumon resulted in prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6973,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG2$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6974,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6975,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG1$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (@DRUG2$ may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6976,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG1$, grapefruit juice, @DRUG2$, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6977,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, @DRUG1$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6978,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], @DRUG1$ [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6979,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or @DRUG1$, with @DRUG2$, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6980,
        "sentence": "Inhibitors of CYP2D6: Because CYP2D6 is involved in @DRUG1$ metabolism, concomitant use of duloxetine with potent inhibitors of CYP2D6 may result in higher concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6981,
        "sentence": "Warfarin: Multiple oral doses of @DRUG1$ (20 mg q24h for 13 days) did not affect the pharmacokinetics of @DRUG2$ (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6982,
        "sentence": "Concomitant administration of @DRUG1$ with the oral anticoagulant @DRUG2$ has been shown not to potentiate the anticoagulant effect of warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6983,
        "sentence": "The concurrent administration of @DRUG1$ and ampicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6984,
        "sentence": "Warfarin, Digoxin, @DRUG1$, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when @DRUG2$ plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6985,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, @DRUG-DRUG$, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6986,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, @DRUG1$, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, @DRUG2$, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6987,
        "sentence": "Tablets: The benzodiazepines, including @DRUG1$, produce CNS-depressant effects when administered with such medications as barbiturates or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6988,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6989,
        "sentence": "The appropriate dose for @DRUG1$ incombination with @DRUG2$, with respectto safety and efficacy, has not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6990,
        "sentence": "In clinical studies, coadministration of @DRUG1$  with @DRUG2$, lovastatin, or simvastatin did not interfere with the lipid-lowering activity of the HMG-CoA reductase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6991,
        "sentence": "It is, however, possible that concomitant use of other known @DRUG1$ such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the @DRUG2$ for Topical Solution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6992,
        "sentence": "Concomitant use of @DRUG1$ and other @DRUG2$ is generally not recommended because of possible potentiating effects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 6993,
        "sentence": "The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, @DRUG1$, methotrexate, phenytoin, tolbutamide, and @DRUG2$ have been studied in vivo and clinically important interactions have not been found.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6994,
        "sentence": "Although there was no effect of @DRUG1$ on the plasma AUC of R(+) or @DRUG2$ determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6995,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, @DRUG1$, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6996,
        "sentence": "These in vitro studies suggest that concomitant administration of @DRUG1$ and @DRUG2$ in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine, which may lead to a decreased antiretroviral effect of zalcitabine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 6997,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with @DRUG2$ may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6998,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, @DRUG1$, chloral hydrate, diazepam, @DRUG2$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6999,
        "sentence": "The concurrent use of Robinul Injection with other @DRUG1$ or medications with anticholinergic activity, such as @DRUG2$, antiparkinson drugs, or tricyclic antidepressants, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7000,
        "sentence": "@DRUG1$ midazolam, @DRUG2$ cisapride ergot derivatives voriconazole",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7001,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, @DRUG1$, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7002,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), @DRUG1$ (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with @DRUG2$ may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7003,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG1$, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7004,
        "sentence": "Paroxetine: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7005,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, @DRUG2$, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7006,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, @DRUG1$, methotrexate, famotidine, furosemide, @DRUG2$ agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7007,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, @DRUG1$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7008,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other @DRUG1$ (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7009,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG2$, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7010,
        "sentence": "The concurrent use of Robinul Injection with other anticholinergics or medications with anticholinergic activity, such as @DRUG1$, @DRUG2$, or tricyclic antidepressants, may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7011,
        "sentence": "Increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased @DRUG1$ metabolism due to @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7012,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7013,
        "sentence": "@DRUG1$: In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term @DRUG2$ therapy (eg, phenytoin, carbamazepine, or phenobarbital) than in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7014,
        "sentence": "@DRUG1$ midazolam, triazolam cisapride ergot derivatives @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7015,
        "sentence": "@DRUG1$ at 648 mg bid decreased the bioavailability (AUC) of @DRUG2$ by 26%, but not the peak concentration.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7016,
        "sentence": "Ethanol or @DRUG1$: No significant differences were observed in the pharmacokinetics of @DRUG2$ (0.125 mg) and tiagabine (10 mg) when given together as a single dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7017,
        "sentence": "These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an @DRUG1$-sensitive (N-type) channel, an @DRUG2$-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7018,
        "sentence": "@DRUG1$ (spironolactone, amiloride, triamterene, and others) or @DRUG2$ supplements can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7019,
        "sentence": "In @DRUG1$ clinical trials, patients who were receiving @DRUG2$ concurrently did not experience an increased incidence of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7020,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG1$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7021,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG1$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7022,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of @DRUG1$ other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and @DRUG2$, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7023,
        "sentence": "@DRUG1$: amphotericin B-induced hypokalemia may enhance the curariform effect of @DRUG2$ (e.g., tubocurarine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7024,
        "sentence": "Aspirin: @DRUG1$ can be used with low dose @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7025,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7026,
        "sentence": "Patients taking @DRUG1$ may not benefit from @DRUG2$ containing medicines, such as cough and cold preparations, antidiarrheal preparations, and opioid analgesics.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7027,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, @DRUG1$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7028,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, @DRUG2$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7029,
        "sentence": "Concomitant use of @DRUG1$ with alcohol, tricyclic antidepressants, barbiturates, or other @DRUG2$ may have an additive effect.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7030,
        "sentence": "Limited clinical experience indicates that requirements for @DRUG1$ are reduced by 30 to 50% for the first sixty (60) minutes following ALFENTA induction The concomitant use of erythromycin with @DRUG2$ can significantly inhibit ALFENTA clearance and may increase the risk of prolonged or delayed respiratory depression.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7031,
        "sentence": "The effect of @DRUG1$ on the pharmacokinetics of @DRUG2$ was not evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7032,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7033,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, @DRUG2$, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7034,
        "sentence": "The behavioral effects of the stereoisomers of @DRUG1$ (@DRUG2$) were compared with those of phencyclidine (PCP) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7035,
        "sentence": "@DRUG1$ (carbamazepine, felbamate, phenobarbital, @DRUG2$, topiramate): Increase the metabolism of ethinyl estradiol and/or some progestins, leading to possible decrease in contraceptive effectiveness.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7036,
        "sentence": "astemizole @DRUG1$, triazolam @DRUG2$ ergot derivatives voriconazole",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7037,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7038,
        "sentence": "Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG1$ (concurrent use with @DRUG2$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7039,
        "sentence": "Other CYP3A4 inducers include, but are not limited to, rifabutin, @DRUG1$, @DRUG2$, carbamazepine, phenobarbital and St. Johns Wort.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7040,
        "sentence": "Twelve strains of Staphylococcus aureus (a frequent cause of infection in @DRUG1$, but not in @DRUG2$ and tripelennamine, addicts) were completely inhibited by the drug combination.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7041,
        "sentence": "Oral Anticoagulants: In some normal volunteers, the concomitant administration of @DRUG1$ and warfarin, @DRUG2$, or phenprocoumon resulted in prolongation of prothrombin time.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7042,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (@DRUG1$) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, @DRUG2$, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7043,
        "sentence": "Coadministration of SULAR with @DRUG1$ or any known CYP3A4 inducer should be avoided and alternative @DRUG2$ therapy should be considered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7044,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, @DRUG2$, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7045,
        "sentence": "@DRUG1$ or H 2 receptor antagonists: When dirithromycin is administered immediately following antacids or @DRUG2$, the absorption of dirithromycin is slightly enhanced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7046,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG2$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7047,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, @DRUG1$, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, @DRUG2$, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7048,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, @DRUG1$, propanolol, @DRUG2$, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7049,
        "sentence": "In patients on chronic @DRUG1$ therapy, the prothrombin time (INR) should be closely monitored in the 2-week period, particularly at 7 to 10 days, following initiation of the 3-day regimen of @DRUG2$ with each chemotherapy cycle.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7050,
        "sentence": "@DRUG1$: Aerosol @DRUG2$ of the short-acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using formoterol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7051,
        "sentence": "In vitro interaction of @DRUG1$ and @DRUG2$ in placental vessels.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 7052,
        "sentence": "[The GABA-ergic system and brain edema]  It has been shown in rats with experimental toxic and traumatic edemas that picrotoxin (1 mg/kg) removes the antiedematous action of diazepam, @DRUG1$, phenibut and @DRUG2$ and reduces the action of phentolamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7053,
        "sentence": "The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, @DRUG1$, @DRUG2$, and nefazadone may result in an increase in fentanyl plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7054,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, @DRUG1$, grapefruit juice, nefazadone, norfloxacin, quinine, @DRUG2$) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7055,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, @DRUG1$, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7056,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, @DRUG2$, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7057,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG1$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7058,
        "sentence": "These in vitro studies suggest that concomitant administration of zalcitabine and @DRUG1$ in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine, which may lead to a decreased antiretroviral effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7059,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as @DRUG1$ (@DRUG2$) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7060,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, @DRUG1$, cyclosporin, delavirdine, desipramine, diazepam, @DRUG2$, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7061,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, @DRUG2$, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7062,
        "sentence": "The objective of this study was to determine if there is a pharmacokinetic interaction when @DRUG1$ is given with @DRUG2$ or rifampin and to determine the effects of these drugs on the erythromycin breath test (ERMBT).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7063,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, @DRUG2$, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7064,
        "sentence": "Glibenclamide: In a study of 7 healthy male volunteers, @DRUG1$ treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to @DRUG2$) in 3 of the 7 subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7065,
        "sentence": "@DRUG1$, Digoxin, @DRUG2$, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7066,
        "sentence": "Drug-Drug Interactions Albuterol - @DRUG1$ should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other @DRUG2$) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7067,
        "sentence": "Additive depressant effect when used with general @DRUG1$, @DRUG2$, antianxiety drugs, hypnotics, alcohol, and other opiate analgesics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7068,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, @DRUG1$, cisapride, disopyramide, @DRUG2$, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7069,
        "sentence": "Two different types of therapy with magnesium are used: physiological oral magnesium supplementation which is totally atoxic since it palliates @DRUG1$ deficiencies by simply normalizing the magnesium intake and pharmacological magnesium therapy which may induce toxicity since it creates iatrogenic @DRUG2$ overload.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7070,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, @DRUG1$, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously coadministered with @DRUG2$ as they can potentially increase dofetilide levels.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7071,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7072,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), @DRUG1$, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, @DRUG2$, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7073,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7074,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7075,
        "sentence": "Co-administration of @DRUG1$ and @DRUG2$ resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7076,
        "sentence": "and calcium channel antagonists e.g., @DRUG1$), CYP1A2 inducers (omeprazole) and CYP1A2 inhibitors (furafylline and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7077,
        "sentence": "The safety of using @DRUG1$ and IMITREX (@DRUG2$) Nasal Spray during the same episode of migraine has not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7078,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., @DRUG2$), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., Parnate): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7079,
        "sentence": "Inhibitors or substrates of CYP2D6 (i.e., quinidine, @DRUG1$ [@DRUG2$]) may increase the plasma concentration of doxepin when administered concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7080,
        "sentence": "Concomitant treatment with @DRUG1$ (aminophylline, theophylline), @DRUG2$, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7081,
        "sentence": "There have been reports of interactions of erythromycin with carbamazepine, @DRUG1$, @DRUG2$, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and astemizole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7082,
        "sentence": "In addition, neuromuscular blocking action is enhanced by general anesthetics, local anesthetics like @DRUG1$, procaine, beta-blockers, @DRUG2$, lithium carbonate, and terbutaline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7083,
        "sentence": "Pharmacokinetic interaction studies with cetirizine in adults were conducted with @DRUG1$, antipyrine, ketoconazole, @DRUG2$ and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7084,
        "sentence": "@DRUG1$:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of @DRUG2$ and ethanol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7085,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, @DRUG1$, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7086,
        "sentence": "Concomitant use of @DRUG1$ with @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7087,
        "sentence": "Binding to plasma proteins is reduced by @DRUG1$ and clotibrate and increased by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7088,
        "sentence": "However, coadministration of @DRUG1$ (20 mg) and @DRUG2$ (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of escitalopram.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7089,
        "sentence": "Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, @DRUG1$, carbamazepine, and @DRUG2$ (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7090,
        "sentence": "In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propanolol, @DRUG1$, @DRUG2$, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7091,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, @DRUG2$, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7092,
        "sentence": "SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER @DRUG1$ @DRUG2$ (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7093,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7094,
        "sentence": "Probenecid: Concomitant administration of TORADOL ORAL and @DRUG1$ resulted in decreased clearance of @DRUG2$ and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7095,
        "sentence": "When ertapenem is co-administered with @DRUG1$ (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7096,
        "sentence": "- a beta-blocker such as propranolol (Inderal), atenolol (Tenormin), @DRUG1$ (Sectral), @DRUG2$ (Lopressor), and others;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7097,
        "sentence": "Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG1$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7098,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], @DRUG1$ [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], @DRUG2$ [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7099,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of @DRUG1$ due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, @DRUG2$, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7100,
        "sentence": "The administration of local @DRUG1$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG2$ may produce severe, prolonged hypertension.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7101,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG1$, fluconazole, lamivudine, lorazepam, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7102,
        "sentence": "Ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of Innovar, @DRUG1$, or droperidol but not after administration of fentayl alone or after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7103,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as @DRUG1$, terfenadine, ketoconazole, erythromycin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7104,
        "sentence": "@DRUG1$ with desipramine or @DRUG2$ and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7105,
        "sentence": "@DRUG1$ and ketoconazole should not beadministered concomitantly becausedecreases in @DRUG2$ plasmaconcentrations may reduce the efficacy of the drug.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7106,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7107,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG1$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., @DRUG2$]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7108,
        "sentence": "@DRUG1$: Increased serum @DRUG2$ levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7109,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, @DRUG2$, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7110,
        "sentence": "May interact with addictive medications, especially @DRUG1$ with habituating potential (prolonged concurrent use may increase the risk of habituation), alcohol or CNS depression producing medications (concurrent use may increase the CNS depressant effects of either these medications or @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7111,
        "sentence": "Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, @DRUG1$, @DRUG2$, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7112,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), @DRUG1$ (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, @DRUG2$ (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7113,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG2$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7114,
        "sentence": "In this study we investigated the effect of ginsenosides on high threshold voltage-dependent Ca(2+) channel subtypes using their selective Ca(2+) channel blockers @DRUG1$ (L-type), @DRUG2$ (N-type), or omega-agatoxin IVA (P-type) in bovine chromaffin cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7115,
        "sentence": "Since @DRUG1$ (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate @DRUG2$ serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7116,
        "sentence": "Reported examples of this interaction include the following: @DRUG1$: Rifampin is a potent inducer of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7117,
        "sentence": "The authors examined the effect of the cyclooxygenase-2 (COX-2) inhibitor, @DRUG1$, at steady state on the pharmacokinetics of @DRUG2$ following a single dose in healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7118,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, @DRUG1$, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, @DRUG2$, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7119,
        "sentence": "therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, @DRUG1$) may result in reduced plasma concentrations of @DRUG2$ that may result in decreased efficacy of Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7120,
        "sentence": "- @DRUG1$ (e.g., @DRUG2$) (with long-term, high-dose use) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7121,
        "sentence": "Administration of quinolones with antacids containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as iron, or with @DRUG1$ containing iron or @DRUG2$, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7122,
        "sentence": "Tablets: The @DRUG1$, including lorazepam, produce CNS-depressant effects when administered with such medications as barbiturates or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7123,
        "sentence": "@DRUG1$ (5-35 micromol/l) induced concentration-dependent relaxation of mesenteric arteries preconstricted with noradrenaline (8 micromol/l) or @DRUG2$ (125 mmol/l) from both lean and dietary-obese rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7124,
        "sentence": "SINCE @DRUG1$ @DRUG2$ MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7125,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., @DRUG1$], promazine [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7126,
        "sentence": "[Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics]  It has been established in experiments on white male rats that prolonged administration (twice a day for 14 days) of @DRUG1$ (0.25 mg/kg) and @DRUG2$ (0.25 mg/kg) resulted in the reduced interaction between 3H-spiroperidol and low affinity binding sites for apomorphine in subcortical structures, whereas 3H-spiroperidol binding with high affinity binding sites for apomorphine increased both in the frontal cortex and subcortical structures of the forebrain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7127,
        "sentence": "In patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent @DRUG1$ therapy, discontinuation of @DRUG2$ has been reported to decrease established steady-state serum tricyclic antidepressant levels and compromise their therapeutic effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7128,
        "sentence": "THE POTENTIATING ACTION OF @DRUG1$ MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS, NON-NARCOTIC ANALGESICS AND @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7129,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving @DRUG1$ metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, @DRUG2$ such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7130,
        "sentence": "Use of @DRUG1$ in a patient who has previously received @DRUG2$ increases the risk of cardiotoxicity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7131,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, @DRUG1$ agents, @DRUG2$, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7132,
        "sentence": "In controlled clinical trials, however, @DRUG1$ including @DRUG2$ were concurrently administered with felodipine and were well tolerated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7133,
        "sentence": "@DRUG1$ (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7134,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, @DRUG1$, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, @DRUG2$, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7135,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, @DRUG1$, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, @DRUG2$, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7136,
        "sentence": "@DRUG1$, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7137,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, @DRUG2$, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7138,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, @DRUG1$ and related anabolic hormones, complex anions (@DRUG2$, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7139,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG1$ [e.g., Sparine], promethazine [e.g., @DRUG2$], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7140,
        "sentence": "@DRUG1$s: After repeated co-administration of Trileptal, the AUC of @DRUG2$ was lowered by 28% [90% CI: 20-33].",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7141,
        "sentence": "Antacids and sucralfate: Sucralfate and @DRUG1$ containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as @DRUG2$  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7142,
        "sentence": "These include @DRUG1$, cholestyramine, and some antibiotics (e.g. erythromycin, rifamipicin, @DRUG2$ and chloramphenicol).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7143,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, @DRUG1$, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, @DRUG2$, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7144,
        "sentence": "On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, @DRUG1$, @DRUG2$, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7145,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, @DRUG1$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, @DRUG2$, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7146,
        "sentence": "Cisapride should not be used concomitantly with other drugs known to prolong the QT interval: certain antiarrhythmics, including those of Class IA (such as quinidine and @DRUG1$) and Class III (such as @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7147,
        "sentence": "The anxiogenic effects of @DRUG1$ were reduced by pretreatment with @DRUG2$, an A2-selective agonist, but not by N6-cyclopentyladenosine (CPA), an A1-selective agonist.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7148,
        "sentence": "In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce, inhibit, or are metabolized by cytochrome P450 3A4, such as cyclosporine, @DRUG1$, ketoconazole, @DRUG2$, and troleandomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7149,
        "sentence": "While the effects of chronic @DRUG1$ or carbamazepine therapy on the action of @DRUG2$ are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7150,
        "sentence": "@DRUG1$ and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as @DRUG2$  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7151,
        "sentence": "- @DRUG1$ (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., @DRUG2$], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7152,
        "sentence": "Tissue culture and animal studies indicate that @DRUG1$ can diminish or abolish the effect of methotrexate on malignant cells.14 This effect on @DRUG2$ activity persists as long as plasma asparagine levels are suppressed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7153,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG1$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], @DRUG2$ [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7154,
        "sentence": "Antacid: When @DRUG1$ and @DRUG2$ suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7155,
        "sentence": "Erythromycin has been reported to significantly alter the metabolism of nonsedating @DRUG1$ @DRUG2$ and astemizole when taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7156,
        "sentence": "Since @DRUG1$ (@DRUG2$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7157,
        "sentence": "@DRUG1$ : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, @DRUG2$, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7158,
        "sentence": "Serum @DRUG1$ concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, antibiotics (@DRUG2$ or ciprofloxacin) and aminosalicylates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7159,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, @DRUG1$, pertechnetate), antithyroid drugs, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7160,
        "sentence": "Antacids and sucralfate: @DRUG1$ and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with @DRUG2$ and interfere with its bioavailability.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7161,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, @DRUG1$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG2$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7162,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, @DRUG1$, @DRUG2$, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7163,
        "sentence": "@DRUG1$ levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and @DRUG2$ dose should be adjusted accordingly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7164,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including @DRUG1$, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG2$, protamine, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7165,
        "sentence": "@DRUG1$ and Celexa - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic @DRUG2$ 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7166,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7167,
        "sentence": "Although there was no effect of Aprepitant on the plasma AUC of R(+) or @DRUG1$ determined on Day 3, there was a 34% decrease in @DRUG2$ (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7168,
        "sentence": "In a parallel group drug interaction study comparing the intravenous prodrug form of valdecoxib at 40 mg BID (n=10) vs placebo (n=9), @DRUG1$ had no effect on in vitro @DRUG2$-mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7169,
        "sentence": "Administration of quinolones with @DRUG1$ containing aluminum, magnesium, or calcium, with sucralfate, with metal cations such as @DRUG2$, or with multivitamins containing iron or zinc, or with formulations containing divalent and trivalent cations such as VIDEX (didanosine) chewable/buffered tablets or the pediatric powder for oral solution, may substantially interfere with the absorption of quinolones, resulting in systemic concentrations considerably lower than desired.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7170,
        "sentence": "Probenecid : @DRUG1$ is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG2$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7171,
        "sentence": "@DRUG1$ is considered to be a non-enzyme inducing @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7172,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], @DRUG2$ [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7173,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, @DRUG1$, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7174,
        "sentence": "Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when @DRUG1$ (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, @DRUG2$, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7175,
        "sentence": "Nevertheless, caution is indicated in the co-administration of @DRUG1$ with any of the @DRUG2$ and also in switching from one class to the other.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7176,
        "sentence": "Estazolam: Interaction with Drugs that Inhibit Metabolism via Cytochrome P450 3A (CYP3A): The metabolism of estazolam to the major circulating metabolite @DRUG1$ and the metabolism of other @DRUG2$ is catalyzed by CYP3A.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7177,
        "sentence": "Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of @DRUG1$  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of @DRUG2$ by blocking the vasodilating property of epinephrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7178,
        "sentence": "@DRUG1$ may also interfere with the absorption of oral phosphate supplements and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7179,
        "sentence": "No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral @DRUG1$, @DRUG2$, or warfarin have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7180,
        "sentence": "Pharmacokinetic interaction studies with @DRUG1$ in adults were conducted with pseudoephedrine, antipyrine, @DRUG2$, erythromycin and azithromycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7181,
        "sentence": "Drug interaction studies with SUSTIVA and these @DRUG-DRUG$ have not been conducted.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7182,
        "sentence": "@DRUG1$: Coadministration of @DRUG2$ with VIRACEPT resulted in a 35% increase in nelfinavir plasma A.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7183,
        "sentence": "Coadministration of @DRUG1$ with @DRUG2$ or any known CYP3A4 inducer should be avoided and alternative antihypertensive therapy should be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7184,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, clindamycin, clofibrate, methyldopa, @DRUG2$ (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7185,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, @DRUG1$, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7186,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral @DRUG1$(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7187,
        "sentence": "The interaction of @DRUG1$ and synthetic @DRUG2$ on placental vessels was studied in vitro.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7188,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, @DRUG1$, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7189,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, @DRUG1$, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, @DRUG2$, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7190,
        "sentence": "In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to @DRUG1$ given concomitantly with @DRUG2$, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7191,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, @DRUG1$, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, @DRUG2$, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7192,
        "sentence": "Effects of other Antiepilepsy Drugs (@DRUG1$) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that @DRUG2$ clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7193,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG1$, @DRUG2$, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7194,
        "sentence": "- Phenothiazines (acetophenazine [e.g., @DRUG1$], chlorpromazine [e.g., Thorazine], fluphenazine [e.g., Prolixin], @DRUG2$ [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7195,
        "sentence": "@DRUG1$: Some @DRUG2$ may increase the concentration of digitalis preparations in the blood.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7196,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine @DRUG1$ of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. @DRUG2$), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7197,
        "sentence": "@DRUG1$ may add to or potentiate the action of other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7198,
        "sentence": "Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by @DRUG1$, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, @DRUG2$ and the tricyclic antidepressants, and by other anticonvulsant drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7199,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7200,
        "sentence": "Warfarin, Digoxin, @DRUG1$, and @DRUG2$ The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7201,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, @DRUG1$, bupropion, buspirone, citalopram, @DRUG2$, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7202,
        "sentence": "Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with @DRUG1$ for the following: @DRUG2$, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 7203,
        "sentence": "Anesthetics/@DRUG1$/Hypnotics/Opioids: Co-administration of PRECEDEX with @DRUG2$, sedatives, hypnotics, and opioids is likely to lead to an enhancement of effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7204,
        "sentence": "@DRUG1$, oral: Co-administration of @DRUG2$ and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7205,
        "sentence": "@DRUG1$ should not be administered concomitantly with potent loop diuretics such as @DRUG2$ and ethacrynic acid as the potential for ototoxicity is enhanced by the combination.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7206,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, @DRUG1$, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG2$, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7207,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, @DRUG1$, clobazam, @DRUG2$, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7208,
        "sentence": "Antacids and sucralfate: Sucralfate and antacids containing magnesium or @DRUG1$, as well as formulations containing divalent and trivalent cations such as @DRUG2$  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7209,
        "sentence": "In addition, studies in healthy volunteers have shown that @DRUG1$ does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of propranolol (40 mg twice daily), phenytoin, theophylline, or oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7210,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, @DRUG1$, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, @DRUG2$, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7211,
        "sentence": "Monoamine oxidase (MAO) inhibitors such as @DRUG1$ (e.g., Marplan), phenelzine (e.g., Nardil), procarbazine (e.g., Matulane), selegiline (e.g., Eldepryl), and tranylcypromine (e.g., @DRUG2$): Using these medicines with L-tryptophan may increase the chance of side effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7212,
        "sentence": "Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, @DRUG1$, @DRUG2$, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7213,
        "sentence": "Concurrent use of butorphanol with @DRUG1$ (e.g., alcohol, barbiturates, tranquilizers, and @DRUG2$) may result in increased central nervous system depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7214,
        "sentence": "Digoxin: Coadministration of digoxin, a P-glycoprotein substrate, with oral @DRUG1$ resulted in a reduction in clearance and an increase in @DRUG2$ Cmax and AUC values.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7215,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, @DRUG1$, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), @DRUG2$, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7216,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., @DRUG1$], fluphenazine [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., @DRUG2$], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], trimeprazine [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7217,
        "sentence": "Leukocyte transfusions: acute pulmonary toxicity has been reported in patients receiving intravenous @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 7218,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, @DRUG1$ and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, @DRUG2$, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7219,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, @DRUG1$, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , @DRUG2$, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7220,
        "sentence": "Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (@DRUG1$s), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), @DRUG2$, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7221,
        "sentence": "There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, @DRUG1$, @DRUG2$, potassium chloride, folic acid, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7222,
        "sentence": "Loop Diuretics: Furosemide administered concurrently with @DRUG1$ does not alter the pharmacokinetics of @DRUG2$ in renally impaired hypertensive patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7223,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, @DRUG1$, somatostatin analogs, sulfonamides, sulfonylureas, @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7224,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, @DRUG1$, diazepam, dicumarol, doxycycline, @DRUG2$, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7225,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), @DRUG1$ @DRUG2$ (e.g. phenothiazines), benzodiazepines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7226,
        "sentence": "@DRUG1$: When coadministered with MONUROL, @DRUG2$, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7227,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, @DRUG1$, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, @DRUG2$, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7228,
        "sentence": "Concomitant single dose administration of valdecoxib 20 mg with multiple doses of @DRUG1$ and fluconazole produced a significant increase in exposure of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7229,
        "sentence": "No depressant effect on blood levels in humans was noted when @DRUG1$ was administered with any of the following drugs: aspirin, clindamycin, @DRUG2$, methyldopa, nicotinic acid (niacin), tolbutamide, phenytoin or warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7230,
        "sentence": "Inhibitors of this isoenzyme (e.g., @DRUG1$, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7231,
        "sentence": "There was no evidence of drug interactions in clinical studies in which @DRUG1$ was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, @DRUG2$, and acetaminophen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7232,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, @DRUG1$, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, @DRUG2$, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7233,
        "sentence": "Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, @DRUG1$, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, @DRUG2$, quinine, zafirlukast) should be cautiously coadministered with TIKOSYN as they can potentially increase dofetilide levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7234,
        "sentence": "Coadministration of oral contraceptives, diazepam, phenytoin, or @DRUG1$ did not seem to change the pharmacokinetic profile of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7235,
        "sentence": "- Phenothiazines (acetophenazine [e.g., Tindal], chlorpromazine [e.g., Thorazine], @DRUG1$ [e.g., Prolixin], mesoridazine [e.g., Serentil], perphenazine [e.g., Trilafon], prochlorperazine [e.g., Compazine], promazine [e.g., Sparine], promethazine [e.g., Phenergan], thioridazine [e.g., Mellaril], trifluoperazine [e.g., Stelazine], triflupromazine [e.g., Vesprin], @DRUG2$ [e.g., Temaril]) or",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7236,
        "sentence": "Because @DRUG1$ reduces the clearance of both @DRUG2$ and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 7237,
        "sentence": "Thus, when @DRUG1$ and @DRUG2$ are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 7238,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, @DRUG1$, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, @DRUG2$, warfarin(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7239,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, @DRUG1$), antithyroid drugs, @DRUG2$, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7240,
        "sentence": "There have been reports of interactions of erythromycin with @DRUG1$, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, bromocriptine, valproate, terfenadine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7241,
        "sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, @DRUG1$, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, @DRUG2$, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7242,
        "sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, @DRUG1$, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, @DRUG2$(5) , ziprasidone, and zonisamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7243,
        "sentence": "Concomitant treatment with methylxanthines (aminophylline, @DRUG1$), steroids, or @DRUG2$ may potentiate any hypokalemic effect of adrenergic agonists.",
        "answer": "none",
        "label": 4
    }
]